ontology,root,fragment,text,statements,llm_used
doid,http://purl.obolibrary.org/obo/DOID_0111452,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_myoclonus_epilepsy_1a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :unverricht_lundborg_syndrome ;
    :has_definition ""An Unverricht-Lundborg syndrome that has_material_basis_in homozygous or compound heterozygous in the CSTB gene on chromosome 21q22.3."" ;
    :has_exact_synonym ""EPM1A""@en .

","Progressive myoclonus epilepsy 1A (EPM1A) is a type of autosomal recessive disease and an Unverricht-Lundborg syndrome, which is characterized by a material basis in some autosomal recessive inheritance. This condition is defined by its association with homozygous or compound heterozygous mutations in the CSTB gene located on chromosome 21q22.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111453,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:2_aminoadipic_2_oxoadipic_aciduria rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :amino_acid_metabolic_disorder,
        :autosomal_recessive_disease ;
    :has_definition ""An amino acid metabolic disorder characterized by defects in L-lysine degradation resulting in variable neurological symptoms but in many cases patients are asymptomatic that has_material_basis_in homozygous or compound heterozygous mutation in the DHTKD1 gene on chromosome 10p14."" ;
    :has_exact_synonym ""AMOXAD""@en,
        ""alpha-aminoadipic aciduria""@en .

","2-Aminoadipic 2-oxoadipic aciduria is a type of autosomal recessive disease and an amino acid metabolic disorder that essentially has its material basis in autosomal recessive inheritance. It is characterized by defects in L-lysine degradation, which leads to variable neurological symptoms; however, many patients remain asymptomatic. This condition has its material basis in homozygous or compound heterozygous mutation in the DHTKD1 gene on chromosome 10p14. Furthermore, 2-aminoadipic 2-oxoadipic aciduria is exactly synonymous with AMOXAD and alpha-aminoadipic aciduria.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111454,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:short_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome of multiple anomalies whose name stands for short stature, hyperextensibility of joints, ocular depression, Rieger anomaly and teething delay which, along with mild intrauterine growth restriction, partial lipodystrophy, delayed bone age, hernias and progeroid appearance, that has_material_basis_in heterozygous mutation in the PIK3R1 gene on chromosome 5q13."" ;
    :has_exact_synonym ""Aarskog-Ose-Pande syndrome""@en,
        ""Lipodystrophy-Rieger anomaly-diabetes syndrome""@en,
        ""Rieger anomaly-partial lipodystrophy syndrome""@en,
        ""short stature, hyperextensibility, hernia, ocular depression, Rieger anomaly, and teething delay""@en .

","Short syndrome is a type of autosomal dominant disease and syndrome that has its material basis in some autosomal dominant inheritance. It is defined as a syndrome of multiple anomalies characterized by short stature, hyperextensibility of joints, ocular depression, Rieger anomaly, and teething delay, along with mild intrauterine growth restriction, partial lipodystrophy, delayed bone age, hernias, and a progeroid appearance. This condition is caused by a heterozygous mutation in the PIK3R1 gene on chromosome 5q13. Short syndrome is also known by its exact synonyms: Aarskog-Ose-Pande syndrome, Lipodystrophy-Rieger anomaly-diabetes syndrome, Rieger anomaly-partial lipodystrophy syndrome, and short stature, hyperextensibility, hernia, ocular depression, Rieger anomaly, and teething delay.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111455,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gracile_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :mitochondrial_metabolism_disease ;
    :has_definition ""A mitochondrial disorder characterized by fetal growth restriction, aminoaciduria, cholestasis, iron overload, lactocidosis, and early death that has_material_basis_in homozygous or compound heterozygous mutation in the BCS1L gene on chromosome 2q35."" ;
    :has_exact_synonym ""FLNMS""@en,
        ""Fellman disease""@en,
        ""Finnish lactic acidosis with hepatic hemosiderosis""@en,
        ""Finnish lethal neonatal metabolic syndrome""@en,
        ""growth delay-aminoaciduria-cholestasis-iron overload-lactic acidosis-early death syndrome""@en,
        ""growth restriction-aminoaciduria-cholestasis-iron overload-lactic acidosis-early death syndrome""@en,
        ""growth retardation, amino aciduria, cholestasis, iron overload, lactic acidosis, and early death""@en .

","Gracile syndrome is a type of disease that falls under both autosomal recessive and mitochondrial metabolism categories, indicating that it has a material basis in some autosomal recessive inheritance. It is defined as a mitochondrial disorder characterized by a series of symptoms including fetal growth restriction, aminoaciduria, cholestasis, iron overload, lactocidosis, and early death, which result from homozygous or compound heterozygous mutations in the BCS1L gene located on chromosome 2q35. Additionally, Gracile syndrome is known by several exact synonyms, including FLNMS (Finnish Lactic acidosis with hepatic hemosiderosis), Fellman disease, Finnish lethal neonatal metabolic syndrome, and a descriptive term that encompasses its main features: growth delay-aminoaciduria-cholestasis-iron overload-lactic acidosis-early death syndrome, also expressed as growth restriction-aminoaciduria-cholestasis-iron overload-lactic acidosis-early death syndrome, or succinctly as growth retardation, amino aciduria, cholestasis, iron overload, lactic acidosis, and early death.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111456,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kaufman_oculocerebrofacial_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :neurodevelopmental_delay ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndromic_intellectual_disability ;
    :has_definition ""A syndromic intellectual disability characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels that has_material_basis_in homozygous or compund heterozygous mutation in the UBE3B gene on chromosome 12q24.11."" ;
    :has_exact_synonym ""KOS""@en,
        ""blepharophimosis ptosis intellectual disability syndrome""@en,
        ""oculocerebrofacial syndrome, Kaufman type""@en .

","Kaufman oculocerebrofacial syndrome is a type of autosomal recessive disease and syndromic intellectual disability characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels. This condition has a material basis in homozygous or compound heterozygous mutation in the UBE3B gene on chromosome 12q24.11. It is also noted for having a phenotype that includes neurodevelopmental delay. Furthermore, Kaufman oculocerebrofacial syndrome has exact synonyms: KOS, blepharophimosis ptosis intellectual disability syndrome, and oculocerebrofacial syndrome, Kaufman type.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111457,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:sting_associated_vasculopathy_with_onset_in_infancy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :infantile_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :necrosis ],
        :autoimmune_disease_of_cardiovascular_system,
        :autosomal_dominant_disease ;
    :has_definition ""An autoimmune disease of the cardiovascular system characterized by onset in infancy of autoinflammatory vasculopathy causing severe skin lesions, particularly affecting the face, ears, nose, and digits, and resulting in ulceration, eschar formation, necrosis, and, in some cases, amputation that has_material_basis_in heterozygous gain of function mutation in the TMEM173 gene on chromosome 5q31."" ;
    :has_exact_synonym ""SAVI""@en .

","Sting associated vasculopathy with onset in infancy (SAVI) is a type of disease that is both autosomal dominant and an autoimmune disease of the cardiovascular system. It is characterized by autoinflammatory vasculopathy that leads to severe skin lesions, particularly affecting the face, ears, nose, and digits. This condition results in ulceration, eschar formation, necrosis, and, in some cases, amputation. The onset of SAVI occurs during infancy, and its development is at least partially due to a heterozygous gain of function mutation in the TMEM173 gene located on chromosome 5q31. This disease's manifestations include symptoms such as necrosis, and its genetic basis involves some form of autosomal dominant inheritance.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111458,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:galactose_epimerase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :galactosemia ;
    :has_definition ""A galactosemia that has_material_basis_in homozygous or compund heterozygous mutation in the GALE gene on chromosome 1p36.11."" ;
    :has_exact_synonym ""GALE deficiency""@en,
        ""GALE-D""@en,
        ""UDP-galactose-4-epimerase deficiency""@en,
        ""epimerase deficiency galactosemia""@en,
        ""galactosemia III""@en,
        ""galactosemia type 3""@en,
        ""uridine diphosphate galactose-4-epimerase deficiency""@en .

","Galactose epimerase deficiency is a type of autosomal recessive disease and a type of galactosemia, which at least has a material basis in some autosomal recessive inheritance. It is defined as a galactosemia that has a material basis in homozygous or compound heterozygous mutation in the GALE gene on chromosome 1p36.11. Galactose epimerase deficiency is also known by several exact synonyms, including GALE deficiency, GALE-D, UDP-galactose-4-epimerase deficiency, epimerase deficiency galactosemia, galactosemia III, galactosemia type 3, and uridine diphosphate galactose-4-epimerase deficiency.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111459,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:classic_galactosemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :galactosemia ;
    :has_definition ""A galactosemia that has_material_basis_in homozygous or compund heterozygous mutation in the GALT gene on chromosome 9p13.3."" ;
    :has_exact_synonym ""GALT deficiency""@en,
        ""galactose-1-phosphate uridyltransferase deficiency""@en,
        ""galactosemia type 1""@en .

","Classic galactosemia is a type of galactosemia and an autosomal recessive disease, which specifically has its material basis in autosomal recessive inheritance. It is defined as a galactosemia that has its material basis in homozygous or compound heterozygous mutation in the GALT gene on chromosome 9p13.3. Classic galactosemia is exactly synonymous with GALT deficiency, galactose-1-phosphate uridyltransferase deficiency, and galactosemia type 1.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111460,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cardiofaciocutaneous_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cardiofaciocutaneous_syndrome ;
    :has_definition ""A cardiofaciocutaneous syndrome that has_material_basis_in heterozygous mutation in the BRAF gene on chromosome 7q34."" ;
    :has_exact_synonym ""CFC1""@en .

","Cardiofaciocutaneous syndrome 1 is a type of autosomal dominant disease and a type of cardiofaciocutaneous syndrome, specifically something that at least has a material basis in some autosomal dominant inheritance. It is defined as a cardiofaciocutaneous syndrome that has its material basis in a heterozygous mutation in the BRAF gene on chromosome 7q34. Additionally, cardiofaciocutaneous syndrome 1 has the exact synonym CFC1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111461,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cardiofaciocutaneous_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cardiofaciocutaneous_syndrome ;
    :has_definition ""A cardiofaciocutaneous syndrome that has_material_basis_in heterozygous mutation in the KRAS gene on chromosome 12p12.1."" ;
    :has_exact_synonym ""CFC2""@en .

","Cardiofaciocutaneous syndrome 2, also known exactly as CFC2, is a type of autosomal dominant disease and a specific form of cardiofaciocutaneous syndrome. It is characterized by having a material basis in some form of autosomal dominant inheritance. Furthermore, the syndrome is defined by a heterozygous mutation in the KRAS gene located on chromosome 12p12.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111462,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cardiofaciocutaneous_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cardiofaciocutaneous_syndrome ;
    :has_definition ""A cardiofaciocutaneous syndrome that has_material_basis_in heterozygous mutation in the MAP2K1 gene on chromosome 15q22.31."" ;
    :has_exact_synonym ""CFC3""@en .

","Cardiofaciocutaneous syndrome 3 is a type of autosomal dominant disease and a specific type of cardiofaciocutaneous syndrome, characterized by having a material basis in autosomal dominant inheritance. It is defined as a cardiofaciocutaneous syndrome that originates from a heterozygous mutation in the MAP2K1 gene located on chromosome 15q22.31. Furthermore, cardiofaciocutaneous syndrome 3 is exactly synonymous with CFC3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111463,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cardiofaciocutaneous_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cardiofaciocutaneous_syndrome ;
    :has_definition ""A cardiofaciocutaneous syndrome that has_material_basis_in heterozygous mutation in the MAPK2K2 gene on chromosome 19p13.3."" ;
    :has_exact_synonym ""CFC4""@en .

",Cardiofaciocutaneous syndrome 4 (CFC4) is a subtype of cardiofaciocutaneous syndrome and an autosomal dominant disease. It is characterized by a specific type of inheritance that involves a material basis in autosomal dominant inheritance. The definition of cardiofaciocutaneous syndrome 4 includes it being a cardiofaciocutaneous syndrome that originates from a heterozygous mutation in the MAPK2K2 gene located on chromosome 19p13.3.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111464,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_35 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by global developmental delay with intellectual disability, microcephaly, and early-onset seizures that has_material_basis_in homozygous or compound heterozygous mutation in the TRIT1 gene on chromosome 1p34.2."" ;
    :has_exact_synonym ""COXPD35""@en .

","Combined oxidative phosphorylation deficiency 35 (COXPD35) is a form of autosomal recessive disease and a specific type of combined oxidative phosphorylation deficiency. It is characterized by a condition that inherently has a material basis in autosomal recessive inheritance. COXPD35 is defined as a combined oxidative phosphorylation deficiency that is marked by global developmental delay with intellectual disability, microcephaly, and early-onset seizures. This condition arises from homozygous or compound heterozygous mutation in the TRIT1 gene located on chromosome 1p34.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111465,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_21 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by axial hypotonia, limb hypertonia, psychomotor delay, and hyperlactatemia that has_material_basis_in homozygous or compound heterozygous mutation in the TARS2 gene on chromosome 1q21.2."" ;
    :has_exact_synonym ""COXPD21""@en .

","Combined Oxidative Phosphorylation Deficiency 21 (COXPD21) is a type of autosomal recessive disease, which also falls under the category of combined oxidative phosphorylation deficiencies. It is defined by conditions such as axial hypotonia, limb hypertonia, psychomotor delay, and hyperlactatemia. These symptoms are due to homozygous or compound heterozygous mutations in the TARS2 gene located on chromosome 1q21.2. Additionally, it is characterized as a condition that at least has a material basis in some autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111466,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_38 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the MRPS14 gene on chromosome 1q25.1."" ;
    :has_exact_synonym ""COXPD38""@en .

",Combined Oxidative Phosphorylation Deficiency 38 (COXPD38) is a specific type of autosomal recessive disease and falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by having a material basis in autosomal recessive inheritance. The definition of COXPD38 is that it is a combined oxidative phosphorylation deficiency which results from homozygous or compound heterozygous mutations in the MRPS14 gene located on chromosome 1q25.1.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111467,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by development of severe neurological impairment in the first months of life that has_material_basis_in homozygous or compound heterozygous mutation in the PNPT1 gene on chromosome 2p16.1."" ;
    :has_exact_synonym ""COXPD13""@en .

","Combined Oxidative Phosphorylation Deficiency 13 (COXPD13) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized by a severe neurological impairment that develops in the first months of life, which has its material basis in homozygous or compound heterozygous mutations in the PNPT1 gene located on chromosome 2p16.1. This condition is also known to be associated with autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111468,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_25 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the MARS2 gene on chromosome 2q33.1."" ;
    :has_exact_synonym ""COXPD25""@en .

","Combined Oxidative Phosphorylation Deficiency 25 (COXPD25) is a type of autosomal recessive disease and falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by a material basis in autosomal recessive inheritance. Specifically, COXPD25 is defined by a combined oxidative phosphorylation deficiency that occurs due to homozygous or compound heterozygous mutations in the MARS2 gene located on chromosome 2q33.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111469,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compund heterozygous mutation in the MRPL44 gene on chromosome 2q36.1."" ;
    :has_exact_synonym ""COXPD16""@en,
        ""infantile hypertrophic cardiomyopathy due to MRPL44 deficiency""@en .

","Combined Oxidative Phosphorylation Deficiency 16 (COXPD16), also known as infantile hypertrophic cardiomyopathy due to MRPL44 deficiency, is a specific form of autosomal recessive disease. It falls under the broader category of combined oxidative phosphorylation deficiencies and is characterized by having a material basis in autosomal recessive inheritance. The definition of COXPD16 includes being a combined oxidative phosphorylation deficiency that arises from homozygous or compound heterozygous mutations in the MRPL44 gene located on chromosome 2q36.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111470,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_28 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the SLC25A26 gene on chromosome 3p14.1."" ;
    :has_exact_synonym ""COXPD28""@en,
        ""neonatal severe cardiopulmonary failure due to mitochondrial methylation defect""@en .

","Combined Oxidative Phosphorylation Deficiency 28 (COXPD28), also known as neonatal severe cardiopulmonary failure due to mitochondrial methylation defect, is an autosomal recessive disease. It falls under the broader category of combined oxidative phosphorylation deficiencies and is characterized by autosomal recessive inheritance. This specific deficiency has its material basis in homozygous or compound heterozygous mutations in the SLC25A26 gene located on chromosome 3p14.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111471,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_30 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the TRMT10C gene on chromosome 3q12.3."" ;
    :has_exact_synonym ""COXPD30""@en .

",Combined oxidative phosphorylation deficiency 30 (COXPD30) is a type of autosomal recessive disease and a type of combined oxidative phosphorylation deficiency. It is characterized as something that at least has a material basis in autosomal recessive inheritance. COXPD30 is defined as a combined oxidative phosphorylation deficiency that has its material basis in homozygous or compound heterozygous mutations in the TRMT10C gene on chromosome 3q12.3.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111472,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the MRPL3 gene on chromosome 3q22.1."" ;
    :has_exact_synonym ""COXPD9""@en .

",Combined Oxidative Phosphorylation Deficiency 9 (COXPD9) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized by a material basis in autosomal recessive inheritance. COXPD9 is defined as a combined oxidative phosphorylation deficiency that arises from homozygous or compound heterozygous mutations in the MRPL3 gene located on chromosome 3q22.1.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111473,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by severe hypotonia, lactic academia and congenital hyperammonemia that has_material_basis_in homozygous or compound heterozygous mutation in the MRPS22 gene on chromosome 3q23."" ;
    :has_exact_synonym ""COXPD5""@en,
        ""hypotonia with lactic acidemia and hyperammonemia""@en .

","Combined Oxidative Phosphorylation Deficiency 5 (COXPD5), also known as hypotonia with lactic acidemia and hyperammonemia, is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is recognized by its severe hypotonia, lactic academia, and congenital hyperammonemia, attributed to either homozygous or compound heterozygous mutations in the MRPS22 gene located on chromosome 3q23. This condition is characterized as a disorder that fundamentally has a material basis in some form of autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111474,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the GFM1 gene on chromosome 3q25.32."" ;
    :has_exact_synonym ""COXPD1""@en,
        ""early fatal progressive hepatoencephalopathy""@en,
        ""hepatoencephalopathy due to COXPD1""@en,
        ""hepatoencephalopathy due to combined oxidative phosphorylation defect type 1""@en .

","Combined Oxidative Phosphorylation Deficiency 1 (COXPD1) is a type of autosomal recessive disease, which belongs to the category of combined oxidative phosphorylation deficiencies. It is characterized by a material basis in autosomal recessive inheritance. This specific deficiency is defined by a homozygous or compound heterozygous mutation in the GFM1 gene located on chromosome 3q25.32. COXPD1 is also known by several exact synonyms including early fatal progressive hepatoencephalopathy, hepatoencephalopathy due to COXPD1, and hepatoencephalopathy due to combined oxidative phosphorylation defect type 1.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111475,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_39 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the GFM2 gene on chromosome 5q13.3."" ;
    :has_exact_synonym ""COXPD39""@en .

",Combined oxidative phosphorylation deficiency 39 (COXPD39) is a type of autosomal recessive disease and falls under the broader category of combined oxidative phosphorylation deficiencies. It specifically arises from a material basis in autosomal recessive inheritance. COXPD39 is defined as a combined oxidative phosphorylation deficiency that results from homozygous or compound heterozygous mutations in the GFM2 gene located on chromosome 5q13.3.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111476,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_19 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the LYRM4 gene on chromosome 6p25.1."" ;
    :has_exact_synonym ""COXPD19""@en,
        ""severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency""@en .

","Combined oxidative phosphorylation deficiency 19 (COXPD19), also known as severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency, is a type of autosomal recessive disease, and more specifically, it is a form of combined oxidative phosphorylation deficiency. This condition is characterized by its material basis in autosomal recessive inheritance and is defined by a combined oxidative phosphorylation deficiency that arises from homozygous or compound heterozygous mutation in the LYRM4 gene on chromosome 6p25.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111477,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by neonatal onset of global developmental delay, refractory seizures, and lactic acidosis that has_material_basis_in homozygous or compound heterozygous mutation in the FARS2 gene on chromosome 6p25.1."" ;
    :has_exact_synonym ""COXPD14""@en .

","Combined Oxidative Phosphorylation Deficiency 14 (COXPD14) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized by a neonatal onset of global developmental delay, refractory seizures, and lactic acidosis. This condition fundamentally arises from either homozygous or compound heterozygous mutations in the FARS2 gene located on chromosome 6p25.1. Moreover, COXPD14 is also recognized as a condition that has its material basis in autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111478,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_20 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the VARS2 gene on chromosome 6p21.33."" ;
    :has_exact_synonym ""COXPD20""@en .

","Combined Oxidative Phosphorylation Deficiency 20 (COXPD20) is a type of disease that falls under the category of autosomal recessive diseases, and it specifically belongs to the group of combined oxidative phosphorylation deficiencies. This condition is characterized by having a material basis in autosomal recessive inheritance. Moreover, COXPD20 is defined as a combined oxidative phosphorylation deficiency that is caused by homozygous or compound heterozygous mutation in the VARS2 gene located on chromosome 6p21.33.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111479,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by lethal infantile hypertrophic cardiomyopathy and in some cases subtle skeletal muscle and brain involvement that has_material_basis_in homozygous or compound heterozygous mutation in the AARS2 gene on chromosome 6p21.1."" ;
    :has_exact_synonym ""COXPD8""@en .

","Combined Oxidative Phosphorylation Deficiency 8 (COXPD8) is a type of autosomal recessive disease and is categorized under combined oxidative phosphorylation deficiencies. It is defined as a combined oxidative phosphorylation deficiency characterized by lethal infantile hypertrophic cardiomyopathy, and in some instances, there is subtle involvement of the skeletal muscle and brain. This condition has a material basis in homozygous or compound heterozygous mutations in the AARS2 gene located on chromosome 6p21.1. Furthermore, COXPD8 is an entity that inherently involves some form of autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111480,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by hypertrophic cardiomyopathy and lactic acidosis that has_material_basis_in homozygous or compound heterozygous mutation in the MTO1 gene on chromosome 6q13."" ;
    :has_exact_synonym ""COXPD10""@en,
        ""infantile hypertrophic mitochondrial cardiomyopathy and lactic acidosis""@en,
        ""mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency""@en .

","Combined Oxidative Phosphorylation Deficiency 10 (COXPD10) is a type of autosomal recessive disease and also falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by certain conditions that have a genetic basis in autosomal recessive inheritance. Specifically, COXPD10 is defined as a combined oxidative phosphorylation deficiency characterized by hypertrophic cardiomyopathy and lactic acidosis, which results from homozygous or compound heterozygous mutations in the MTO1 gene located on chromosome 6q13. Besides COXPD10, this condition is also exactly known as infantile hypertrophic mitochondrial cardiomyopathy and lactic acidosis, as well as mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111481,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_11 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by neonatal hypotonia, lactic acidosis, death in infancy and in some cases respiratory insufficiency, foot deformities, or seizures that has_material_basis_in homozygous or compound heterozygous mutation in the RMND1 gene on chromosome 6q25.1."" ;
    :has_exact_synonym ""COXPD11""@en,
        ""infantile encephaloneuromyopathy due to mitochondrial translation defect""@en .

","Combined Oxidative Phosphorylation Deficiency 11 (COXPD11), also known as infantile encephaloneuromyopathy due to mitochondrial translation defect, is a type of autosomal recessive disease and a specific category of combined oxidative phosphorylation deficiency. This condition is characterized by a material basis in some form of autosomal recessive inheritance. COXPD11 is defined as a combined oxidative phosphorylation deficiency that features neonatal hypotonia, lactic acidosis, and death in infancy, with some cases also presenting respiratory insufficiency, foot deformities, or seizures. These symptoms have a material basis in homozygous or compound heterozygous mutations in the RMND1 gene located on chromosome 6q25.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111482,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_36 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the MRPS2 gene on chromosome 9q34.3."" ;
    :has_exact_synonym ""COXPD36""@en .

","Combined Oxidative Phosphorylation Deficiency 36 (COXPD36) is classified as a type of autosomal recessive disease, and it falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by having its material basis in autosomal recessive inheritance. Specifically, COXPD36 is defined by a combined oxidative phosphorylation deficiency that arises due to homozygous or compound heterozygous mutation in the MRPS2 gene located on chromosome 9q34.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111483,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the MRPS16 gene on chromosome 10q22.2."" ;
    :has_exact_synonym ""COXPD2""@en,
        ""agenesis of corpus callosum with dysmorphism and fatal lactic acidosis""@en .

","Combined Oxidative Phosphorylation Deficiency 2 (COXPD2), also known as agenesis of corpus callosum with dysmorphism and fatal lactic acidosis, is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized by a material basis in autosomal recessive inheritance. The condition is defined by a combined oxidative phosphorylation deficiency that results from homozygous or compound heterozygous mutation in the MRPS16 gene located on chromosome 10q22.2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111484,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_18 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by intrauterine growth retardation, hypotonia, visual impairment, speech delay, and lactic acidosis that has_material_basis_in homozygous or compound heterozygous mutation in the SFXN4 gene on chromosome 10q26.11."" ;
    :has_exact_synonym ""COXPD18""@en,
        ""growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome""@en .

","Combined Oxidative Phosphorylation Deficiency 18 (COXPD18), also known as growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome, is a type of autosomal recessive disease, as well as a specific form of combined oxidative phosphorylation deficiency. It is characterized by a condition that fundamentally has a material basis in autosomal recessive inheritance. COXPD18 is defined as a combined oxidative phosphorylation deficiency marked by intrauterine growth retardation, hypotonia, visual impairment, speech delay, and lactic acidosis. This condition is due to homozygous or compound heterozygous mutations in the SFXN4 gene located on chromosome 10q26.11.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111485,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_24 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :neurodevelopmental_delay ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency typically characterized by delayed neurodevelopment, refractory seizures, hypotonia, and hearing impairment that has_material_basis_in homozygous or compound heterozygous mutation in the NARS2 gene on chromosome 11q14.1."" ;
    :has_exact_synonym ""COXPD24""@en .

","Combined Oxidative Phosphorylation Deficiency 24 (COXPD24) is a type of autosomal recessive disease, which falls under the broader category of combined oxidative phosphorylation deficiencies. It is associated with conditions that have a material basis in autosomal recessive inheritance and is characterized by neurodevelopmental delay among other symptoms. Specifically, COXPD24 is typically characterized by delayed neurodevelopment, refractory seizures, hypotonia, and hearing impairment. This condition is caused by homozygous or compound heterozygous mutation in the NARS2 gene on chromosome 11q14.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111486,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the TSFM gene on chromosome 12q14.1."" ;
    :has_exact_synonym ""COXPD3""@en,
        ""Fatal mitochondrial disease due to COXPD3""@en,
        ""concentric cardiomyopathy, hypotonia, and lactic acidosis""@en,
        ""encephalomyopathy, respiratory failure, and lactic acidosis""@en,
        ""fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3""@en .

","Combined Oxidative Phosphorylation Deficiency 3 (COXPD3) is a type of autosomal recessive disease, which is also a form of combined oxidative phosphorylation deficiency. This condition is characterized by having a material basis in autosomal recessive inheritance. Specifically, COXPD3 is caused by homozygous or compound heterozygous mutation in the TSFM gene located on chromosome 12q14.1. It is known by several exact synonyms including Fatal mitochondrial disease due to COXPD3, concentric cardiomyopathy, hypotonia, and lactic acidosis, encephalomyopathy, respiratory failure, and lactic acidosis, and fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111487,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in C12orf65 on chromosome 12q24.31."" ;
    :has_exact_synonym ""COXPD7""@en,
        ""severe C12ORF65-related COXPD""@en,
        ""severe C12ORF65-related combined oxidative phosphorylation defect""@en .

","Combined Oxidative Phosphorylation Deficiency 7 (COXPD7) is a type of autosomal recessive disease and falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by having a material basis in autosomal recessive inheritance. More specifically, COXPD7 is defined by a combined oxidative phosphorylation deficiency that arises from homozygous or compound heterozygous mutations in the C12orf65 gene located on chromosome 12q24.31. The condition is also precisely known by the synonyms severe C12ORF65-related COXPD and severe C12ORF65-related combined oxidative phosphorylation defect.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111488,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_31 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by global developmental delay, severe hypotonia, and left ventricular non-compaction that has_material_basis_in homozygous or compound heterozygous mutation in the MIPEP gene on chromosome 13q12.12."" ;
    :has_exact_synonym ""COXPD31""@en,
        ""lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome""@en .

","Combined Oxidative Phosphorylation Deficiency 31 (COXPD31), also known exactly as Lethal Left Ventricular Non-compaction-Seizures-Hypotonia-Cataract-Developmental Delay Syndrome, is a type of autosomal recessive disease, and more specifically, it is part of the combined oxidative phosphorylation deficiencies. This particular condition is characterized as a combined oxidative phosphorylation deficiency that notably features global developmental delay, severe hypotonia, and left ventricular non-compaction. Its material basis is attributed to either homozygous or compound heterozygous mutations in the MIPEP gene located on chromosome 13q12.12. Essentially, COXPD31 is a disorder that inherently has an autosomal recessive inheritance pattern.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111489,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_27 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the CARS2 gene on chromosome 13q34."" ;
    :has_exact_synonym ""COXPD27""@en .

","Combined oxidative phosphorylation deficiency 27 (COXPD27) is a specific type of autosomal recessive disease, which falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by having a material basis in autosomal recessive inheritance. Specifically, COXPD27 is defined by a combined oxidative phosphorylation deficiency that results from homozygous or compound heterozygous mutations in the CARS2 gene located on chromosome 13q34.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111490,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_26 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the TRMT5 gene on chromosome 14q23.1."" ;
    :has_exact_synonym ""COXPD26""@en .

",Combined Oxidative Phosphorylation Deficiency 26 (COXPD26) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized by a material basis in autosomal recessive inheritance. The definition of COXPD26 is a combined oxidative phosphorylation deficiency that originates from homozygous or compound heterozygous mutation in the TRMT5 gene located on chromosome 14q23.1.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111491,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_15 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation] in the MTFMT gene on chromosome 15q22.31."" ;
    :has_exact_synonym ""COXPD15""@en .

",Combined Oxidative Phosphorylation Deficiency 15 (COXPD15) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized by having a material basis in some autosomal recessive inheritance. COXPD15 is defined by a combined oxidative phosphorylation deficiency that has a material basis in homozygous or compound heterozygous mutation in the MTFMT gene on chromosome 15q22.31.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111492,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_32 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by onset in infancy of delayed psychomotor development and developmental regression that has_material_basis_in homozygous or compound heterozygous mutation in the MRPS34 gene on chromosome 16p13.3."" ;
    :has_exact_synonym ""COXPD32""@en .

","Combined Oxidative Phosphorylation Deficiency 32 (COXPD32) is a type of autosomal recessive disease and falls under the broader category of combined oxidative phosphorylation deficiencies. It is defined as a combined oxidative phosphorylation deficiency characterized by its onset in infancy, manifesting as delayed psychomotor development and developmental regression. This condition specifically arises due to homozygous or compound heterozygous mutations in the MRPS34 gene located on chromosome 16p13.3. Moreover, it is identified as a condition that inherently has a material basis in some form of autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111493,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by infantile onset of hypotonia and delayed psychomotor development or developmental regression that has_material_basis_in homozygous or compound heterozygous mutation in the EARS2 gene on chromosome 16p12.2."" ;
    :has_exact_synonym ""COXPD12""@en,
        ""LTBL""@en,
        ""leukoencephalopathy with thalamus and brainstem involvement and high lactate""@en,
        ""leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome""@en .

","Combined Oxidative Phosphorylation Deficiency 12 is a type of autosomal recessive disease, combined oxidative phosphorylation deficiency, and something that at least has a material basis in some autosomal recessive inheritance. It is characterized by infantile onset of hypotonia and delayed psychomotor development or developmental regression, with its material basis in homozygous or compound heterozygous mutation in the EARS2 gene on chromosome 16p12.2. This condition is also known by its exact synonyms: COXPD12, LTBL, leukoencephalopathy with thalamus and brainstem involvement and high lactate, and leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111494,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the TUFM gene on chromosome 16p11.2."" ;
    :has_exact_synonym ""COXPD4""@en .

",Combined Oxidative Phosphorylation Deficiency 4 (COXPD4) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized as something that fundamentally arises from autosomal recessive inheritance. The definition of COXPD4 is a combined oxidative phosphorylation deficiency that results from homozygous or compound heterozygous mutation in the TUFM gene located on chromosome 16p11.2.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111495,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_33 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the C1QBP gene on chromosome 17p13.2."" ;
    :has_exact_synonym ""COXPD33""@en .

",Combined Oxidative Phosphorylation Deficiency 33 (COXPD33) is a type of autosomal recessive disease and falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by having a material basis in autosomal recessive inheritance. COXPD33 is defined as a combined oxidative phosphorylation deficiency that results from homozygous or compound heterozygous mutations in the C1QBP gene located on chromosome 17p13.2.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111496,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_17 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by onset in the first years of life of severe hypertrophic cardiomyopathy that has_material_basis_in homozygous or compound heterozygous mutation in the ELAC2 gene on chromosome 17p12."" ;
    :has_exact_synonym ""COXPD17""@en .

","Combined Oxidative Phosphorylation Deficiency 17 (COXPD17) is a type of autosomal recessive disease and also falls under the category of combined oxidative phosphorylation deficiencies. It is defined as a combined oxidative phosphorylation deficiency characterized by the onset in the first years of life of severe hypertrophic cardiomyopathy, which is based on homozygous or compound heterozygous mutation in the ELAC2 gene on chromosome 17p12. This condition exemplifies something that at least has a material basis in some form of autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111497,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_34 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :hepatic_dysfunction ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency typically characterized by congenital sensorineural deafness, increased serum lactate, and hepatic and renal dysfunction that has_material_basis_in homozygous or compound heterozygous mutation in the MRPS7 gene on chromosome 17q25.1."" ;
    :has_exact_synonym ""COXPD34""@en,
        ""syndromic sensorineural deafness due to COXPD""@en,
        ""syndromic sensorineural deafness due to combined oxidative phosphorylation defect""@en,
        ""syndromic sensorineural hearing loss due to COXPD""@en .

","Combined Oxidative Phosphorylation Deficiency 34 (COXPD34) is a type of autosomal recessive disease, which falls under the broader category of combined oxidative phosphorylation deficiencies. This condition is characterized by a material basis in autosomal recessive inheritance and is associated with symptoms such as hepatic dysfunction. COXPD34 is specifically defined as a combined oxidative phosphorylation deficiency typically marked by congenital sensorineural deafness, increased serum lactate, and both hepatic and renal dysfunction. This is due to homozygous or compound heterozygous mutations in the MRPS7 gene located on chromosome 17q25.1. Additionally, COXPD34 is exactly synonymous with syndromic sensorineural deafness due to COXPD, syndromic sensorineural deafness due to combined oxidative phosphorylation defect, and syndromic sensorineural hearing loss due to COXPD.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111498,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_22 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the ATP5A1 gene on chromosome 18q21.1."" ;
    :has_exact_synonym ""COXPD22""@en .

",Combined Oxidative Phosphorylation Deficiency 22 (COXPD22) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized by a condition that fundamentally arises from autosomal recessive inheritance. The definition of COXPD22 is a combined oxidative phosphorylation deficiency that originates from either homozygous or compound heterozygous mutations in the ATP5A1 gene located on chromosome 18q21.1.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111499,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_37 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by hypotonia, failure to thrive, liver disfunction, and neurodegeneration that has_material_basis_in homozygous or compound heterozygous mutation in MICOS13 on chromosome 19p13.3."" ;
    :has_exact_synonym ""COXPD37""@en .

","Combined Oxidative Phosphorylation Deficiency 37 (COXPD37) is a type of autosomal recessive disease and a specific form of combined oxidative phosphorylation deficiency. It is characterized as something that at least has a material basis in some autosomal recessive inheritance. The definition of COXPD37 includes it being a combined oxidative phosphorylation deficiency characterized by symptoms such as hypotonia, failure to thrive, liver dysfunction, and neurodegeneration. This condition has its material basis in homozygous or compound heterozygous mutation in the MICOS13 gene located on chromosome 19p13.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111500,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_23 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :delayed_psychomotor_development ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency characterized by early childhood onset of hypertrophic cardiomyopathy and/or neurologic symptoms, including hypotonia and delayed psychomotor development that has_material_basis_in homozygous or compound heterozygous mutation in the GTPBP3 gene on chromosome 19p13.11."" ;
    :has_exact_synonym ""COXPD23""@en .

","Combined Oxidative Phosphorylation Deficiency 23 (COXPD23) is a type of autosomal recessive disease, which falls under the broader category of combined oxidative phosphorylation deficiencies. It is characterized by a material basis in autosomal recessive inheritance and presents symptoms such as delayed psychomotor development. COXPD23 is defined as a combined oxidative phosphorylation deficiency that manifests in early childhood with hypertrophic cardiomyopathy and/or neurologic symptoms, including hypotonia and delayed psychomotor development. This condition is caused by homozygous or compound heterozygous mutations in the GTPBP3 gene located on chromosome 19p13.11.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111501,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_29 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_oxidative_phosphorylation_deficiency ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in homozygous or compound heterozygous mutation in the TXN2 gene on chromosome 22q12.3."" ;
    :has_exact_synonym ""COXPD29""@en .

","Combined oxidative phosphorylation deficiency 29 is a type of disease that falls under the broader category of combined oxidative phosphorylation deficiencies and is characterized by autosomal recessive inheritance. Specifically, this condition has a material basis in homozygous or compound heterozygous mutations in the TXN2 gene located on chromosome 22q12.3. It is also known by its exact synonym, COXPD29.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111502,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_oxidative_phosphorylation_deficiency_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :combined_oxidative_phosphorylation_deficiency,
        :x_linked_recessive_disease ;
    :has_definition ""A combined oxidative phosphorylation deficiency that has_material_basis_in hemizygous mutation in the AIFM1 gene on chromosome Xq26.1."" ;
    :has_exact_synonym ""COXPD6""@en,
        ""Mitochondrial encephalomyopathy due to COXPD6""@en,
        ""Mitochondrial encephalomyopathy due to combined oxidative phosphorylation defect 6""@en,
        ""severe X-linked mitochondrial encephalomyopathy""@en .

","Combined Oxidative Phosphorylation Deficiency 6 (COXPD6) is a type of combined oxidative phosphorylation deficiency and is also characterized as an X-linked recessive disease. This condition is specifically understood to have a material basis in some X-linked recessive inheritance. Moreover, COXPD6 is defined by a combined oxidative phosphorylation deficiency that results from a hemizygous mutation in the AIFM1 gene located on chromosome Xq26.1. Additionally, COXPD6 is known by several exact synonyms, including Mitochondrial Encephalomyopathy due to COXPD6, Mitochondrial Encephalomyopathy due to Combined Oxidative Phosphorylation Defect 6, and Severe X-linked Mitochondrial Encephalomyopathy.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111503,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:li_fraumeni_syndrome_1 rdfs:subClassOf :li_fraumeni_syndrome ;
    :has_definition ""A Li-Fraumeni syndrome that has_material_basis_in heterozygous mutation in the TP53 gene on chromosome 17p13.1."" ;
    :has_exact_synonym ""LFS1""@en .

","Li-Fraumeni syndrome 1 is a type of Li-Fraumeni syndrome, which is defined as a Li-Fraumeni syndrome that has a material basis in heterozygous mutation in the TP53 gene on chromosome 17p13.1. Furthermore, Li-Fraumeni syndrome 1 is exactly synonymous with LFS1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111504,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:li_fraumeni_syndrome_2 rdfs:subClassOf :li_fraumeni_syndrome ;
    :has_definition ""A Li-Fraumeni syndrome that has_material_basis_in heterozygous mutation in the CHEK2 gene on chromosome 22q12.1."" ;
    :has_exact_synonym ""LFS2""@en .

","Li-Fraumeni syndrome 2 is a specific type of Li-Fraumeni syndrome, which is defined as a Li-Fraumeni syndrome that has its material basis in a heterozygous mutation in the CHEK2 gene on chromosome 22q12.1. Furthermore, it is exactly synonymous with LFS2.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111505,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:palmoplantar_keratoderma_deafness_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by sensorineural hearing loss and progressive hyperkeratosis of the palms and soles that has_material_basis_in heterozygous mutation in the GJB2 gene on chromosome 13q12.11."" ;
    :has_exact_synonym ""PPK-deafness syndrome""@en,
        ""keratoderma palmoplantar deafness""@en,
        ""palmoplantar hyperkeratosis-deafness syndrome""@en,
        ""palmoplantar hyperkeratosis-hearing loss syndrome""@en,
        ""palmoplantar keratoderma with deafness""@en,
        ""palmoplantar keratoderma-hearing loss syndrome""@en .

","Palmoplantar keratoderma deafness syndrome is a type of syndrome that is classified as an autosomal dominant disease, which suggests it at least has a material basis in some form of autosomal dominant inheritance. This syndrome is defined as a condition characterized by sensorineural hearing loss and progressive hyperkeratosis of the palms and soles, which is caused by a heterozygous mutation in the GJB2 gene on chromosome 13q12.11. It is also known by several exact synonyms, including PPK-deafness syndrome, keratoderma palmoplantar deafness, palmoplantar hyperkeratosis-deafness syndrome, palmoplantar hyperkeratosis-hearing loss syndrome, palmoplantar keratoderma with deafness, and palmoplantar keratoderma-hearing loss syndrome.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111506,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:palmoplantar_keratoderma_esophageal_carcinoma_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by palmoplantar keratoderma and esophageal cancer that has_material_basis_in heterozygous mutation in the RHBDF2 gene on chromosome 17q25.1."" ;
    :has_exact_synonym ""Bennion-Patterson syndrome""@en,
        ""Howell-Evans syndrome""@en,
        ""TOC""@en,
        ""keratosis palmaris et plantaris with esophageal cancer""@en,
        ""keratosis palmoplantaris-esophageal carcinoma syndrome""@en,
        ""palmoplantar hyperkeratosis-esophageal carcinoma syndrome""@en,
        ""palmoplantar keratoderma with esophageal cancer""@en,
        ""tylosis with esophageal cancer""@en,
        ""tylosis-oesophageal carcinoma syndrome""@en .

","Palmoplantar Keratoderma Esophageal Carcinoma Syndrome is a type of syndrome and an autosomal dominant disease, which at least has a material basis in some autosomal dominant inheritance. This syndrome is characterized by palmoplantar keratoderma and esophageal cancer, with its material basis in a heterozygous mutation in the RHBDF2 gene on chromosome 17q25.1. It is also known by several exact synonyms, including Bennion-Patterson Syndrome, Howell-Evans Syndrome, TOC, Keratosis Palmaris et Plantaris with Esophageal Cancer, Keratosis Palmoplantaris-Esophageal Carcinoma Syndrome, Palmoplantar Hyperkeratosis-Esophageal Carcinoma Syndrome, Palmoplantar Keratoderma with Esophageal Cancer, Tylosis with Esophageal Cancer, and Tylosis-Oesophageal Carcinoma Syndrome.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0111507,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lenz_majewski_hyperostotic_dwarfism rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by intellectual disability, sclerosing bone dysplasia, distinct craniofacial, dental, cutaneous and distal-limb anomalies that has_material_basis_in heterozygous mutation in the PTDSS1 gene on chromosome 8q22.1."" ;
    :has_exact_synonym ""Lenz-Majewski syndrome""@en .

","Lenz Majewski Hyperostotic Dwarfism is a syndrome that is considered a type of autosomal dominant disease and is associated with autosomal dominant inheritance. It is characterized by intellectual disability, sclerosing bone dysplasia, distinct craniofacial, dental, cutaneous, and distal-limb anomalies, which have a material basis in a heterozygous mutation in the PTDSS1 gene on chromosome 8q22.1. Lenz Majewski Hyperostotic Dwarfism is also exactly synonymous with Lenz-Majewski syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111508,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:torrance_type_platyspondylic_dysplasia rdfs:subClassOf :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia characterized by decreased ossification of the skull base, disc-like platyspondyly, short thin ribs, hypoplastic pelvis with wide sacrosciatic notches and flat acetabular roof, and short tubular long bones with metaphyseal cupping that has_material_basis_in heterozygous mutation in the COL2A1 gene on chromosome 12q13.11."" ;
    :has_exact_synonym ""PLSD-T""@en,
        ""PLSDT""@en,
        ""lethal short-limbed platyspondylic dwarfism, Torrance type""@en,
        ""platyspondylic dysplasia, Torrance-Luton type""@en,
        ""platyspondylic lethal skeletal dysplasia, Torrance type""@en,
        ""thanatophoric dysplasia, Torrance variant""@en .

","Torrance type platyspondylic dysplasia is a type of osteochondrodysplasia, characterized by decreased ossification of the skull base, disc-like platyspondyly, short thin ribs, hypoplastic pelvis with wide sacrosciatic notches and flat acetabular roof, and short tubular long bones with metaphyseal cupping. This condition has a material basis in heterozygous mutation in the COL2A1 gene on chromosome 12q13.11. It is also known by several exact synonyms including PLSD-T, PLSDT, lethal short-limbed platyspondylic dwarfism, Torrance type, platyspondylic dysplasia, Torrance-Luton type, platyspondylic lethal skeletal dysplasia, Torrance type, and thanatophoric dysplasia, Torrance variant.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111509,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:lymphedema_distichiasis_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by lymphedema of the limbs and double rows of eyelashes that has_material_basis_in heterozygous mutation in the FOXC2 gene on chromosome 16q24.1."" ;
    :has_exact_synonym ""LPHDST""@en,
        ""lymphedema with distichiasis""@en .

","Lymphedema distichiasis syndrome is a type of syndrome and a specific kind of autosomal dominant disease, which means it is something that at least has its material basis in autosomal dominant inheritance. It is characterized by lymphedema of the limbs and double rows of eyelashes due to a heterozygous mutation in the FOXC2 gene on chromosome 16q24.1. Moreover, it has exact synonyms: LPHDST and lymphedema with distichiasis.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111510,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:marshall_syndrome rdfs:subClassOf :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by hypoplasia of the maxilla, nasal bones, and frontal sinuses, as well as calvarial thickening, myopia, early-onset cataracts, and sensorineural hearing loss that has_material_basis_in heterozygous or homozygous mutation (most frequently affecting splice sites) in the COL11A1 gene on chromosome 1p21.1. Mutations, typically null, in the COL11A1 gene may also cause Stickler syndrome."" ;
    :has_exact_synonym ""MRSHS""@en,
        ""deafness, myopia, cataract, saddle nose-Marshall type""@en .

","Marshall syndrome is a type of ectodermal dysplasia with a definition as an ectodermal dysplasia characterized by the underdevelopment (hypoplasia) of the maxilla, nasal bones, and frontal sinuses, as well as thickening of the calvaria, myopia, early-onset cataracts, and sensorineural hearing loss. This condition has its material basis in either heterozygous or homozygous mutations, most frequently affecting splice sites, in the COL11A1 gene located on chromosome 1p21.1. Such mutations, which are typically null, in the COL11A1 gene may also lead to Stickler syndrome. Additionally, Marshall syndrome is exactly synonymous with MRSHS and also known as deafness, myopia, cataract, saddle nose-Marshall type.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111511,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:melanoma_and_neural_system_tumor_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by predisposition to cutaneous melanoma and neural tumor (typically astrocytomas) development that has_material_basis_in heterozygous mutation in the CDKN2A gene on chromosome 9p21.3."" ;
    :has_exact_synonym ""melanoma-astrocytoma syndrome""@en .

","Melanoma and neural system tumor syndrome, also precisely known as melanoma-astrocytoma syndrome, is a type of autosomal dominant disease and syndrome. This condition is characterized by a predisposition to cutaneous melanoma and neural tumor (typically astrocytomas) development, which has its material basis in heterozygous mutation in the CDKN2A gene on chromosome 9p21.3. Additionally, this syndrome can be classified as something that at least has a material basis in some form of autosomal dominant inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111512,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:metachondromatosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia characterized by the presence of both multiple multiple enchondromas and exostoses that has_material_basis_in heterozygous mutation in the PTPN11 gene on chromosome 12q24.13."" ;
    :has_exact_synonym ""METCDS""@en .

","Metachondromatosis is a type of autosomal dominant disease and osteochondrodysplasia that has its material basis in autosomal dominant inheritance. It is characterized as an osteochondrodysplasia by the presence of both multiple enchondromas and exostoses, resulting from a heterozygous mutation in the PTPN11 gene on chromosome 12q24.13. Additionally, metachondromatosis is exactly synonymous with METCDS.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111513,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:metaphyseal_dysplasia_maxillary_hypoplasia_brachydactyly_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth that has_material_basis_in heterozygous duplication of the RUNX2 gene on chromosome 6p21.1."" ;
    :has_exact_synonym ""metaphyseal dysplasia maxillary hypoplasia brachydactyly""@en,
        ""metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly""@en .

","Metaphyseal dysplasia maxillary hypoplasia brachydactyly syndrome is a type of autosomal dominant disease and osteochondrodysplasia. It is considered a condition that at least has a material basis in some form of autosomal dominant inheritance. This syndrome is characterized by an osteochondrodysplasia that features metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth. The condition's material basis is linked to a heterozygous duplication of the RUNX2 gene on chromosome 6p21.1. Furthermore, metaphyseal dysplasia maxillary hypoplasia brachydactyly syndrome has exact synonyms, including metaphyseal dysplasia maxillary hypoplasia brachydactyly and metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111514,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:metatropic_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spondyloepimetaphyseal_dysplasia ;
    :has_definition ""A spondyloepimetaphyseal dysplasia characterized by short limbs with limitation and enlargement of joints, usually severe and progressive kyphoscoliosis, severe platyspondyly, and severe metaphyseal enlargement that has_material_basis_in heterozygous mutation in the TRPV4 gene on chromosome 12q24.11."" ;
    :has_exact_synonym ""metatropic dwarfism""@en .

","Metatropic dysplasia, which is also exactly synonymous with metatropic dwarfism, is a type of autosomal dominant disease, spondyloepimetaphyseal dysplasia, and a condition that at least has a material basis in some form of autosomal dominant inheritance. It is defined as a spondyloepimetaphyseal dysplasia characterized by short limbs with limitation and enlargement of joints, usually severe and progressive kyphoscoliosis, severe platyspondyly, and severe metaphyseal enlargement, all of which have a material basis in a heterozygous mutation in the TRPV4 gene on chromosome 12q24.11.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111515,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_feature ;
            owl:someValuesFrom :dementia ],
        :autosomal_recessive_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia characterized by adult onset of progressive external ophthalmoplegia, exercise intolerance, muscle weakness, and signs and symptoms of spinocerebellar ataxia that has_material_basis_in homozygous or compound heterozygous mutation in the RNASEH1 gene on chromosome 2p25.3."" ;
    :has_exact_synonym ""PEOB2""@en,
        ""adult-onset CPEO with mitochondrial myopathy""@en,
        ""adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy""@en,
        ""autosomal recessive progressive external ophthalmoplegia 2""@en .

","Autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (PEOB2) is a type of autosomal recessive disease and chronic progressive external ophthalmoplegia. It is characterized by having a material basis in autosomal recessive inheritance and exhibits symptoms such as muscle weakness and features like dementia. Specifically, it is a chronic progressive external ophthalmoplegia distinguished by the adult onset of progressive external ophthalmoplegia, exercise intolerance, muscle weakness, and signs and symptoms of spinocerebellar ataxia. This condition is caused by homozygous or compound heterozygous mutations in the RNASEH1 gene on chromosome 2p25.3. PEOB2 is also exactly synonymous with adult-onset CPEO with mitochondrial myopathy, adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy, and autosomal recessive progressive external ophthalmoplegia 2.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111516,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia characterized by adult onset of eye muscle weakness and proximal limb muscle weakness that has_material_basis_in homozygous or compound heterozygous mutation in the DGUOK gene on chromosome 2p13.1."" ;
    :has_exact_synonym ""PEOB4""@en,
        ""adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency""@en,
        ""adult-onset multiple mtDNA deletion syndrome due to DGUOK deficiency""@en,
        ""autosomal recessive progressive external ophthalmoplegia 4""@en .

","Autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 4, also known exactly as PEOB4, adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency, adult-onset multiple mtDNA deletion syndrome due to DGUOK deficiency, and autosomal recessive progressive external ophthalmoplegia 4, is a type of autosomal recessive disease, chronic progressive external ophthalmoplegia, and conditions that have a material basis in autosomal recessive inheritance and exhibit symptoms such as muscle weakness. This condition is characterized by adult onset of eye muscle weakness and proximal limb muscle weakness that results from homozygous or compound heterozygous mutation in the DGUOK gene on chromosome 2p13.1.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111517,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in heterozygous mutation in the SLC25A4 gene on chromosome 4q35.1."" ;
    :has_exact_synonym ""PEOA2""@en,
        ""autosomal dominant progressive external ophthalmoplegia 2""@en .

","Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2, also exactly known as PEOA2 and autosomal dominant progressive external ophthalmoplegia 2, is a type of disease that falls into several categories. It is an autosomal dominant disease, a type of chronic progressive external ophthalmoplegia, and belongs to the category of diseases that have a material basis in autosomal dominant inheritance. This specific condition is defined as a chronic progressive external ophthalmoplegia characterized by a heterozygous mutation in the SLC25A4 gene on chromosome 4q35.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111518,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in heterozygous mutation in the RRM2B gene on chromosome 8q22.3."" ;
    :has_exact_synonym ""PEOA5""@en,
        ""autosomal dominant progressive external ophthalmoplegia 5""@en .

","Autosomal Dominant Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions 5 (ADPEO5) is a type of autosomal dominant disease, chronic progressive external ophthalmoplegia, and a condition that inherently has a material basis in autosomal dominant inheritance. It is defined as a chronic progressive external ophthalmoplegia that results from a heterozygous mutation in the RRM2B gene located on chromosome 8q22.3. Furthermore, ADPEO5 is precisely synonymous with PEOA5 and Autosomal Dominant Progressive External Ophthalmoplegia 5.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111519,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia characterized by muscle weakness, mainly affecting the lower limbs, external ophthalmoplegia, exercise intolerance and mtDNA deletions that has_material_basis_in heterozygous mutation in the DNA2 gene on chromosome 10q21.3."" ;
    :has_exact_synonym ""DNA2-related mitochondrial DNA deletion syndrome""@en,
        ""PEOA6""@en,
        ""autosomal dominant progressive external ophthalmoplegia 6""@en,
        ""mitochondrial DNA deletion syndrome with limb-girdle weakness""@en,
        ""mitochondrial DNA deletion syndrome with progressive myopathy""@en,
        ""mtDNA deletion syndrome with limb-girdle weakness""@en,
        ""mtDNA deletion syndrome with progressive myopathy""@en .

","Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 6 is a type of disease that falls under several categories: it is a type of autosomal dominant disease, chronic progressive external ophthalmoplegia, and is characterized by having a material basis in autosomal dominant inheritance and symptoms including muscle weakness. Specifically, it is defined as a chronic progressive external ophthalmoplegia characterized by muscle weakness, mainly affecting the lower limbs, external ophthalmoplegia, exercise intolerance, and mitochondrial DNA (mtDNA) deletions, resulting from a heterozygous mutation in the DNA2 gene on chromosome 10q21.3. This condition is also known by several exact synonyms: DNA2-related mitochondrial DNA deletion syndrome, PEOA6, autosomal dominant progressive external ophthalmoplegia 6, mitochondrial DNA deletion syndrome with limb-girdle weakness, mitochondrial DNA deletion syndrome with progressive myopathy, mtDNA deletion syndrome with limb-girdle weakness, and mtDNA deletion syndrome with progressive myopathy.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111520,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in heterozygous mutation in the TWNK gene on chromosome 10q24.31."" ;
    :has_exact_synonym ""PEOA3""@en,
        ""autosomal dominant progressive external ophthalmoplegia 3""@en .

","Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3, also known as PEOA3 or autosomal dominant progressive external ophthalmoplegia 3, is categorized as a type of autosomal dominant disease, chronic progressive external ophthalmoplegia, and a condition that fundamentally arises from autosomal dominant inheritance. It is specifically defined as a chronic progressive external ophthalmoplegia that develops due to a heterozygous mutation in the TWNK gene located on chromosome 10q24.31.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111521,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_progressive_external_ophthalmoplegia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in heterozygous mutation in the POLG gene on chromosome 15q26.1."" ;
    :has_exact_synonym ""PEOA1""@en .

","Autosomal dominant progressive external ophthalmoplegia 1 (PEOA1) is a type of autosomal dominant disease, chronic progressive external ophthalmoplegia, and something that at least has a material basis in some autosomal dominant inheritance. It is defined as a chronic progressive external ophthalmoplegia that has its material basis in a heterozygous mutation in the POLG gene on chromosome 15q26.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111522,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_progressive_external_ophthalmoplegia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in homozygous or compound heterozygous mutation in the POLG gene on chromosome 15q26.1."" ;
    :has_exact_synonym ""PEOB1""@en .

","Autosomal recessive progressive external ophthalmoplegia 1 is a type of autosomal recessive disease, chronic progressive external ophthalmoplegia, and something that at least has a material basis in some autosomal recessive inheritance. It is defined as a chronic progressive external ophthalmoplegia that has a material basis in homozygous or compound heterozygous mutation in the POLG gene on chromosome 15q26.1. Additionally, autosomal recessive progressive external ophthalmoplegia 1 has the exact synonym PEOB1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111523,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in homozygous or compound heterozygous mutation in TK2 on chromosome 16q21."" ;
    :has_exact_synonym ""PEOB3""@en,
        ""autosomal recessive progressive external ophthalmoplegia 3""@en .

","Autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 3, also known precisely as PEOB3 or autosomal recessive progressive external ophthalmoplegia 3, is classified as a type of autosomal recessive disease, chronic progressive external ophthalmoplegia, and something that inherently has its material basis in autosomal recessive inheritance. This condition is defined as a chronic progressive external ophthalmoplegia that originates from homozygous or compound heterozygous mutation in the TK2 gene located on chromosome 16q21.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111524,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in homozygous or compound heterozygous mutation in the TOP3A gene on chromosome 17p11.2."" ;
    :has_exact_synonym ""PEOB5""@en,
        ""autosomal recessive progressive external ophthalmoplegia 5""@en .

","Autosomal recessive progressive external ophthalmoplegia with mitochondrial DNA deletions 5 (PEOB5), also known as autosomal recessive progressive external ophthalmoplegia 5, is classified as a type of autosomal recessive disease, chronic progressive external ophthalmoplegia, and a condition that fundamentally has a material basis in autosomal recessive inheritance. It is defined as a chronic progressive external ophthalmoplegia characterized by a material basis in homozygous or compound heterozygous mutation in the TOP3A gene on chromosome 17p11.2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111525,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_progressive_external_ophthalmoplegia_with_mitochondrial_dna_deletions_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :chronic_progressive_external_ophthalmoplegia ;
    :has_definition ""A chronic progressive external ophthalmoplegia that has_material_basis_in heterozygous mutation in the POLG2 gene on chromosome 17q23.3."" ;
    :has_exact_synonym ""PEOA4""@en,
        ""autosomal dominant progressive external ophthalmoplegia 4""@en .

","Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4, also known exactly as PEOA4 and autosomal dominant progressive external ophthalmoplegia 4, is a type of autosomal dominant disease, chronic progressive external ophthalmoplegia, and something that at least has a material basis in autosomal dominant inheritance. It is defined as a chronic progressive external ophthalmoplegia that has a material basis in a heterozygous mutation in the POLG2 gene on chromosome 17q23.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111526,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mullerian_aplasia_and_hyperandrogenism rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :disorder_of_sexual_development ;
    :has_definition ""A disorder of sexual development characterized by primary amenorrhea, an underdeveloped or absent uterus, and clinical hyperandrogenism that has_material_basis_in heterozygous mutation in the WNT4 gene on chromosome 1p36.12."" ;
    :has_exact_synonym ""Mullerian duct failure and hyperandrogenism""@en,
        ""WNT4 deficiency""@en .

","Mullerian aplasia and hyperandrogenism is a type of autosomal dominant disease, a disorder of sexual development, and something that at least has a material basis in some autosomal dominant inheritance. It is defined as a disorder of sexual development characterized by primary amenorrhea, an underdeveloped or absent uterus, and clinical hyperandrogenism that has a material basis in heterozygous mutation in the WNT4 gene on chromosome 1p36.12. Additionally, Mullerian aplasia and hyperandrogenism has exact synonyms: Mullerian duct failure and hyperandrogenism, and WNT4 deficiency.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111527,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spinal_muscular_atrophy_with_progressive_myoclonic_epilepsy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spinal_muscular_atrophy ;
    :has_definition ""A motor neuron disease characterized by severe and progressive myoclonic epilepsy and lower-motor-neuron disease that has_material_basis_in homozygous or compound heterozygous mutation in the ASAH1 gene on chromosome 8p22."" ;
    :has_exact_synonym ""Jankovic-Rivera syndrome""@en,
        ""SMA-PME""@en,
        ""SMAPME""@en,
        ""hereditary myoclonus-progressive distal muscular atrophy syndrome""@en .

","Spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME) is a type of autosomal recessive disease, which is also a form of spinal muscular atrophy. It is characterized as a condition that, at the very least, has a material basis in some form of autosomal recessive inheritance. Specifically, it is a motor neuron disease marked by severe and progressive myoclonic epilepsy and lower-motor-neuron disease, with its material basis being homozygous or compound heterozygous mutations in the ASAH1 gene on chromosome 8p22. SMA-PME is also known by several exact synonyms, including Jankovic-Rivera syndrome, SMA-PME, SMAPME, and hereditary myoclonus-progressive distal muscular atrophy syndrome.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111528,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:naegeli_franceschetti_jadassohn_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :ectodermal_dysplasia ;
    :has_definition ""A ectodermal dysplasia characterized by reticulate hyperpigmentation that made fade with age, palmoplantar keratoderma, absence of dermatoglyphics, abnormal sweat function and dental anomalies that has_material_basis_in heterozygous mutation in the KRT14 gene on chromosome 17q21.2."" ;
    :has_exact_synonym ""NFJ syndrome""@en,
        ""Naegeli syndrome""@en .

","Naegeli-Franceschetti-Jadassohn syndrome is a type of autosomal dominant disease, ectodermal dysplasia, and something that at least has a material basis in some autosomal dominant inheritance. It is characterized by reticulate hyperpigmentation that may fade with age, palmoplantar keratoderma, the absence of dermatoglyphics, abnormal sweat function, and dental anomalies. These characteristics have a material basis in a heterozygous mutation in the KRT14 gene on chromosome 17q21.2. Additionally, Naegeli-Franceschetti-Jadassohn syndrome has exact synonyms, including NFJ syndrome and Naegeli syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111529,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_multiple_nevi_flammei rdfs:subClassOf :capillary_disease ;
    :has_definition ""A capillary disease characterized by dark red to purple, nonelevated, sharply circumscribed patches which blanch on pressure with a glass, do not spontaneously regress, and have normal rates endothelial cell turnover."" ;
    :has_exact_synonym ""CMC""@en,
        ""congenital capillary malformations""@en,
        ""familial multiple port-wine stains""@en .

","Familial multiple nevi flammei is a type of capillary disease characterized by dark red to purple, nonelevated, sharply circumscribed patches which blanch on pressure with a glass, do not spontaneously regress, and have normal rates of endothelial cell turnover. It is also exactly synonymous with CMC, congenital capillary malformations, and familial multiple port-wine stains.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111530,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:linear_nevus_sebaceous_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by sebaceous nevi typically on the face and associated with variable ipsilateral abnormalities of the central nervous system, ocular anomalies, and skeletal defects that has_material_basis_in somatic mosaic mutations in the NRAS, HRAS, or KRAS genes on chromosomes 1p13.2, 11p15.5, or 12p12.1, respectively."" ;
    :has_exact_synonym ""JNP""@en,
        ""Jadassohn nevus phakomatosis""@en,
        ""SFM syndrome""@en,
        ""Schimmelpenning Feuerstein Mims syndrome""@en,
        ""Schimmelpenning syndrome""@en,
        ""Solomon syndrome""@en,
        ""nevus sebaceus of Jadassohn""@en,
        ""nevus sebaceus syndrome""@en,
        ""organoid nevus phakomatosis""@en,
        ""organoid nevus syndrome""@en .

","Linear Nevus Sebaceous Syndrome is a type of syndrome characterized by sebaceous nevi typically on the face and associated with variable ipsilateral abnormalities of the central nervous system, ocular anomalies, and skeletal defects. This syndrome's material basis lies in somatic mosaic mutations in the NRAS, HRAS, or KRAS genes on chromosomes 1p13.2, 11p15.5, or 12p12.1, respectively. It is also known by several exact synonyms: JNP, Jadassohn Nevus Phakomatosis, SFM syndrome, Schimmelpenning Feuerstein Mims syndrome, Schimmelpenning syndrome, Solomon syndrome, Nevus Sebaceus of Jadassohn, Nevus Sebaceus Syndrome, Organoid Nevus Phakomatosis, and Organoid Nevus Syndrome.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111531,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bilateral_optic_nerve_hypoplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :optic_nerve_disease ;
    :has_definition ""An optic nerve disease characterized by isolated optic nerve hypoplasia or aplasia that has_material_basis_in heterozygous mutation in the PAX6 gene on chromosome 11p13."" ;
    :has_exact_synonym ""ONH""@en,
        ""familial bilateral optic nerve hypoplasia""@en,
        ""isolated optic nerve hypoplasia/aplasia""@en .

","Bilateral optic nerve hypoplasia (ONH), also known exactly as familial bilateral optic nerve hypoplasia and isolated optic nerve hypoplasia/aplasia, is a type of autosomal dominant disease as well as a specific optic nerve disease. Furthermore, it is characterized by a condition that necessarily has a material basis in some form of autosomal dominant inheritance. Specifically, this optic nerve disease is defined by isolated optic nerve hypoplasia or aplasia, which has a material basis in a heterozygous mutation in the PAX6 gene located on chromosome 11p13.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111532,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:osteoglophonic_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia characterized by rhizomelic dwarfism, craniosynostosis, prominent supraorbital ridge, depressed nasal bridge, nonossifying bone lesions, and multiple unerupted teeth that has_material_basis_in heterozygous missense mutation in the FGFR1 gene on chromosome 8p11.23."" ;
    :has_exact_synonym ""Fairbank-Keats syndrome""@en,
        ""OGD""@en,
        ""osteoglophonic dwarfism""@en .

","Osteoglophonic dysplasia is an autosomal dominant disease that falls under the category of osteochondrodysplasia. It is characterized by a specific type of inheritance that has a material basis in autosomal dominant inheritance. The disease is defined as an osteochondrodysplasia characterized by features such as rhizomelic dwarfism, craniosynostosis, a prominent supraorbital ridge, a depressed nasal bridge, nonossifying bone lesions, and multiple unerupted teeth. These characteristics are due to a heterozygous missense mutation in the FGFR1 gene located on chromosome 8p11.23. Additionally, osteoglophonic dysplasia is also known by exact synonyms including Fairbank-Keats syndrome, OGD, and osteoglophonic dwarfism.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111533,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gnathodiaphyseal_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia characterized by cementoosseous lesions of the jawbones, bone fragility, bowing/cortical thickening of tubular bones, and diaphyseal sclerosis of long bones that has_material_basis_in heterozygous mutation in the ANO5 gene on chromosome 11p14.3."" ;
    :has_exact_synonym ""GDD""@en,
        ""Levin syndrome 2""@en,
        ""gnathodiaphyseal sclerosis""@en,
        ""osteogenesis imperfecta with unusual skeletal lesions""@en,
        ""osteogenesis imperfecta, Levin type""@en .

","Gnathodiaphyseal dysplasia is a type of autosomal dominant disease and also falls under the category of osteochondrodysplasia. It is characterized by conditions that have a material basis in autosomal dominant inheritance. Specifically, it is an osteochondrodysplasia characterized by cementoosseous lesions of the jawbones, bone fragility, bowing/cortical thickening of tubular bones, and diaphyseal sclerosis of long bones, which is due to heterozygous mutation in the ANO5 gene on chromosome 11p14.3. This condition is exactly synonymous with several other names, including GDD, Levin syndrome 2, gnathodiaphyseal sclerosis, osteogenesis imperfecta with unusual skeletal lesions, and osteogenesis imperfecta, Levin type.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111534,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:multicentric_carpotarsal_osteolysis_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by progressive loss of bone, typically involving the carpal and tarsal bones, and in many cases chronic renal failure that has_material_basis_in heterozygous mutation in the MAFB gene on chromosome 20q12."" ;
    :has_exact_synonym ""MCTO""@en,
        ""autosomal dominant multicentric osteolysis""@en,
        ""hereditary osteolysis of carpal bones with or without nephropathy""@en,
        ""idiopathic multicentric osteolysis with or without nephropathy""@en,
        ""multicentric carpo-tarsal osteolysis with or without nephropathy""@en,
        ""multicentric osteolysis nephropathy""@en .

","Multicentric carpotarsal osteolysis syndrome is a type of autosomal dominant disease and syndrome, which is characterized by a progressive loss of bone, typically involving the carpal and tarsal bones, and in many cases, chronic renal failure. This condition has a material basis in heterozygous mutation in the MAFB gene on chromosome 20q12. It is also known by several exact synonyms, including MCTO, autosomal dominant multicentric osteolysis, hereditary osteolysis of carpal bones with or without nephropathy, idiopathic multicentric osteolysis with or without nephropathy, multicentric carpo-tarsal osteolysis with or without nephropathy, and multicentric osteolysis nephropathy.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111535,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:progressive_osseous_heteroplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by infantile onset of dermal ossification followed by progressive bone formation in skeletal muscle and deep fascia that has_material_basis_in heterozygous loss of function mutation in the Gs-alpha isoform of the GNAS gene on chromosome 20q13.32."" ;
    :has_exact_synonym ""POH""@en,
        ""ectopic ossification familial type""@en,
        ""familial ectopic ossification""@en,
        ""osteoma cutis""@en .

","Progressive osseous heteroplasia is a type of autosomal dominant disease, syndrome, and something that at least has a material basis in some autosomal dominant inheritance. It is defined as a syndrome characterized by the infantile onset of dermal ossification followed by progressive bone formation in skeletal muscle and deep fascia. This condition has a material basis in the heterozygous loss of function mutation in the Gs-alpha isoform of the GNAS gene on chromosome 20q13.32. Progressive osseous heteroplasia is exactly synonymous with POH, ectopic ossification familial type, familial ectopic ossification, and osteoma cutis.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111536,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:buschke_ollendorff_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by multiple subcutaneous nevi or nodules and osteopoikilosis that has_material_basis_in heterozygous mutation in the LEMD3 gene on chromosome 12q14.3."" ;
    :has_exact_synonym ""BOS""@en,
        ""dermatofibrosis lenticularis disseminata with osteopoikilosis""@en,
        ""dermatoosteopoikilosis""@en,
        ""disseminated dermatofibrosis with osteopoikilosis""@en,
        ""osteopathia condensans disseminata""@en .

","Buschke Ollendorff Syndrome (BOS), also known by its exact synonyms dermatofibrosis lenticularis disseminata with osteopoikilosis, dermatoosteopoikilosis, disseminated dermatofibrosis with osteopoikilosis, and osteopathia condensans disseminata, is a type of syndrome that is classified as an autosomal dominant disease. It is a condition that fundamentally has a material basis in autosomal dominant inheritance. BOS is characterized by multiple subcutaneous nevi or nodules and osteopoikilosis, which is due to a heterozygous mutation in the LEMD3 gene located on chromosome 12q14.3.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111537,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:paroxysmal_extreme_pain_disorder rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autonomic_nervous_system_disease,
        :autosomal_dominant_disease ;
    :has_definition ""An autonomic nervous system disease characterized by onset in the neonatal period or infancy of paroxysms of rectal, ocular, or submandibular pain with flushing that has_material_basis_in heterozygous mutation in the SCN9A gene on chromosome 2q24.3."" ;
    :has_exact_synonym ""PEPD""@en,
        ""PEXPD""@en,
        ""familial rectal pain""@en,
        ""submandibular, ocular and rectal pain with flushing""@en .

","Paroxysmal Extreme Pain Disorder (PEPD), also known exactly as PEXPD, familial rectal pain, and submandibular, ocular, and rectal pain with flushing, is a type of disease that falls under several categories: it is an autosomal dominant disease, an autonomic nervous system disease, and is characterized by its material basis in some autosomal dominant inheritance. Specifically, PEPD is defined as an autonomic nervous system disease that begins in the neonatal period or infancy, featuring paroxysms of rectal, ocular, or submandibular pain accompanied by flushing. This condition is caused by a heterozygous mutation in the SCN9A gene located on chromosome 2q24.3.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111538,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:paramyotonia_congenita_of_von_eulenburg rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :autosomal_dominant_disease,
        :neuromuscular_disease ;
    :has_definition ""A neuromuscular disease characterized by onset in infancy or early childhood of bouts of myotonia and muscle weakness that are increased by cold exposure that has_material_basis_in heterozygous mutation in the SCN4A gene on chromosome 17q23.3."" ;
    :has_exact_synonym ""Eulenburg disease""@en,
        ""PMC""@en,
        ""Von Eulenburg paramyotonia congenita""@en,
        ""myotonia congenita intermittens""@en,
        ""paralysis periodica paramyotonica""@en,
        ""paramyotonia congenita""@en .

","Paramyotonia congenita of von Eulenburg is classified as a type of autosomal dominant and neuromuscular disease. It is characterized by having a material basis in autosomal dominant inheritance and presenting symptoms such as muscle weakness. The condition is specifically defined as a neuromuscular disease that manifests in infancy or early childhood with episodes of myotonia and muscle weakness, which worsen with exposure to cold. This condition is caused by a heterozygous mutation in the SCN4A gene located on chromosome 17q23.3. Paramyotonia congenita of von Eulenburg is also known by several exact synonyms, including Eulenburg disease, PMC, Von Eulenburg paramyotonia congenita, myotonia congenita intermittens, paralysis periodica paramyotonica, and simply paramyotonia congenita.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111539,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:parastremmatic_dwarfism rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :osteochondrodysplasia ;
    :has_definition ""An osteochondrodysplasia characterized by severe dwarfism, kyphoscoliosis, stiffness of large joints and bowing and twisting of lower limbs that has_material_basis_in heterozygous mutation in the TRPV4 gene on chromosome 12q24.11."" ;
    :has_exact_synonym ""parastremmatic dysplasia""@en .

","Parastremmatic dwarfism is a type of autosomal dominant disease, osteochondrodysplasia, and is something that at least has a material basis in some autosomal dominant inheritance. It is characterized by severe dwarfism, kyphoscoliosis, stiffness of large joints, and bowing and twisting of lower limbs due to a heterozygous mutation in the TRPV4 gene on chromosome 12q24.11. Additionally, parastremmatic dwarfism is exactly synonymous with parastremmatic dysplasia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111540,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:prolidase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :amino_acid_metabolic_disorder,
        :autosomal_recessive_disease ;
    :has_definition ""An amino acid metabolic disorder characterized by massive imidodipeptiduria, chronic and slowly healing ulcerations, recurrent infections, dysmorphic facial features, variable cognitive impairment, splenomegaly, and lack of or reduced prolidase activity that has_material_basis_in homozygous or compound heterozygous mutation in the PEPD gene on chromosome 19q13.11."" ;
    :has_exact_synonym ""hyperimidodipeptiduria""@en,
        ""imidodipeptidase deficiency""@en,
        ""peptidase deficiency""@en .

","Prolidase deficiency is a type of autosomal recessive disease and an amino acid metabolic disorder that has a material basis in autosomal recessive inheritance. This condition is characterized by massive imidodipeptiduria, chronic and slowly healing ulcerations, recurrent infections, dysmorphic facial features, variable cognitive impairment, splenomegaly, and either a lack of or reduced prolidase activity. This is due to homozygous or compound heterozygous mutations in the PEPD gene located on chromosome 19q13.11. Moreover, prolidase deficiency is also exactly synonymous with hyperimidodipeptiduria, imidodipeptidase deficiency, and peptidase deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111541,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pigmented_paravenous_chorioretinal_atrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :eye_disease ;
    :has_definition ""An eye disease characterized by the presence of bone corpuscle pigmentation in a paravenous distribution in the ocular fundus that has_material_basis_in heterozygous mutation in the CRB1 gene on chromosome 1q31.3."" ;
    :has_exact_synonym ""PPRCA""@en .

",Pigmented paravenous chorioretinal atrophy (PPRCA) is a type of eye disease that is also an autosomal dominant disease. This condition specifically has a material basis in some autosomal dominant inheritance and is characterized by the presence of bone corpuscle pigmentation in a paravenous distribution in the ocular fundus. The underlying cause of pigmented paravenous chorioretinal atrophy is a heterozygous mutation in the CRB1 gene located on chromosome 1q31.3.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111542,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_expansile_osteolysis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :bone_remodeling_disease ;
    :has_definition ""A bone remodeling disease characterized by increased bone remodeling with osteolytic lesions mainly affecting the appendicular skeleton, bone pain, pathological fractures, childhood onset of conductive hearing loss, and premature tooth loss that has_material_basis_in heterozygous mutation in the TNFRSF11A gene on chromosome 18q21.33."" ;
    :has_exact_synonym ""FEO""@en,
        ""McCabe disease""@en,
        ""hereditary expansile polyostotic osteolytic dysplasia""@en .

","Familial expansile osteolysis is a type of autosomal dominant disease, bone remodeling disease, and something that at least has a material basis in some autosomal dominant inheritance. It is characterized by increased bone remodeling with osteolytic lesions mainly affecting the appendicular skeleton, bone pain, pathological fractures, childhood onset of conductive hearing loss, and premature tooth loss, resulting from a heterozygous mutation in the TNFRSF11A gene on chromosome 18q21.33. Furthermore, familial expansile osteolysis is also known by its exact synonyms: FEO, McCabe disease, and hereditary expansile polyostotic osteolytic dysplasia.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111543,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:juvenile_polyposis_hereditary_hemorrhagic_telangiectasia_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :young_adult_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by hamartomatous polyps in the gastrointestinal tract, telangiectases of the skin, and oral and nasal mucosa, epistaxis, and arteriovenous malformations of the lungs, liver, brain, and gastrointestinal tract that has_material_basis_in heterozygous mutation in the SMAD4 gene on chromosome 18q21.2."" ;
    :has_exact_synonym ""JP-HHT""@en .

","Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome (JP-HHT) is a type of syndrome classified as an autosomal dominant disease. It is characterized by features that include hamartomatous polyps in the gastrointestinal tract, telangiectases of the skin, and oral and nasal mucosa, epistaxis, and arteriovenous malformations of the lungs, liver, brain, and gastrointestinal tract. The material basis for this syndrome is at least in part due to autosomal dominant inheritance, and its existence typically begins during young adult onset. This syndrome is specifically linked to a heterozygous mutation in the SMAD4 gene located on chromosome 18q21.2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111544,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:guttmacher_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by preaxial deficiencies of the hands and feet, postaxial polydactyly of the hands, and hypospadias that has_material_basis_in heterozygous mutation in the HOXA13 gene on chromosome 7p15.2."" ;
    :has_exact_synonym ""autosomal dominant preaxial deficiency, postaxial polydactyly, and hypospadias""@en,
        ""preaxial deficiency-postaxial polydactyly-hypospadias syndrome""@en .

","Guttmacher Syndrome is a type of syndrome and an autosomal dominant disease, which is characterized by a specific set of features. These features include preaxial deficiencies of the hands and feet, postaxial polydactyly of the hands, and hypospadias. This condition has a material basis in a heterozygous mutation in the HOXA13 gene located on chromosome 7p15.2. Furthermore, Guttmacher Syndrome is exactly synonymous with autosomal dominant preaxial deficiency, postaxial polydactyly, and hypospadias, as well as with preaxial deficiency-postaxial polydactyly-hypospadias syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111545,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_male_limited_precocious_puberty rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :endocrine_system_disease ;
    :has_definition ""An endocrine system disease characterized by onset in early childhood of accelerated growth, early development of secondary sexual characteristics, and reduced adult height in males only that has_material_basis_in heterozygous mutation in the LHCGR gene on chromosome 2p16.3."" ;
    :has_exact_synonym ""FMPP""@en,
        ""familial gonadotropin-independent male-limited sexual precocity""@en,
        ""male-limited precocious puberty""@en,
        ""testotoxicosis""@en .

","Familial Male Limited Precocious Puberty (FMPP), also known as familial gonadotropin-independent male-limited sexual precocity, male-limited precocious puberty, and testotoxicosis, is a type of disease that falls under three categories: an autosomal dominant disease, an endocrine system disease, and a condition that has at least a material basis in some form of autosomal dominant inheritance. It is characterized by an onset in early childhood of accelerated growth, early development of secondary sexual characteristics, and reduced adult height in males only, which has its material basis in a heterozygous mutation in the LHCGR gene on chromosome 2p16.3.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111546,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:currarino_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by anorectal malformations, a presacral mass, and partial sacral agenesis with intact first sacral vertebra that has_material_basis_in heterozygous mutation in HLXB9 on chromosome 7q36.3."" ;
    :has_exact_synonym ""Currarino triad""@en .

","Currarino syndrome is a type of syndrome and an autosomal dominant disease, which specifically has a material basis in autosomal dominant inheritance. It is defined as a syndrome characterized by anorectal malformations, a presacral mass, and partial sacral agenesis with an intact first sacral vertebra, resulting from a heterozygous mutation in HLXB9 on chromosome 7q36.3. Additionally, Currarino syndrome is exactly synonymous with Currarino triad.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111547,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:retinal_arterial_tortuosity rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :artery_disease,
        :autosomal_dominant_disease ;
    :has_definition ""An artery disease characterized by pronounced tortuosity of second- and third-order retinal arteries with normal first-order arteries and venous system that has_material_basis_in heterozygous mutation in the COL4A1 gene on chromosome 13q34."" ;
    :has_exact_synonym ""RATOR""@en,
        ""retinal arteriolar tortuosity""@en,
        ""retinal hemorrhage with vascular tortuosity""@en,
        ""tortuosity of retinal arteries""@en .

","Retinal arterial tortuosity is a type of autosomal dominant and artery disease, which at least has a material basis in some autosomal dominant inheritance. It is defined as an artery disease characterized by pronounced tortuosity of second- and third-order retinal arteries with normal first-order arteries and venous system, and this condition has a material basis in a heterozygous mutation in the COL4A1 gene on chromosome 13q34. Retinal arterial tortuosity is also exactly synonymous with RATOR, retinal arteriolar tortuosity, retinal hemorrhage with vascular tortuosity, and tortuosity of retinal arteries.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111548,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ring_dermoid_of_cornea rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :corneal_disease ;
    :has_definition ""A corneal disease characterized by annular limbal dermoids with corneal and conjunctival extension that has_material_basis_in heterozygous mutation in the PITX2 gene on chromosome 4q25."" ;
    :has_exact_synonym ""RDC""@en,
        ""ring dermoid syndrome""@en .

","Ring dermoid of cornea (RDC), also known as ring dermoid syndrome, is a type of corneal disease and an autosomal dominant disease. It specifically falls under the category of diseases that have a material basis in some form of autosomal dominant inheritance. The definition of ring dermoid of cornea is a corneal disease characterized by annular limbal dermoids with corneal and conjunctival extension that is caused by a heterozygous mutation in the PITX2 gene on chromosome 4q25.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111549,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:aplasia_of_lacrimal_and_salivary_glands rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by irritable eyes, epiphora, xerostomia, variable aplasia or hypoplasia of the lacrimal, parotid, submandibular, and sublingual glands, and absence of the lacrimal puncta that has_material_basis_in heterozygous mutation in the FGF10 gene on chromosome 5p12."" ;
    :has_exact_synonym ""ALSG""@en,
        ""congenital absence of lacrimal puncta and salivary glands""@en .

","Aplasia of lacrimal and salivary glands is a condition categorized as an autosomal dominant disease, a syndrome, and is described as having a material basis in some form of autosomal dominant inheritance. It is defined as a syndrome characterized by irritable eyes, epiphora, xerostomia, and variable aplasia or hypoplasia of the lacrimal, parotid, submandibular, and sublingual glands, including the absence of the lacrimal puncta, which is caused by a heterozygous mutation in the FGF10 gene on chromosome 5p12. This condition is also known by its exact synonyms: ALSG and congenital absence of lacrimal puncta and salivary glands.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111550,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:scalp_ear_nipple_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by cutis aplasia of the scalp, breast anomalies that range from hypothelia or athelia to amastia, and minor anomalies of the external ears that has_material_basis_in heterozygous mutation in the KCTD1 gene on chromosome 18q11.2."" ;
    :has_exact_synonym ""Finlay-Marks syndrome""@en,
        ""SENS""@en,
        ""Sen Syndrome""@en,
        ""hereditary syndrome of lumpy scalp, odd ears and rudimentary nipples""@en .

","Scalp ear nipple syndrome, also known exactly as Finlay-Marks syndrome, SENS, Sen Syndrome, and hereditary syndrome of lumpy scalp, odd ears and rudimentary nipples, is a type of autosomal dominant disease, ectodermal dysplasia, and something that at least has a material basis in autosomal dominant inheritance. It is defined as an ectodermal dysplasia characterized by cutis aplasia of the scalp, breast anomalies that range from hypothelia or athelia to amastia, and minor anomalies of the external ears. This syndrome has its material basis in a heterozygous mutation in the KCTD1 gene on chromosome 18q11.2.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111551,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurogenic_scapuloperoneal_syndrome_kaeser_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        :autosomal_dominant_disease,
        :myopathy ;
    :has_definition ""A myopathy characterized by adult onset of foot dorsiflexor weakness, peroneal muscle weakness, scapuloperoneal weakness, and shoulder girdle muscle atrophy that has_material_basis_in heterozygous mutation in DES on chromosome 2q35."" ;
    :has_exact_synonym ""Kaeser syndrome""@en,
        ""Stark-Kaeser syndrome""@en,
        ""scapuloperoneal syndrome type Kaeser""@en,
        ""scapuloperoneal syndrome, neurogenic, Kaeser type""@en .

","Neurogenic scapuloperoneal syndrome Kaeser type is a type of autosomal dominant disease and a type of myopathy. It is characterized by a material basis in autosomal dominant inheritance and presents symptoms such as muscle weakness. This condition is defined as a myopathy characterized by adult onset of foot dorsiflexor weakness, peroneal muscle weakness, scapuloperoneal weakness, and shoulder girdle muscle atrophy, resulting from a heterozygous mutation in the DES gene on chromosome 2q35. Neurogenic scapuloperoneal syndrome Kaeser type is also known by its exact synonyms: Kaeser syndrome, Stark-Kaeser syndrome, scapuloperoneal syndrome type Kaeser, and scapuloperoneal syndrome, neurogenic, Kaeser type.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111552,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:scapuloperoneal_spinal_muscular_atrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :motor_neuron_disease ;
    :has_definition ""A motor neuron disease characterized by progressive scapuloperoneal atrophy and weakness, laryngeal palsy, congenital absence of muscles and in some cases developmental abnormalities of the bones that has_material_basis_in heterozygous mutation in the TRPV4 gene on chromosome 12q24.11."" ;
    :has_exact_synonym ""SPSMA""@en,
        ""neurogenic scapuloperoneal amyotrophy, New England type""@en,
        ""scapuloperoneal neuronopathy""@en .

","Scapuloperoneal spinal muscular atrophy (SPSMA) is a type of autosomal dominant disease and motor neuron disease, which has a material basis in some autosomal dominant inheritance and exhibits symptoms such as muscle weakness. It is characterized by progressive scapuloperoneal atrophy and weakness, laryngeal palsy, congenital absence of muscles, and in some cases, developmental abnormalities of the bones. This condition is caused by heterozygous mutation in the TRPV4 gene on chromosome 12q24.11. Scapuloperoneal spinal muscular atrophy is also known by its exact synonyms: neurogenic scapuloperoneal amyotrophy, New England type, and scapuloperoneal neuronopathy.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111553,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spondyloepiphyseal_dysplasia_maroteaux_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spondyloepiphyseal_dysplasia ;
    :has_definition ""An osteochondrodysplasia characterized by dysplastic epiphyses, short stature appearing in infancy, short neck, short and stubby hands and feet, platyspondyly, severe brachydactyly, and pelvic abnormalities that has_material_basis_in heterozygous mutation in the TRPV4 gene on chromosome 12q24.11."" ;
    :has_exact_synonym ""Brachyolmia Type 2""@en,
        ""Pseudo-Morquio syndrome type 2""@en,
        ""SED, Maroteaux type""@en,
        ""spondyloepiphyseal dysplasia of Maroteaux""@en .

","Spondyloepiphyseal dysplasia Maroteaux type is classified as a type of spondyloepiphyseal dysplasia and is also known as an autosomal dominant disease. Additionally, it is identified as a condition that inherently has a material basis in some form of autosomal dominant inheritance. This disease is defined as an osteochondrodysplasia characterized by dysplastic epiphyses, short stature that becomes apparent in infancy, a short neck, short and stubby hands and feet, platyspondyly, severe brachydactyly, and pelvic abnormalities, all of which are due to a heterozygous mutation in the TRPV4 gene on chromosome 12q24.11. Furthermore, Spondyloepiphyseal dysplasia Maroteaux type is exactly synonymous with Brachyolmia Type 2, Pseudo-Morquio Syndrome Type 2, SED Maroteaux type, and spondyloepiphyseal dysplasia of Maroteaux, indicating the variety of names by which this disease is recognized.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111554,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spondylometaphyseal_dysplasia_kozlowski_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spondylometaphyseal_dysplasia ;
    :has_definition ""A spondylometaphyseal dysplasia characterized by vetebral platyspondyly and overfaced pedicles, scoliosis, and mild metaphyseal abnormalities in the pelvis that has_material_basis_in heterozygous mutation in the TRPV4 gene on chromosome 12q24.11."" ;
    :has_exact_synonym ""Jequier Kozlowski skeletal dysplasia""@en,
        ""Jequier-Kozlowski syndrome""@en,
        ""SMD Kozlowski type""@en,
        ""dysmorphism arthrogryposis skeletal maturation advanced""@en,
        ""skeletal dysplasia Jequier-Kozlowski type""@en .

","Spondylometaphyseal dysplasia Kozlowski type is a form of spondylometaphyseal dysplasia and an autosomal dominant disease, which essentially has a material basis in some form of autosomal dominant inheritance. It is characterized by vertebral platyspondyly, overfaced pedicles, scoliosis, and mild metaphyseal abnormalities in the pelvis, resulting from a heterozygous mutation in the TRPV4 gene on chromosome 12q24.11. This condition is also known by several exact synonyms, including Jequier Kozlowski skeletal dysplasia, Jequier-Kozlowski syndrome, SMD Kozlowski type, dysmorphism arthrogryposis skeletal maturation advanced, and skeletal dysplasia Jequier-Kozlowski type.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111555,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:alkuraya_kucinskas_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by arthrogryposis, cerebral parenchymal underdevelopment, clubfoot, and global developmental delay with severe cases being incompatible with life that has_material_basis_in homozygous or compound heterozygous mutation in the KIAA1109 gene on chromosome 4q27."" ;
    :has_exact_synonym ""ALKKUCS""@en .

","Alkuraya Kucinskas syndrome is a type of syndrome that is also an autosomal recessive disease and has a material basis in autosomal recessive inheritance. It is defined as a syndrome characterized by arthrogryposis, cerebral parenchymal underdevelopment, clubfoot, and global developmental delay, with severe cases being incompatible with life. This condition has its material basis in homozygous or compound heterozygous mutations in the KIAA1109 gene on chromosome 4q27. Additionally, Alkuraya Kucinskas syndrome has the exact synonym ALKKUCS.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111556,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:steatocystoma_multiplex rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :sebaceous_gland_disease ;
    :has_definition ""A sebaceous gland disease characterized by the presence of multiple benign sebaceous cysts that has_material_basis_in heterozygous mutation in the KRT17 gene on chromosome 17q21.2."" ;
    :has_exact_synonym ""multiple sebaceous cysts""@en,
        ""sebocystomatosis""@en .

","Steatocystoma multiplex is a type of disease that is autosomal dominant, relates to sebaceous gland conditions, and has a material basis in autosomal dominant inheritance. It is defined as a sebaceous gland disease characterized by the presence of multiple benign sebaceous cysts, which results from a heterozygous mutation in the KRT17 gene on chromosome 17q21.2. Additionally, steatocystoma multiplex is exactly synonymous with multiple sebaceous cysts and sebocystomatosis.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111557,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:charcot_marie_tooth_disease_type_2a2b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :charcot_marie_tooth_disease_type_2 ;
    :has_definition ""A Charcot-Marie-Tooth disease type 2 characterized by onset of peripheral neuropathy in the first years of life that has_material_basis_in homozygous or compound heterozygous mutation in the MFN2 gene on chromosome 1p36.22."" ;
    :has_exact_synonym ""AR-CMT2, Ouvrier type""@en,
        ""CMT2A2B""@en,
        ""Charcot-Marie-Tooth disease, axonal, type 2A2B""@en,
        ""SEOAN due to MFN2 deficiency""@en,
        ""autosomal recessive Charcot-Marie-Tooth disease, Ouvrier type""@en,
        ""severe early-onset axonal neuropathy due to MFN2 deficiency""@en .

","Charcot Marie Tooth disease type 2A2B is a subtype of Charcot Marie Tooth disease type 2 and is classified as an autosomal recessive disease. This particular type of disease is rooted in autosomal recessive inheritance that specifically involves a material basis. Charcot Marie Tooth disease type 2A2B is characterized by the onset of peripheral neuropathy within the first years of life, which results from homozygous or compound heterozygous mutation in the MFN2 gene located on chromosome 1p36.22. It is known by several exact synonyms including AR-CMT2, Ouvrier type; CMT2A2B; Charcot-Marie-Tooth disease, axonal, type 2A2B; SEOAN due to MFN2 deficiency; autosomal recessive Charcot-Marie-Tooth disease, Ouvrier type; and severe early-onset axonal neuropathy due to MFN2 deficiency.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111558,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:charcot_marie_tooth_disease_type_2dd rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :charcot_marie_tooth_disease_type_2 ;
    :has_definition ""A Charcot-Marie-Tooth disease type 2 characterized by neuropathy mainly affecting the lower limbs that has_material_basis_in heterozygous mutation in the ATP1A1 gene on chromosome 1p13.1."" ;
    :has_exact_synonym ""ATP1A1-related CMT2""@en,
        ""ATP1A1-related autosomal dominant Charcot-Marie-Tooth disease type 2""@en,
        ""CMT2DD""@en,
        ""Charcot-Marie-Tooth disease, axonal, type 2DD""@en,
        ""Charcot-Marie-Tooth neuropathy, type 2DD""@en .

","Charcot Marie Tooth disease type 2DD is a subtype of Charcot Marie Tooth disease type 2 and also falls under the category of autosomal dominant diseases. This specific condition is characterized by a neuropathy that predominantly affects the lower limbs, which is due to a heterozygous mutation in the ATP1A1 gene located on chromosome 1p13.1. It is synonymous with several terms, including ATP1A1-related CMT2, ATP1A1-related autosomal dominant Charcot-Marie-Tooth disease type 2, CMT2DD, Charcot-Marie-Tooth disease, axonal, type 2DD, and Charcot-Marie-Tooth neuropathy, type 2DD.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111559,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:charcot_marie_tooth_disease_type_2ee rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :charcot_marie_tooth_disease_type_2 ;
    :has_definition ""A Charcot-Marie-Tooth disease type 2 characterized by slowly progressive axonal neuropathy primarily affecting the lower limbs with onset in the first or second decades of life that has_material_basis_in homozygous or compound heterozygous mutation in the MPV17 gene on chromosome 2p23.3."" ;
    :has_exact_synonym ""CMT2EE""@en,
        ""Charcot-Marie-Tooth disease, axonal, type 2EE""@en .

","Charcot Marie Tooth disease type 2EE is a subtype of Charcot Marie Tooth disease type 2 and falls under the broader category of autosomal recessive diseases. It is characterized by a specific type of inheritance, which is at least partially based on autosomal recessive genetics. This disease is defined as a Charcot-Marie-Tooth disease type 2 that is marked by a slowly progressive axonal neuropathy primarily affecting the lower limbs, with the onset occurring in the first or second decades of life. This condition is caused by homozygous or compound heterozygous mutations in the MPV17 gene located on chromosome 2p23.3. Charcot Marie Tooth disease type 2EE is also known by its exact synonyms, CMT2EE and Charcot-Marie-Tooth disease, axonal, type 2EE.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111560,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:charcot_marie_tooth_disease_type_1g rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :charcot_marie_tooth_disease_type_1 ;
    :has_definition ""A Charcot-Marie-Tooth disease type 1 characterized by distal muscle weakness and atrophy with onset in the first or second decade of life that has_material_basis_in heterozygous mutation in the PMP2 gene on chromosome 8q21.13."" ;
    :has_exact_synonym ""CMT1G""@en,
        ""PMP2-related CMT1""@en,
        ""PMP2-related Charcot-Marie-Tooth disease type 1""@en,
        ""PMP2-related Charcot-Marie-Tooth neuropathy type 1""@en,
        ""PMP2-related hereditary motor and sensory neuropathy type 1""@en .

","Charcot Marie Tooth disease type 1G is a subtype of Charcot Marie Tooth disease type 1 and an autosomal dominant disease characterized by specific traits. These traits include a material basis in autosomal dominant inheritance and symptoms such as muscle weakness. Specifically, Charcot Marie Tooth disease type 1G is defined as a Charcot-Marie-Tooth disease type 1 characterized by distal muscle weakness and atrophy, which begins in the first or second decade of life. This condition has a material basis in a heterozygous mutation in the PMP2 gene on chromosome 8q21.13. Moreover, Charcot Marie Tooth disease type 1G is also known by several exact synonyms: CMT1G, PMP2-related CMT1, PMP2-related Charcot-Marie-Tooth disease type 1, PMP2-related Charcot-Marie-Tooth neuropathy type 1, and PMP2-related hereditary motor and sensory neuropathy type 1.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111561,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:stiff_skin_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :skin_disease ;
    :has_definition ""A skin disease characterized by hard, thick skin, usually over the entire body, limiting joint mobility and causing flexion contractures that has_material_basis_in heterozygous mutation in the FBN1 gene on chromosome 15q21.1."" ;
    :has_exact_synonym ""SSKS""@en .

","Stiff skin syndrome (SSKS) is a type of skin disease that falls under the category of autosomal dominant diseases and is specifically characterized by autosomal dominant inheritance. It is defined as a skin disease marked by hard, thick skin that typically covers the entire body, which limits joint mobility and leads to flexion contractures. This condition is caused by a heterozygous mutation in the FBN1 gene located on chromosome 15q21.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111562,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:overhydrated_hereditary_stomatocytosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :macrocytic_anemia ;
    :has_definition ""A macrocytic anemia characterized by macrocytic hemolytic anemia and monovalent cation leak from red blood cells that has_material_basis_in heterozygous mutation in the RHAG gene on chromosome 6p12.3."" ;
    :has_exact_synonym ""OHS""@en,
        ""potassium sodium disorder of erythrocyte""@en,
        ""stomatocytosisIOHST""@en .

","Overhydrated hereditary stomatocytosis (OHS), also known as potassium sodium disorder of erythrocyte or stomatocytosisIOHST, is a type of autosomal dominant disease, macrocytic anemia, and is characterized by a condition that inherently has a material basis in some form of autosomal dominant inheritance. It is defined as a macrocytic anemia characterized by macrocytic hemolytic anemia and a monovalent cation leak from red blood cells, attributing this condition to a heterozygous mutation in the RHAG gene located on chromosome 6p12.3.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111563,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:sturge_weber_syndrome rdfs:subClassOf :vascular_disease ;
    :has_definition ""A vascular disease characterized by intracranial vascular anomaly, leptomeningeal angiomatosis, facial cutaneous vascular malformations, and glaucoma that has_material_basis_in somatic mutation in the GNAQ gene on chromosome 9q21.2."" ;
    :has_exact_synonym ""SWS""@en,
        ""Sturge-Weber-Dimitri syndrome""@en,
        ""Sturge-Weber-Krabbe angiomatosis""@en,
        ""Sturge-Weber-Krabbe syndrome""@en,
        ""encephalofacial angiomatosis""@en,
        ""encephalotrigeminal angiomatosis""@en,
        ""fourth phacomatosis""@en,
        ""leptomeningeal angiomatosis""@en,
        ""meningeal capillary angiomatosis""@en .

","Sturge-Weber syndrome is a type of vascular disease characterized by an intracranial vascular anomaly, leptomeningeal angiomatosis, facial cutaneous vascular malformations, and glaucoma. This condition has a material basis in a somatic mutation in the GNAQ gene located on chromosome 9q21.2. It is exactly synonymous with several terms, including SWS, Sturge-Weber-Dimitri syndrome, Sturge-Weber-Krabbe angiomatosis, Sturge-Weber-Krabbe syndrome, encephalofacial angiomatosis, encephalotrigeminal angiomatosis, fourth phacomatosis, leptomeningeal angiomatosis, and meningeal capillary angiomatosis.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111564,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hypoplastic_or_aplastic_tibia_with_polydactyly rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by preaxial polydactyly of the hands and feet and hypoplasia or aplasia of the tibia that has_material_basis_in heterozygous mutation in the SHH regulatory region (ZRS) located in intron 5 of the LMBR1 gene on chromosome 7q36.3."" ;
    :has_exact_synonym ""Werner mesomelic syndrome""@en,
        ""absence of tibia with polydactyly""@en,
        ""absent tibia-polydactyly syndrome""@en,
        ""hypoplastic tibiae-postaxial polydactyly syndrome""@en,
        ""tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome""@en .

","Hypoplastic or aplastic tibia with polydactyly, also known as Werner mesomelic syndrome, absence of tibia with polydactyly, absent tibia-polydactyly syndrome, hypoplastic tibiae-postaxial polydactyly syndrome, and tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome, is identified as a type of autosomal dominant disease, syndrome, and something that fundamentally has a material basis in autosomal dominant inheritance. This condition is defined as a syndrome characterized by preaxial polydactyly of the hands and feet and hypoplasia or aplasia of the tibia, which is caused by a heterozygous mutation in the SHH regulatory region (ZRS) located in intron 5 of the LMBR1 gene on chromosome 7q36.3.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111565,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:trichodontoosseous_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by curly kinky hair at birth, enamel hypoplasia, taurodontism, thickening of cortical bones and variable expression of craniofacial morphology that has_material_basis_in heterozygous mutation in the DLX3 gene on chromosome 17q21.33."" ;
    :has_exact_synonym ""TDO syndrome""@en,
        ""tricho-dento-osseous syndrome""@en .

","Trichodontoosseous syndrome, also known exactly as TDO syndrome or tricho-dento-osseous syndrome, is a type of autosomal dominant disease and a syndrome that has its material basis in autosomal dominant inheritance. It is defined as a syndrome characterized by curly kinky hair at birth, enamel hypoplasia, taurodontism, thickening of cortical bones, and variable expression of craniofacial morphology, which is caused by a heterozygous mutation in the DLX3 gene on chromosome 17q21.33.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111566,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_isolated_trichomegaly rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :eyelid_disease ;
    :has_definition ""An eyelid disease characterized by prolonged anagen phase of the eyelash hairs resulting in extremely long eyelashes that has_material_basis_in homozygous or compund heterozygous mutation in the FGF5 gene on chromosome 4q21.21."" ;
    :has_exact_synonym ""TCMGLY""@en,
        ""long eyelashes""@en .

","Familial isolated trichomegaly, which has the exact synonyms TCMGLY and long eyelashes, is a type of disease that falls under the categories of autosomal recessive disease, eyelid disease, and anything that at least has a material basis in some form of autosomal recessive inheritance. It is defined as an eyelid disease characterized by a prolonged anagen phase of the eyelash hairs, resulting in extremely long eyelashes. This condition has its material basis in homozygous or compound heterozygous mutations in the FGF5 gene on chromosome 4q21.21.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111567,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:retinal_vasculopathy_with_cerebral_leukodystrophy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :vascular_disease ;
    :has_definition ""A vascular disease characterized by adult onset of microvascular endotheliopathy resulting in central nervous system degeneration with progressive loss of vision, stroke, motor impairment, and cognitive decline that has_material_basis_in heterozygous mutation in TREX1 on chromosome 3p21.31."" ;
    :has_exact_synonym ""CRV""@en,
        ""RVCL""@en,
        ""RVCL-S""@en,
        ""hereditary cerebroretinal vasculopathy""@en,
        ""retinal vasculopathy and cerebral leukoencephalopathy""@en,
        ""retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations""@en,
        ""retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena""@en .

","Retinal vasculopathy with cerebral leukodystrophy (RVCL) is a type of disease that is both autosomal dominant and vascular in nature. It can also be described as something that at least has a material basis in autosomal dominant inheritance. RVCL is defined as a vascular disease characterized by adult onset of microvascular endotheliopathy leading to central nervous system degeneration with progressive loss of vision, stroke, motor impairment, and cognitive decline. This condition has its material basis in a heterozygous mutation in the TREX1 gene located on chromosome 3p21.31. RVCL is known by several exact synonyms including CRV, RVCL-S, hereditary cerebroretinal vasculopathy, retinal vasculopathy and cerebral leukoencephalopathy, retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, and retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111568,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_vertical_talus rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :connective_tissue_disease,
        :physical_disorder ;
    :has_definition ""A connective tissue disease characterized by dislocation of the talonavicular joint with vertical orientation of the talus and rigid dorsal dislocation of the navicular, equinus deformity of the calcaneus, abduction deformity of the forefoot, and contracture of the soft tissues of the hind- and mid-foot that has_material_basis_in heterozygous mutation in the HOXD10 gene on chromosome 2q31.1."" ;
    :has_exact_synonym ""CVT""@en,
        ""congenital convex foot""@en,
        ""congenital convex pes valgus""@en,
        ""congenital rocker-bottom foot""@en,
        ""rocker-bottom foot deformity""@en .

","Congenital vertical talus is a type of autosomal dominant disease, a physical disorder, and a connective tissue disease. It is characterized by a condition that fundamentally has a material basis in autosomal dominant inheritance and involves abnormalities of prenatal development or birth. Specifically, this disease is defined by the dislocation of the talonavicular joint with a vertical orientation of the talus and rigid dorsal dislocation of the navicular, equinus deformity of the calcaneus, abduction deformity of the forefoot, and contracture of the soft tissues of the hind- and mid-foot. This condition is caused by a heterozygous mutation in the HOXD10 gene on chromosome 2q31.1. Congenital vertical talus is also known by several exact synonyms, including CVT, congenital convex foot, congenital convex pes valgus, congenital rocker-bottom foot, and rocker-bottom foot deformity.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111569,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_vitreoretinochoroidopathy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_retinal_dystrophy ;
    :has_definition ""A hereditary retinal dystrophy characterized by abnormal chorioretinal hypopigmentation and hyperpigmentation typically lying between the vortex veins and the ora serrata for 360 degrees and other ocular developmental anomalies that has_material_basis_in heterozygous mutation in the BEST1 gene on chromosome 11q12.3."" ;
    :has_exact_synonym ""ADVIRC""@en,
        ""VRCP autosomal dominant""@en,
        ""vitreoretinochoroidopathy dominant""@en,
        ""vitreoretinochoroidopathy with microcornea, glaucoma, and cataract""@en,
        ""vitreoretinochoroidopathy, autosomal dominant, with nanophthalmos""@en .

","Autosomal dominant vitreoretinochoroidopathy (ADVIRC) is a type of autosomal dominant disease and also falls under the category of hereditary retinal dystrophy. It is characterized as a condition that inherently has a material basis in autosomal dominant inheritance. Specifically, ADVIRC is defined as a hereditary retinal dystrophy that features abnormal chorioretinal hypopigmentation and hyperpigmentation typically situated between the vortex veins and the ora serrata for 360 degrees, along with other ocular developmental anomalies. These anomalies have their material basis in a heterozygous mutation in the BEST1 gene on chromosome 11q12.3. The condition is known by several exact synonyms, including VRCP autosomal dominant, vitreoretinochoroidopathy dominant, vitreoretinochoroidopathy with microcornea, glaucoma, and cataract, as well as vitreoretinochoroidopathy, autosomal dominant, with nanophthalmos.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111570,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:snowflake_vitreoretinal_degeneration rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :eye_degenerative_disease ;
    :has_definition ""An eye degenerative disease characterized by fibrillar degeneration of the vitreous humor, early-onset cataract, minute crystalline deposits in the neurosensory retina, and retinal detachment that has_material_basis_in heterozygous mutation in KCNJ13 on chromosome 2q37.1."" ;
    :has_exact_synonym ""SVD""@en,
        ""vitreoretinal degeneration, snowflake type""@en .

","Snowflake vitreoretinal degeneration is a type of autosomal dominant disease, eye degenerative disease, and something that at least has a material basis in some autosomal dominant inheritance. It is characterized by fibrillar degeneration of the vitreous humor, early-onset cataract, minute crystalline deposits in the neurosensory retina, and retinal detachment, which has a material basis in a heterozygous mutation in KCNJ13 on chromosome 2q37.1. Furthermore, snowflake vitreoretinal degeneration has exact synonyms SVD and vitreoretinal degeneration, snowflake type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111571,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:weyers_acrofacial_dysostosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :acrofacial_dysostosis,
        :autosomal_dominant_disease ;
    :has_definition ""An acrofacial dysostosis characterized by dental anomalies, nail dystrophy, postaxial polydactyly, and mild short stature that has_material_basis_in heterozygous mutation in the genes EVC2 or EVC on chromosome 4p16.2."" ;
    :has_exact_synonym ""Curry-Hall syndrome""@en,
        ""WAD""@en,
        ""Weyers acrodental dysostosis""@en,
        ""acrofacial dysostosis, Weyers type""@en .

","Weyers acrofacial dysostosis is an autosomal dominant disease and a type of acrofacial dysostosis that stems from autosomal dominant inheritance. Specifically, it is characterized by dental anomalies, nail dystrophy, postaxial polydactyly, and mild short stature, resulting from heterozygous mutations in the EVC2 or EVC genes located on chromosome 4p16.2. This condition is also known by several exact synonyms: Curry-Hall syndrome, WAD, Weyers acrodental dysostosis, and acrofacial dysostosis, Weyers type.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111572,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_woolly_hair_syndrome rdfs:subClassOf :hair_disease ;
    :has_definition ""A hair disease characterized by fine and tightly curled hair that grows slowly and stops growing after a few inches with hair shafts that display trichorrhexis nodosa and tapered ends."" ;
    :has_exact_synonym ""familial wooly hair syndrome""@en,
        ""hereditary woolly hair syndrome""@en,
        ""hereditary wooly hair syndrome""@en,
        ""woolly hair""@en,
        ""wooly hair""@en .

","Familial woolly hair syndrome is a type of hair disease characterized by fine and tightly curled hair that grows slowly and stops growing after a few inches, with hair shafts that display trichorrhexis nodosa and tapered ends. It is also known by exact synonyms including familial wooly hair syndrome, hereditary woolly hair syndrome, hereditary wooly hair syndrome, woolly hair, and wooly hair.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111573,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_woolly_hair rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_woolly_hair_syndrome ;
    :has_definition ""A familial woolly hair syndrome that has_material_basis_in heterozygous mutation in the KRT74 gene on chromosome 12q13.13."" ;
    :has_exact_synonym ""ADWH""@en .

","Autosomal dominant woolly hair is a type of autosomal dominant disease and a form of familial woolly hair syndrome, which is characterized by at least having a material basis in some autosomal dominant inheritance. It is defined as a familial woolly hair syndrome that has its material basis in a heterozygous mutation in the KRT74 gene located on chromosome 12q13.13. Additionally, autosomal dominant woolly hair is exactly synonymous with ADWH.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111574,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_woolly_hair_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :familial_woolly_hair_syndrome ;
    :has_definition ""A familial woolly hair syndrome that has_material_basis_in homozygous or compound heterozygous mutation in the KRT24 gene on chromosome 17q21.2."" ;
    :has_exact_synonym ""ARWH3""@en .

","Autosomal recessive woolly hair 3 is a type of autosomal recessive disease and is also a type of familial woolly hair syndrome. It is characterized by a condition that has its material basis in autosomal recessive inheritance. Specifically, autosomal recessive woolly hair 3, which has the exact synonym ARWH3, is defined as a familial woolly hair syndrome that originates from homozygous or compound heterozygous mutations in the KRT24 gene located on chromosome 17q21.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111575,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dehydrated_hereditary_stomatocytosis rdfs:subClassOf :hemolytic_anemia ;
    :has_definition ""A hemolytic anemia characterized by altered intracellular cation content and cellular dehydration of erythocytes resulting in increased mean corpuscular hemoglobin concentrations and altered cell shapes."" ;
    :has_exact_synonym ""hereditary desiccytosis""@en,
        ""hereditary xerocytosis""@en .

","Dehydrated hereditary stomatocytosis is a type of hemolytic anemia, which is defined as a hemolytic anemia characterized by altered intracellular cation content and cellular dehydration of erythrocytes. This results in increased mean corpuscular hemoglobin concentrations and altered cell shapes. It is also exactly synonymous with hereditary desiccytosis and hereditary xerocytosis.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111576,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dehydrated_hereditary_stomatocytosis_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dehydrated_hereditary_stomatocytosis ;
    :has_definition ""A dehydrated hereditary stomatocytosis that has_material_basis_in heterozygous mutation in the PIEZO1 gene on chromosome 16q24.3."" ;
    :has_exact_synonym ""PSHK1""@en,
        ""dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema""@en,
        ""pseudohyperkalemia edinburgh""@en,
        ""pseudohyperkalemia familial 1, due to red cell leak""@en .

","Dehydrated hereditary stomatocytosis 1 (DHS1) is a type of autosomal dominant disease and also a specific form of dehydrated hereditary stomatocytosis. It is characterized by having a material basis in autosomal dominant inheritance. DHS1 is defined by a heterozygous mutation in the PIEZO1 gene located on chromosome 16q24.3. Furthermore, DHS1 is known by several exact synonyms, including PSHK1, dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema, pseudohyperkalemia Edinburgh, and pseudohyperkalemia familial 1, due to red cell leak.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111577,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dehydrated_hereditary_stomatocytosis_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :dehydrated_hereditary_stomatocytosis ;
    :has_definition ""A dehydrated hereditary stomatocytosis that has_material_basis_in heterozygous mutation in the KCNN4 gene on chromosome 19q13.31."" ;
    :has_exact_synonym ""desiccytosis Gardos""@en,
        ""xerocytosis Gardos""@en .

","Dehydrated hereditary stomatocytosis 2 is a type of autosomal dominant disease and also a specific form of dehydrated hereditary stomatocytosis, with its nature rooted in autosomal dominant inheritance. It is defined as a dehydrated hereditary stomatocytosis that results from a heterozygous mutation in the KCNN4 gene located on chromosome 19q13.31. Furthermore, this condition is precisely known by the synonyms desiccytosis Gardos and xerocytosis Gardos.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111578,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gillespie_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        :autosomal_genetic_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by iris hypoplasia, congenital hypotonia, cerebellar hypoplasia, variably cognitive impairment, and ataxia that has_material_basis_in heterozygous, homozygous, or compound heterozygous mutation in the ITPR1 gene on chromosome 3p26.1."" ;
    :has_exact_synonym ""GLSP""@en,
        ""aniridia, cerebellar ataxia and mental deficiency""@en,
        ""aniridia-cerebellar ataxia-intellectual disability syndrome""@en .

","Gillespie syndrome, a type of autosomal genetic disease and syndrome, is fundamentally linked to autosomal inheritance. It is defined as a syndrome marked by iris hypoplasia, congenital hypotonia, cerebellar hypoplasia, variably cognitive impairment, and ataxia, stemming from heterozygous, homozygous, or compound heterozygous mutations in the ITPR1 gene located on chromosome 3p26.1. This condition is also precisely known as GLSP, aniridia, cerebellar ataxia and mental deficiency, and aniridia-cerebellar ataxia-intellectual disability syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111579,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:asthma_nasal_polyps_and_aspirin_intolerance rdfs:subClassOf :respiratory_system_disease ;
    :has_definition ""A respiratory system disease characterized by asthma, aspirin-induced bronchoconstriction, and nasal polyps."" ;
    :has_exact_synonym ""ASA triad""@en .

","Asthma nasal polyps and aspirin intolerance is a type of respiratory system disease characterized by asthma, aspirin-induced bronchoconstriction, and nasal polyps. This condition is also exactly synonymous with ASA triad.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111580,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:behr_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :nervous_system_disease ;
    :has_definition ""A nervous system disease characterized by early-onset optic atrophy, ataxia, pyramidal signs, spasticity, and intellectual disability that has_material_basis_in homozygous or compound heterozygous mutation in the OPA1 gene on chromosome 3q29."" ;
    :has_exact_synonym ""Abortive cerebellar ataxia (BEHRS)""@en,
        ""BEHRS""@en,
        ""optic atrophy in early childhood, associated with ataxia, spasticity, mental retardation, and posterior column sensory loss""@en,
        ""optic atrophy, infantile hereditary, Behr complicated form of""@en .

","Behr syndrome is a type of disease that falls under the category of both an autosomal recessive disease and a nervous system disease. It specifically has a material basis in autosomal recessive inheritance. This condition is defined by a nervous system disease characterized by early-onset optic atrophy, ataxia, pyramidal signs, spasticity, and intellectual disability. These symptoms are the result of homozygous or compound heterozygous mutations in the OPA1 gene located on chromosome 3q29. Behr syndrome is known by several exact synonyms, including Abortive cerebellar ataxia (BEHRS), BEHRS, optic atrophy in early childhood associated with ataxia, spasticity, mental retardation, and posterior column sensory loss, and optic atrophy, infantile hereditary, Behr complicated form of.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111581,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:c_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by trigonocephaly, psychomotor retardation, hypotonia, variable cardiac defects, redundant skin, and dysmorphic facial features that has_material_basis_in heterozygous mutation in the CD96 gene on chromosome 3q13.1-q13.2."" ;
    :has_exact_synonym ""OTCS""@en,
        ""Opitz C trigonocephaly""@en,
        ""Opitz trigonocephaly C syndrome""@en,
        ""Opitz trigonocephaly syndrome""@en,
        ""trigonocephaly C syndrome""@en .

","C syndrome is a type of autosomal dominant disease, syndrome, and something that at least has a material basis in some autosomal dominant inheritance. It is defined as a syndrome characterized by trigonocephaly, psychomotor retardation, hypotonia, variable cardiac defects, redundant skin, and dysmorphic facial features, which has a material basis in a heterozygous mutation in the CD96 gene on chromosome 3q13.1-q13.2. Furthermore, C syndrome has several exact synonyms including OTCS, Opitz C trigonocephaly, Opitz trigonocephaly C syndrome, Opitz trigonocephaly syndrome, and trigonocephaly C syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111582,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_arterial_and_articular_multiple_calcification_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by adult onset of calcification of arteries in the lower extremities and of the hand and foot capsule joints that has_material_basis_in homozygous or compound heterozygous mutation in the NT5E gene on chromosome 6q14.3."" ;
    :has_exact_synonym ""CALJA""@en,
        ""arterial calcification and distal joint calcification""@en,
        ""arterial calcification due to CD73 deficiency""@en,
        ""arterial calcification due to deficiency of CD73""@en,
        ""calcification of joints and arteries""@en .

","Hereditary Arterial and Articular Multiple Calcification Syndrome is a type of syndrome that falls under the category of autosomal recessive diseases. It is characterized by adult onset of calcification of arteries in the lower extremities and of the hand and foot capsule joints, which is due to homozygous or compound heterozygous mutation in the NT5E gene on chromosome 6q14.3. This syndrome is also known by several exact synonyms: CALJA, arterial calcification and distal joint calcification, arterial calcification due to CD73 deficiency, arterial calcification due to deficiency of CD73, and calcification of joints and arteries.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111583,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:carboxypeptidase_n_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :plasma_protein_metabolism_disease ;
    :has_definition ""A plasma protein metabolism disease characterized by low levels of carboxypeptidase N in the serum that may result in episodic angioedema, chronic urticaria, asthma and/or allergic hypersensitivity that has_material_basis_in homozygous or compound heterozygous mutation in the CPN1 gene on chromosome 10q24.2."" ;
    :has_exact_synonym ""anaphylotoxin inactivator deficiency""@en,
        ""deficiency of carboxypeptidase B""@en .

","Carboxypeptidase N deficiency is a type of autosomal recessive disease and a type of plasma protein metabolism disease, which also falls under a category that has at least a material basis in autosomal recessive inheritance. This condition is defined as a plasma protein metabolism disease characterized by low levels of carboxypeptidase N in the serum, which may result in episodic angioedema, chronic urticaria, asthma, and/or allergic hypersensitivity. The disease has its material basis in homozygous or compound heterozygous mutations in the CPN1 gene located on chromosome 10q24.2. Additionally, carboxypeptidase N deficiency is exactly synonymous with anaphylotoxin inactivator deficiency and deficiency of carboxypeptidase B.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111584,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dilated_cardiomyopathy_hypergonadotropic_hypogonadism_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by dilated cardiomyopathy and hypergonadotropic hypogonadism that has_material_basis_in heterozygous mutation in the LMNA gene on chromosome 1q22."" ;
    :has_exact_synonym ""Malouf syndrome""@en,
        ""Najjar syndrome""@en,
        ""cardiogenital syndrome""@en,
        ""cardiomyopathy eith primary testicular failure""@en,
        ""congestive cardiomyopathy with hypergonadotropic hypogonadism""@en,
        ""dilated cardiomyopathy with hypergonadotropic hypogonadism""@en,
        ""dilated cardiomyopathy with premature ovarian failure""@en,
        ""genital anomaly with cardiomyopathy""@en .

","Dilated cardiomyopathy hypergonadotropic hypogonadism syndrome is a type of syndrome and an autosomal dominant disease that has a material basis in autosomal dominant inheritance. This syndrome is characterized by dilated cardiomyopathy and hypergonadotropic hypogonadism, with its material basis in a heterozygous mutation in the LMNA gene on chromosome 1q22. It is also known by several exact synonyms: Malouf syndrome, Najjar syndrome, cardiogenital syndrome, cardiomyopathy with primary testicular failure, congestive cardiomyopathy with hypergonadotropic hypogonadism, dilated cardiomyopathy with hypergonadotropic hypogonadism, dilated cardiomyopathy with premature ovarian failure, and genital anomaly with cardiomyopathy.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111585,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:carnitine_acylcarnitine_translocase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :lipid_metabolism_disorder ;
    :has_definition ""A lipid metabolism disorder characterized by impaired long-chain fatty acid ozidation resulting in fasting-induced hypoketotic hypoglycemia, hyperammonemia, elevated creatine kinase and transaminases, dicarboxylic aciduria, very low free carnitine and abnormal acylcarnitine profile with marked elevation of the long-chain acylcarnitines that has_material_basis_in homozygous or compound heterozygous mutation in the SLC25A20 gene on chromosome 3p21.31."" ;
    :has_exact_synonym ""CACT deficiency""@en,
        ""CACTD""@en .

","Carnitine acylcarnitine translocase deficiency, also known precisely as CACT deficiency or CACTD, is a type of autosomal recessive disease and a specific lipid metabolism disorder. This condition is characterized by a material basis in autosomal recessive inheritance and is defined as a lipid metabolism disorder that results in impaired long-chain fatty acid oxidation. This impairment leads to fasting-induced hypoketotic hypoglycemia, hyperammonemia, elevated creatine kinase and transaminases, dicarboxylic aciduria, very low free carnitine, and an abnormal acylcarnitine profile with a marked elevation of long-chain acylcarnitines. The disorder stems from homozygous or compound heterozygous mutation in the SLC25A20 gene located on chromosome 3p21.31.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111586,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:martsolf_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by intellectual deficit, congenital cataract, and hypogonadotropic hypogonadism that has_material_basis_in homozygous or compound heterozygous mutation in the RAB3GAP2 gene on chromosome 1q41."" ;
    :has_exact_synonym ""cataract-intellectual disability-hypogonadism syndrome""@en .

","Martsolf syndrome is a type of syndrome and autosomal recessive disease that at least has a material basis in some autosomal recessive inheritance. It is characterized by intellectual deficit, congenital cataract, and hypogonadotropic hypogonadism, which has its material basis in homozygous or compound heterozygous mutation in the RAB3GAP2 gene on chromosome 1q41. Additionally, Martsolf syndrome has an exact synonym: cataract-intellectual disability-hypogonadism syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111587,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:gordon_holmes_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :inherited_metabolic_disorder ;
    :has_definition ""An inherited metabolic disorder characterized by progressive cognitive decline, dementia, hypogonadotropic hypogonadism, and variable movement disorders resulting from disordered ubiquitination that has_material_basis_in homozygous or compound heterozygous mutation in the RNF216 gene on chromosome 7p22.1."" ;
    :has_exact_synonym ""CAHH""@en,
        ""GDHS""@en,
        ""LHRH deficiency and ataxia""@en,
        ""cerebellar ataxia-hypogonadism syndrome""@en,
        ""luteinizing hormone-releasing hormone deficiency with ataxia""@en .

","Gordon Holmes syndrome is a type of autosomal recessive disease and an inherited metabolic disorder that has a material basis in autosomal recessive inheritance. It is defined as an inherited metabolic disorder characterized by progressive cognitive decline, dementia, hypogonadotropic hypogonadism, and variable movement disorders resulting from disordered ubiquitination. This condition is caused by homozygous or compound heterozygous mutation in the RNF216 gene on chromosome 7p22.1. Gordon Holmes syndrome is also known by several exact synonyms including CAHH, GDHS, LHRH deficiency and ataxia, cerebellar ataxia-hypogonadism syndrome, and luteinizing hormone-releasing hormone deficiency with ataxia.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111588,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:greenberg_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :inherited_metabolic_disorder ;
    :has_definition ""An inherited metabolic disorder characterized by a defect in cholesterol biosynthesis resulting in fetal hydrops, severe shortening of all long bones with a moth-eaten radiographic appearance, platyspondyly, disorganization of chondroosseous calcification, and ectopic ossification centers that has_material_basis_in homozygous or compound heterozygous mutation in LBR on chromosome 1q42.12."" ;
    :has_exact_synonym ""GRBGD""@en,
        ""Greenberg skeletal dysplasia""@en,
        ""HEM dysplasia""@en,
        ""Skeletal dysplasia, Greenberg type""@en,
        ""autosomal recessive lethal chondrodystrophy with congenital hydrops""@en,
        ""hydrops, ectopic calcification, moth-eaten skeletal dysplasia""@en,
        ""hydrops-ectopic calcification-motheaten syndrome""@en .

","Greenberg dysplasia is a type of autosomal recessive disease, inherited metabolic disorder, and something that at least has a material basis in some autosomal recessive inheritance. It is defined as an inherited metabolic disorder characterized by a defect in cholesterol biosynthesis resulting in fetal hydrops, severe shortening of all long bones with a moth-eaten radiographic appearance, platyspondyly, disorganization of chondroosseous calcification, and ectopic ossification centers. This condition has its material basis in homozygous or compound heterozygous mutation in LBR on chromosome 1q42.12. Additionally, Greenberg dysplasia is known by several exact synonyms including GRBGD, Greenberg skeletal dysplasia, HEM dysplasia, Skeletal dysplasia, Greenberg type, autosomal recessive lethal chondrodystrophy with congenital hydrops, hydrops, ectopic calcification, moth-eaten skeletal dysplasia, and hydrops-ectopic calcification-motheaten syndrome.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111589,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:coach_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by autosomal recessive inheritance of cerebellar vermis hypo/aplasia, oligophrenia, ataxia, ocular coloboma, and hepatic fibrosis that has_material_basis_in homozygous or compound heterozygous mutation in one of 3 genes (TMEM67, CC2D2A, RPGRIP1L)."" ;
    :has_exact_synonym ""Gentile syndrome""@en,
        ""JS-H""@en,
        ""Joubert syndrome with congenital hepatic fibrosis""@en,
        ""Joubert syndrome with hepatic defect""@en,
        ""cerebellar vermis hypo/aplasia, oligophrenia, congenital ataxia, ocular coloboma, and hepatic fibrosis""@en .

","Coach syndrome is a type of autosomal recessive disease and syndrome, which specifically has a material basis in autosomal recessive inheritance. It is defined as a syndrome characterized by autosomal recessive inheritance of cerebellar vermis hypo/aplasia, oligophrenia, ataxia, ocular coloboma, and hepatic fibrosis, resulting from homozygous or compound heterozygous mutation in one of three genes: TMEM67, CC2D2A, or RPGRIP1L. Moreover, Coach syndrome is also known by several exact synonyms, including Gentile syndrome, JS-H, Joubert syndrome with congenital hepatic fibrosis, Joubert syndrome with hepatic defect, and cerebellar vermis hypo/aplasia, oligophrenia, congenital ataxia, ocular coloboma, and hepatic fibrosis.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111590,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cohen_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by facial dysmorphism, microcephaly, truncal obesity, impaired intellectual development, progressive retinopathy, and intermittent congenital neutropenia that has_material_basis_in homozygous or compound heterozygous mutation in the VPS13B gene on chromosome 8q22.2."" ;
    :has_exact_synonym ""COH1""@en,
        ""Hypotonia, obesity, and prominent incisors""@en,
        ""Pepper syndrome""@en .

","Cohen syndrome is a type of autosomal recessive disease and syndrome, specifically rooted in autosomal recessive inheritance. It is characterized by facial dysmorphism, microcephaly, truncal obesity, impaired intellectual development, progressive retinopathy, and intermittent congenital neutropenia, stemming from homozygous or compound heterozygous mutation in the VPS13B gene located on chromosome 8q22.2. Cohen syndrome is also precisely known as COH1, Hypotonia, obesity, and prominent incisors, and Pepper syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111591,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_heart_defects_hamartomas_of_tongue_and_polysyndactyly rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :physical_disorder,
        :syndrome ;
    :has_definition ""A syndrome characterized by congenital heart defects, hamartomas of tongue, and polysyndactyly that has_material_basis_in homozygous or compound heterozygous mutation in the WDPCP gene on chromosome 2p15."" ;
    :has_exact_synonym ""CHDTHP""@en,
        ""Ostravik-Lindemann-Solberg syndrome""@en,
        ""heart defect-tongue hamartoma-polysyndactyly syndrome""@en .

","Congenital heart defects, hamartomas of the tongue, and polysyndactyly constitute a syndrome that is an autosomal recessive disease, a physical disorder, and is characterized by having at least a material basis in some autosomal recessive inheritance as well as a basis in some abnormality of prenatal development or birth. This syndrome is defined as a condition characterized by congenital heart defects, hamartomas of the tongue, and polysyndactyly, which has its material basis in homozygous or compound heterozygous mutation in the WDPCP gene on chromosome 2p15. Furthermore, this syndrome is also known by its exact synonyms: CHDTHP, Ostravik-Lindemann-Solberg syndrome, and heart defect-tongue hamartoma-polysyndactyly syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111592,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:plasminogen_deficiency_type_i rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by decreased serum plasminogen activity, decreased plasminogen antigen levels, and chronic mucosal pseudomembranous lesions typically manifesting as ligneous conjunctivitis that has_material_basis_in homozygous or compound heterozygous mutation in PLG on chromosome 6q26."" ;
    :has_exact_synonym ""hypoplasminogenemia""@en .

","Plasminogen deficiency type I is a syndrome that falls under the category of autosomal recessive diseases, and it specifically involves conditions that have a material basis in autosomal recessive inheritance. It is defined as a syndrome characterized by decreased serum plasminogen activity, decreased plasminogen antigen levels, and chronic mucosal pseudomembranous lesions typically manifesting as ligneous conjunctivitis. This condition is caused by homozygous or compound heterozygous mutation in the PLG gene located on chromosome 6q26. Additionally, plasminogen deficiency type I is exactly synonymous with hypoplasminogenemia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111593,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis that has_material_basis_in heterozygous mutation in the chromosome region 2q31.3-q32.1."" ;
    :has_exact_synonym ""DA10""@en,
        ""plantar flexion contracture""@en,
        ""short Achilles tendon""@en,
        ""short tendo calcaneus""@en .

","Distal arthrogryposis type 10 (DA10) is a type of distal arthrogryposis as well as a type of autosomal dominant disease. It is characterized by having a material basis in autosomal dominant inheritance, specifically due to a heterozygous mutation in the chromosome region 2q31.3-q32.1. This condition is also known by its exact synonyms including plantar flexion contracture, short Achilles tendon, and short tendo calcaneus.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111594,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_5d rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by severe camptodactyly of the hands, mild camptodactyly of the toes, extension contractures of the knee, and distinctive facial features that has_material_basis_in homozygous or compound heterozygous mutation in the ECEL1 gene on chromosome 2q37.1."" ;
    :has_exact_synonym ""DA5D""@en,
        ""distal arthrogryposis type 5 without ophthalmoparesis""@en,
        ""distal arthrogryposis type 5 without ophthalmoplegia""@en .

","Distal arthrogryposis type 5d (DA5D), also known as distal arthrogryposis type 5 without ophthalmoparesis or ophthalmoplegia, is a form of distal arthrogryposis. It is categorized as an autosomal recessive disease, which fundamentally has its material basis in autosomal recessive inheritance. The definition of distal arthrogryposis type 5d encompasses a distal arthrogryposis characterized by severe camptodactyly of the hands, mild camptodactyly of the toes, extension contractures of the knee, and distinctive facial features, arising from homozygous or compound heterozygous mutation in the ECEL1 gene on chromosome 2q37.1.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111595,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_contractural_arachnodactyly rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis,
        :physical_disorder ;
    :has_definition ""A distal arthrogryposis characterized by contractures, arachnodactyly, scoliosis, and crumpled ears that has_material_basis_in heterozygous mutation in the FBN2 gene on chromosome 5q23.3."" ;
    :has_exact_synonym ""Beals syndrome""@en,
        ""Beals-Hecht syndrome""@en,
        ""CCA""@en,
        ""arachnodactyly, contractural Beals type""@en,
        ""contractures, multiple with arachnodactyly""@en,
        ""distal arthrogryposis type 9""@en,
        ""ear anomalies-contractures-dysplasia of bone with kyphoscoliosis""@en .

","Congenital contractural arachnodactyly (CCA) is a type of distal arthrogryposis, an autosomal dominant disease, and a physical disorder. It falls under the category of diseases that have a material basis in autosomal dominant inheritance and are rooted in some abnormality of prenatal development or birth. CCA is specifically characterized by contractures, arachnodactyly, scoliosis, and crumpled ears, resulting from a heterozygous mutation in the FBN2 gene on chromosome 5q23.3. It is also known by several exact synonyms, including Beals syndrome, Beals-Hecht syndrome, CCA, arachnodactyly, contractural Beals type, contractures, multiple with arachnodactyly, distal arthrogryposis type 9, and ear anomalies-contractures-dysplasia of bone with kyphoscoliosis.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0111596,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_1 rdfs:subClassOf :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by autosomal domiant inheritance of contractures of the distal regions of the hands and feet with no facial involvement or other anomalies."" ;
    :has_exact_synonym ""DA1""@en,
        ""digitotalar dysmorphism""@en .

","Distal arthrogryposis type 1 is a type of distal arthrogryposis characterized by an autosomal dominant inheritance of contractures of the distal regions of the hands and feet, with no facial involvement or other anomalies. It has exact synonyms which include DA1 and digitotalar dysmorphism.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111597,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_1a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis_type_1 ;
    :has_definition ""A distal arthrogryposis type 1 that has_material_basis_in heterozygous mutation in the TPM2 gene on chromosome 9p13.3."" ;
    :has_exact_synonym ""DA1A""@en .

","Distal arthrogryposis type 1a, which has the exact synonym DA1A, is classified as a type of autosomal dominant disease and also falls under the category of distal arthrogryposis type 1. This specific type of condition is based on material that has autosomal dominant inheritance characteristics. Furthermore, distal arthrogryposis type 1a is defined as a distal arthrogryposis type 1 that has its material basis in a heterozygous mutation in the TPM2 gene located on chromosome 9p13.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111598,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_1b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis_type_1 ;
    :has_definition ""A distal arthrogryposis type 1 that has_material_basis_in heterozygous mutation in the MYBPC1 gene on chromosome 12q23.2."" ;
    :has_exact_synonym ""DA1B""@en .

","Distal arthrogryposis type 1b is a subtype of distal arthrogryposis type 1, which is categorized as an autosomal dominant disease. This condition specifically has a material basis in some form of autosomal dominant inheritance. Furthermore, distal arthrogryposis type 1b is defined as a distal arthrogryposis type 1 that arises from a heterozygous mutation in the MYBPC1 gene located on chromosome 12q23.2. Additionally, it is exactly synonymous with DA1B.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111599,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_2b rdfs:subClassOf :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by contractures of the distal joints of the limbs, triangular face, downslanting palpebral fissures, small mouth, and high arched palate."" ;
    :has_exact_synonym ""DA2B""@en,
        ""Freeman-Sheldon syndrome variant""@en,
        ""Sheldon-Hall syndrome""@en .

","Distal arthrogryposis type 2B is a specific type of distal arthrogryposis. It is characterized by contractures of the distal joints of the limbs, a triangular face, downslanting palpebral fissures, a small mouth, and a high arched palate. This condition is also referred to by its exact synonyms, including DA2B, Freeman-Sheldon syndrome variant, and Sheldon-Hall syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111600,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_2b1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis_type_2b ;
    :has_definition ""A distal arthrogryposis type 2B that has_material_basis_in heterozygous mutation in the TNNI2 gene on chromosome 11p15.5."" ;
    :has_exact_synonym ""DA2B1""@en .

",Distal arthrogryposis type 2b1 (DA2B1) is classified as a subtype of distal arthrogryposis type 2b and is identified as a form of autosomal dominant disease. This condition is specifically characterized by having a material basis in autosomal dominant inheritance. The definition of distal arthrogryposis type 2b1 is a distal arthrogryposis type 2B that results from a heterozygous mutation in the TNNI2 gene located on chromosome 11p15.5.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111601,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_2b2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis_type_2b ;
    :has_definition ""A distal arthrogryposis type 2B that has_material_basis_in heterozygous mutation in the TNNT3 gene on chromosome 11p15.5."" ;
    :has_exact_synonym ""DA2B2""@en .

","Distal arthrogryposis type 2b2, which is exactly synonymous with DA2B2, is classified as a type of autosomal dominant disease and falls under the category of distal arthrogryposis type 2b. It is characterized by a condition that fundamentally has a material basis in autosomal dominant inheritance. Specifically, distal arthrogryposis type 2b2 is defined as a distal arthrogryposis type 2B that results from a heterozygous mutation in the TNNT3 gene located on chromosome 11p15.5.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111602,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_2b3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis_type_2b ;
    :has_definition ""A distal arthrogryposis type 2B that has_material_basis_in heterozygous mutation in the MYH3 gene on chromosome 17p13.1."" ;
    :has_exact_synonym ""DA2B3""@en,
        ""distal arthrogryposis type 2B3 (Sheldon-Hall)""@en .

","Distal arthrogryposis type 2b3 is a type of autosomal dominant disease, specifically a subtype of distal arthrogryposis type 2b, and it is characterized by having a material basis in autosomal dominant inheritance. It is defined as a distal arthrogryposis type 2B characterized by a heterozygous mutation in the MYH3 gene on chromosome 17p13.1. Furthermore, distal arthrogryposis type 2b3 is exactly synonymous with DA2B3 and distal arthrogryposis type 2B3 (Sheldon-Hall).",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111603,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by inability to open the mouth fully and pseudocamptodactyly that has_material_basis_in heterozygous mutation in the MYH8 gene on chromosome 17p13.1."" ;
    :has_exact_synonym ""DA7""@en,
        ""Dutch-Kentucky syndrome""@en,
        ""Hecht syndrome""@en,
        ""Hecht-Beals syndrome""@en,
        ""mouth, inability to completely open, and short finger-flexor tendons""@en,
        ""trismus-pseudocamptodactyly syndrome""@en .

","Distal arthrogryposis type 7, also known exactly as DA7, Dutch-Kentucky syndrome, Hecht syndrome, Hecht-Beals syndrome, mouth, inability to completely open, and short finger-flexor tendons, and trismus-pseudocamptodactyly syndrome, is a type of distal arthrogryposis, and it is also a type of autosomal dominant disease. It has a material basis in autosomal dominant inheritance, specifically characterized by the inability to open the mouth fully and pseudocamptodactyly. This condition is due to heterozygous mutation in the MYH8 gene on chromosome 17p13.1.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111604,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:freeman_sheldon_syndrome rdfs:subClassOf :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by microstomia with a whistling appearance of the mouth, distinctive facies, club foot and joint contractures."" ;
    :has_exact_synonym ""craniocarpotarsal dysplasia""@en,
        ""craniocarpotarsal dystrophy""@en,
        ""whistling face syndrome""@en,
        ""whistling face-windmill vane hand syndrome""@en .

","Freeman Sheldon syndrome is a type of distal arthrogryposis, which is defined as a distal arthrogryposis characterized by microstomia with a whistling appearance of the mouth, distinctive facies, club foot, and joint contractures. It is also known by exact synonyms such as craniocarpotarsal dysplasia, craniocarpotarsal dystrophy, whistling face syndrome, and whistling face-windmill vane hand syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111605,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_2a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :freeman_sheldon_syndrome ;
    :has_definition ""A Freeman-Sheldon syndrome that has_material_basis_in heterozygous mutation in the MYH3 gene on chromosome 17p13.1."" ;
    :has_exact_synonym ""DA2A""@en,
        ""distal arthrogryposis type 2A (Freeman-Sheldon)""@en .

","Distal arthrogryposis type 2A, also known exactly as DA2A or distal arthrogryposis type 2A (Freeman-Sheldon), is a type of autosomal dominant disease, specifically a Freeman Sheldon syndrome. It is characterized by a material basis in autosomal dominant inheritance and is defined as a Freeman-Sheldon syndrome that arises from a heterozygous mutation in the MYH3 gene on chromosome 17p13.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111606,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_whistling_face_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :freeman_sheldon_syndrome ;
    :has_definition ""A Freeman-Sheldon syndrome that has autosomal recessive inheritance."" .

","Autosomal recessive whistling face syndrome is a type of autosomal recessive disease, a type of Freeman Sheldon syndrome, and a type that at least has a material basis in some autosomal recessive inheritance. Additionally, it is defined as a Freeman-Sheldon syndrome that has autosomal recessive inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111607,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by distal arthrogryposis with short stature and cleft palate that has_material_basis_in heterozygous mutation in the PIEZO2 gene on chromosome 18p11.22-p11.21."" ;
    :has_exact_synonym ""DA3""@en,
        ""Gordon syndrome""@en,
        ""camptodactyly-cleft palate-clubfoot syndrome""@en,
        ""distal arthrogryposis multiplex congenita type IIA""@en .

","Distal arthrogryposis type 3 is a type of distal arthrogryposis and is also classified as a type of autosomal dominant disease, which inherently has a material basis in some form of autosomal dominant inheritance. It is specifically characterized by distal arthrogryposis with short stature and cleft palate, a condition that arises from a heterozygous mutation in the PIEZO2 gene located on chromosome 18p11.22-p11.21. Furthermore, distal arthrogryposis type 3 is known by several exact synonyms, including DA3, Gordon syndrome, camptodactyly-cleft palate-clubfoot syndrome, and distal arthrogryposis multiplex congenita type IIA.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111608,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by distal arthrogryposis with ocular abnormalities that has_material_basis_in heterozygous gain of function mutation in the PIEZO2 gene on chromosome 18p11.22-p11.21."" ;
    :has_exact_synonym ""DA5""@en,
        ""DAIIB""@en,
        ""arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome""@en,
        ""distal arthrogryposis type IIB""@en,
        ""distal arthrogryposis with ophthalmoplegia""@en,
        ""oculomelic amyoplasia""@en .

","Distal Arthrogryposis Type 5 is a specific form of distal arthrogryposis and falls under the category of autosomal dominant diseases. It is characterized by distal arthrogryposis with ocular abnormalities, which are caused by a heterozygous gain of function mutation in the PIEZO2 gene located on chromosome 18p11.22-p11.21. This condition is uniquely identified by several exact synonyms, including DA5, DAIIB, arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome, distal arthrogryposis type IIB, distal arthrogryposis with ophthalmoplegia, and oculomelic amyoplasia.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111609,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_6 rdfs:subClassOf :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by distal arthrogryposis with sensorineural deafness."" ;
    :has_exact_synonym ""DA6""@en,
        ""arthrogryposis and sensorineural deafness""@en,
        ""arthrogryposis-like hand anomaly-sensorineural deafness syndrome""@en,
        ""familial hand abnormality and sensori-neural deafness""@en .

","Distal arthrogryposis type 6 is a specific type of distal arthrogryposis characterized by distal arthrogryposis with sensorineural deafness. It is also known by its exact synonyms: DA6, arthrogryposis and sensorineural deafness, arthrogryposis-like hand anomaly-sensorineural deafness syndrome, and familial hand abnormality and sensori-neural deafness.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111610,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:distal_arthrogryposis_type_4 rdfs:subClassOf :distal_arthrogryposis ;
    :has_definition ""A distal arthrogryposis characterized by distal arthrogryposis with severe scoliosis."" ;
    :has_exact_synonym ""DA4""@en,
        ""DAIID""@en,
        ""arthrogryposis-severe scoliosis syndrome""@en,
        ""distal arthrogryposis type IID""@en .

","Distal arthrogryposis type 4, which is a type of distal arthrogryposis, is characterized by distal arthrogryposis with severe scoliosis. It is exactly synonymous with DA4, DAIID, arthrogryposis-severe scoliosis syndrome, and distal arthrogryposis type IID.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111611,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_4 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by ataxic gait with spasticity, hyperreflexia of the lower limbs, and mitochondrial defects that has_material_basis_in homozygous or compound heterozygous mutation in the VPS13D gene on chromosome 1p36.22-p36.21."" ;
    :has_exact_synonym ""SCA24""@en,
        ""SCAR4""@en,
        ""SCASI""@en,
        ""autosomal recessive cerebellar ataxia-saccadic intrusion syndrome""@en,
        ""spinocerebellar ataxia 24""@en,
        ""spinocerebellar ataxia with saccadic intrusions""@en .

","Autosomal recessive spinocerebellar ataxia 4 is a type of autosomal recessive cerebellar ataxia characterized by an ataxic gait with spasticity, hyperreflexia of the lower limbs, and mitochondrial defects. This condition has a material basis in homozygous or compound heterozygous mutations in the VPS13D gene located on chromosome 1p36.22-p36.21. It is also known by several exact synonyms including SCA24, SCAR4, SCASI, autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, spinocerebellar ataxia 24, and spinocerebellar ataxia with saccadic intrusions.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111612,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_3 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by spinocerebellar ataxia with optic and cochlear degeneration that has_material_basis_in homozygous or compound heterozygous mutation in a region on chromosome 6p23-p21."" ;
    :has_exact_synonym ""SCABD""@en,
        ""SCAR3""@en,
        ""autosomal recessive spinocerebellar ataxia type 3""@en,
        ""autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome""@en,
        ""autosomal recessive spinocerebellar ataxia-blindness-hearing loss syndrome""@en .

","Autosomal recessive spinocerebellar ataxia 3 is a type of autosomal recessive cerebellar ataxia, defined as an autosomal recessive cerebellar ataxia characterized by spinocerebellar ataxia with optic and cochlear degeneration. This condition has a material basis in homozygous or compound heterozygous mutation in a region on chromosome 6p23-p21. It is also exactly synonymous with SCABD, SCAR3, autosomal recessive spinocerebellar ataxia type 3, autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome, and autosomal recessive spinocerebellar ataxia-blindness-hearing loss syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111613,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_23 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by epilepsy, intellectual disability, and gait ataxia that has_material_basis_in homozygous or compound heterozygous mutation in the TDP2 gene on chromosome 6p22.3."" ;
    :has_exact_synonym ""SCAR23""@en,
        ""autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency""@en .

","Autosomal recessive spinocerebellar ataxia 23 is a type of autosomal recessive cerebellar ataxia, which is characterized by epilepsy, intellectual disability, and gait ataxia. This condition has a material basis in homozygous or compound heterozygous mutation in the TDP2 gene on chromosome 6p22.3. It is exactly synonymous with SCAR23 and is also known as the autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111614,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_22 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia that has_material_basis_in homozygous or compound heterozygous mutation in the VWA3B gene on chromosome 2q11.2."" ;
    :has_exact_synonym ""SCAR22""@en .

","Autosomal recessive spinocerebellar ataxia 22 is a type of autosomal recessive cerebellar ataxia, which has an exact synonym, SCAR22. This condition is defined as an autosomal recessive cerebellar ataxia that has its material basis in homozygous or compound heterozygous mutation in the VWA3B gene on chromosome 2q11.2.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111615,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_24 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia that has_material_basis_in homozygous or compound heterozygous mutation in the UBA5 gene on chromosome 3q22.1."" ;
    :has_exact_synonym ""SCAR24""@en .

","Autosomal recessive spinocerebellar ataxia 24 is a type of autosomal recessive cerebellar ataxia, and it is defined as an autosomal recessive cerebellar ataxia that has its material basis in homozygous or compound heterozygous mutation in the UBA5 gene on chromosome 3q22.1. Additionally, it has the exact synonym SCAR24.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111616,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_27 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by adult onset of progressive gait difficulties and other cerebellar signs that has_material_basis_in homozygous or compound heterozygous mutation in the GDAP2 gene on chromosome 1p12."" ;
    :has_exact_synonym ""SCAR27""@en .

","Autosomal recessive spinocerebellar ataxia 27 is a type of autosomal recessive cerebellar ataxia, which has an exact synonym SCAR27. It is defined as an autosomal recessive cerebellar ataxia characterized by adult onset of progressive gait difficulties and other cerebellar signs. This condition has its material basis in homozygous or compound heterozygous mutation in the GDAP2 gene on chromosome 1p12.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111617,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_6 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by onset in infancy of nonprogressive cerebellar ataxia without intellectual disability that has_material_basis_in homozygous or compound heterozygous mutation in a region on chromosome 20q11-q13."" ;
    :has_exact_synonym ""SCAR6""@en,
        ""autosomal recessive spinocerebellar ataxia type 6""@en,
        ""infantile-onset autosomal recessive nonprogressive cerebellar ataxia""@en .

","Autosomal recessive spinocerebellar ataxia 6 is a type of autosomal recessive cerebellar ataxia characterized by an onset in infancy of nonprogressive cerebellar ataxia without intellectual disability. This condition has a material basis in homozygous or compound heterozygous mutations in a region on chromosome 20q11-q13. It is also known by its exact synonyms SCAR6, autosomal recessive spinocerebellar ataxia type 6, and infantile-onset autosomal recessive nonprogressive cerebellar ataxia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111618,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_spinocerebellar_ataxia_8 rdfs:subClassOf :autosomal_recessive_cerebellar_ataxia ;
    :has_definition ""An autosomal recessive cerebellar ataxia characterized by slowly progressive neurodegeneration resulting in gait ataxia and other cerebellar signs, spasticity, secondary musculoskeletal abnormalities, and ocular movement anomalies that has_material_basis_in homozygous or compound heterozygous mutation in SYNE1 on chromosome 6q25.2."" ;
    :has_exact_synonym ""ARCA1""@en,
        ""Autosomal recessive cerebellar ataxia type 1""@en,
        ""SCAR8""@en,
        ""SYNE1-related autosomal recessive cerebellar ataxia""@en,
        ""autosomal recessive ataxia, Beauce type""@en,
        ""recessive ataxia of Beauce""@en .

","Autosomal recessive spinocerebellar ataxia 8, a type of autosomal recessive cerebellar ataxia, is characterized by a definition that includes it as an autosomal recessive cerebellar ataxia marked by gradually progressive neurodegeneration. This results in gait ataxia and other cerebellar symptoms, spasticity, secondary musculoskeletal abnormalities, and ocular movement anomalies. The condition has its material basis in homozygous or compound heterozygous mutation in SYNE1 on chromosome 6q25.2. It is also known by several exact synonyms, including ARCA1, Autosomal recessive cerebellar ataxia type 1, SCAR8, SYNE1-related autosomal recessive cerebellar ataxia, autosomal recessive ataxia, Beauce type, and recessive ataxia of Beauce.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111619,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:combined_d_2_and_l_2_hydroxyglutaric_aciduria rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :2_hydroxyglutaric_aciduria,
        :autosomal_recessive_disease ;
    :has_definition ""A 2-hydroxyglutaric aciduria characterized by neonatal-onset encephalopathy with severe hypotonia, intractable seizures, respiratory distress, and lack of psychomotor development resulting in early death that has_material_basis_in homozygous or compound heterozygous mutation in the SLC25A1 gene on chromosome 22q11.21."" ;
    :has_exact_synonym ""D,L-2-HGA""@en,
        ""D,L-2-hydroxyglutaric acidemia""@en,
        ""D,L-2-hydroxyglutaric aciduria""@en,
        ""combined D,L-2-hydroxyglutaric aciduria""@en,
        ""combined D-2-hydroxyglutaric acidemia and L-2-hydroxyglutaric acidemia""@en,
        ""combined D-2-hydroxyglutaric aciduria and L-2-hydroxyglutaric aciduria""@en .

","Combined D 2 and L 2 hydroxyglutaric aciduria is a type of 2 hydroxyglutaric aciduria and also a type of autosomal recessive disease. It is characterized as a condition that, at the very least, has a material basis in autosomal recessive inheritance. Specifically, this form of 2-hydroxyglutaric aciduria is characterized by neonatal-onset encephalopathy accompanied by severe hypotonia, intractable seizures, respiratory distress, and a lack of psychomotor development, leading to early death. These symptoms have their material basis in homozygous or compound heterozygous mutations in the SLC25A1 gene located on chromosome 22q11.21. 

Moreover, Combined D 2 and L 2 hydroxyglutaric aciduria is known by several exact synonyms, including D,L-2-HGA, D,L-2-hydroxyglutaric acidemia, D,L-2-hydroxyglutaric aciduria, combined D,L-2-hydroxyglutaric aciduria, combined D-2-hydroxyglutaric acidemia and L-2-hydroxyglutaric acidemia, and combined D-2-hydroxyglutaric aciduria and L-2-hydroxyglutaric aciduria.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111620,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:corneal_dystrophy_perceptive_deafness_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by congenital corneal endothelial dystrophy and progressive, postlingual sensorineural hearing loss that has_material_basis_in homozygous or compound heterozygous mutation in the SLC4A11 gene on chromosome 20p13."" ;
    :has_exact_synonym ""CDPD""@en,
        ""CDPD1""@en,
        ""Harboyan syndrome""@en,
        ""corneal dystrophy and perceptive deafness""@en,
        ""corneal dystrophy with progressive deafness""@en,
        ""corneal endothelial dystrophy and perceptive deafness""@en .

","Corneal dystrophy perceptive deafness syndrome is a type of syndrome and an autosomal recessive disease that at least has a material basis in some autosomal recessive inheritance. It is characterized by congenital corneal endothelial dystrophy and progressive, postlingual sensorineural hearing loss, with its material basis in homozygous or compound heterozygous mutation in the SLC4A11 gene on chromosome 20p13. The syndrome is also exactly synonymous with CDPD, CDPD1, Harboyan syndrome, corneal dystrophy and perceptive deafness, corneal dystrophy with progressive deafness, and corneal endothelial dystrophy and perceptive deafness.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111621,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:temtamy_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by variable craniofacial dysmorphism, ocular coloboma, seizures, and brain abnormalities including partial or complete absence of the corpus callosum that has_material_basis_in [zygosity of] mutation in the C12ORF57 gene on chromosome 12p13.31."" ;
    :has_exact_synonym ""Temtamy-Shalash syndrome""@en,
        ""craniofacial dysmorphism with ocular coloboma absent corpus callosum and aortic dilatation""@en,
        ""craniofacial dysmorphism-coloboma-corpus callosum agenesis syndrome""@en,
        ""dysmorphism, corpus callosum agenesis and colobomas""@en .

","Temtamy syndrome is a type of autosomal recessive disease and syndrome, which is something that at least has a material basis in some autosomal recessive inheritance. It is characterized by variable craniofacial dysmorphism, ocular coloboma, seizures, and brain abnormalities including partial or complete absence of the corpus callosum. This syndrome has a material basis in a mutation in the C12ORF57 gene on chromosome 12p13.31. Temtamy syndrome is also known by its exact synonyms: Temtamy-Shalash syndrome, craniofacial dysmorphism with ocular coloboma absent corpus callosum and aortic dilatation, craniofacial dysmorphism-coloboma-corpus callosum agenesis syndrome, and dysmorphism, corpus callosum agenesis and colobomas.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111622,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acth_independent_macronodular_adrenal_hyperplasia rdfs:subClassOf :primary_hyperaldosteronism ;
    :has_definition ""A primary hyperaldosteronism characterized by multiple bilateral adrenocortical nodules that cause a striking enlargement of the adrenal gland and production of an excess of cortisol."" ;
    :has_exact_synonym ""ACTH-independent macronodular adrenocortical hyperplasia""@en,
        ""AIMAH""@en,
        ""Cushing syndrome due to macronodular adrenal hyperplasia""@en,
        ""MMAD""@en,
        ""adrenocorticotropic hormone-independent macronodular adrenal hyperplasia""@en,
        ""corticotropin-independent macronodular adrenal hyperplasia""@en,
        ""massive macronodular adrenocortical disease""@en,
        ""primary macronodular adrenal hyperplasia""@en .

","ACTH independent macronodular adrenal hyperplasia is a type of primary hyperaldosteronism characterized by multiple bilateral adrenocortical nodules that cause a striking enlargement of the adrenal gland and production of an excess of cortisol. It has several exact synonyms, including ACTH-independent macronodular adrenocortical hyperplasia, AIMAH, Cushing syndrome due to macronodular adrenal hyperplasia, MMAD, adrenocorticotropic hormone-independent macronodular adrenal hyperplasia, corticotropin-independent macronodular adrenal hyperplasia, massive macronodular adrenocortical disease, and primary macronodular adrenal hyperplasia.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111623,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acth_independent_macronodular_adrenal_hyperplasia_1 rdfs:subClassOf :acth_independent_macronodular_adrenal_hyperplasia ;
    :has_definition ""An ACTH-independent macronodular adrenal hyperplasia that has_material_basis_in somatic mutation in the GNAS gene on chromosome 20q13.32."" ;
    :has_exact_synonym ""AIMAH1""@en .

","ACTH independent macronodular adrenal hyperplasia 1 is a type of ACTH independent macronodular adrenal hyperplasia. It is defined as an ACTH-independent macronodular adrenal hyperplasia that has its material basis in a somatic mutation in the GNAS gene on chromosome 20q13.32. Additionally, ACTH independent macronodular adrenal hyperplasia 1 is exactly synonymous with AIMAH1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111624,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:acth_independent_macronodular_adrenal_hyperplasia_2 rdfs:subClassOf :acth_independent_macronodular_adrenal_hyperplasia ;
    :has_definition ""An ACTH-independent macronodular adrenal hyperplasia that has_material_basis_in a combination of autosomal dominant and second hit somatic mutation in the ARMC5 gene on chromosome 16p11.2."" ;
    :has_exact_synonym ""AIMAH2""@en .

","ACTH independent macronodular adrenal hyperplasia 2 is a type of ACTH independent macronodular adrenal hyperplasia, which is defined as an ACTH-independent macronodular adrenal hyperplasia that has a material basis in a combination of autosomal dominant and second hit somatic mutation in the ARMC5 gene on chromosome 16p11.2. Additionally, it has the exact synonym AIMAH2.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111625,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ventriculomegaly_cystic_kidney_disease rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by onset in utero of dilated cerebral ventricles and microscopic renal tubular cysts that has_material_basis_in homozygous or compound heterozygous mutation in the CRB2 gene on chromosome 9q33.3."" ;
    :has_exact_synonym ""VMCKD""@en,
        ""congenital nephrosis-cerebral ventriculomegaly syndrome""@en,
        ""cystic kidney disease with ventriculomegaly""@en,
        ""ventriculomegaly with cystic kidney disease""@en .

","Ventriculomegaly cystic kidney disease is a syndrome that falls under the category of autosomal recessive diseases and is characterized by a type of condition that inherently has a material basis in some form of autosomal recessive inheritance. Specifically, it is defined as a syndrome that manifests in utero with symptoms including dilated cerebral ventricles and microscopic renal tubular cysts, which are caused by homozygous or compound heterozygous mutations in the CRB2 gene located on chromosome 9q33.3. Furthermore, ventriculomegaly cystic kidney disease is known by several exact synonyms: VMCKD, congenital nephrosis-cerebral ventriculomegaly syndrome, cystic kidney disease with ventriculomegaly, and ventriculomegaly with cystic kidney disease.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111626,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:d_glyceric_aciduria rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :inherited_metabolic_disorder ;
    :has_definition ""An inherited metabolic disorder characterized by impaired serine and fructose metabolism resulting in elevated excretion of D-glyceric acid that has_material_basis_in homozygous or compound heterozygous mutation in the GLYCTK gene on chromosome 3p21.2."" ;
    :has_exact_synonym ""D-glycerate kinase deficiency""@en,
        ""D-glyceric acidemia""@en,
        ""D-glycericacidemia""@en,
        ""deficiency of glycerate kinase""@en,
        ""non ketotic hyperglycinemia syndrome""@en .

","D-glyceric aciduria is a type of autosomal recessive disease, an inherited metabolic disorder, and something that at least has a material basis in some autosomal recessive inheritance. It is defined as an inherited metabolic disorder characterized by impaired serine and fructose metabolism resulting in elevated excretion of D-glyceric acid due to homozygous or compound heterozygous mutation in the GLYCTK gene on chromosome 3p21.2. D-glyceric aciduria has exact synonyms including D-glycerate kinase deficiency, D-glyceric acidemia, D-glycericacidemia, deficiency of glycerate kinase, and non-ketotic hyperglycinemia syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111627,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:doors_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by sensorineural deafness, onychodystrophy, osteodystrophy, seizures, and intellectual disability that has_material_basis_in homozygous or compound heterozygous mutation in the TBC1D24 gene on chromosome 16p13.3."" ;
    :has_exact_synonym ""DOOR syndrome""@en,
        ""DOORS""@en,
        ""autosomal recessive deafness-onychodystrophy syndrome""@en,
        ""deafness-onychodystrophy-osteodystrophy-intellectual disability syndrome""@en,
        ""deafness-onychodystrophy-osteodystrophy-intellectual disability-seizures syndrome""@en,
        ""deafness-onychoosteodystrophy-intellectual disability syndrome""@en .

","Doors syndrome is a type of syndrome and an autosomal recessive disease with a material basis in some autosomal recessive inheritance. It is characterized by sensorineural deafness, onychodystrophy, osteodystrophy, seizures, and intellectual disability, which is caused by homozygous or compound heterozygous mutation in the TBC1D24 gene on chromosome 16p13.3. Doors syndrome is also known by several exact synonyms: DOOR syndrome, DOORS, autosomal recessive deafness-onychodystrophy syndrome, deafness-onychodystrophy-osteodystrophy-intellectual disability syndrome, deafness-onychodystrophy-osteodystrophy-intellectual disability-seizures syndrome, and deafness-onychoosteodystrophy-intellectual disability syndrome.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111628,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:high_myopia_sensorineural_deafness_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by severe myopia and moderate to profound, bilateral, progressive sensorineural hearing loss that has_material_basis_in homozygous or compound heterozygous mutation in the SLITRK6 gene on chromosome 13q31.1."" ;
    :has_exact_synonym ""DFNMYP""@en,
        ""deafness and myopia""@en,
        ""deafness and myopia syndrome""@en .

","High myopia sensorineural deafness syndrome is a type of autosomal recessive disease and a type of syndrome that at least has a material basis in some autosomal recessive inheritance. It is characterized by severe myopia and moderate to profound, bilateral, progressive sensorineural hearing loss. This syndrome has its material basis in homozygous or compound heterozygous mutation in the SLITRK6 gene on chromosome 13q31.1. Furthermore, high myopia sensorineural deafness syndrome is exactly synonymous with DFNMYP, deafness and myopia, and deafness and myopia syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111629,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:dihydropyrimidinase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :pyrimidine_metabolic_disorder ;
    :has_definition ""A pyrimidine metabolic disorder characterized by a defect in the degredation of uracil and thymine resulting in elevated levels of 5,6-dihydrouracil and 5,6-dihydrothymine in urine that has_material_basis_in homozygous or compound heterozygous mutation in the DPYS gene on chromosome 8q22.3."" ;
    :has_exact_synonym ""DPH deficiency""@en,
        ""DPYS deficiency""@en,
        ""DPYSD""@en,
        ""dihydropyrimidinuria""@en .

","Dihydropyrimidinase deficiency is a type of autosomal recessive disease and also a type of pyrimidine metabolic disorder, which at least has a material basis in some autosomal recessive inheritance. It is characterized by a defect in the degradation of uracil and thymine, resulting in elevated levels of 5,6-dihydrouracil and 5,6-dihydrothymine in urine. This condition has a material basis in homozygous or compound heterozygous mutation in the DPYS gene on chromosome 8q22.3. Moreover, dihydropyrimidinase deficiency has several exact synonyms, including DPH deficiency, DPYS deficiency, DPYSD, and dihydropyrimidinuria.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111630,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_erythrocytosis_8 rdfs:subClassOf :primary_polycythemia ;
    :has_definition ""A primary polycythemia characterized by erythrocytosis and in some cases hemolytic anemia that has_material_basis_in homozygous or compound heterozygous mutation in the BPGM gene on chromosome 7q33."" ;
    :has_exact_synonym ""BPGM deficiency""@en,
        ""DPGM deficiency""@en,
        ""ECYT8""@en,
        ""bisphosphoglycerate mutase deficiency""@en,
        ""bisphosphoglyceromutase deficiency""@en,
        ""diphosphoglycerate mutase deficiency of erythrocyte""@en,
        ""hemolytic anemia due to diphosphoglycerate mutase deficiency""@en .

","Familial erythrocytosis 8 is a type of primary polycythemia, which is characterized by erythrocytosis and, in some cases, hemolytic anemia. This condition has a material basis in homozygous or compound heterozygous mutation in the BPGM gene on chromosome 7q33. It is also known by several exact synonyms including BPGM deficiency, DPGM deficiency, ECYT8, bisphosphoglycerate mutase deficiency, bisphosphoglyceromutase deficiency, diphosphoglycerate mutase deficiency of erythrocyte, and hemolytic anemia due to diphosphoglycerate mutase deficiency.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111631,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_erythrocytosis_7 rdfs:subClassOf :primary_polycythemia ;
    :has_definition ""A primary polycythemia characterized by high oxygen affinity hemoglobin and compensatory polycythemia that has_material_basis_in heterozygous mutation in either the HBA2 or HBA1 gene on chromosome 16p13.3."" ;
    :has_exact_synonym ""ECYT7""@en,
        ""alpha-globin type erythrocytosis""@en,
        ""alpha-globin type polycythemia""@en .

","Familial erythrocytosis 7 is a type of primary polycythemia characterized by high oxygen affinity hemoglobin and compensatory polycythemia, which has a material basis in heterozygous mutation in either the HBA2 or HBA1 gene on chromosome 16p13.3. It is exactly synonymous with ECYT7, alpha-globin type erythrocytosis, and alpha-globin type polycythemia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111632,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_erythrocytosis_6 rdfs:subClassOf :primary_polycythemia ;
    :has_definition ""A primary polycythemia characterized by high oxygen affinity hemoglobin and compensatory polycythemia that has_material_basis_in heterozygous mutation in HBB on chromosome 11p15.4."" ;
    :has_exact_synonym ""ECYT6""@en,
        ""beta-globin type erythrocytosis""@en,
        ""beta-globin type polycythemia""@en .

","Familial erythrocytosis 6 is a type of primary polycythemia, defined as a primary polycythemia characterized by high oxygen affinity hemoglobin and compensatory polycythemia that has a material basis in heterozygous mutation in HBB on chromosome 11p15.4. It is also exactly synonymous with ECYT6, beta-globin type erythrocytosis, and beta-globin type polycythemia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111633,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_sucrase_isomaltase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :carbohydrate_metabolic_disorder,
        :physical_disorder ;
    :has_definition ""A carbohydrate metabolic disorder characterized by malabsorption of oligosaccharides and disaccharides that has_material_basis_in homozygous or compound heterozygous mutation in SI on chromosome 3q26.1."" ;
    :has_exact_synonym ""CSID""@en,
        ""SI deficiency""@en,
        ""congenital sucrase-isomaltose malabsorption""@en,
        ""congenital sucrose intolerance""@en,
        ""disaccharide intolerance""@en .

","Congenital sucrase isomaltase deficiency is a type of autosomal recessive disease, physical disorder, carbohydrate metabolic disorder, and it is something that at least has a material basis in autosomal recessive inheritance. It is also a type of condition that at least has disease basis in some abnormality of prenatal development or birth. This disorder is defined as a carbohydrate metabolic disorder characterized by malabsorption of oligosaccharides and disaccharides, which has its material basis in homozygous or compound heterozygous mutation in the SI gene on chromosome 3q26.1. Additionally, congenital sucrase isomaltase deficiency is exactly synonymous with CSID, SI deficiency, congenital sucrase-isomaltose malabsorption, congenital sucrose intolerance, and disaccharide intolerance.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111634,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_99 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by prelingual, severe to profound sensorineural hearing loss without vestibular dysfunction that has_material_basis_in homozygous or compound heterozygous mutation in the TMEM132E gene on chromosome 17q12."" ;
    :has_exact_synonym ""DFNB99""@en,
        ""autosomal recessive deafness 99""@en .

","Autosomal recessive nonsyndromic deafness 99 is a specific type of autosomal recessive nonsyndromic deafness. It is characterized by prelingual, severe to profound sensorineural hearing loss without vestibular dysfunction. This condition has its material basis in homozygous or compound heterozygous mutation in the TMEM132E gene on chromosome 17q12. Additionally, autosomal recessive nonsyndromic deafness 99 is exactly synonymous with DFNB99 and autosomal recessive deafness 99.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111635,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_57 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by symmetric bilateral moderate to severe hearing loss that has_material_basis_in homozygous or compound heterozygous mutation in the PDZD7 gene on chromosome 10q24.31."" ;
    :has_exact_synonym ""DFNB57""@en,
        ""autosomal recessive deafness 57""@en .

","Autosomal recessive nonsyndromic deafness 57 is a type of autosomal recessive nonsyndromic deafness characterized by symmetric bilateral moderate to severe hearing loss. This is due to the material basis in homozygous or compound heterozygous mutation in the PDZD7 gene on chromosome 10q24.31. Additionally, autosomal recessive nonsyndromic deafness 57 is precisely synonymous with DFNB57 and autosomal recessive deafness 57.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111636,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_113 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by postlingual progressive hearing impairment that has_material_basis_in homozygous or compound heterozygous mutation in the CEACAM16 gene on chromosome 19q13."" ;
    :has_exact_synonym ""DFNB113""@en,
        ""autosomal recessive deafness 113""@en .

","Autosomal recessive nonsyndromic deafness 113 is a specific type of autosomal recessive nonsyndromic deafness. It is characterized by postlingual progressive hearing impairment that arises from homozygous or compound heterozygous mutations in the CEACAM16 gene located on chromosome 19q13. Additionally, autosomal recessive nonsyndromic deafness 113 is precisely referred to by two exact synonyms: DFNB113 and autosomal recessive deafness 113.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111637,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_112 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by postlingual progressive sensorineural hearing impairment that has_material_basis_in homozygous or compound heterozygous mutation in the BDP1 gene on chromosome 5q13.2."" ;
    :has_exact_synonym ""DFNB112""@en,
        ""autosomal recessive deafness 112""@en .

","Autosomal recessive nonsyndromic deafness 112 is a type of autosomal recessive nonsyndromic deafness, characterized by postlingual progressive sensorineural hearing impairment that has its material basis in homozygous or compound heterozygous mutation in the BDP1 gene on chromosome 5q13.2. It also has the exact synonyms DFNB112 and autosomal recessive deafness 112.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111638,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_100 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by prelingual onset of profound sensorineural deafness without vestibular involvement that has_material_basis_in homozygous or compound heterozygous mutation in the PPIP5K2 gene on chromosome 5q21.1."" ;
    :has_exact_synonym ""DFNB100""@en,
        ""autosomal recessive deafness 100""@en .

","Autosomal recessive nonsyndromic deafness 100 is a type of autosomal recessive nonsyndromic deafness characterized by prelingual onset of profound sensorineural deafness without vestibular involvement, which has its material basis in homozygous or compound heterozygous mutation in the PPIP5K2 gene on chromosome 5q21.1. It has the exact synonyms DFNB100 and autosomal recessive deafness 100.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111639,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_109 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by bilateral congenital severe to profound sensorineural hearing loss and vestibular dysplasia without balance or movement issues that has_material_basis_in homozygous or compound heterozygous mutation in the ESRP1 gene on chromosome 8q22.1."" ;
    :has_exact_synonym ""DFNB109""@en,
        ""autosomal recessive deafness 109""@en .

","Autosomal recessive nonsyndromic deafness 109 is a type of autosomal recessive nonsyndromic deafness, which is characterized by bilateral congenital severe to profound sensorineural hearing loss and vestibular dysplasia without balance or movement issues. This condition has a material basis in homozygous or compound heterozygous mutation in the ESRP1 gene on chromosome 8q22.1. Moreover, autosomal recessive nonsyndromic deafness 109 is exactly synonymous with DFNB109 and autosomal recessive deafness 109.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111640,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_111 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by early-onset, moderate to severe sensorineural hearing loss with no vestibular involvement that has_material_basis_in homozygous or compound heterozygous mutation in the MPZL2 gene on chromosome 11q23.33."" ;
    :has_exact_synonym ""DFNB111""@en,
        ""autosomal recessive deafness 111""@en .

","Autosomal recessive nonsyndromic deafness 111 is a type of autosomal recessive nonsyndromic deafness, which is defined as an autosomal recessive nonsyndromic deafness characterized by early-onset, moderate to severe sensorineural hearing loss with no vestibular involvement. This condition has its material basis in homozygous or compound heterozygous mutation in the MPZL2 gene on chromosome 11q23.33. Autosomal recessive nonsyndromic deafness 111 is exactly synonymous with DFNB111 and autosomal recessive deafness 111.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111641,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_94 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by prelingual profound sensorineural hearing loss that has_material_basis_in homozygous or compound heterozygous mutation in the NARS2 gene on chromosome 11q14.1."" ;
    :has_exact_synonym ""DFNB94""@en,
        ""autosomal recessive deafness 94""@en .

","Autosomal recessive nonsyndromic deafness 94 is a type of autosomal recessive nonsyndromic deafness characterized by prelingual profound sensorineural hearing loss. This condition has its material basis in homozygous or compound heterozygous mutation in the NARS2 gene located on chromosome 11q14.1. Moreover, autosomal recessive nonsyndromic deafness 94 is exactly synonymous with DFNB94 and autosomal recessive deafness 94.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111642,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_114 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by congenital profound sensorineural hearing loss that has_material_basis_in homozygous or compound heterozygous mutation in the GRAP gene on chromosome 17p11.2."" ;
    :has_exact_synonym ""DFNB114""@en,
        ""autosomal recessive deafness 114""@en .

","Autosomal recessive nonsyndromic deafness 114 is a type of autosomal recessive nonsyndromic deafness, which is characterized by congenital profound sensorineural hearing loss. This condition has its material basis in homozygous or compound heterozygous mutation in the GRAP gene on chromosome 17p11.2. Moreover, autosomal recessive nonsyndromic deafness 114 is exactly synonymous with DFNB114 and autosomal recessive deafness 114.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111643,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_115 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by onset in early childhood of severe sensorineural hearing impairment that has_material_basis_in homozygous or compound heterozygous mutation in the SPNS2 gene on chromosome 17p13.2."" ;
    :has_exact_synonym ""DFNB115""@en,
        ""autosomal recessive deafness 115""@en .

","Autosomal recessive nonsyndromic deafness 115 is a specific type of autosomal recessive nonsyndromic deafness. It is characterized by the onset in early childhood of severe sensorineural hearing impairment, which has its material basis in homozygous or compound heterozygous mutation in the SPNS2 gene located on chromosome 17p13.2. This condition is also exactly known as DFNB115 and autosomal recessive deafness 115.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111644,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_nonsyndromic_deafness_110 rdfs:subClassOf :autosomal_recessive_nonsyndromic_deafness ;
    :has_definition ""An autosomal recessive nonsyndromic deafness characterized by prelingual, bilateral hearing loss that has_material_basis_in homozygous or compound heterozygous mutation in the COCH gene on chromosome 14q12."" ;
    :has_exact_synonym ""DFNB110""@en,
        ""autosomal recessive deafness 110""@en .

","Autosomal recessive nonsyndromic deafness 110, also precisely known as DFNB110 or autosomal recessive deafness 110, is a type of autosomal recessive nonsyndromic deafness. It is defined as an autosomal recessive nonsyndromic deafness characterized by prelingual, bilateral hearing loss that arises from either homozygous or compound heterozygous mutation in the COCH gene located on chromosome 14q12.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111645,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:rolandic_epilepsy_paroxysmal_exercise_induced_dystonia_writer_s_cramp_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :infantile_onset ],
        :autosomal_recessive_disease,
        :infancy_electroclinical_syndrome ;
    :has_definition ""An infancy electroclinical syndrome characterized by onset of focal seizures in infancy and exercise-induced dystonia in childhood that has_material_basis_in homozygous or compound heterozygous mutation in the TBC1D24 gene on chromosome 16p13.3."" ;
    :has_exact_synonym ""EPRPDC""@en,
        ""RE-PED-WC""@en,
        ""Rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp""@en,
        ""Rolandic-type focal motor epilepsy and exercise-induced dystonia""@en .

","Rolandic epilepsy paroxysmal exercise-induced dystonia writer's cramp syndrome, also known by its exact synonyms EPRPDC, RE-PED-WC, Rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp, and Rolandic-type focal motor epilepsy and exercise-induced dystonia, is a type of infancy electroclinical syndrome, autosomal recessive disease, and is characterized by having at least a material basis in autosomal recessive inheritance and beginning during infantile onset. This syndrome is defined as an infancy electroclinical syndrome characterized by the onset of focal seizures in infancy and exercise-induced dystonia in childhood, with the condition having a material basis in homozygous or compound heterozygous mutations in the TBC1D24 gene on chromosome 16p13.3.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111646,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_lactase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :carbohydrate_metabolic_disorder,
        :physical_disorder ;
    :has_definition ""A carbohydrate metabolic disorder characterized by watery diarrhea in infants fed with breast milk or other lactose-containing formulas that has_material_basis_in homozygous or compound heterozygous mutation in LCT on chromosome 2q21.3."" ;
    :has_exact_synonym ""CLD""@en,
        ""congenital alactasia""@en,
        ""congenital alactasia syndrome""@en,
        ""congenital lactose intolerance""@en,
        ""congenital lactose malabsorption""@en,
        ""disaccharide intolerance II""@en .

","Congenital lactase deficiency, also known by its exact synonyms CLD, congenital alactasia, congenital alactasia syndrome, congenital lactose intolerance, congenital lactose malabsorption, and disaccharide intolerance II, is a type of autosomal recessive disease, physical disorder, and carbohydrate metabolic disorder. It specifically has a material basis in autosomal recessive inheritance and is associated with an abnormality of prenatal development or birth. This disorder is defined as a carbohydrate metabolic disorder characterized by watery diarrhea in infants fed with breast milk or other lactose-containing formulas, which is caused by homozygous or compound heterozygous mutations in the LCT gene on chromosome 2q21.3.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111647,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schopf_schulz_passarge_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by multiple eyelid apocrine hidrocystomas, palmoplantar keratoderma, hypotrichosis, hypodontia and nail dystrophy that has_material_basis_in homozygous or compound heterozygous mutation in the WNT10A gene on chromosome 2q35."" ;
    :has_exact_synonym ""SSPS""@en,
        ""eccrine tumors-ectodermal dysplasia""@en,
        ""keratosis palmoplantaris-cystic eyelids-hypodontia-hypotrichosis syndrome""@en,
        ""palmoplantar hyperkeratosis-cystic eyelids-hypodontia-hypotrichosis syndrome""@en,
        ""palmoplantar keratoderma-cystic eyelids-hypodontia-hypotrichosis syndrome""@en .

","Schopf Schulz Passarge syndrome is a type of autosomal dominant disease and ectodermal dysplasia, which is at least characterized by having a material basis in some autosomal dominant inheritance. This syndrome is defined as an ectodermal dysplasia characterized by multiple eyelid apocrine hidrocystomas, palmoplantar keratoderma, hypotrichosis, hypodontia, and nail dystrophy, with its material basis in homozygous or compound heterozygous mutation in the WNT10A gene on chromosome 2q35. It has several exact synonyms, including SSPS, eccrine tumors-ectodermal dysplasia, keratosis palmoplantaris-cystic eyelids-hypodontia-hypotrichosis syndrome, palmoplantar hyperkeratosis-cystic eyelids-hypodontia-hypotrichosis syndrome, and palmoplantar keratoderma-cystic eyelids-hypodontia-hypotrichosis syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111648,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectopia_lentis_with_ectopia_of_pupil rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :eye_disease ;
    :has_definition ""An eye disease characterized by displacement of the lenses and the pupils in association with other ocular anomalies that has_material_basis_in homozygous or compound heterozygous mutation mutation in the ADAMTSL4 gene on chromosome 1q21.2."" ;
    :has_exact_synonym ""ectopia lentis et pupillae""@en .

","Ectopia lentis with ectopia of pupil is a type of eye disease and also falls under the category of autosomal recessive diseases. It is defined as an eye disease characterized by the displacement of the lenses and the pupils in association with other ocular anomalies. This condition has its material basis in homozygous or compound heterozygous mutation in the ADAMTSL4 gene on chromosome 1q21.2, indicating that it at least has a material basis in some form of autosomal recessive inheritance. Additionally, ectopia lentis with ectopia of pupil has the exact synonym ectopia lentis et pupillae.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111649,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_ectrodactyly_and_macular_dystrophy_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by ectodermal dysplasia, ectrodactyly, and macular dystrophy that has_material_basis_in homozygous or compound heterozygous mutation in the CDH3 gene on chromosome 16q22.1."" ;
    :has_exact_synonym ""EEM syndrome""@en,
        ""EEMS""@en,
        ""ectodermal dysplasia-ectrodactyly-macular dystrophy syndrome""@en .

","Ectodermal Dysplasia Ectrodactyly and Macular Dystrophy Syndrome, also known precisely as EEM syndrome, EEMS, and ectodermal dysplasia-ectrodactyly-macular dystrophy syndrome, is categorized as a type of autosomal recessive disease, a subset of ectodermal dysplasia, and something that invariably has a material basis in autosomal recessive inheritance. This syndrome is specifically defined as an ectodermal dysplasia characterized by the combination of ectodermal dysplasia, ectrodactyly, and macular dystrophy, arising from homozygous or compound heterozygous mutations in the CDH3 gene located on chromosome 16q22.1.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111650,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by severe oligodontia accompanied by anomalies of hair and skin that has_material_basis_in homozygous or compound heterozygous mutation in the KREMEN1 gene on chromosome 22q12.1."" ;
    :has_exact_synonym ""ECTD13""@en,
        ""ectodermal dysplasia 13, hair/tooth type""@en .

","Ectodermal dysplasia 13 is a type of autosomal recessive disease and a type of ectodermal dysplasia. It is categorized as something that at least has a material basis in some autosomal recessive inheritance. This specific condition is defined as an ectodermal dysplasia characterized by severe oligodontia accompanied by anomalies of hair and skin, which has its material basis in homozygous or compound heterozygous mutation in the KREMEN1 gene on chromosome 22q12.1. Additionally, ectodermal dysplasia 13 has exact synonyms, including ECTD13 and ectodermal dysplasia 13, hair/tooth type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111651,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_15 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by onset in early childhood of hypotrichosis and absence of sweating except with extreme exercise that has_material_basis_in homozygous or compound heterozygous mutation in the CST6 gene on chromosome 11q13.1."" ;
    :has_exact_synonym ""ECTD15""@en,
        ""ectodermal dysplasia 15, hypohidrotic/hair type""@en .

","Ectodermal Dysplasia 15 is a type of autosomal recessive disease and ectodermal dysplasia, which specifically has a material basis in autosomal recessive inheritance. It is characterized by an onset in early childhood of hypotrichosis and the absence of sweating except with extreme exercise, due to homozygous or compound heterozygous mutation in the CST6 gene on chromosome 11q13.1. Additionally, Ectodermal Dysplasia 15 is exactly synonymous with ECTD15 and ectodermal dysplasia 15, hypohidrotic/hair type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111652,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypohidrotic_ectodermal_dysplasia ;
    :has_definition ""A hypohidrotic ectodermal dysplasia that has_material_basis_in heterozygous mutation in the KDF1 gene on chromosome 1p36.11."" ;
    :has_exact_synonym ""ECTD12""@en,
        ""ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type""@en .

","Ectodermal dysplasia 12 is a type of autosomal dominant disease and a type of hypohidrotic ectodermal dysplasia, characterized by having a material basis in some form of autosomal dominant inheritance. It is defined as a hypohidrotic ectodermal dysplasia that results from a heterozygous mutation in the KDF1 gene located on chromosome 1p36.11. Additionally, ectodermal dysplasia 12 is exactly synonymous with ECTD12 and ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111653,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_11a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypohidrotic_ectodermal_dysplasia ;
    :has_definition ""A hypohidrotic ectodermal dysplasia that has_material_basis_in heterozygous mutation in the EDARADD gene on chromosome 1q42-q43."" ;
    :has_exact_synonym ""ECTD11A""@en,
        ""ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant""@en .

","Ectodermal dysplasia 11A (ECTD11A), also known exactly as ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, is a type of autosomal dominant disease, hypohidrotic ectodermal dysplasia, and a condition that at least has a material basis in some form of autosomal dominant inheritance. It is defined as a hypohidrotic ectodermal dysplasia that arises from a heterozygous mutation in the EDARADD gene located on chromosome 1q42-q43.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111654,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_11b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypohidrotic_ectodermal_dysplasia ;
    :has_definition ""A hypohidrotic ectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in the EDARADD gene on chromosome 1q42-q43."" ;
    :has_exact_synonym ""ECTD11B""@en,
        ""ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive""@en .

","Ectodermal Dysplasia 11B is a specific type of autosomal recessive disease and is also categorized under hypohidrotic ectodermal dysplasias. It is characterized by conditions that fundamentally have a material basis in autosomal recessive inheritance. Specifically, it is a hypohidrotic ectodermal dysplasia that arises from either homozygous or compound heterozygous mutations in the EDARADD gene located on chromosome 1q42-q43. Additionally, Ectodermal Dysplasia 11B is precisely synonymized as ECTD11B and ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111655,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pure_hair_and_nail_ectodermal_dysplasia rdfs:subClassOf :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by onychodystrophy and severe hypotrichosis without nonectodermal or other ectodermal manifestations."" .

","Pure hair and nail ectodermal dysplasia is a type of ectodermal dysplasia that is characterized by onychodystrophy and severe hypotrichosis, with the absence of nonectodermal or other ectodermal manifestations.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111656,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :pure_hair_and_nail_ectodermal_dysplasia ;
    :has_definition ""A pure hair and nail ectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in the HOXC13 gene on chromosome 12q13.13."" ;
    :has_exact_synonym ""ECTD9""@en,
        ""ectodermal dysplasia 9, hair/nail type""@en .

","Ectodermal Dysplasia 9 is a type of autosomal recessive disease, which is a pure hair and nail ectodermal dysplasia, and it can also be described as a condition that has its material basis in some form of autosomal recessive inheritance. It is defined as a pure hair and nail ectodermal dysplasia that occurs due to homozygous or compound heterozygous mutation in the HOXC13 gene located on chromosome 12q13.13. Furthermore, Ectodermal Dysplasia 9 is precisely referred to by the exact synonyms ECTD9 and ectodermal dysplasia 9, hair/nail type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111657,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :pure_hair_and_nail_ectodermal_dysplasia ;
    :has_definition ""A pure hair and nail ectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in a region on chromosome 10q24.32-q25.1."" ;
    :has_exact_synonym ""ECTD5""@en,
        ""ectodermal dysplasia 5, hair/nail type""@en .

","Ectodermal Dysplasia 5 (ED5), which is also known precisely as ECTD5 and ectodermal dysplasia 5, hair/nail type, is identified as a type of autosomal recessive disease, specifically falling under the category of pure hair and nail ectodermal dysplasia. This condition is characterized by having its material basis in homozygous or compound heterozygous mutations located in a region on chromosome 10q24.32-q25.1. Additionally, ED5 is recognized for being a type of disorder that inherently involves autosomal recessive inheritance, highlighting its genetic underpinnings.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111658,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :pure_hair_and_nail_ectodermal_dysplasia ;
    :has_definition ""A pure hair and nail ectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in the KRT85 gene on chromosome 12q13.13."" ;
    :has_exact_synonym ""ECTD4""@en,
        ""ectodermal dysplasia 4, hair/nail type""@en .

","Ectodermal dysplasia 4 is a type of autosomal recessive disease, specifically a pure hair and nail ectodermal dysplasia, and is characterized by having a material basis in autosomal recessive inheritance. It is defined as a pure hair and nail ectodermal dysplasia that results from homozygous or compound heterozygous mutation in the KRT85 gene on chromosome 12q13.13. Moreover, ectodermal dysplasia 4 is also known by its exact synonyms ECTD4 and ectodermal dysplasia 4, hair/nail type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111659,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :pure_hair_and_nail_ectodermal_dysplasia ;
    :has_definition ""A pure hair and nail ectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in a region on chromosome 17p12-q21.2."" ;
    :has_exact_synonym ""ECTD6""@en,
        ""ectodermal dysplasia 6, hair/nail type""@en .

","Ectodermal dysplasia 6, which is also precisely known as ECTD6 and ectodermal dysplasia 6, hair/nail type, is a type of autosomal recessive disease, pure hair and nail ectodermal dysplasia, and a condition that fundamentally has a material basis in autosomal recessive inheritance. It is defined as a pure hair and nail ectodermal dysplasia that occurs due to homozygous or compound heterozygous mutations in a specific region on chromosome 17p12-q21.2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111660,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :pure_hair_and_nail_ectodermal_dysplasia ;
    :has_definition ""A pure hair and nail ectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in the KRT74 gene on chromosome 12q13.13."" ;
    :has_exact_synonym ""ECTD7""@en,
        ""ectodermal dysplasia 7, hair/nail type""@en .

","Ectodermal dysplasia 7, also known precisely as ECTD7 or ectodermal dysplasia 7, hair/nail type, is categorized as an autosomal recessive disease. It falls under the subgroup of pure hair and nail ectodermal dysplasia and is characterized by its autosomal recessive inheritance. The condition is defined by a pure hair and nail ectodermal dysplasia that results from homozygous or compound heterozygous mutations in the KRT74 gene located on chromosome 12q13.13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111661,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by hypotrichosis, hypodontia, and dystrophic toenails that has_material_basis_in homozygous or compound heterozygous mutation in a region on chromosome 18q22.1-q22.3."" ;
    :has_exact_synonym ""ECTD8""@en,
        ""Fried's tooth and nail syndrome""@en,
        ""ectodermal dysplasia 8, hair/tooth/nail type""@en .

","Ectodermal dysplasia 8 is a type of autosomal recessive disease and ectodermal dysplasia, which is characterized by a condition that necessarily has a material basis in some form of autosomal recessive inheritance. Specifically, it is defined as an ectodermal dysplasia characterized by hypotrichosis, hypodontia, and dystrophic toenails, and this condition has a material basis in homozygous or compound heterozygous mutation located in a region on chromosome 18q22.1-q22.3. Furthermore, ectodermal dysplasia 8 is also known by its exact synonyms: ECTD8, Fried's tooth and nail syndrome, and ectodermal dysplasia 8, hair/tooth/nail type.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111662,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by scalp hypotrichosis and hypodontia that has_material_basis_in homozygous or compound heterozygous mutation in the TSPEAR gene on chromosome 21q22.3."" ;
    :has_exact_synonym ""ECTN14""@en,
        ""ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis""@en .

","Ectodermal dysplasia 14 is a type of autosomal recessive disease, which is a category of ectodermal dysplasia. It is characterized by a condition that inherently has a material basis in autosomal recessive inheritance. Specifically, ectodermal dysplasia 14 is defined as an ectodermal dysplasia characterized by scalp hypotrichosis and hypodontia, which has its material basis in homozygous or compound heterozygous mutations in the TSPEAR gene located on chromosome 21q22.3. Additionally, ectodermal dysplasia 14 is exactly synonymous with ECTN14 and ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111663,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_10a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hypohidrotic_ectodermal_dysplasia ;
    :has_definition ""A hypohidrotic ectodermal dysplasia that has_material_basis_in heterozygous mutation in the EDAR gene on chromosome 2q13."" ;
    :has_exact_synonym ""ECTD10A""@en,
        ""ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant""@en .

","Ectodermal Dysplasia 10A, also precisely known as ECTD10A or ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, is a type of autosomal dominant disease and falls under the category of hypohidrotic ectodermal dysplasia. It is characterized by a condition that fundamentally arises from autosomal dominant inheritance. Specifically, it is a hypohidrotic ectodermal dysplasia that results from a heterozygous mutation in the EDAR gene located on chromosome 2q13.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111664,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :hypohidrotic_ectodermal_dysplasia,
        :x_linked_recessive_disease ;
    :has_definition ""A hypohidrotic ectodermal dysplasia that has_material_basis_in X-linked recessive mutation in EDA on chromosome Xq13.1."" ;
    :has_exact_synonym ""CST syndrome""@en,
        ""Christ-Siemens-Touraine syndrome""@en,
        ""ED1""@en,
        ""HED1""@en,
        ""X-linked anhidrotic ectodermal dysplasia""@en,
        ""XHED""@en,
        ""XLHED""@en,
        ""ectodermal dysplasia 1, anhidrotic""@en,
        ""ectodermal dysplasia 1, hypohidrotic, X-linked""@en,
        ""ectodermal dysplasia 1, hypohidrotic/hair/tooth type, X-linked""@en,
        ""hypohidrotic ectodermal dysplasia, X-Linked""@en .

","Ectodermal dysplasia 1 is a type of disease that falls into several categories: it is a kind of X-linked recessive disease, a type of hypohidrotic ectodermal dysplasia, and it has a material basis in some form of X-linked recessive inheritance. It is specifically defined as a hypohidrotic ectodermal dysplasia that results from an X-linked recessive mutation in the EDA gene found on chromosome Xq13.1. This condition is known by various exact synonyms, including CST syndrome, Christ-Siemens-Touraine syndrome, ED1, HED1, X-linked anhidrotic ectodermal dysplasia, XHED, XLHED, ectodermal dysplasia 1, anhidrotic, ectodermal dysplasia 1, hypohidrotic, X-linked, and ectodermal dysplasia 1, hypohidrotic/hair/tooth type, X-linked, as well as hypohidrotic ectodermal dysplasia, X-Linked, indicating its diverse but specific identification within medical terminology.",15,True
doid,http://purl.obolibrary.org/obo/DOID_0111665,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ectodermal_dysplasia_10b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :hypohidrotic_ectodermal_dysplasia ;
    :has_definition ""A hypohidrotic ectodermal dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in the EDAR gene on chromosome 2q13."" ;
    :has_exact_synonym ""ECTD10B""@en,
        ""ectodermal dysplasia 10B, hypohidrotic/hair/nail type, autosomal recessive""@en .

","Ectodermal dysplasia 10b is classified as a type of autosomal recessive disease, hypohidrotic ectodermal dysplasia, and a condition that essentially involves autosomal recessive inheritance. It is specifically defined as a hypohidrotic ectodermal dysplasia that results from homozygous or compound heterozygous mutation in the EDAR gene located on chromosome 2q13. Additionally, ectodermal dysplasia 10b is also known by its exact synonyms ECTD10B and ectodermal dysplasia 10B, hypohidrotic/hair/nail type, autosomal recessive.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111666,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proliferative_vasculopathy_and_hydranencephaly_hydrocephaly_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by hydranencephaly, glomeruloid vasculopathy of the central nervous system and retinal vessels, diffuse clastic ischemic lesions of the brain stem, basal ganglia, and spinal cord with calcifications, and fetal akinesia with arthrogryposis that has_material_basis_in homozygous or compound heterozygous mutation in the FLVCR2 gene on chromosome 14q24.3."" ;
    :has_exact_synonym ""EPV""@en,
        ""Fowler syndrome""@en,
        ""Fowler vasculopathy""@en,
        ""PVHH""@en,
        ""cerebral proliferative glomeruloid vasculopathy""@en,
        ""encephaloclastic proliferative vasculopathy""@en,
        ""hydranencephaly, Fowler type""@en,
        ""hydrocephaly/hydranencephaly due to cerebral vasculopathy""@en,
        ""proliferative vasculopathy and hydranencephaly/hydrocephaly""@en .

","Proliferative vasculopathy and hydranencephaly hydrocephaly syndrome is a type of syndrome, autosomal recessive disease, and something that at least has a material basis in autosomal recessive inheritance. It is defined as a syndrome characterized by hydranencephaly, glomeruloid vasculopathy of the central nervous system and retinal vessels, diffuse clastic ischemic lesions of the brain stem, basal ganglia, and spinal cord with calcifications, and fetal akinesia with arthrogryposis. This condition has its material basis in homozygous or compound heterozygous mutation in the FLVCR2 gene on chromosome 14q24.3. Moreover, proliferative vasculopathy and hydranencephaly hydrocephaly syndrome has several exact synonyms: EPV, Fowler syndrome, Fowler vasculopathy, PVHH, cerebral proliferative glomeruloid vasculopathy, encephaloclastic proliferative vasculopathy, hydranencephaly, Fowler type, hydrocephaly/hydranencephaly due to cerebral vasculopathy, and proliferative vasculopathy and hydranencephaly/hydrocephaly.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0111667,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:enterokinase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :intestinal_disease ;
    :has_definition ""An intestinal disease characterized by early-onset failure to thrive, edema, hypoproteinemia, diarrhea and fat malabsorption that has_material_basis_in homozygous or compound heterozygous mutation in the TMPRSS15 gene on chromosome 21q21.1."" ;
    :has_exact_synonym ""congenital enterokinase deficiency""@en,
        ""congenital enteropathy due to enteropeptidase deficiency""@en,
        ""deficiency of enteropeptidase""@en .

","Enterokinase deficiency is classified as a type of autosomal recessive disease, an intestinal disease, and is associated with autosomal recessive inheritance due to its material basis. It is defined as an intestinal disease characterized by early-onset failure to thrive, edema, hypoproteinemia, diarrhea, and fat malabsorption, which results from homozygous or compound heterozygous mutations in the TMPRSS15 gene located on chromosome 21q21.1. Additionally, enterokinase deficiency is precisely known by several synonyms, including congenital enterokinase deficiency, congenital enteropathy due to enteropeptidase deficiency, and deficiency of enteropeptidase.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111668,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kohlschutter_tonz_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by severe global developmental delay, early-onset intractable seizures, spasticity, and amelogenesis imperfecta that has_material_basis_in homozygous or compound heterozygous mutation in ROGDI on chromosome 16p13.3."" ;
    :has_exact_synonym ""KTZS""@en,
        ""Kohlschutter's syndrome""@en,
        ""amelocerebrohypohidrotic syndrome""@en,
        ""epilepsy and yellow teeth""@en,
        ""epilepsy dementia amelogenesis imperfecta""@en,
        ""epilepsy-dementia-amelogenesis imperfecta syndrome""@en .

","Kohlschutter Tonz Syndrome is a type of syndrome that falls under the category of autosomal recessive diseases, which means it at least partly has a material basis in some form of autosomal recessive inheritance. It is characterized by severe global developmental delay, early-onset intractable seizures, spasticity, and amelogenesis imperfecta, with its material basis being in homozygous or compound heterozygous mutation in the ROGDI gene on chromosome 16p13.3. The syndrome is also known by several exact synonyms, including KTZS, Kohlschutter's syndrome, amelocerebrohypohidrotic syndrome, epilepsy and yellow teeth, epilepsy dementia amelogenesis imperfecta, and epilepsy-dementia-amelogenesis imperfecta syndrome.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111669,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hyaline_fibromatosis_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :connective_tissue_disease ;
    :has_definition ""A connective tissue disease characterized by abnormal growth of hyalinized fibrous tissue especially around the subcutaneous regions on the scalp, ears, neck, face, hands, and feet, gingival hypertrophy, joint contractures, and osteolytic bone lesions that has_material_basis_in homozygous or compound heterozygous mutation in the ANTXR2 gene on chromosome 4q21.21."" ;
    :has_exact_synonym ""HFS""@en,
        ""inherited systemic hyalinosis""@en,
        ""puretic syndrome""@en,
        ""systemic hyalinosis""@en .

","Hyaline fibromatosis syndrome (HFS), also known exactly as inherited systemic hyalinosis, puretic syndrome, and systemic hyalinosis, is a type of autosomal recessive disease, which is also classified under connective tissue diseases. This syndrome is characterized by the abnormal growth of hyalinized fibrous tissue, particularly around the subcutaneous regions on the scalp, ears, neck, face, hands, and feet, as well as gingival hypertrophy, joint contractures, and osteolytic bone lesions. The material basis for HFS is linked to homozygous or compound heterozygous mutations in the ANTXR2 gene located on chromosome 4q21.21.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111670,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_hyperoxaluria_type_1 rdfs:subClassOf :primary_hyperoxaluria ;
    :has_definition ""A primary hyperoxaluria characterized by failure to transaminate glyoxylate resulting in accumulation of calcium oxalate in various tissues that has_material_basis_in homozygous or compound heterozygous mutation in the AGXT gene on chromosome 2q37.3."" ;
    :has_exact_synonym ""HP1""@en,
        ""alanine-glyoxylate aminotransferase deficiency""@en,
        ""glycolic aciduria""@en,
        ""hepatic AGT deficiency""@en,
        ""oxalosis I""@en,
        ""peroxisomal alanine-glyoxylate aminotransferase deficiency""@en,
        ""serine pyruvate aminotransferase deficiency""@en .

","Primary hyperoxaluria type 1 is a specific type of primary hyperoxaluria. It is characterized by a failure to transaminate glyoxylate, leading to the accumulation of calcium oxalate in various tissues. This condition has a material basis in homozygous or compound heterozygous mutations in the AGXT gene located on chromosome 2q37.3. Additionally, primary hyperoxaluria type 1 is precisely known by several exact synonyms, including HP1, alanine-glyoxylate aminotransferase deficiency, glycolic aciduria, hepatic AGT deficiency, oxalosis I, peroxisomal alanine-glyoxylate aminotransferase deficiency, and serine pyruvate aminotransferase deficiency.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111671,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_hyperoxaluria_type_2 rdfs:subClassOf :primary_hyperoxaluria ;
    :has_definition ""A primary hyperoxaluria characterized by elevated urinary excretion of oxalate and L-glycerate, recurrent nephrolithiasis and nephrocalcinosis, and end-stage renal disease that has_material_basis_in homozygous or compound heterozygous mutation in the GRHPR gene on chromosome 9p13.2."" ;
    :has_exact_synonym ""oxalosis II"",
        ""D-glycerate dehydrogenase deficiency""@en,
        ""HP2""@en,
        ""L-glyceric aciduria""@en,
        ""glyoxylate reductase/hydroxypyruvate reductase deficiency""@en .

","Primary hyperoxaluria type 2 is a type of primary hyperoxaluria. It is characterized by elevated urinary excretion of oxalate and L-glycerate, recurrent nephrolithiasis and nephrocalcinosis, and end-stage renal disease. This condition has a material basis in homozygous or compound heterozygous mutation in the GRHPR gene on chromosome 9p13.2. Primary hyperoxaluria type 2 is also known by several exact synonyms, including D-glycerate dehydrogenase deficiency, HP2, L-glyceric aciduria, glyoxylate reductase/hydroxypyruvate reductase deficiency, and oxalosis II.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111672,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_hyperoxaluria_type_3 rdfs:subClassOf :primary_hyperoxaluria ;
    :has_definition ""A primary hyperoxaluria characterized by recurring calcium oxalate stones that has_material_basis_in homozygous or compound heterozygous mutation in the HOGA1 gene on chromosome 10q24.2."" ;
    :has_exact_synonym ""HP3""@en,
        ""PH III""@en,
        ""primary hyperoxaluria type III""@en .

","Primary Hyperoxaluria Type 3 is a type of Primary Hyperoxaluria. It is defined as a primary hyperoxaluria characterized by recurring calcium oxalate stones that occurs due to homozygous or compound heterozygous mutation in the HOGA1 gene on chromosome 10q24.2. Moreover, it has exact synonyms including HP3, PH III, and Primary Hyperoxaluria Type III.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111673,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:saul_wilson_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :bone_development_disease ;
    :has_definition ""A bone development disease characterized by early developmental delay primarily involving speech, distinct facial features, short stature, brachydactyly, clubfoot deformities, cataracts, and microcephaly that has_material_basis_in heterozygous mutation in the COG4 gene on chromosome 16q22.1."" ;
    :has_exact_synonym ""SWILS""@en,
        ""microcephalic osteodysplastic dysplasia, Saul-Wilson type""@en .

","Saul Wilson syndrome is a type of autosomal dominant disease that is also categorized as a bone development disease, indicating that it has a material basis in some form of autosomal dominant inheritance. It is characterized by early developmental delays, particularly in speech, distinct facial features, short stature, brachydactyly, clubfoot deformities, cataracts, and microcephaly. This condition is caused by a heterozygous mutation in the COG4 gene on chromosome 16q22.1. Saul Wilson syndrome is alternatively known by its exact synonyms, SWILS and microcephalic osteodysplastic dysplasia, Saul-Wilson type.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111674,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:intellectual_developmental_disorder_with_short_stature_and_behavioral_abnormalities rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by intellectual disability, global developmental delay, short stature, aphasia, and hypotonia that has_material_basis_in homozygous or compound heterozygous mutation in the IQSEC1 gene on chromosome 3p25.2-p25.1."" ;
    :has_exact_synonym ""IDDSSBA""@en .

","Intellectual developmental disorder with short stature and behavioral abnormalities (IDDSSBA) is a syndrome characterized by a range of symptoms including intellectual disability, global developmental delay, short stature, aphasia, and hypotonia. This disorder is a type of autosomal recessive disease and also falls under the category of syndromes that have a material basis in autosomal recessive inheritance. Specifically, IDDSSBA has its material basis in homozygous or compound heterozygous mutations in the IQSEC1 gene located on chromosome 3p25.2-p25.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111675,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurooculocardiogenitourinary_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by impaired growth and anomalies of the ocular, craniofacial, neurologic, cardiovascular, genitourinary, skeletal, and gastrointestinal systems that has_material_basis_in heterozygous mutation in the WDR37 gene on chromosome 10p15.3."" ;
    :has_exact_synonym ""NOCGUS""@en .

","Neurooculocardiogenitourinary syndrome, also known exactly as NOCGUS, is a type of syndrome and an autosomal dominant disease that inherently has a material basis in autosomal dominant inheritance. It is defined as a syndrome characterized by impaired growth along with anomalies of the ocular, craniofacial, neurologic, cardiovascular, genitourinary, skeletal, and gastrointestinal systems, which has its material basis in a heterozygous mutation in the WDR37 gene located on chromosome 10p15.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111676,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:high_molecular_weight_kininogen_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :blood_coagulation_disease ;
    :has_definition ""A blood coagulation disease characterized by deficiency of high molecular weight kininogen but not of low molecular weight kininogen resulting in abnormal surface-mediated activation of fibrinolysis that has_material_basis_in homozygous or compound heterozygous mutation in the KNG1 gene on chromosome 3q27.3. Both high and low molecular weight kininogen are encoded by the KNG1 gene."" ;
    :has_exact_synonym ""Fitzgerald trait""@en,
        ""HMWK deficiency""@en,
        ""congenital high-molecular-weight kininogen deficiency""@en .

","High molecular weight kininogen deficiency is a type of autosomal recessive disease and a type of blood coagulation disease. It is also recognized as a condition that at least has a material basis in some form of autosomal recessive inheritance. This disease is defined as a blood coagulation disease characterized by a deficiency of high molecular weight kininogen but not of low molecular weight kininogen, resulting in abnormal surface-mediated activation of fibrinolysis. This is due to homozygous or compound heterozygous mutation in the KNG1 gene on chromosome 3q27.3, with both high and low molecular weight kininogen being encoded by the KNG1 gene. Additionally, high molecular weight kininogen deficiency is exactly synonymous with Fitzgerald trait, HMWK deficiency, and congenital high-molecular-weight kininogen deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111677,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_benign_fleck_retina rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :retinal_disease ;
    :has_definition ""A retinal disease characterized by a striking pattern of diffuse, yellow-white, fleck-like lesions extending to the far periphery of the retina but with no apparent visual or electrophysiologic deficits that has_material_basis_in homozygous or compound heterozygous mutation in the PLA2G5 gene on chromosome 1p36.13."" ;
    :has_exact_synonym ""FRFB""@en .

","Familial benign fleck retina (FRFB) is a type of retinal disease, specifically an autosomal recessive disease. It is characterized by a condition that fundamentally has a material basis in autosomal recessive inheritance. The disease is defined by a retinal disease distinguished by a unique pattern of diffuse, yellow-white, fleck-like lesions that extend to the far periphery of the retina, yet without any noticeable visual or electrophysiologic deficits. This condition is caused by homozygous or compound heterozygous mutation in the PLA2G5 gene located on chromosome 1p36.13.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111678,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_folate_malabsorption rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :vitamin_metabolic_disorder ;
    :has_definition ""A vitamin metabolic disorder characterized by impaired intestinal folate absorption and impaired transport of folate into the central nervous system resulting in megaloblastic anemia, diarrhea, immune deficiency, infections, and neurologic deficits that has_material_basis_in homozygous or compound heterozygous mutation in the SLC46A1 gene on chromosome 17q11.2."" ;
    :has_exact_synonym ""congenital defect of folate absorption""@en,
        ""congenital folate malabsorption""@en .

","Hereditary folate malabsorption is a type of vitamin metabolic disorder, autosomal recessive disease, and something that at least has a material basis in some autosomal recessive inheritance. It is defined as a vitamin metabolic disorder characterized by impaired intestinal folate absorption and impaired transport of folate into the central nervous system, resulting in megaloblastic anemia, diarrhea, immune deficiency, infections, and neurologic deficits. This condition has a material basis in homozygous or compound heterozygous mutation in the SLC46A1 gene on chromosome 17q11.2. It is also exactly synonymous with congenital defect of folate absorption and congenital folate malabsorption.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111679,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:glutamate_formiminotransferase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :vitamin_metabolic_disorder ;
    :has_definition ""A vitamin metabolic disorder characterized by elevated formiminoglutamate in urine and plasma and variable intellectual, developmental, and hematological phenotypes that has_material_basis_in homozygous or compound heterozygous mutation in the FTCD gene on chromosome 21q22.3."" ;
    :has_exact_synonym ""Arakawa syndrome 1""@en,
        ""FIGLUria""@en,
        ""FTCD deficiency""@en,
        ""formiminoglutamic acidemia""@en,
        ""formiminoglutamic aciduria""@en,
        ""formiminotransferase cyclodeaminase deficiency""@en,
        ""formiminotransferase deficiency syndrome""@en .

","Glutamate formiminotransferase deficiency is a type of vitamin metabolic disorder and also falls under the category of autosomal recessive diseases. This condition is characterized by having a material basis in some form of autosomal recessive inheritance. Specifically, it is defined as a vitamin metabolic disorder marked by elevated formiminoglutamate levels in both urine and plasma, accompanied by variable intellectual, developmental, and hematological phenotypes due to homozygous or compound heterozygous mutation in the FTCD gene located on chromosome 21q22.3. Furthermore, this deficiency is known by several exact synonyms including Arakawa syndrome 1, FIGLUria, FTCD deficiency, formiminoglutamic acidemia, formiminoglutamic aciduria, formiminotransferase cyclodeaminase deficiency, and formiminotransferase deficiency syndrome.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111680,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:essential_fructosuria rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :carbohydrate_metabolic_disorder ;
    :has_definition ""A carbohydrate metabolic disorder characterized by elevated fructose levels in the blood and urine following ingestion of fructose and related sugars that has_material_basis_in homozygous or compound heterozygous mutation in KHK on chromosome 2p23.3."" ;
    :has_exact_synonym ""fructokinase deficiency""@en,
        ""hepatic fructokinase deficiency""@en,
        ""ketohexokinase deficiency""@en .

","Essential fructosuria is a type of autosomal recessive disease, carbohydrate metabolic disorder, and something that at least has a material basis in autosomal recessive inheritance. It is characterized by elevated fructose levels in the blood and urine following ingestion of fructose and related sugars, resulting from homozygous or compound heterozygous mutation in the KHK gene on chromosome 2p23.3. Essential fructosuria is also precisely known as fructokinase deficiency, hepatic fructokinase deficiency, and ketohexokinase deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111681,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:glutamate_cysteine_ligase_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :amino_acid_metabolic_disorder,
        :autosomal_recessive_disease ;
    :has_definition ""An amino acid metabolic disorder characterized by decreased levels of cellular glutathione and gamma-glutamylcysteine and hemolytic anemia that has_material_basis_in homozygous or compound heterozygous mutation in the GCLC gene on chromosome 6p12.1."" ;
    :has_exact_synonym ""gamma-glutamylcysteine synthetase deficiency""@en,
        ""hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency""@en .

","Glutamate cysteine ligase deficiency is a type of autosomal recessive disease, which is also a type of amino acid metabolic disorder. It is characterized by something that at least has a material basis in some autosomal recessive inheritance. Specifically, this disorder is defined as an amino acid metabolic disorder characterized by decreased levels of cellular glutathione and gamma-glutamylcysteine, along with hemolytic anemia. This condition has its material basis in homozygous or compound heterozygous mutation in the GCLC gene on chromosome 6p12.1. Moreover, glutamate cysteine ligase deficiency is exactly synonymous with gamma-glutamylcysteine synthetase deficiency and hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111682,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diffuse_cystic_renal_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :cystic_kidney_disease ;
    :has_definition ""A cystic kidney disease characterized by nonsyndromic diffuse cystic dysplasia of the kidneys that has_material_basis_in heterozygous mutation in the BICC1 gene on chromosome 10q21.1. The same mutation maybe found in unaffected parents suggesting incomplete penetrance of the disorder or that additional environmental factors are required for development of the disorder."" ;
    :has_exact_synonym ""CYSRD""@en,
        ""renal dysplasia diffuse cystic""@en,
        ""susceptibility to cystic renal dysplasia""@en .

","Diffuse cystic renal dysplasia is a type of autosomal dominant disease, cystic kidney disease, and it is something that at least has a material basis in some form of autosomal dominant inheritance. It is characterized by nonsyndromic diffuse cystic dysplasia of the kidneys, which is due to a heterozygous mutation in the BICC1 gene on chromosome 10q21.1. This same mutation may also be found in unaffected parents, suggesting the disorder has incomplete penetrance or that additional environmental factors are required for the development of the disorder. This condition is also known by its exact synonyms: CYSRD, renal dysplasia diffuse cystic, and susceptibility to cystic renal dysplasia.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111683,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:neurofibromatosis_noonan_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ptosis ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :muscle_weakness ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :short_stature ],
        :autosomal_dominant_disease,
        :ra_sopathy ;
    :has_definition ""A RASopathy characterized by neurofibromatosis and manifestations of Noonan syndrome including short stature, ptosis, midface hypoplasia, webbed neck, learning disabilities, and muscle weakness that has_material_basis_in heterozygous mutation in NF1 on chromosome 17q11.2."" ;
    :has_exact_match ""GARD:372"",
        ""MESH:C537393"",
        ""OMIM:601321"",
        ""ORDO:638"",
        ""SNOMEDCT_US_2023_03_01:715344006"",
        ""UMLS_CUI:C2931482"" ;
    :has_exact_synonym ""NFNS""@en,
        ""Noonan neurofibromatosis syndrome""@en,
        ""neurofibromatosis type 1-Noonan syndrome""@en,
        ""neurofibromatosis with Noonan phenotype""@en .

","Neurofibromatosis Noonan syndrome is a type of autosomal dominant disease and also a type of RASopathy. This condition is characterized by having a material basis in autosomal dominant inheritance and exhibits phenotypes such as short stature and symptoms like muscle weakness and ptosis. It is defined as a RASopathy characterized by neurofibromatosis and manifestations of Noonan syndrome, which include short stature, ptosis, midface hypoplasia, webbed neck, learning disabilities, and muscle weakness, due to a heterozygous mutation in NF1 on chromosome 17q11.2. Neurofibromatosis Noonan syndrome is exactly synonymous with NFNS, Noonan Neurofibromatosis Syndrome, Neurofibromatosis Type 1-Noonan Syndrome, and Neurofibromatosis with Noonan Phenotype. It has exact matches in several databases, including GARD:372, MESH:C537393, OMIM:601321, ORDO:638, SNOMEDCT_US_2023_03_01:715344006, and UMLS_CUI:C2931482.",17,True
doid,http://purl.obolibrary.org/obo/DOID_0111684,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_mixed_polyposis_syndrome rdfs:subClassOf :intestinal_disease ;
    :has_definition ""An intestinal disease characterized by a mixture of hyperplastic, atypical juvenile and adenomatous polyps that are associated with an increased risk of developing colorectal cancer when untreated."" ;
    :has_exact_synonym ""HMPS""@en .

","Hereditary mixed polyposis syndrome is a type of intestinal disease and has an exact synonym HMPS. It is defined as an intestinal disease characterized by a mixture of hyperplastic, atypical juvenile, and adenomatous polyps that are associated with an increased risk of developing colorectal cancer when untreated.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111685,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_mixed_polyposis_syndrome_1 rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :chromosome ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :duplication ] ;
                            rdf:rest :nil ] ] ],
        :chromosomal_duplication_syndrome,
        :hereditary_mixed_polyposis_syndrome ;
    :has_definition ""A hereditary mixed polyposis syndrome that has_material_basis_in heterozygous duplication of a region on chromosome 15q15.3-q22.1."" ;
    :has_exact_synonym ""CRAC1""@en,
        ""HMPS1""@en,
        ""chromosome 15q13-q14 duplication syndrome, 40-KB""@en,
        ""colorectal adenoma and carcinoma 1""@en .

","Hereditary Mixed Polyposis Syndrome 1 (HMPS1), also known precisely as CRAC1, HMPS1, Chromosome 15q13-q14 Duplication Syndrome, 40-KB, and Colorectal Adenoma and Carcinoma 1, is a type of Chromosomal Duplication Syndrome, as well as a type of Hereditary Mixed Polyposis Syndrome. It is characterized as a condition that intersects with entities having at least a material basis in some chromosome and entities having at least a material basis in some duplication. Specifically, HMPS1 is defined as a hereditary mixed polyposis syndrome that is caused by a heterozygous duplication of a region on chromosome 15q15.3-q22.1.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111686,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:hereditary_mixed_polyposis_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :hereditary_mixed_polyposis_syndrome ;
    :has_definition ""A hereditary mixed polyposis syndrome that has_material_basis_in heterozygous mutation in the BMPR1A gene on chromosome 10q23.2."" ;
    :has_exact_synonym ""HMPS2""@en .

","Hereditary Mixed Polyposis Syndrome 2 (HMPS2) is a type of hereditary mixed polyposis syndrome and an autosomal dominant disease. It specifically has a material basis in autosomal dominant inheritance. Furthermore, HMPS2 is defined as a hereditary mixed polyposis syndrome that results from a heterozygous mutation in the BMPR1A gene located on chromosome 10q23.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111687,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:potocki_shaffer_syndrome rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :deletion ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :chromosome ] ;
                            rdf:rest :nil ] ] ],
        :chromosomal_deletion_syndrome,
        :syndrome ;
    :has_definition ""A syndrome characterized by craniofacial abnormalities, developmental delay, intellectual disability, multiple exostoses, and biparietal foramina that has_material_basis_in heterozygosity for a contiguous gene deletion on chromosome 11p11.2."" ;
    :has_exact_synonym ""11p11.2 deletion""@en,
        ""PSS""@en,
        ""proximal 11p deletion syndrome""@en .

","Potocki Shaffer Syndrome (PSS) is a type of syndrome and specifically, a chromosomal deletion syndrome. It is characterized by an intersection of conditions that have a material basis in some deletion and in some chromosome, indicating its complex nature involving chromosomal abnormalities. This syndrome is defined as a disorder marked by craniofacial abnormalities, developmental delay, intellectual disability, multiple exostoses, and biparietal foramina. It arises from heterozygosity for a contiguous gene deletion on chromosome 11p11.2. Moreover, Potocki Shaffer Syndrome is also known by exact synonyms including 11p11.2 deletion, PSS, and proximal 11p deletion syndrome, highlighting its diverse nomenclature based on its genetic characteristics.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111688,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ayme_gripp_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by congenital cataracts, sensorineural hearing loss, intellectual disability, seizures, brachycephaly, a distinctive flat facial appearance, and reduced growth that has_material_basis_in heterozygous mutation in MAF on chromosome 16q23.2."" ;
    :has_exact_synonym ""AYGRP""@en,
        ""cataracts, congenital, with sensorineural deafness, Down syndrome-like facial appearance, short stature, and mental retardation""@en .

","Ayme Gripp syndrome is a type of autosomal dominant disease and a syndrome that has its material basis in autosomal dominant inheritance. It is characterized by congenital cataracts, sensorineural hearing loss, intellectual disability, seizures, brachycephaly, a distinctive flat facial appearance, and reduced growth, all of which are due to a heterozygous mutation in the MAF gene on chromosome 16q23.2. Additionally, Ayme Gripp syndrome has exact synonyms, including AYGRP and cataracts, congenital, with sensorineural deafness, Down syndrome-like facial appearance, short stature, and mental retardation.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111689,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :adolescence_adult_electroclinical_syndrome ;
    :has_definition ""An adolescence-adult electroclinical syndrome characterized by adult-onset cortical myoclonus typically first seen as tremulous finger movements and myoclonus of the extremities."" ;
    :has_exact_synonym ""BAFME""@en,
        ""FAME""@en,
        ""FCMTE""@en,
        ""benign adult familial myoclonic epilepsy""@en,
        ""benign adult familial myoclonus epilepsy""@en,
        ""familial cortical myoclonic tremor and epilepsy""@en .

","Familial adult myoclonic epilepsy (FAME), also known as benign adult familial myoclonic epilepsy, familial cortical myoclonic tremor and epilepsy, BAFME, and FCMTE, is a type of adolescence-adult electroclinical syndrome. It is characterized by an adult-onset cortical myoclonus typically first seen as tremulous finger movements and myoclonus of the extremities. This condition is known to start during adult onset and is a form of something that at least exists from some adult onset.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111690,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_adult_myoclonic_epilepsy ;
    :has_definition ""A familial adult myoclonic epilepsy that has_material_basis_in a heterozygous 5-bp repeat expansion in the SAMD12 gene on chromosome 8q24.11-q24.12."" ;
    :has_exact_synonym ""BAFME1""@en,
        ""FAME1""@en,
        ""FCMTE1""@en,
        ""benign adult familial myoclonic epilepsy 1""@en,
        ""familial cortical myoclonic tremor and epilepsy 1""@en .

","Familial Adult Myoclonic Epilepsy 1 (FAME1) is a type of autosomal dominant disease and also falls under the broader category of familial adult myoclonic epilepsy. It is characterized by a material basis in some autosomal dominant inheritance and typically begins during adult onset. FAME1 is defined by a heterozygous 5-bp repeat expansion in the SAMD12 gene located on chromosome 8q24.11-q24.12. Moreover, FAME1 is known by several exact synonyms, including BAFME1, FCMTE1, benign adult familial myoclonic epilepsy 1, and familial cortical myoclonic tremor and epilepsy 1.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111691,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :autosomal_recessive_disease,
        :familial_adult_myoclonic_epilepsy ;
    :has_definition ""A familial adult myoclonic epilepsy characterized by onset of seizures in adolescence, followed by the development of cortical myoclonic tremor that has_material_basis_in homozygous or compound heterozygous mutation in the CNTN2 gene on chromosome 1q32.1."" ;
    :has_exact_synonym ""FAME5""@en,
        ""FCMTE5""@en,
        ""familial cortical myoclonic tremor and epilepsy 5""@en .

","Familial adult myoclonic epilepsy 5 (FAME5), also known exactly as FCMTE5 and familial cortical myoclonic tremor and epilepsy 5, is a type of autosomal recessive disease that falls under the broader category of familial adult myoclonic epilepsy. It is characterized by the onset of seizures in adolescence, followed by the development of cortical myoclonic tremor. This condition specifically arises from homozygous or compound heterozygous mutation in the CNTN2 gene located on chromosome 1q32.1. Notably, FAME5's existence begins during adulthood and is attributed to some form of autosomal recessive inheritance.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111692,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_adult_myoclonic_epilepsy ;
    :has_definition ""A familial adult myoclonic epilepsy characterized by onset of tremor affecting the fingers, hand, and voice in adolescence or young adulthood with somewhat later onset of rhythmic myoclonic jerks and generalized tonic-clonic seizures that has_material_basis_in a heterozygous 5-bp repeat expansion in STARD7 on chromosome 2q11.2."" ;
    :has_exact_synonym ""ADCME""@en,
        ""BAFME2""@en,
        ""FAME2""@en,
        ""FCMTE2""@en,
        ""autosomal dominant cortical myoclonus and epilepsy""@en,
        ""benign adult familial myoclonic epilepsy 2""@en,
        ""familial cortical myoclonic tremor and epilepsy 2""@en .

","Familial Adult Myoclonic Epilepsy 2 (FAME2) is a type of autosomal dominant disease and a specific form of familial adult myoclonic epilepsy. It is characterized by having a material basis in some autosomal dominant inheritance and its existence typically starts during adult onset. FAME2 is defined as a familial adult myoclonic epilepsy where the onset of tremor affects the fingers, hand, and voice in adolescence or young adulthood, followed by somewhat later onset of rhythmic myoclonic jerks and generalized tonic-clonic seizures. This condition has its material basis in a heterozygous 5-bp repeat expansion in the STARD7 gene on chromosome 2q11.2. It is also known by several exact synonyms including ADCME, BAFME2, FCMTE2, autosomal dominant cortical myoclonus and epilepsy, benign adult familial myoclonic epilepsy 2, and familial cortical myoclonic tremor and epilepsy 2.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111693,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_adult_myoclonic_epilepsy ;
    :has_definition ""A familial adult myoclonic epilepsy that has_material_basis_in heterozygous mutation in the YEATS2 gene on chromosome 3q27.1."" ;
    :has_exact_synonym ""FAME4""@en,
        ""FCMTE4""@en,
        ""familial cortical myoclonic tremor and epilepsy 4""@en .

","Familial adult myoclonic epilepsy 4 (FAME4), also known exactly as FCMTE4 and familial cortical myoclonic tremor and epilepsy 4, is a subtype of autosomal dominant disease and familial adult myoclonic epilepsy. It is characterized by having a material basis in some autosomal dominant inheritance and typically begins during adult onset. The condition is defined by a heterozygous mutation in the YEATS2 gene on chromosome 3q27.1.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111694,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :autosomal_dominant_disease,
        :familial_adult_myoclonic_epilepsy ;
    :has_definition ""A familial adult myoclonic epilepsy that has_material_basis_in a heterozygous 5-bp repeat expansion in the RAPGEF2 gene on chromosome 4q32.1."" ;
    :has_exact_synonym ""BAFME7""@en,
        ""FAME7""@en,
        ""FCMTE7""@en,
        ""benign adult familial myoclonic epilepsy 7""@en,
        ""familial cortical myoclonic tremor and epilepsy 7""@en .

","Familial adult myoclonic epilepsy 7 (FAME7) is a type of autosomal dominant disease and a form of familial adult myoclonic epilepsy. It is characterized by a material basis in autosomal dominant inheritance and typically begins in adulthood. The condition is defined by a familial adult myoclonic epilepsy that has a material basis in a heterozygous 5-bp repeat expansion in the RAPGEF2 gene on chromosome 4q32.1. FAME7 is also known by several exact synonyms, including BAFME7, FCMTE7, benign adult familial myoclonic epilepsy 7, and familial cortical myoclonic tremor and epilepsy 7.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111695,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :autosomal_dominant_disease,
        :familial_adult_myoclonic_epilepsy ;
    :has_definition ""A familial adult myoclonic epilepsy characterized by onset between 10 and 40 years of age of cortical tremor, mainly affecting the hands and voice that has_material_basis_in a heterozygous 5-bp repeat expansion in the MARCHF6 gene on chromosome 5p15.2."" ;
    :has_exact_synonym ""FAME3""@en,
        ""FCMTE3""@en,
        ""familial cortical myoclonic tremor and epilepsy 3""@en .

","Familial adult myoclonic epilepsy 3 (FAME3) is a type of autosomal dominant disease and is specifically categorized under familial adult myoclonic epilepsy. This condition is characterized by having a material basis in some autosomal dominant inheritance and its existence typically begins during adult onset. FAME3 is defined as a familial adult myoclonic epilepsy characterized by the onset between 10 and 40 years of age of cortical tremor, primarily affecting the hands and voice, which has a material basis in a heterozygous 5-bp repeat expansion in the MARCHF6 gene on chromosome 5p15.2. Additionally, FAME3 is exactly synonymous with FCMTE3 and familial cortical myoclonic tremor and epilepsy 3.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111696,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_adult_myoclonic_epilepsy_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_adult_myoclonic_epilepsy ;
    :has_definition ""A familial adult myoclonic epilepsy that has_material_basis_in a heterozygous 5-bp repeat expansion in the TNRC6A gene on chromosome 16p12.1."" ;
    :has_exact_synonym ""BAFME6""@en,
        ""FAME6""@en,
        ""FCMTE6""@en,
        ""benign adult familial myoclonic epilepsy 6""@en,
        ""familial cortical myoclonic tremor and epilepsy 6""@en .

","Familial Adult Myoclonic Epilepsy 6 (FAME6) is a specific type of familial adult myoclonic epilepsy and is categorized as an autosomal dominant disease. This condition is characterized by its genetic basis, which involves a heterozygous 5-bp repeat expansion in the TNRC6A gene located on chromosome 16p12.1. FAME6 typically begins during adulthood, indicating its adult onset nature. Furthermore, it is known by several exact synonyms, including BAFME6, FCMTE6, benign adult familial myoclonic epilepsy 6, and familial cortical myoclonic tremor and epilepsy 6.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111697,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cleft_palate_cardiac_defects_and_intellectual_disabillity rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by a combination of congenital heart defects, variable cleft lip/palate, short stature, microcephaly, and digital anomalies that has_material_basis_in heterozygous mutation in the MEIS2 gene on chromosome 15q14."" ;
    :has_exact_synonym ""CPCMR"",
        ""cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies"",
        ""cleft palate, cardiac defects, and mental retardation"" .

","Cleft palate, cardiac defects, and intellectual disability is a syndrome and a type of autosomal dominant disease, which also falls under the category of conditions that at least have a material basis in some autosomal dominant inheritance. This syndrome is characterized by a combination of congenital heart defects, variable cleft lip/palate, short stature, microcephaly, and digital anomalies, which has its material basis in a heterozygous mutation in the MEIS2 gene on chromosome 15q14. Additionally, it has the exact synonyms CPCMR, cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies, as well as cleft palate, cardiac defects, and mental retardation.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111698,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:proprotein_convertase_1_3_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by severe childhood obesity, hypoadrenalism, hypogonadism, reactive hypoglycaemia, and elevated circulating levels of certain prohormones that has_material_basis_in homozygous or compound heterozygous mutation in the PCSK1 gene on chromosome 5q15."" ;
    :has_exact_synonym ""PCI deficiency"",
        ""obesity and endocrinopathy due to impaired processing of prohormones"",
        ""obesity due to prohormone convertase I deficiency"",
        ""obesity with impaired prohormone processing"" .

","Proprotein convertase 1 3 deficiency is a type of autosomal recessive disease, syndrome, and something that has a material basis in autosomal recessive inheritance. It is characterized as a syndrome marked by severe childhood obesity, hypoadrenalism, hypogonadism, reactive hypoglycaemia, and elevated circulating levels of certain prohormones, which is due to homozygous or compound heterozygous mutation in the PCSK1 gene on chromosome 5q15. Additionally, proprotein convertase 1 3 deficiency is also known by several exact synonyms including PCI deficiency, obesity and endocrinopathy due to impaired processing of prohormones, obesity due to prohormone convertase I deficiency, and obesity with impaired prohormone processing.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111699,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:van_den_ende_gupta_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by severe contractual arachnodactyly, distinctive facial features, blepharophimosis, and absence of neurological involvement that has_material_basis_in homozygous or compound heterozygous mutation in the SCARF2 gene on chromosome 22q11.21."" ;
    :has_exact_synonym ""Marden-Walker-like syndrome"",
        ""Marden-Walker-like syndrome without psychmotor retardation"",
        ""VDEGS"",
        ""blepharophimosis, arachnodactyly, and congenital contractures"" .

","Van den Ende Gupta syndrome is a type of syndrome, specifically an autosomal recessive disease, which fundamentally has a material basis in autosomal recessive inheritance. It is characterized by severe contractural arachnodactyly, distinctive facial features, blepharophimosis, and the absence of neurological involvement, stemming from homozygous or compound heterozygous mutations in the SCARF2 gene on chromosome 22q11.21. This syndrome is also precisely known by several exact synonyms including Marden-Walker-like syndrome, Marden-Walker-like syndrome without psychomotor retardation, VDEGS, and blepharophimosis, arachnodactyly, and congenital contractures.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111700,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ankyrin_b_related_cardiac_arrhythmia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :heart_disease ;
    :has_definition ""A heart disease characterized by a broad spectrum of cardiac arrhythmias including; bradycardia, sinus arrhythmia, delayed conduction/conduction block, idiopathic ventricular fibrillation, and catecholaminergic polymorphic ventricular tachycardia that has_material_basis_in heterozygous mutation in the ANK2 gene on chromosome 4q25-q26."" ;
    :has_exact_synonym ""ankyrin-B syndrome"" .

","Ankyrin b related cardiac arrhythmia, also known as ankyrin-B syndrome, is a type of heart disease and autosomal dominant disease. It specifically involves a condition that at least has a material basis in some form of autosomal dominant inheritance. The disease is characterized by a broad spectrum of cardiac arrhythmias, including bradycardia, sinus arrhythmia, delayed conduction/conduction block, idiopathic ventricular fibrillation, and catecholaminergic polymorphic ventricular tachycardia. These symptoms have their material basis in a heterozygous mutation in the ANK2 gene located on chromosome 4q25-q26.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111701,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:long_qt_syndrome_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :long_qt_syndrome ;
    :has_definition ""A long QT syndrome that has_material_basis_in heterozygous mutation in the ANK2 gene on chromosome 4q25-q26."" ;
    :has_exact_synonym ""LQT4"" .

","Long QT syndrome 4 is a type of long QT syndrome and is classified as an autosomal dominant disease. This classification is based on the fact that it at least has a material basis in some form of autosomal dominant inheritance. Furthermore, Long QT syndrome 4, which is exactly synonymous with LQT4, is defined by a long QT syndrome that has its material basis in a heterozygous mutation in the ANK2 gene located on chromosome 4q25-q26.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111702,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:loose_anagen_hair_syndrome rdfs:subClassOf :alopecia ;
    :has_definition ""An alopecia characterized by anagen phase (actively growing) hair that is easily pulled from the scalp typically presenting in childhood in fair haired individuals and improving with age."" ;
    :has_exact_synonym ""loose anagen syndrome"" .

","Loose anagen hair syndrome is a type of alopecia and has the definition of being an alopecia characterized by anagen phase (actively growing) hair that is easily pulled from the scalp, typically presenting in childhood in fair-haired individuals and improving with age. It also has the exact synonym ""loose anagen syndrome.""",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111703,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_hypertryptophanemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :amino_acid_metabolic_disorder,
        :autosomal_recessive_disease ;
    :has_definition ""An amino acid metabolic disorder characterized by elevated urine and plasma tryptophan levels that has_material_basis_in homozygous or compound heterozygous mutation in the TDO2 gene on chromosome 4q32.1."" ;
    :has_exact_synonym ""HYPTRP"" .

","Familial hypertryptophanemia is a type of autosomal recessive disease and an amino acid metabolic disorder, which essentially has a material basis in autosomal recessive inheritance. It is characterized by elevated urine and plasma tryptophan levels, resulting from homozygous or compound heterozygous mutation in the TDO2 gene located on chromosome 4q32.1. This condition is also precisely known by its synonym, HYPTRP.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111704,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:chromosome_2q37_deletion_syndrome rdfs:subClassOf :chromosomal_deletion_syndrome ;
    :has_definition ""A chromosomal deletion syndrome characterized by variable features, likely resulting from different sized deletions, including; brachydactyly type E, short stature, mild to moderate intellectual disability, behavioral abnormalities, and dysmorphic facial features that has_material_basis_in heterozygosity for a contiguous deletion of several genes on chromosome 2q37.2."" ;
    :has_exact_synonym ""2q37 microdeletion syndrome"",
        ""Albright hereditary osteodystrophy type 3"",
        ""Albright hereditary osteodystrophy-like syndrome"",
        ""Albright's hereditary osteodystrophy-like syndrome"",
        ""BDMR"",
        ""Brachydactyly-intellectual disability syndrome"",
        ""Del(2)(q37)"",
        ""deletion 2q37"",
        ""monosomy 2q37qter"" .

","Chromosome 2q37 deletion syndrome is a type of chromosomal deletion syndrome characterized by a variety of features potentially due to deletions of different sizes. These features include brachydactyly type E, short stature, mild to moderate intellectual disability, behavioral abnormalities, and dysmorphic facial features. The syndrome's material basis is in heterozygosity for a contiguous deletion of several genes on chromosome 2q37.2. Chromosome 2q37 deletion syndrome is also known by several exact synonyms: 2q37 microdeletion syndrome, Albright hereditary osteodystrophy type 3, Albright hereditary osteodystrophy-like syndrome, Albright's hereditary osteodystrophy-like syndrome, BDMR, Brachydactyly-intellectual disability syndrome, Del(2)(q37), deletion 2q37, and monosomy 2q37qter.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111705,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oculoectodermal_syndrome rdfs:subClassOf :ectodermal_dysplasia ;
    :has_definition ""An ectodermal dysplasia characterized by epibulbar dermoids and aplasia cutis congenita that has_material_basis_in somatic mosaic mutation in the KRAS gene on chromosome 12p12.1."" ;
    :has_exact_synonym ""Toriello-Lacassie-Droste syndrome"",
        ""aplasia cutis congenita-epibulbar dermoids syndrome"" .

",Oculoectodermal syndrome is a type of ectodermal dysplasia characterized by epibulbar dermoids and aplasia cutis congenita. This condition has a material basis in somatic mosaic mutation in the KRAS gene on chromosome 12p12.1. It is also precisely known by two other names: Toriello-Lacassie-Droste syndrome and aplasia cutis congenita-epibulbar dermoids syndrome.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0111706,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:oblique_facial_clefting_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :orofacial_cleft ;
    :has_definition ""An orofacial cleft characterized by a congenital unilateral or bilateral oculo-facial defect beginning at the upper lip lateral to the Cupid's bow, then running lateral to the nasal wing, ending at the the lower eyelid lateral to the inferior punctum that has_material_basis_in heterozygous mutation in the SPECC1L gene on chromosome 22q11.23."" ;
    :has_exact_synonym ""Tessier number 4 facial cleft"" .

","Oblique facial clefting 1 is a type of orofacial cleft, autosomal dominant disease, and something that at least has a material basis in some autosomal dominant inheritance. It is defined as an orofacial cleft characterized by a congenital unilateral or bilateral oculo-facial defect starting at the upper lip lateral to the Cupid's bow, extending lateral to the nasal wing, and ending at the lower eyelid lateral to the inferior punctum. This condition has its material basis in a heterozygous mutation in the SPECC1L gene on chromosome 22q11.23. Additionally, oblique facial clefting 1 has an exact synonym, Tessier number 4 facial cleft.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111707,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:bothnian_type_palmoplantar_keratoderma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :nonepidermolytic_palmoplantar_keratoderma ;
    :has_definition ""A nonepidermolytic palmoplantar keratoderma characterized by a diffuse nonepidermolytic form of palmoplantar keratoderma where the affected areas take on a white, spongy appearance upon exposure to water that has_material_basis_in heterozygous mutation in the AQP5 gene on chromosome 12q13.12."" ;
    :has_exact_synonym ""PPKB"",
        ""diffuse palmoplantar keratoderma, Bothnian type"" .

","Bothnian type palmoplantar keratoderma (PPKB) is a specific form of nonepidermolytic palmoplantar keratoderma which is also classified as an autosomal dominant disease. It is a condition that inherently has a material basis in autosomal dominant inheritance. This particular type of keratoderma is characterized by a diffuse nonepidermolytic form where the affected areas become white and spongy upon exposure to water due to a heterozygous mutation in the AQP5 gene on chromosome 12q13.12. Additionally, it is precisely known by the exact synonyms ""PPKB"" and ""diffuse palmoplantar keratoderma, Bothnian type.""",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111708,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:focal_nonepidermolytic_palmoplantar_keratoderma rdfs:subClassOf :nonepidermolytic_palmoplantar_keratoderma ;
    :has_definition ""A nonepidermolytic palmoplantar keratoderma characterized by localized areas of hyperkeratosis located mainly on pressure points and sites of recurrent friction."" ;
    :has_exact_synonym ""FNEPPK"",
        ""isolated focal non-epidermolytic palmoplantar keratoderma"" .

","Focal nonepidermolytic palmoplantar keratoderma is a specific type of nonepidermolytic palmoplantar keratoderma, characterized by localized areas of hyperkeratosis primarily on pressure points and sites of recurrent friction. It is also precisely known by the synonyms FNEPPK and isolated focal non-epidermolytic palmoplantar keratoderma.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111709,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:focal_nonepidermolytic_palmoplantar_keratoderma_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :focal_nonepidermolytic_palmoplantar_keratoderma ;
    :has_definition ""A focal nonepidermolytic palmoplantar keratoderma that has_material_basis_in heterozygous mutation in the KRT16 gene on chromosome 17q21.2."" ;
    :has_exact_synonym ""FNEPPK1"" .

","Focal nonepidermolytic palmoplantar keratoderma 1 (FNEPPK1) is a type of autosomal dominant disease and a specific form of focal nonepidermolytic palmoplantar keratoderma. It is characterized by a condition that inherently has a material basis in autosomal dominant inheritance. Notably, FNEPPK1 is defined by a focal nonepidermolytic palmoplantar keratoderma that arises from a heterozygous mutation in the KRT16 gene located on chromosome 17q21.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111710,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:focal_or_diffuse_nonepidermolytic_palmoplantar_keratoderma rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :nonepidermolytic_palmoplantar_keratoderma ;
    :has_definition ""A nonepidermolytic palmoplantar keratoderma characterized by focal or diffuse palmoplantar keratodermas with minor or absent nail changes that has_material_basis_in heterozygous mutation in the KRT6C gene on chromosome 12q13.13."" ;
    :has_exact_synonym ""PPKNEFD"",
        ""autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering"" .

","Focal or diffuse nonepidermolytic palmoplantar keratoderma (PPKNEFD) is a type of nonepidermolytic palmoplantar keratoderma and falls under the category of autosomal dominant diseases. It is characterized by focal or diffuse palmoplantar keratodermas with minor or absent nail changes, which have a material basis in heterozygous mutation in the KRT6C gene on chromosome 12q13.13. This condition is an example of something that at least has a material basis in some form of autosomal dominant inheritance. Additionally, PPKNEFD is also known by the exact synonym ""autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering.""",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111711,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:focal_nonepidermolytic_palmoplantar_keratoderma_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :focal_nonepidermolytic_palmoplantar_keratoderma ;
    :has_definition ""A focal nonepidermolytic palmoplantar keratoderma that has_material_basis_in heterozygous mutation in the TRPV3 gene on chromosome 17p13.2."" ;
    :has_exact_synonym ""FNEPPK2"" .

","Focal nonepidermolytic palmoplantar keratoderma 2 (FNEPPK2) is a type of autosomal dominant disease, specifically a subtype of focal nonepidermolytic palmoplantar keratoderma, which inherently has a material basis in some form of autosomal dominant inheritance. It is defined as a focal nonepidermolytic palmoplantar keratoderma with its material basis in a heterozygous mutation in the TRPV3 gene on chromosome 17p13.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111712,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:kagami_ogata_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by polyhydramnios, fetal macrosomia, abdominal wall defects, skeletal abnormalities, feeding difficulties and impaired swallowing, dysmorphic features, developmental delay and intellectual disability that has_material_basis_in heterozygous mutation in an imprinting region on chromosome 14q32."" ;
    :has_exact_synonym ""KOS"" .

","Kagami Ogata Syndrome (KOS) is a type of syndrome characterized by a variety of symptoms including polyhydramnios, fetal macrosomia, abdominal wall defects, skeletal abnormalities, feeding difficulties and impaired swallowing, dysmorphic features, developmental delay, and intellectual disability. This condition has a material basis in a heterozygous mutation in an imprinting region on chromosome 14q32.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111713,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:temple_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by low birth weight, hypotonia and motor delay, feeding problems early in life, early puberty, and significantly reduced final height that has_material_basis_in heterozygous mutation in an impriniting region on chromosome 14q32."" .

","Temple syndrome is a type of syndrome defined by a range of characteristics including low birth weight, hypotonia and motor delay, feeding problems early in life, early puberty, and a significantly reduced final height. It has a material basis in a heterozygous mutation in an imprinting region on chromosome 14q32.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111714,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mulchandani_bhoj_conlin_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by prenatal growth restriction, severe short stature with proportional head circumference, and profound feeding difficulty that has_material_basis_in heterozygous mutation in an imprinting region on chromosome 20q11-q13."" ;
    :has_exact_synonym ""MBCS"",
        ""UPD(20)mat"",
        ""maternal UPD(20)"",
        ""maternal uniparental disomy of chromosome 20"" .

","Mulchandani Bhoj Conlin Syndrome is a type of syndrome characterized by prenatal growth restriction, severe short stature with proportional head circumference, and profound feeding difficulty. It has a material basis in a heterozygous mutation in an imprinting region on chromosome 20q11-q13. The syndrome is also exactly known as MBCS, UPD(20)mat, maternal UPD(20), and maternal uniparental disomy of chromosome 20.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111715,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:schaaf_yang_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by delayed psychomotor development, impaired intellectual development, hypotonia, and behavioral abnormalities that has_material_basis_in heterozygous mutation in the maternally imprinted gene MAGEL2 on chromosome 15q11.2."" ;
    :has_exact_synonym ""MAGEL2-related PWLS"",
        ""MAGEL2-related Prader-Willi-like syndrome"",
        ""PWLS"",
        ""SHFYNG"" .

","Schaaf-Yang syndrome is a type of syndrome characterized by delayed psychomotor development, impaired intellectual development, hypotonia, and behavioral abnormalities. This syndrome has its material basis in a heterozygous mutation in the maternally imprinted gene MAGEL2 on chromosome 15q11.2. Schaaf-Yang syndrome is also exactly synonymous with MAGEL2-related Prader-Willi-like syndrome (PWLS), MAGEL2-related PWLS, PWLS, and SHFYNG.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111716,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cryptophthalmia rdfs:subClassOf :physical_disorder ;
    :has_definition ""A physical disorder characterized by ocular dysplasia with eyelid malformation."" ;
    :has_exact_synonym ""cryptophthalmos"" .

","Cryptophthalmia is a type of physical disorder characterized by ocular dysplasia with eyelid malformation, and it is exactly synonymous with cryptophthalmos.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111717,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:isolated_cryptophthalmia rdfs:subClassOf :cryptophthalmia ;
    :has_definition ""A cryptophthalmia characterized by absence of the eyelids with skin covering the eye and often an underlying malformed eye."" ;
    :has_exact_synonym ""CRYPTOP"",
        ""unilateral or bilateral isolated cryptophthalmos"" .

","Isolated cryptophthalmia is a type of cryptophthalmia characterized by the absence of the eyelids with skin covering the eye, and often an underlying malformed eye. It is also exactly known as CRYPTOP and as unilateral or bilateral isolated cryptophthalmos.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111718,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:partial_cryptophthalmia rdfs:subClassOf :isolated_cryptophthalmia ;
    :has_definition ""An isolated cryptophthalmia characterized by an ill-defined upper eyelid that is completely fused, often over an abnormally developed globe and a keratinized cornea."" ;
    :has_exact_synonym ""incomplete cryptophthalmos"" .

","Partial cryptophthalmia is a type of isolated cryptophthalmia characterized by an ill-defined upper eyelid that is completely fused, often over an abnormally developed globe and a keratinized cornea. It is also known as incomplete cryptophthalmos.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111719,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:complete_cryptophthalmia rdfs:subClassOf :isolated_cryptophthalmia ;
    :has_definition ""An isolated cryptophthalmia characterized by failure of formation of the lid folds and globe results in skin extending from the brow to the cheek without identifiable adnexal structures and often the presence of a vestigial ocular structure or cyst within the socket."" .

","Complete cryptophthalmia is a subtype of isolated cryptophthalmia. It is defined as an isolated cryptophthalmia where there is a failure of the lid folds and globe to form, resulting in skin extending from the brow to the cheek without identifiable adnexal structures. Often, there is also the presence of a vestigial ocular structure or cyst within the socket.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111720,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_symblepharon rdfs:subClassOf :isolated_cryptophthalmia ;
    :has_definition ""An isolated cryptophthalmia characterized by fusion of the upper eyelid skin to the superior aspect of the globe often associated with microphthalmia."" .

","Congenital symblepharon, a type of isolated cryptophthalmia, is defined by the fusion of the upper eyelid skin to the superior aspect of the globe, often associated with microphthalmia.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111721,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:amelogenesis_imperfecta_type_3 rdfs:subClassOf :amelogenesis_imperfecta ;
    :has_definition ""An amelogenesis imperfecta characterized by soft enamel that is initially of normal thickness but lost soon after tooth eruption."" ;
    :has_exact_synonym ""AI3"",
        ""hypocalcified amelogenesis imperfecta"" .

",Amelogenesis imperfecta type 3 is a type of amelogenesis imperfecta characterized by soft enamel that is initially of normal thickness but is lost soon after tooth eruption. It has the exact synonyms AI3 and hypocalcified amelogenesis imperfecta.,4,True
doid,http://purl.obolibrary.org/obo/DOID_0111722,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:amelogenesis_imperfecta_type_3c rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :amelogenesis_imperfecta_type_3,
        :autosomal_recessive_disease ;
    :has_definition ""An amelogenesis imperfecta type 3 that is characterized by hypocalcified enamel in both the primary and secondary dentition and that has_material_basis_in homozygous mutation in the RELT gene on chromosome 11q13."" ;
    :has_exact_synonym ""AI3C"",
        ""amelogenesis imperfecta type IIIC"",
        ""autosomal recessive amelogenesis imperfecta hypocalcification type"" .

","Amelogenesis imperfecta type 3c is a type of autosomal recessive disease, specifically a subtype of amelogenesis imperfecta type 3, which is characterized by its basis in autosomal recessive inheritance. It is defined as an amelogenesis imperfecta type 3 distinguished by hypocalcified enamel affecting both the primary and secondary dentition, resulting from a homozygous mutation in the RELT gene located on chromosome 11q13. Additionally, amelogenesis imperfecta type 3c is exactly synonymous with AI3C, amelogenesis imperfecta type IIIC, and autosomal recessive amelogenesis imperfecta hypocalcification type.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111723,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:jacobsen_syndrome rdfs:subClassOf :chromosomal_deletion_syndrome ;
    :has_definition ""A chromosomal deletion syndrome that is characterized by growth retardation, psychomotor retardation, distinctive facial features, skeletal abnormalities, and isoimmune thrombocytopenia that has_material_basis_in deletion of terminal chromosome 11q."" ;
    :has_exact_synonym ""Jacobsen distal 11q deletion syndrome"",
        ""chromosome 11q deletion syndrome"",
        ""partial 11q monosomy syndrome"" .

","Jacobsen syndrome is a type of chromosomal deletion syndrome characterized by growth retardation, psychomotor retardation, distinctive facial features, skeletal abnormalities, and isoimmune thrombocytopenia. This condition has a material basis in the deletion of the terminal chromosome 11q. It is also precisely referred to as Jacobsen distal 11q deletion syndrome, chromosome 11q deletion syndrome, and partial 11q monosomy syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111724,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:geleophysic_dysplasia rdfs:subClassOf :bone_development_disease ;
    :has_definition ""A bone development disease characterized by short-limb dwarfism, brachydactyly, cardiac valvular disease, characteristic facial appearance, skin thickening, and laryngotracheal stenosis."" ;
    :has_exact_synonym ""GPHYSD"",
        ""geleophysic dwarfism"" .

","Geleophysic dysplasia is a type of bone development disease characterized by short-limb dwarfism, brachydactyly, cardiac valvular disease, characteristic facial appearance, skin thickening, and laryngotracheal stenosis. It has exact synonyms including GPHYSD and geleophysic dwarfism.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111725,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:geleophysic_dysplasia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :geleophysic_dysplasia ;
    :has_definition ""A geleophysic dysplasia that has_material_basis_in homozygous or compound heterozygous mutation in the ADAMTSL2 gene on chromosome 9q34.2."" ;
    :has_exact_synonym ""GPHYSD1"" .

","Geleophysic dysplasia 1, which is exactly synonymous with GPHYSD1, is classified as a type of geleophysic dysplasia and falls under the broader category of autosomal recessive diseases. It specifically entails a condition that originates from a material basis in autosomal recessive inheritance. The definition of geleophysic dysplasia 1 includes being a geleophysic dysplasia characterized by having its material basis in homozygous or compound heterozygous mutations in the ADAMTSL2 gene located on chromosome 9q34.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111726,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:geleophysic_dysplasia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :geleophysic_dysplasia ;
    :has_definition ""A geleophysic dysplasia that has_material_basis_in heterozygous mutation in exon 41 or 42 of the FBN1 gene on chromosome 15q21.1."" ;
    :has_exact_synonym ""GPHYSD2"" .

","Geleophysic dysplasia 2 is a type of geleophysic dysplasia, and it is also known as GPHYSD2. It is characterized as a type of autosomal dominant disease and something that at least has a material basis in some autosomal dominant inheritance. Specifically, geleophysic dysplasia 2 is defined as a geleophysic dysplasia that has its material basis in heterozygous mutation in exon 41 or 42 of the FBN1 gene on chromosome 15q21.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111727,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:geleophysic_dysplasia_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :geleophysic_dysplasia ;
    :has_definition ""A geleophysic dysplasia that has_material_basis_in heterozygous mutation in the LTBP3 gene on chromosome 11q13.1."" ;
    :has_exact_synonym ""GPHYSD3"" .

","Geleophysic dysplasia 3, which has the exact synonym GPHYSD3, is a type of geleophysic dysplasia. It is classified as an autosomal dominant disease and is specifically a type of condition that has a material basis in autosomal dominant inheritance. The definition of geleophysic dysplasia 3 is a geleophysic dysplasia that has its material basis in a heterozygous mutation in the LTBP3 gene on chromosome 11q13.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111728,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_episodic_pain_syndrome rdfs:subClassOf :neuropathy ;
    :has_definition ""A peripheral neuropathy characterized by recurrent, stereotyped, episodic intense pain, occurring predominantly in either the upper body or lower limbs, which is triggered or exacerbated by fatigue, cold exposure, fasting, weather changes and/or physical stress or exertion."" ;
    :has_exact_synonym ""FEPS"" .

","Familial Episodic Pain Syndrome is a type of neuropathy with a definition as a peripheral neuropathy characterized by recurrent, stereotyped, episodic intense pain. This pain predominantly occurs in either the upper body or lower limbs and is triggered or exacerbated by fatigue, cold exposure, fasting, weather changes, and/or physical stress or exertion. Familial Episodic Pain Syndrome also has an exact synonym, FEPS.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111729,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_episodic_pain_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_episodic_pain_syndrome ;
    :has_definition ""A familial episodic pain syndrome characterized by onset in infancy of episodic debilitating upper body pain triggered by fasting, cold, and physical stress that has_material_basis_in heterozygous mutation in the TRPA1 gene on chromosome 8q13."" ;
    :has_exact_synonym ""FEPS1"" .

","Familial Episodic Pain Syndrome 1 (FEPS1) is a type of autosomal dominant disease and also falls under the broader category of familial episodic pain syndromes. It arises from a material basis that includes at least some aspects of autosomal dominant inheritance. FEPS1 is characterized by the onset in infancy of episodic debilitating upper body pain, which is triggered by fasting, cold, and physical stress. This syndrome has its material basis in a heterozygous mutation in the TRPA1 gene located on chromosome 8q13.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111730,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_episodic_pain_syndrome_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_episodic_pain_syndrome ;
    :has_definition ""A familial episodic pain syndrome characterized by adult-onset of paroxysmal pain mainly affecting the distal lower extremities that has_material_basis_in heterozygous mutation in the SCN10A gene on chromosome 3p22."" ;
    :has_exact_synonym ""FEPS2"" .

","Familial Episodic Pain Syndrome 2 (FEPS2) is a type of autosomal dominant disease and a specific form of familial episodic pain syndrome, indicating it is a condition with at least a material basis in some form of autosomal dominant inheritance. It is characterized by adult-onset of paroxysmal pain, primarily affecting the distal lower extremities, and this condition has a material basis in a heterozygous mutation in the SCN10A gene on chromosome 3p22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111731,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:familial_episodic_pain_syndrome_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :familial_episodic_pain_syndrome ;
    :has_definition ""A familial episodic pain syndrome characterized by early childhood onset of intense episodic pain mainly affecting the distal lower extremities, but sometimes also the upper extremities, with pain cycles lasting several days and exacerbated by fatigue that has_material_basis_in heterozygous mutation in the SCN11A gene on chromosome 3p22."" ;
    :has_exact_synonym ""FEPS3"" .

","Familial Episodic Pain Syndrome 3 (FEPS3) is classified as a type of autosomal dominant disease, specifically falling under the broader category of familial episodic pain syndromes. It is identified by a condition that inherently has a material basis in autosomal dominant inheritance. FEPS3 is characterized by an early childhood onset of intense episodic pain predominantly affecting the distal lower extremities, and occasionally the upper extremities, with episodes of pain lasting several days and being exacerbated by fatigue. This condition is directly attributed to a heterozygous mutation in the SCN11A gene located on chromosome 3p22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111732,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:eiken_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :bone_development_disease ;
    :has_definition ""A bone development disease characterized by severely delayed ossification primarily of the epiphyses, pelvis, hands, and feet and abnormal bone modeling of the hands and feet that has_material_basis_in homozygous or compound heterozygous mutation in the PTHR1 gene on chromosome 3p21.31."" ;
    :has_exact_synonym ""Eiken skeletal dysplasia"",
        ""bone modeling defect of hands and feet"" .

","Eiken syndrome is a type of autosomal recessive and bone development disease, essentially rooted in some form of autosomal recessive inheritance. It is defined as a bone development disease characterized by severely delayed ossification primarily of the epiphyses, pelvis, hands, and feet along with abnormal bone modeling of the hands and feet, resulting from homozygous or compound heterozygous mutation in the PTHR1 gene on chromosome 3p21.31. Furthermore, Eiken syndrome is precisely synonymous with Eiken skeletal dysplasia and bone modeling defect of hands and feet.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111733,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:pancreatic_hypoplasia_diabetes_congenital_heart_disease_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :physical_disorder,
        :syndrome ;
    :has_definition ""A syndrome characterized by partial pancreatic agenesis, diabetes mellitus, and heart anomalies that has_material_basis_in heterozygous mutation in GATA6 on chromosome 18q11.2."" ;
    :has_exact_synonym ""HDCA"",
        ""PACHD"",
        ""Yorifuji-Okuno syndrome"",
        ""congenital heart defects and other congenital anomalies"",
        ""congenital pancreatic hypoplasia with diabetes mellitus and congenital heart disease"",
        ""pancreatic agenesis and congenital heart defects"" .

","Pancreatic hypoplasia diabetes congenital heart disease syndrome is a type of syndrome that falls under the categories of autosomal dominant disease and physical disorder. It is characterized by being a condition that at least has a material basis in some autosomal dominant inheritance and has basis in some abnormality of prenatal development or birth. Specifically, it is a syndrome characterized by partial pancreatic agenesis, diabetes mellitus, and heart anomalies, which has its material basis in a heterozygous mutation in the GATA6 gene on chromosome 18q11.2. This syndrome is also known by several exact synonyms, including HDCA, PACHD, Yorifuji-Okuno syndrome, congenital heart defects and other congenital anomalies, congenital pancreatic hypoplasia with diabetes mellitus and congenital heart disease, as well as pancreatic agenesis and congenital heart defects.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111734,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:aminoglycoside_induced_deafness rdfs:subClassOf :drug_induced_hearing_loss ;
    :has_definition ""A drug-induced hearing loss characterized by hearing loss induced by therapeutic doses of aminoglycoside antibiotics that has_material_basis_in mutation in the mitochondrial genes MTRNR1 or MTCO1 in combination with homozygous mutation in TRMU on chromosome 22q13.31."" ;
    :has_exact_synonym ""streptomycin ototoxicity"",
        ""streptomycin-induced deafness"" .

","Aminoglycoside induced deafness, also known exactly as streptomycin ototoxicity or streptomycin-induced deafness, is a specific form of drug-induced hearing loss. It is defined as a hearing loss triggered by therapeutic doses of aminoglycoside antibiotics. This condition is caused by mutations in the mitochondrial genes MTRNR1 or MTCO1, in combination with a homozygous mutation in TRMU on chromosome 22q13.31.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111735,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_deafness_4 rdfs:subClassOf :x_linked_nonsyndromic_deafness ;
    :has_definition ""An X-linked nonsyndromic deafness characterized by progressive hearing loss with postlingual onset and earlier onset in males compared to females that has_material_basis_in mutation in the SMPX gene on chromosome Xp22.12."" ;
    :has_exact_synonym ""DFN6"",
        ""DFNX4"",
        ""X-linked progressive deafness 6"",
        ""nonsyndromic sensorineural progressive deafness 6"" .

","X-linked deafness 4 is a type of X-linked nonsyndromic deafness with a definition that delineates it as an X-linked nonsyndromic deafness characterized by progressive hearing loss with postlingual onset, where the onset occurs earlier in males compared to females. This condition has a material basis in a mutation in the SMPX gene on chromosome Xp22.12. Furthermore, X-linked deafness 4 is also known by exact synonyms such as DFN6, DFNX4, X-linked progressive deafness 6, and nonsyndromic sensorineural progressive deafness 6.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111736,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_deafness_3 rdfs:subClassOf :x_linked_nonsyndromic_deafness ;
    :has_definition ""An X-linked nonsyndromic deafness characterized by congenital, bilateral, profound and sensorineural hearing loss in males and bilateral, mild to moderate high frequency sensorineural hearing impairment with later onset in heterozygous females that has_material_basis_in mutation in a region on chromosome Xp21.2."" ;
    :has_exact_synonym ""DFN4"",
        ""DFNX3"",
        ""congenital sensorineural X-linked deafness 4"" .

","X-linked deafness 3 is a type of X-linked nonsyndromic deafness characterized by congenital, bilateral, profound sensorineural hearing loss in males and bilateral, mild to moderate high-frequency sensorineural hearing impairment with later onset in heterozygous females. This condition has its material basis in a mutation in a region on chromosome Xp21.2. It is also known by its exact synonyms DFN4, DFNX3, and congenital sensorineural X-linked deafness 4.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111737,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_deafness_2 rdfs:subClassOf :x_linked_nonsyndromic_deafness ;
    :has_definition ""An X-linked nonsyndromic deafness characterized by progressive conductive and sensorineural hearing loss and pathognomonic inner ear anomalies that has_material_basis_in hemizygous or homozygous mutation in POU3F4 or upstream regulatory elements of this gene on chromosome Xq21.1."" ;
    :has_exact_synonym ""DFN3"",
        ""DFNX2"",
        ""Nance deafness"",
        ""X-linked deafness type 2"",
        ""X-linked mixed conductive and neurosensory deafness"",
        ""X-linked mixed conductive and neurosensory hearing loss"",
        ""X-linked mixed conductive and sensorineural deafness"",
        ""X-linked mixed conductive and sensorineural hearing loss"",
        ""X-linked sensorineural deafness"",
        ""X-linked stapes gusher syndrome"",
        ""conductive deafness 3 with stapes fixation"",
        ""conductive deafness with stapes fixation"",
        ""mixed deafness with perilymphatic gusher"" .

","X-linked deafness 2 is a type of X-linked nonsyndromic deafness characterized by progressive conductive and sensorineural hearing loss and pathognomonic inner ear anomalies. This condition has a material basis in hemizygous or homozygous mutation in the POU3F4 gene or upstream regulatory elements of this gene on chromosome Xq21.1. It is also known by several exact synonyms, including DFN3, DFNX2, Nance deafness, X-linked deafness type 2, X-linked mixed conductive and neurosensory deafness, X-linked mixed conductive and neurosensory hearing loss, X-linked mixed conductive and sensorineural deafness, X-linked mixed conductive and sensorineural hearing loss, X-linked sensorineural deafness, X-linked stapes gusher syndrome, conductive deafness 3 with stapes fixation, conductive deafness with stapes fixation, and mixed deafness with perilymphatic gusher.",15,True
doid,http://purl.obolibrary.org/obo/DOID_0111738,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_deafness_7 rdfs:subClassOf :x_linked_nonsyndromic_deafness ;
    :has_definition ""An X-linked nonsyndromic deafness characterized by congenital, bilateral, mixed or conductive hearing loss and other ear anomalies that has_material_basis_in homozygous or hemizygous mutation in the GPRASP2 gene on chromosome Xq22.1."" ;
    :has_exact_synonym ""DFNX7"",
        ""X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome"" .

","X-linked deafness 7 is a type of X-linked nonsyndromic deafness, characterized by congenital, bilateral, mixed or conductive hearing loss and other ear anomalies. This condition is caused by homozygous or hemizygous mutation in the GPRASP2 gene on chromosome Xq22.1. It is also known by its exact synonyms: DFNX7 and X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111739,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_deafness_1 rdfs:subClassOf :x_linked_nonsyndromic_deafness ;
    :has_definition ""An X-linked nonsyndromic deafness characterized by congenital profound sensorineural hearing loss in males and mild to moderate high-frequency hearing loss in heterozygous females that has_material_basis_in mutation in the PRPS1 gene on chromosome Xq22.3."" ;
    :has_exact_synonym ""DFN2"",
        ""DFNX1"",
        ""X-linked sensorineural congenital deafness 2"" .

","X-linked deafness 1 is a type of X-linked nonsyndromic deafness characterized by congenital profound sensorineural hearing loss in males and mild to moderate high-frequency hearing loss in heterozygous females, which has its material basis in mutation in the PRPS1 gene on chromosome Xq22.3. Furthermore, X-linked deafness 1 is exactly synonymous with DFN2, DFNX1, and X-linked sensorineural congenital deafness 2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111740,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_deafness_6 rdfs:subClassOf :x_linked_nonsyndromic_deafness ;
    :has_definition ""An X-linked nonsyndromic deafness characterized by severe bilateral sensorineural hearing loss with cochlear malformation in males and mild to moderate hearing loss in females with later onset that has_material_basis_in mutation in the COL4A6 gene on chromosome Xq22.3."" ;
    :has_exact_synonym ""DFNX6"" .

","X-linked deafness 6 is a type of X-linked nonsyndromic deafness and has the exact synonym DFNX6. It is defined as an X-linked nonsyndromic deafness characterized by severe bilateral sensorineural hearing loss with cochlear malformation in males, and mild to moderate hearing loss in females with later onset. This condition has a material basis in a mutation in the COL4A6 gene on chromosome Xq22.3.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111741,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_deafness_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :neuropathy,
        :x_linked_recessive_disease ;
    :has_definition ""A neuropathy characterized by childhood onset of auditory neuropathy and later onset of distal sensory impairment due to diffuse peripheral neuropathy that has_material_basis_in hemizygous or homozygous mutation in the AIFM1 gene on chromosome Xq26.1."" ;
    :has_exact_synonym ""AUNX1"",
        ""DFNX5"",
        ""X-linked HSAN with deafness"",
        ""X-linked auditory neuropathy 1 with peripheral sensory neuropathy"",
        ""X-linked auditory neuropathy with peripheral sensory neuropathy type 1"" .

","X-linked deafness 5 is a type of X-linked recessive disease, neuropathy, and something that at least has a material basis in some X-linked recessive inheritance. It is defined as a neuropathy characterized by childhood onset of auditory neuropathy and later onset of distal sensory impairment due to diffuse peripheral neuropathy. This condition has a material basis in hemizygous or homozygous mutation in the AIFM1 gene on chromosome Xq26.1. X-linked deafness 5 is also known by its exact synonyms: AUNX1, DFNX5, X-linked HSAN with deafness, X-linked auditory neuropathy 1 with peripheral sensory neuropathy, and X-linked auditory neuropathy with peripheral sensory neuropathy type 1.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111742,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_ataxia_type_42 rdfs:subClassOf :autosomal_dominant_cerebellar_ataxia ;
    :has_definition ""An autosomal dominant cerebellar ataxia characterized by gait instability, dysarthria, nystagmus, and saccadic pursuits with variable age of onset and severity and slow progression that has_material_basis_in heterozygous mutation of the CACNA1G gene on chromosome 17q21."" ;
    :has_exact_synonym ""SCA42"" .

","Cerebellar ataxia type 42 is a type of autosomal dominant cerebellar ataxia that is defined as an autosomal dominant cerebellar ataxia characterized by gait instability, dysarthria, nystagmus, and saccadic pursuits with variable age of onset and severity, and slow progression. This condition has its material basis in a heterozygous mutation of the CACNA1G gene on chromosome 17q21. Additionally, cerebellar ataxia type 42 has the exact synonym SCA42.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111743,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_ataxia_type_47 rdfs:subClassOf :autosomal_dominant_cerebellar_ataxia ;
    :has_definition ""An autosomal dominant cerebellar ataxia characterized by adult onset of slowly progressive cerebellar ataxia or in some cases earlier onset of ataxia accompanied by delayed motor development and short stature that has_material_basis_in heterozygous mutation in the PUM1 gene on chromosome 1p35.2."" ;
    :has_exact_synonym ""SCA47"" .

","Cerebellar ataxia type 47, which is an example of autosomal dominant cerebellar ataxia, is defined as an autosomal dominant cerebellar ataxia that typically begins in adulthood with slowly progressive cerebellar ataxia. In some instances, it may start earlier, accompanied by delayed motor development and short stature, and this condition is caused by a heterozygous mutation in the PUM1 gene located on chromosome 1p35.2. Additionally, cerebellar ataxia type 47 is precisely synonymous with SCA47.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111744,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_ataxia_type_41 rdfs:subClassOf :autosomal_dominant_cerebellar_ataxia ;
    :has_definition ""An autosomal dominant cerebellar ataxia that has_material_basis_in heterozygous mutation in the TRPC3 gene on chromosome 4q27."" ;
    :has_exact_synonym ""SCA41"" .

",Cerebellar ataxia type 41 is a type of autosomal dominant cerebellar ataxia and has an exact synonym SCA41. It is defined as an autosomal dominant cerebellar ataxia that has its material basis in a heterozygous mutation in the TRPC3 gene on chromosome 4q27.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0111745,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_ataxia_type_43 rdfs:subClassOf :autosomal_dominant_cerebellar_ataxia ;
    :has_definition ""An autosomal dominant cerebellar ataxia characterized by adult-onset, slowly progressive, gait and limb ataxia, often associated with peripheral neuropathy typically affecting the motor system that has_material_basis_in heterozygous mutation in MME on chromosome 3q25.2."" ;
    :has_exact_synonym ""SCA43"" .

","Cerebellar ataxia type 43 is a type of autosomal dominant cerebellar ataxia, which is defined as an autosomal dominant cerebellar ataxia characterized by adult-onset, slowly progressive, gait and limb ataxia. This condition is often associated with peripheral neuropathy, typically affecting the motor system, and has its material basis in a heterozygous mutation in the MME gene on chromosome 3q25.2. Additionally, cerebellar ataxia type 43 has the exact synonym SCA43.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111746,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_ataxia_type_48 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_symptom ;
            owl:someValuesFrom :ataxia ],
        :autosomal_dominant_cerebellar_ataxia ;
    :has_definition ""An autosomal dominant cerebellar ataxia characterized by mid-adult onset of gait ataxia and/or cognitive-affective symptoms that has_material_basis_in heterozygous mutation in the STUB1 gene on chromosome 16p13.3."" ;
    :has_exact_synonym ""SCA48"" .

","Cerebellar ataxia type 48, which has the exact synonym SCA48, is a type of autosomal dominant cerebellar ataxia. It is characterized by having at least the symptom of some ataxia. Furthermore, it is defined as an autosomal dominant cerebellar ataxia that typically begins in mid-adulthood with symptoms of gait ataxia and/or cognitive-affective issues, and its material basis is a heterozygous mutation in the STUB1 gene located on chromosome 16p13.3.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111747,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:cerebellar_ataxia_type_9 rdfs:subClassOf :autosomal_dominant_cerebellar_ataxia ;
    :has_definition ""An autosomal dominant cerebellar ataxia characterized by adult onset of ataxia and imbalance and demyelinating lesions on brain MRI."" ;
    :has_exact_synonym ""SCA9"" .

","Cerebellar ataxia type 9 is a type of autosomal dominant cerebellar ataxia and has the exact synonym SCA9. It is defined as an autosomal dominant cerebellar ataxia characterized by adult onset of ataxia and imbalance, along with demyelinating lesions visible on brain MRI.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111748,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mitochondrial_complex_v_atp_synthase_deficiency_mitochondrial_type_1 rdfs:subClassOf :mitochondrial_complex_v_atp_synthase_deficiency ;
    :has_definition ""A mitochondrial complex V (ATP synthase) deficiency characterized by lactic acidemia, hypotonia, and neurodegenerative disease that has_material_basis_in mutation in mitochondrial gene MTATP6."" ;
    :has_exact_synonym ""MC5DM1"" .

","Mitochondrial complex V ATP synthase deficiency mitochondrial type 1 is a specific type of mitochondrial complex V ATP synthase deficiency. This deficiency is characterized by lactic acidemia, hypotonia, and neurodegenerative disease, which stems from a mutation in the mitochondrial gene MTATP6. Additionally, it is exactly synonymous with MC5DM1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111749,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mitochondrial_complex_v_atp_synthase_deficiency_nuclear_type_6 rdfs:subClassOf :mitochondrial_complex_v_atp_synthase_deficiency ;
    :has_definition ""A mitochondrial complex V (ATP synthase) deficiency characterized by episodic regression of gross motor skills beginning in early childhood that has_material_basis_in homozygous or compound heterozygous mutation in the ATP5MD gene on chromosome 10q24.33."" ;
    :has_exact_synonym ""MC5DN6"" .

","Mitochondrial complex V ATP synthase deficiency nuclear type 6, also precisely known as MC5DN6, is a subtype of mitochondrial complex V ATP synthase deficiency. It is defined as a mitochondrial complex V (ATP synthase) deficiency characterized by the episodic regression of gross motor skills beginning in early childhood, which has a material basis in homozygous or compound heterozygous mutation in the ATP5MD gene located on chromosome 10q24.33.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111750,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:adult_onset_ataxia_and_polyneuropathy rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :existence_starts_during ;
            owl:someValuesFrom :adult_onset ],
        :mitochondrial_metabolism_disease ;
    :has_definition ""A mitochondrial metabolism disease characterized by adult-onset of ataxia and polyneuropathy that has_material_basis_in heteroplasmic mutation in the mitochondrial gene MTATP6."" .

","Adult onset ataxia and polyneuropathy is a type of mitochondrial metabolism disease, and it also falls into a category of conditions that begin in adulthood. It is defined as a mitochondrial metabolism disease characterized by the adult onset of ataxia and polyneuropathy, which is caused by a heteroplasmic mutation in the mitochondrial gene MTATP6.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111751,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mitochondrial_nonsyndromic_sensorineural_deafness rdfs:subClassOf :sensorineural_hearing_loss ;
    :has_definition ""A sensorineural hearing loss that has_material_basis_in mutation in one of several different mitochondrial genes including; MTRNR1, MTTS1, MTCO1, MTTH, MTND1, and MTTI."" .

","Mitochondrial nonsyndromic sensorineural deafness is a type of sensorineural hearing loss. It is defined as a sensorineural hearing loss that has its material basis in mutation in one of several different mitochondrial genes, including MTRNR1, MTTS1, MTCO1, MTTH, MTND1, and MTTI.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111752,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_mitochondrial_sensorineural_deafness rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :digenic_inheritance ],
        :digenic_disease,
        :sensorineural_hearing_loss ;
    :has_definition ""A sensorineural hearing loss characterized by progressive, severe to profound deafness that has_material_basis_in digenic inheritance of mutations in the mitochondrial gene MTRNR1 and an unidentified nuclear gene."" .

","Autosomal mitochondrial sensorineural deafness is a type of digenic disease, sensorineural hearing loss, and something that at least has a material basis in digenic inheritance. It is defined as a sensorineural hearing loss characterized by progressive, severe to profound deafness that has a material basis in digenic inheritance of mutations in the mitochondrial gene MTRNR1 and an unidentified nuclear gene.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111753,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:infantile_hypertrophic_cardiomyopathy rdfs:subClassOf :hypertrophic_cardiomyopathy ;
    :has_definition ""A hypertrophic cardiomyopathy characterized by isolated hypertrophic cardiomyopathy and congestive heart failure that has_material_basis_in mutation in the overlapping mitochondrial genes MTATP6 and MTATP8."" .

",Infantile hypertrophic cardiomyopathy is a type of hypertrophic cardiomyopathy characterized by isolated hypertrophic cardiomyopathy and congestive heart failure. It has a material basis in mutation in the overlapping mitochondrial genes MTATP6 and MTATP8.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0111754,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leber_plus_disease rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by Leber's hereditary optic neuropathy in combination with other serious systemic or neurological abnormalities."" ;
    :has_exact_synonym ""LHON plus disease"" .

",Leber plus disease is a type of syndrome characterized by Leber's hereditary optic neuropathy in combination with other serious systemic or neurological abnormalities. It is also exactly synonymous with LHON plus disease.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0111755,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leber_hereditary_optic_neuropathy_and_dystonia rdfs:subClassOf :leber_plus_disease ;
    :has_definition ""A Leber plus disease characterized by Leber hereditary optic neuropathy and dystonia that has_material_basis_in mutation in the mitochondrial genes MTND6, MTND4, MTND1 or MTND3 that make up the mitochondrial complex I."" ;
    :has_exact_synonym ""LDYT"",
        ""Leber optic atrophy and dystonia"",
        ""Leber optic atrophy with dystonia"",
        ""Marsden syndrome"",
        ""familial dystonia with visual failure and striatal lucencies"" .

","Leber hereditary optic neuropathy and dystonia is a type of Leber plus disease characterized by Leber hereditary optic neuropathy and dystonia. This condition has a material basis in mutations in the mitochondrial genes MTND6, MTND4, MTND1, or MTND3 that make up the mitochondrial complex I. It is also known by exact synonyms such as LDYT, Leber optic atrophy and dystonia, Leber optic atrophy with dystonia, Marsden syndrome, and familial dystonia with visual failure and striatal lucencies.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111756,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:leber_hereditary_optic_neuropathy_with_demyelinating_disease_of_cns rdfs:subClassOf :leber_plus_disease ;
    :has_definition ""A Leber plus disease characterized by Leber hereditary optic neuropathy and demyelination in the central nervous system."" .

","Leber hereditary optic neuropathy with demyelinating disease of CNS is a type of Leber plus disease, which is defined as a Leber plus disease characterized by Leber hereditary optic neuropathy and demyelination in the central nervous system.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111757,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:y_linked_deafness rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :y_linked_inheritance ],
        :nonsyndromic_deafness,
        :y_linked_monogenic_disease ;
    :has_definition ""A nonsyndromic deafness characterized by a Y-lnked inheritance mode."" ;
    :has_exact_synonym ""DFNY"" .

","Y linked deafness is a type of nonsyndromic deafness, a Y linked monogenic disease, and something that at least has a material basis in some Y linked inheritance. It is defined as a nonsyndromic deafness characterized by a Y-linked inheritance mode. Additionally, Y linked deafness has an exact synonym, DFNY.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111758,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:y_linked_deafness_2 rdfs:subClassOf :y_linked_deafness ;
    :has_definition ""A Y-linked deafness characterized by male-limited bilateral progressive sensorineural hearing loss of variable severity, with onset in the third to fifth decades of life that has_material_basis_in mutation in the TBL1Y gene on chromosome Yp11.2."" ;
    :has_exact_synonym ""DFNY2"" .

","Y linked deafness 2 is a type of Y linked deafness, which is characterized by male-limited bilateral progressive sensorineural hearing loss of variable severity, with onset in the third to fifth decades of life. This condition has its material basis in a mutation in the TBL1Y gene on chromosome Yp11.2. Furthermore, Y linked deafness 2 is also known by its exact synonym, DFNY2.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111759,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:y_linked_deafness_1 rdfs:subClassOf :y_linked_deafness ;
    :has_definition ""A Y-linked deafness characterized by male-limited postlingual progressive sensorineural hearing loss of variable severity, with onset in the first to third decades of life."" ;
    :has_exact_synonym ""DFNY1"" .

","Y-linked deafness 1 is a type of Y-linked deafness, which is characterized by male-limited postlingual progressive sensorineural hearing loss of variable severity, with the onset occurring in the first to third decades of life. It is also known by its exact synonym, DFNY1.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111760,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xx_sex_reversal rdfs:subClassOf :gonadal_dysgenesis ;
    :has_definition ""A gonadal dysgenesis characterized by presentation of an XX karyotype and male external genitalia ranging from normal to ambiguous."" ;
    :has_exact_synonym ""46,XX testicular DSD"",
        ""46,XX testicular disorder of sex development"",
        ""De la Chapelle syndrome"",
        ""SRXX"",
        ""XX, male syndrome"" .

","46 XX sex reversal is a type of gonadal dysgenesis, which is defined as a gonadal dysgenesis characterized by the presentation of an XX karyotype and male external genitalia that can range from normal to ambiguous. It has several exact synonyms including 46,XX testicular DSD, 46,XX testicular disorder of sex development, De la Chapelle syndrome, SRXX, and XX male syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111761,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xx_sex_reversal_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :46_xx_sex_reversal,
        :x_linked_dominant_disease ;
    :has_definition ""A 46,XX sex reversal that has_material_basis_in translocation of SRY onto the X chromosome."" ;
    :has_exact_synonym ""SRXX1"" .

","46 XX sex reversal 1 is a type of X-linked dominant disease and a specific form of 46 XX sex reversal. This condition is characterized by a material basis in X-linked dominant inheritance. It is defined as a 46,XX sex reversal that results from the translocation of SRY onto the X chromosome. Additionally, 46 XX sex reversal 1 is exactly synonymous with SRXX1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111762,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xx_sex_reversal_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :46_xx_sex_reversal,
        :x_linked_dominant_disease ;
    :has_definition ""A 46,XX sex reversal that has_material_basis_in genomic duplications or deletions in the SOX3 regulatory region on chromosome Xq26."" ;
    :has_exact_synonym ""SRXX3"" .

","46 XX sex reversal 3 is a type of X linked dominant disease and also a type of 46 XX sex reversal. It is categorized under conditions that at least have a material basis in X linked dominant inheritance. Furthermore, 46 XX sex reversal 3, which has the exact synonym SRXX3, is defined as a 46,XX sex reversal that results from genomic duplications or deletions in the SOX3 regulatory region on chromosome Xq26.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111763,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xx_sex_reversal_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :46_xx_sex_reversal,
        :autosomal_dominant_disease ;
    :has_definition ""A 46,XX sex reversal that has_material_basis_in heterozygous duplication or triplication of a 68-kb regulatory region -584 to -516 kb upstream of the SOX9 gene on chromosome 17q24."" ;
    :has_exact_synonym ""SRXX2"",
        ""chromosome 17q24 dupication syndrome"" .

","46 XX sex reversal 2 is a type of autosomal dominant disease, which is a specific kind of 46 XX sex reversal and is characterized by a condition that fundamentally requires an autosomal dominant inheritance mechanism. It is defined as a 46,XX sex reversal that arises from a heterozygous duplication or triplication of a 68-kb regulatory region located -584 to -516 kb upstream of the SOX9 gene on chromosome 17q24. Additionally, 46 XX sex reversal 2 is precisely referred to by the synonyms SRXX2 and chromosome 17q24 duplication syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111764,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xx_sex_reversal_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :46_xx_sex_reversal,
        :autosomal_dominant_disease ;
    :has_definition ""A 46,XX sex reversal that has_material_basis_in heterozygous mutation in the NR5A1 gene on chromosome 9q33.3."" ;
    :has_exact_synonym ""SRXX4"" .

","46 XX sex reversal 4 is a type of autosomal dominant disease and a type of 46 XX sex reversal, which at least has a material basis in some autosomal dominant inheritance. It is defined as a 46,XX sex reversal that has its material basis in a heterozygous mutation in the NR5A1 gene on chromosome 9q33.3. Moreover, 46 XX sex reversal 4 has the exact synonym SRXX4.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111765,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_cardiac_valvular_dysplasia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :heart_valve_disease,
        :x_linked_monogenic_disease ;
    :has_definition ""A heart valve disease characterized by multivalvular dysplasia and regurgitation with more severe phenotypes in hemizygous males compared to heterozygous females that has_material_basis_in mutation in the FLNA gene on chromosome Xq28."" ;
    :has_exact_synonym ""CVD1"",
        ""Dystrophie valvulaire associee a FLNA"",
        ""EDS 5"",
        ""Ehlers-Danlos syndrome, type 5"",
        ""FLNA-related X-linked myxomatous valvular dysplasia"",
        ""FLNA-related valvular dystrophy"",
        ""Filamin A-related X-linked myxomatous valvular dysplasia"",
        ""XMVD"" .

","X-linked cardiac valvular dysplasia is a type of heart valve disease, which is also a form of X-linked monogenic disease and is related to X-linked inheritance. It is defined as a heart valve disease characterized by multivalvular dysplasia and regurgitation, showing more severe phenotypes in hemizygous males compared to heterozygous females, and is caused by a mutation in the FLNA gene on chromosome Xq28. This condition is known by several exact synonyms, including CVD1, Dystrophie valvulaire associe  FLNA, EDS 5, Ehlers-Danlos syndrome, type 5, FLNA-related X-linked myxomatous valvular dysplasia, FLNA-related valvular dystrophy, Filamin A-related X-linked myxomatous valvular dysplasia, and XMVD.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111766,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_vacterl_association rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :vacterl_association,
        :x_linked_recessive_disease ;
    :has_definition ""A VACTERL association that has_material_basis_in mutation in the ZIC3 gene on chromosome Xq26.3 or the FANCB gene on chromosome Xp22.2."" ;
    :has_exact_synonym ""VACTERL association, X-linked with or without hydrocephalus"",
        ""VACTERLX"" .

","X-linked VACTERL association is a type of VACTERL association and also a type of X-linked recessive disease. It is characterized by something that at least has a material basis in some X-linked recessive inheritance. X-linked VACTERL association is defined as a VACTERL association that has its material basis in mutation in the ZIC3 gene on chromosome Xq26.3 or the FANCB gene on chromosome Xp22.2. It has exact synonyms including VACTERL association, X-linked with or without hydrocephalus, and VACTERLX.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111767,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_thrombocytopenia_with_beta_thalassemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :hematopoietic_system_disease,
        :x_linked_recessive_disease ;
    :has_definition ""A hematopoietic system disease characterized by variable thrombocytopenia, hemolytic anemia, splenomegaly, and abnormalities in hemoglobin chain synthesis resulting in imbalance between the alpha and beta chains that has_material_basis_in homozygous or hemizygous missense mutation in the DNA binding domain of the GATA1 gene on chromosome Xp11.23."" ;
    :has_exact_synonym ""GATA1-related X-linked cytopenia"",
        ""XLTT"",
        ""beta-thalassemia-X-linked thrombocytopenia syndrome"",
        ""thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis"" .

","X-linked thrombocytopenia with beta thalassemia is a type of hematopoietic system disease, which also falls under the category of X-linked recessive diseases. It is characterized by a condition that essentially has a material basis in some form of X-linked recessive inheritance. Specifically, this disease is defined as a hematopoietic system disease characterized by variable thrombocytopenia, hemolytic anemia, splenomegaly, and abnormalities in hemoglobin chain synthesis resulting in an imbalance between the alpha and beta chains. This condition is caused by homozygous or hemizygous missense mutations in the DNA binding domain of the GATA1 gene on chromosome Xp11.23. Furthermore, X-linked thrombocytopenia with beta thalassemia is known by several exact synonyms including GATA1-related X-linked cytopenia, XLTT, beta-thalassemia-X-linked thrombocytopenia syndrome, and thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111768,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_properdin_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :complement_deficiency,
        :x_linked_recessive_disease ;
    :has_definition ""A complement deficiency characterized by decreased plasma levels of complement factor properdin and increased susceptibility to Neisseria species infections that has_material_basis_in homozygous or hemizygous mutation in PFC on chromosome Xp11.23."" ;
    :has_exact_synonym ""CFPD"",
        ""complement factor properdin deficiency"" .

","X-linked properdin deficiency is a type of X-linked recessive disease, complement deficiency, and something that at least has a material basis in some X-linked recessive inheritance. It is defined as a complement deficiency characterized by decreased plasma levels of complement factor properdin and increased susceptibility to Neisseria species infections, which has its material basis in homozygous or hemizygous mutation in PFC on chromosome Xp11.23. Additionally, X-linked properdin deficiency has exact synonyms: CFPD and complement factor properdin deficiency.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111769,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :46_xy_sex_reversal,
        :autosomal_dominant_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in heterozygous mutation in the MAP3K1 gene on chromosome 5q11.2."" ;
    :has_exact_synonym ""46,XY gonadal dysgenesis, partial or complete, MAP3K1-related"",
        ""46,XY sex reversal, partial or complete, MAP3K1-related"",
        ""SRXY6"" .

","46 XY sex reversal 6 is a type of autosomal dominant disease and a subtype of 46 XY sex reversal, which essentially has a material basis in autosomal dominant inheritance. This condition is characterized by an XY karyotype, phenotypically female genitalia, and the failure to develop secondary sexual characteristics at puberty, including menstruation, due to a heterozygous mutation in the MAP3K1 gene on chromosome 5q11.2. Furthermore, 46 XY sex reversal 6 is exactly synonymous with 46,XY gonadal dysgenesis, partial or complete, MAP3K1-related; 46,XY sex reversal, partial or complete, MAP3K1-related; and SRXY6.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111770,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :46_xy_sex_reversal,
        :autosomal_dominant_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in heterozygous mutation in the ZFPM2 gene on chromosome 8q23.1."" ;
    :has_exact_synonym ""46,XY sex reversal, ZFPM2-related"",
        ""SRXY9"" .

","46 XY sex reversal 9 is a type of autosomal dominant disease and a specific form of 46 XY sex reversal. It is characterized by an XY karyotype, phenotypically female genitalia, and a failure to develop secondary sexual characteristics at puberty, including menstruation. This condition has a material basis in heterozygous mutation in the ZFPM2 gene on chromosome 8q23.1. It is also known by its exact synonyms, 46,XY sex reversal, ZFPM2-related and SRXY9.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111771,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_4 rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :deletion ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :chromosome ] ;
                            rdf:rest :nil ] ] ],
        :46_xy_sex_reversal,
        :chromosomal_deletion_syndrome ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation but with the absence of other features of the chromosome 9p deletion syndrome that has_material_basis_in heterozygous deletion of a region on chromosome 9p."" ;
    :has_exact_synonym ""46,XY gonadal dysgenesis, partial or complete, with 9p24.3 deletion"",
        ""SRXY4"",
        ""chromosome 9p24.3 deletion syndrome"" .

","46 XY sex reversal 4 is a type of chromosomal deletion syndrome and a specific form of 46 XY sex reversal. This condition is part of a category that intersects entities having a material basis in some form of deletion and chromosome. It is characterized by an XY karyotype, phenotypically female genitalia and the failure to develop secondary sexual characteristics at puberty, including menstruation, but without the additional features of chromosome 9p deletion syndrome. This is due to a heterozygous deletion of a region on chromosome 9p. The condition is also precisely known as 46,XY gonadal dysgenesis, partial or complete, with 9p24.3 deletion, SRXY4, and chromosome 9p24.3 deletion syndrome.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111772,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :46_xy_sex_reversal,
        :autosomal_dominant_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in heterozygous mutation in the NR5A1 gene on chromosome 9q33.3."" ;
    :has_exact_synonym ""46,XY gonadal dysgenesis, partial or complete, with or without adrenal failure"",
        ""46,XY sex reversal, partial or complete, NR5A1-related"",
        ""SRXY3"",
        ""disorder of sex development, 46,XY, NR5A1-related"",
        ""sex reversal, XY, with or without adrenal failure"" .

","46 XY sex reversal 3 is a type of autosomal dominant disease and also a specific form of 46 XY sex reversal. This condition is an example of disorders that have a material basis in autosomal dominant inheritance. It is defined as a 46 XY sex reversal characterized by an XY karyotype, with individuals presenting phenotypically female genitalia and experiencing failure to develop secondary sexual characteristics at puberty, including menstruation. This condition is caused by a heterozygous mutation in the NR5A1 gene located on chromosome 9q33.3. Furthermore, 46 XY sex reversal 3 is known by several exact synonyms, including 46,XY gonadal dysgenesis, partial or complete, with or without adrenal failure; 46,XY sex reversal, partial or complete, NR5A1-related; SRXY3; disorder of sex development, 46,XY, NR5A1-related; and sex reversal, XY, with or without adrenal failure.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111773,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xy_sex_reversal,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in homozygous or compound heterozygous mutation in the AKR1C2 gene on chromosome 10p15.1."" ;
    :has_exact_synonym ""SRXY8"",
        ""TDD"",
        ""male pseudohermaphroditism due to deficiency of testicular 17,20-desmolase"" .

","46 XY sex reversal 8 is a type of autosomal recessive disease and also falls under the broader category of 46 XY sex reversals. It is specifically a condition with a material basis in some form of autosomal recessive inheritance. The defining characteristics of 46 XY sex reversal 8 include an XY karyotype, phenotypically female genitalia, and the failure to develop secondary sexual characteristics at puberty, including menstruation. This condition is caused by homozygous or compound heterozygous mutation in the AKR1C2 gene located on chromosome 10p15.1. Additionally, 46 XY sex reversal 8 is precisely synonymous with SRXY8, TDD, and male pseudohermaphroditism due to deficiency of testicular 17,20-desmolase.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111774,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xy_sex_reversal,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in homozygous or compound heterozygous mutation in DHH on chromosome 12q13.12."" ;
    :has_exact_synonym ""46,XY gonadal dysgenesis, partial or complete, DHH-related"",
        ""46,XY sex reversal, partial or complete, DHH-related"",
        ""GDXYM"",
        ""SRXY7"",
        ""gonadal dysgenesis, XY, male limited"" .

","46 XY sex reversal 7 is a type of autosomal recessive disease, which is also a subtype of 46 XY sex reversal, and it specifically falls under the category of conditions with at least a material basis in autosomal recessive inheritance. This condition is characterized by an XY karyotype, phenotypically female genitalia, and the failure to develop secondary sexual characteristics at puberty, including menstruation, due to homozygous or compound heterozygous mutation in DHH on chromosome 12q13.12. Additionally, 46 XY sex reversal 7 is synonymously known as 46,XY gonadal dysgenesis, partial or complete, DHH-related; 46,XY sex reversal, partial or complete, DHH-related; GDXYM; SRXY7; and gonadal dysgenesis, XY, male limited.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111775,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :deletion ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :chromosome ] ;
                            rdf:rest :nil ] ] ],
        :46_xy_sex_reversal,
        :autosomal_dominant_disease,
        :chromosomal_deletion_syndrome ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in heterozygous deletion of a region upstream of the SOX9 gene on chromosome 17q24."" ;
    :has_exact_synonym ""SRXY10"",
        ""chromosome 17q24 deletion syndrome"" .

","46 XY sex reversal 10 is a type of autosomal dominant disease, chromosomal deletion syndrome, and 46 XY sex reversal. It is characterized as something that intersects with conditions that have a material basis in some deletion and chromosome, and it also has a basis in autosomal dominant inheritance. Additionally, 46 XY sex reversal 10 is defined as a 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia, and failure to develop secondary sexual characteristics at puberty including menstruation due to a heterozygous deletion of a region upstream of the SOX9 gene on chromosome 17q24. This condition is also known by its exact synonyms SRXY10 and chromosome 17q24 deletion syndrome.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111776,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :46_xy_sex_reversal,
        :autosomal_recessive_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in homozygous or compound heterozygous mutation in the CBX2 gene on chromosome 17q25.3."" ;
    :has_exact_synonym ""46,XY gonadal dysgenesis, complete, CBX2-related"",
        ""46,XY sex reversal, CBX2-related"",
        ""SRXY5"",
        ""disorder of sex development, 46,XY, CBX2-related"",
        ""sex reversal, XY, CBX2-related"" .

","46 XY sex reversal 5 is a type of autosomal recessive disease, also known as 46 XY sex reversal, which is essentially a condition that has a material basis in autosomal recessive inheritance. It is characterized by an XY karyotype, phenotypically female genitalia, and the failure to develop secondary sexual characteristics at puberty, including menstruation, due to homozygous or compound heterozygous mutation in the CBX2 gene on chromosome 17q25.3. This condition is exactly synonymous with several terms including 46,XY gonadal dysgenesis, complete, CBX2-related; 46,XY sex reversal, CBX2-related; SRXY5; disorder of sex development, 46,XY, CBX2-related; and sex reversal, XY, CBX2-related.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111777,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :46_xy_sex_reversal,
        :x_linked_monogenic_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in hemizygous duplication of the NR0B1 gene on chromosome Xp21.2."" ;
    :has_exact_synonym ""46,XY sex reversal, DAX1-related"",
        ""46XY sex reversal 2, dosage-sensitive"",
        ""DSS"",
        ""SRXY2"",
        ""dosage-sensitive sex reversal"" .

","46 XY sex reversal 2 is a type of X-linked monogenic disease, a subtype of 46 XY sex reversal, and is associated with X-linked inheritance mechanisms. It is defined as a 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia, and failure to develop secondary sexual characteristics at puberty including menstruation, which has its material basis in hemizygous duplication of the NR0B1 gene on chromosome Xp21.2. Moreover, 46 XY sex reversal 2 is exactly synonymized with 46,XY sex reversal, DAX1-related; 46XY sex reversal 2, dosage-sensitive; DSS; SRXY2; and dosage-sensitive sex reversal.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111778,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:46_xy_sex_reversal_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :y_linked_inheritance ],
        :46_xy_sex_reversal,
        :y_linked_monogenic_disease ;
    :has_definition ""A 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia and failure to develop secondary sexual characteristics at puberty including menstruation that has_material_basis_in hemizygous mutation in SRY on chromosome Yp11.2."" ;
    :has_exact_synonym ""46,XY gonadal dysgenesis, complete, SRY-related"",
        ""46,XY sex reversal, SRY-related"",
        ""SRXY1"" .

","46 XY sex reversal 1 is a type of Y linked monogenic disease, which is a specific category of 46 XY sex reversal. This condition is attributed to having at least a material basis in some Y linked inheritance. It is defined as a 46 XY sex reversal characterized by an XY karyotype, phenotypically female genitalia, and the failure to develop secondary sexual characteristics at puberty, including menstruation. This is due to a hemizygous mutation in the SRY gene on chromosome Yp11.2. Furthermore, 46 XY sex reversal 1 is precisely synonymous with 46,XY gonadal dysgenesis, complete, SRY-related; 46,XY sex reversal, SRY-related; and SRXY1.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111779,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_panhypopituitarism rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :panhypopituitarism,
        :x_linked_monogenic_disease ;
    :has_definition ""A panhypopituitarism that has_material_basis_in duplications in the SOX3 gene on chromosome Xq27.1."" ;
    :has_exact_synonym ""PHPX"",
        ""pituitary dwarfism IV"" .

","X-linked panhypopituitarism is a type of panhypopituitarism, as well as a type of X-linked monogenic disease, and it is something that at least has a material basis in some X-linked inheritance. It is defined as a panhypopituitarism that has its material basis in duplications in the SOX3 gene on chromosome Xq27.1. Additionally, X-linked panhypopituitarism has the exact synonyms PHPX and pituitary dwarfism IV.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111780,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:tarp_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :syndrome,
        :x_linked_monogenic_disease ;
    :has_definition ""A syndrome characterized by talipes equinovarus, atrial septal defect, Robin sequence (micrognathia, cleft palate, and glossoptosis), and persistent left superior vena cava typically resulting in late prenatal or early postnatal mortality that has_material_basis_in hemizygous mutation in the RBM10 gene on chromosome Xp11.3."" ;
    :has_exact_synonym ""Pierre Robin sequence-congenital heart defect-talipes syndrome"",
        ""Pierre Robin syndrome-congenital heart defect-talipes syndrome"",
        ""TARPS"",
        ""talipes equinovarus-atrial septal defect-Robin sequence-persistence of the left superior vena cava syndrome"" .

","TARP syndrome is a type of X-linked monogenic disease and is also considered a syndrome that fundamentally has a material basis in some X-linked inheritance. It is defined as a syndrome characterized by talipes equinovarus, atrial septal defect, Robin sequence (micrognathia, cleft palate, and glossoptosis), and persistent left superior vena cava, typically resulting in late prenatal or early postnatal mortality. This syndrome has its material basis in a hemizygous mutation in the RBM10 gene on chromosome Xp11.3. TARP syndrome is also known by several exact synonyms, including Pierre Robin sequence-congenital heart defect-talipes syndrome, Pierre Robin syndrome-congenital heart defect-talipes syndrome, TARPS, and talipes equinovarus-atrial septal defect-Robin sequence-persistence of the left superior vena cava syndrome.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111781,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:waisman_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndrome,
        :x_linked_recessive_disease ;
    :has_definition ""A syndrome characterized by delayed psychomotor development, impaired intellectual development, and early-onset Parkinson disease that has_material_basis_in hemizygous or homozygous mutation in the RAB39B gene on chromosome Xq28."" ;
    :has_exact_synonym ""Laxova-Opitz syndrome"",
        ""early-onset parkinsonism-intellectual disability syndrome"" .

","Waisman syndrome is identified as a type of syndrome that falls under the category of X-linked recessive diseases, indicating it has a material basis in X-linked recessive inheritance. It is characterized by delayed psychomotor development, impaired intellectual development, and early-onset Parkinson disease, stemming from hemizygous or homozygous mutations in the RAB39B gene on chromosome Xq28. Additionally, Waisman syndrome is also known by its exact synonyms: Laxova-Opitz syndrome and early-onset parkinsonism-intellectual disability syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111782,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otopalatodigital_syndrome_spectrum_disorder rdfs:subClassOf :bone_development_disease ;
    :has_definition ""A bone development disease characterized by typical facial anomalies and a generalized bone dysplasia with osteodysplastic changes with skeletal dysplasia developing as varying combinations and degrees of undertubulation of the long bones, cortical irregularity and campomelia. Most but not all subtypes are associated with mutations in FLNA on chromosome Xq28."" ;
    :has_exact_synonym ""OPD spectrum disorder"",
        ""OPSD"",
        ""fronto-otopalatodigital osteodysplasia"" .

","Otopalatodigital syndrome spectrum disorder is a type of bone development disease that is characterized by typical facial anomalies and a generalized bone dysplasia with osteodysplastic changes. This includes varying combinations and degrees of undertubulation of the long bones, cortical irregularity, and campomelia. Most, but not all, subtypes of this disorder are associated with mutations in FLNA on chromosome Xq28. It is also known by exact synonyms such as OPD spectrum disorder, OPSD, and fronto-otopalatodigital osteodysplasia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111783,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otopalatodigital_syndrome_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :otopalatodigital_syndrome_spectrum_disorder,
        :x_linked_dominant_disease ;
    :has_definition ""An otopalatodigital syndrome spectrum disorder characterized by cleft palate, mild skeletal anomalies including digital anomalies, and conductive deafness caused by ossicular anomalies that has_material_basis_in heterozygous or hemizygous mutation in exon 3, 4, or 5 of the FLNA gene on chromosome Xq28."" ;
    :has_exact_synonym ""OPD I syndrome"",
        ""OPD syndrome 1"",
        ""OPD1"",
        ""Taybi syndrome"",
        ""oto-palato-digital syndrome type 1"",
        ""otopalatodigital syndrome type I"" .

","Otopalatodigital syndrome type 1 is a type of X-linked dominant disease and falls under the otopalatodigital syndrome spectrum disorder. It is categorized as a condition that fundamentally has a material basis in some form of X-linked dominant inheritance. The disorder is specifically characterized by a cleft palate, mild skeletal anomalies including digital anomalies, and conductive deafness caused by ossicular anomalies. This condition is due to heterozygous or hemizygous mutations in exon 3, 4, or 5 of the FLNA gene located on chromosome Xq28. Otopalatodigital syndrome type 1 is also known by several exact synonyms including OPD I syndrome, OPD syndrome 1, OPD1, Taybi syndrome, oto-palato-digital syndrome type 1, and otopalatodigital syndrome type I.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111784,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:otopalatodigital_syndrome_type_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :otopalatodigital_syndrome_spectrum_disorder,
        :x_linked_dominant_disease ;
    :has_definition ""An otopalatodigital syndrome spectrum disorder characterized by disabling skeletal anomalies and variable malformations in the hindbrain, heart, intestines, and kidneys that frequently lead to perinatal death in males and less severe phenotypes in females that has_material_basis_in hemizygous or heterozygous mutation in exons 3, 4, or 5 in males or exons 28 or 29 in females of the FLNA gene on chromosome Xq28."" ;
    :has_exact_synonym ""Andre syndrome"",
        ""OPD II syndrome"",
        ""OPD syndrome 2"",
        ""OPD2"",
        ""faciopalatoosseous syndrome"",
        ""oto-palato-digital syndrome type 2"",
        ""otopalatodigital syndrome type II"" .

","Otopalatodigital syndrome type 2 is a type of X-linked dominant disease and is part of the otopalatodigital syndrome spectrum disorder. It is characterized as a condition that has a material basis in X-linked dominant inheritance. This disorder is defined as an otopalatodigital syndrome spectrum disorder characterized by disabling skeletal anomalies and variable malformations in the hindbrain, heart, intestines, and kidneys. These malformations frequently lead to perinatal death in males and present less severe phenotypes in females. The condition has its material basis in hemizygous or heterozygous mutations in exons 3, 4, or 5 in males, or exons 28 or 29 in females, of the FLNA gene on chromosome Xq28. It is also known by several exact synonyms including Andre syndrome, OPD II syndrome, OPD syndrome 2, OPD2, faciopalatoosseous syndrome, oto-palato-digital syndrome type 2, and otopalatodigital syndrome type II.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111785,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:frontometaphyseal_dysplasia rdfs:subClassOf :otopalatodigital_syndrome_spectrum_disorder ;
    :has_definition ""An otopalatodigital syndrome spectrum disorder characterized by abnormal ossification and skeletal patterning of the axial and appendicular skeleton, facial dysmorphism, urogenital anomalies, and hearing loss."" ;
    :has_exact_synonym ""FMD"" .

","Frontometaphyseal dysplasia is a type of otopalatodigital syndrome spectrum disorder characterized by abnormal ossification and skeletal patterning of the axial and appendicular skeleton, facial dysmorphism, urogenital anomalies, and hearing loss. It is also exactly synonymous with FMD.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111786,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:frontometaphyseal_dysplasia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :frontometaphyseal_dysplasia,
        :x_linked_recessive_disease ;
    :has_definition ""A frontometaphyseal dysplasia characterized by generalized skeletal dysplasia, deafness, and urogenital defects that has_material_basis_in homozygous or hemizygous mutation in FLNA on chromosome Xq28."" ;
    :has_exact_synonym ""FMD1"" .

","Frontometaphyseal dysplasia 1 (FMD1) is a type of frontometaphyseal dysplasia and a specific form of X-linked recessive disease, which is characterized by a generalized skeletal dysplasia, deafness, and urogenital defects. This condition has a material basis in homozygous or hemizygous mutations in the FLNA gene located on chromosome Xq28, related to X-linked recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111787,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:frontometaphyseal_dysplasia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :frontometaphyseal_dysplasia ;
    :has_definition ""A frontometaphyseal dysplasia characterized by generalized skeletal dysplasia, deafness, urogenital defects and an increased tendency to form keloid scars that has_material_basis_in heterozygous mutation in MAP3K7 on chromosome 6q15."" ;
    :has_exact_synonym ""FMD2"" .

","Frontometaphyseal dysplasia 2 (FMD2) is a type of autosomal dominant disease and a specific form of frontometaphyseal dysplasia, characterized by a complex of features including generalized skeletal dysplasia, deafness, urogenital defects, and an increased tendency to form keloid scars. This condition is rooted in a material basis that involves autosomal dominant inheritance and is specifically caused by a heterozygous mutation in the MAP3K7 gene located on chromosome 6q15.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111788,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:melnick_needles_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :otopalatodigital_syndrome_spectrum_disorder,
        :x_linked_monogenic_disease ;
    :has_definition ""An otopalatodigital syndrome spectrum disorder characterized by short stature, facial dysmorphism, osseous abnormalities involving the majority of the axial and appendicular skeleton resulting in impaired speech and masticatory problems that has_material_basis_in heterozygous or hemizygous mutation in the FLNA gene on chromosome Xq28."" ;
    :has_exact_synonym ""MNS"",
        ""Melnick-Needles osteodysplasty"",
        ""osteodysplasty of Melnick and Needles"" .

","Melnick Needles Syndrome (MNS), also known as Melnick-Needles osteodysplasty or osteodysplasty of Melnick and Needles, is a type of X-linked monogenic disease, which is part of the otopalatodigital syndrome spectrum disorder. This condition arises from a material basis in X-linked inheritance, specifically due to heterozygous or hemizygous mutations in the FLNA gene on chromosome Xq28. It is characterized by short stature, facial dysmorphism, and osseous abnormalities affecting the majority of the axial and appendicular skeleton, which result in impaired speech and masticatory problems.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111789,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:frank_ter_haar_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :otopalatodigital_syndrome_spectrum_disorder ;
    :has_definition ""An otopalatodigital syndrome spectrum disorder characterized by megalocornea, multiple skeletal anomalies, characteristic facial dysmorphism (wide fontanels, prominent forehead, hypertelorism, prominent eyes, full cheeks, and micrognathia) and developmental delay that has_material_basis_in homozygous or compound heterozygous mutation in the SH3PXD2B gene on chromosome 5q35.1."" ;
    :has_exact_synonym ""Borrone dermatocardioskeletal syndrome"",
        ""FTHS"",
        ""Ter Haar syndrome"",
        ""autosomal recessive Melnick-Needles syndrome"",
        ""megalocornea, multiple skeletal anomalies, and developmental delay"" .

","Frank ter Haar syndrome is a condition that falls under the category of autosomal recessive diseases and is part of the otopalatodigital syndrome spectrum disorder. This syndrome is defined as an otopalatodigital syndrome spectrum disorder characterized by features such as megalocornea, multiple skeletal anomalies, characteristic facial dysmorphism (including wide fontanels, prominent forehead, hypertelorism, prominent eyes, full cheeks, and micrognathia), and developmental delay. The material basis for Frank ter Haar syndrome is found in homozygous or compound heterozygous mutations in the SH3PXD2B gene located on chromosome 5q35.1. Furthermore, Frank ter Haar syndrome is known by several exact synonyms, including Borrone dermatocardioskeletal syndrome, FTHS, Ter Haar syndrome, autosomal recessive Melnick-Needles syndrome, and megalocornea, multiple skeletal anomalies, and developmental delay.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111790,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nystagmus_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_genetic_disease,
        :congenital_nystagmus ;
    :has_definition ""A congenital nystagmus that has_material_basis_in mutation in the FRMD7 gene on chromosome Xq26.2."" ;
    :has_exact_synonym ""NYS1"",
        ""X-linked infantile nystagmus 1"",
        ""congenital motor nystagmus 1"" .

","Congenital Nystagmus 1 is a type of autosomal genetic disease, specifically a variant of congenital nystagmus. It is characterized by having a material basis in some autosomal inheritance and is associated with abnormalities in prenatal development or birth. The condition is defined by a mutation in the FRMD7 gene located on chromosome Xq26.2. Congenital Nystagmus 1 is also known by its exact synonyms: NYS1, X-linked infantile nystagmus 1, and congenital motor nystagmus 1.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111791,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nystagmus_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :congenital_nystagmus ;
    :has_definition ""A congenital nystagmus that has_material_basis_in heterozygous mutation in a region of chromosome 1q31.3-q32.1."" ;
    :has_exact_synonym ""NYS7"",
        ""autosomal dominant congenital nystagmus 7"" .

","Congenital nystagmus 7 is a type of autosomal dominant disease and congenital nystagmus. It is characterized by a condition that fundamentally arises from abnormalities of prenatal development or birth and has a material basis in autosomal dominant inheritance. Specifically, congenital nystagmus 7 is defined by a heterozygous mutation in a region of chromosome 1q31.3-q32.1. Additionally, it is precisely referred to by the synonyms NYS7 and autosomal dominant congenital nystagmus 7.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111792,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nystagmus_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :congenital_nystagmus ;
    :has_definition ""A congenital nystagmus that has_material_basis_in heterozygous mutation in a region of chromosome 6p12."" ;
    :has_exact_synonym ""NYS2"",
        ""autosomal dominant congenital nystagmus 2"",
        ""congenital motor nystagmus 2"" .

","Congenital Nystagmus 2, which is also precisely known as NYS2, Autosomal Dominant Congenital Nystagmus 2, and Congenital Motor Nystagmus 2, is a specific type of autosomal dominant disease. It falls within the broader category of congenital nystagmus. This condition is characterized by having its material basis in some autosomal dominant inheritance and is rooted in an abnormality of prenatal development or birth. Specifically, Congenital Nystagmus 2 is defined by a heterozygous mutation in a region of chromosome 6p12.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111793,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nystagmus_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :congenital_nystagmus ;
    :has_definition ""A congenital nystagmus that has_material_basis_in heterozygous mutation in a region of chromosome 7p11.2."" ;
    :has_exact_synonym ""NYS3"",
        ""autosomal dominant congenital nystagmus 3"" .

","Congenital Nystagmus 3 is a type of autosomal dominant disease and a specific form of congenital nystagmus. It is characterized by having a material basis in autosomal dominant inheritance and is associated with abnormalities of prenatal development or birth. This condition is defined by a congenital nystagmus that results from a heterozygous mutation in a region of chromosome 7p11.2. Furthermore, it is precisely known by two exact synonyms: NYS3 and autosomal dominant congenital nystagmus 3.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111795,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nystagmus_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :congenital_nystagmus ;
    :has_definition ""A congenital nystagmus that has_material_basis_in hemizygous of homoxygous mutation in the GPR143 gene on chromosome Xp22.2."" ;
    :has_exact_synonym ""NYS6"",
        ""X-linked congenital nystagmus 6"" .

","Congenital nystagmus 6 is a type of congenital nystagmus and falls under the category of diseases that originate from some abnormality of prenatal development or birth. It is defined as a congenital nystagmus that has a material basis in hemizygous or homozygous mutations in the GPR143 gene on chromosome Xp22.2. Additionally, congenital nystagmus 6 is exactly synonymous with NYS6 and X-linked congenital nystagmus 6.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111796,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nystagmus_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :congenital_nystagmus,
        :x_linked_dominant_disease ;
    :has_definition ""A congenital nystagmus that has_material_basis_in hemizygous or heterozygous mutation in a region of chromosome Xp11.4."" ;
    :has_exact_synonym ""NYS5"",
        ""X-linked congenital nystagmus 5"" .

","Congenital Nystagmus 5, also known exactly as NYS5 and X-linked Congenital Nystagmus 5, is a type of congenital nystagmus and an X-linked dominant disease. It specifically arises from conditions that have a material basis in X-linked dominant inheritance and abnormalities of prenatal development or birth. Moreover, its definition is established on the basis of a hemizygous or heterozygous mutation in a region of chromosome Xp11.4.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111797,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_congenital_nystagmus rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_nystagmus ;
    :has_definition ""A congenital nystagmus characterized by autosomal recessive inheritance."" ;
    :has_exact_synonym ""autosomal recessive congenital motor nystagmus"" .

","Autosomal recessive congenital nystagmus is a type of disease that falls under the category of autosomal recessive diseases and congenital nystagmus. It is characterized by its autosomal recessive inheritance and is linked to abnormalities of prenatal development or birth. This condition is defined as a congenital nystagmus characterized by autosomal recessive inheritance. Additionally, autosomal recessive congenital nystagmus is exactly synonymous with autosomal recessive congenital motor nystagmus.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111798,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_nephrolithiasis_type_i rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :renal_tubular_transport_disease,
        :x_linked_recessive_disease ;
    :has_definition ""A renal tubular transport disease characterized by proximal renal tubular reabsorptive failure, hypercalciuria, nephrolithiasis, and renal insufficiency with absence of rickets that has_material_basis_in hemizygous or homozygous mutation in the CLCN5 gene on chromosome Xp11.23."" ;
    :has_exact_synonym ""NPHL1"",
        ""X-linked nephrolithiasis with renal failure"",
        ""X-linked recessive urolithiasis type 1"",
        ""XRN"",
        ""nephrolithiasis 1"",
        ""nephrolithiasis X-linked recessive type 1"" .

","X-linked nephrolithiasis type I is a subtype of X-linked recessive disease, renal tubular transport disease, and it is characterized by a material basis in X-linked recessive inheritance. This condition is defined as a renal tubular transport disease characterized by proximal renal tubular reabsorptive failure, hypercalciuria, nephrolithiasis, and renal insufficiency without the presence of rickets. This is due to either hemizygous or homozygous mutations in the CLCN5 gene on chromosome Xp11.23. Moreover, X-linked nephrolithiasis type I is known by several exact synonyms including NPHL1, X-linked nephrolithiasis with renal failure, X-linked recessive urolithiasis type 1, XRN, nephrolithiasis 1, and nephrolithiasis X-linked recessive type 1.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111799,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :syndromic_microphthalmia,
        :x_linked_monogenic_disease ;
    :has_broad_synonym ""syndromic microphthalmia 4"" ;
    :has_definition ""A syndromic microphthalmia characterized by unilateral or bilateral microphthalmia or anophthalmia and defects in the skeletal and genitourinary system that has_material_basis_in mutation in the NAA10 gene on chromosome Xq28."" ;
    :has_exact_match ""MESH:C537464"",
        ""MESH:C564457"" ;
    :has_exact_synonym ""Lenz dysplasia"",
        ""Lenz microphthalmia"",
        ""Lenz type microphthalmia"",
        ""MCOPS1"" .

","Syndromic microphthalmia 1 is classified as a type of X-linked monogenic disease, which is a specific form of syndromic microphthalmia. This condition is defined as a type of disorder that has a material basis in some form of X-linked inheritance. Specifically, syndromic microphthalmia 1 is characterized by unilateral or bilateral microphthalmia or anophthalmia along with defects in the skeletal and genitourinary system. These manifestations are due to a mutation in the NAA10 gene located on chromosome Xq28. Additionally, syndromic microphthalmia 1 is broadly synonymous with syndromic microphthalmia 4 and has exact synonyms including Lenz dysplasia, Lenz microphthalmia, Lenz type microphthalmia, and MCOPS1. Moreover, it has exact matches with MESH identifiers C537464 and C564457.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111800,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        :autosomal_genetic_disease,
        :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by bilateral microphthalmia, pulmonary hypoplasia, and diaphragmatic hernia that has_material_basis_in compound heterozygous or heterozygous mutation in the RARB gene on chromosome 3p24.2."" ;
    :has_exact_synonym ""MCOPS12"",
        ""microphthalmia with or without pulmonary hypoplasia, diaphragmatic hernia, and/or cardiac defects"" .

","Syndromic microphthalmia 12 is a type of autosomal genetic disease, which is also a subtype of syndromic microphthalmia, and it can be characterized by its autosomal inheritance material basis. It is defined as a syndromic microphthalmia characterized by bilateral microphthalmia, pulmonary hypoplasia, and diaphragmatic hernia, with its material basis in compound heterozygous or heterozygous mutation in the RARB gene on chromosome 3p24.2. Moreover, it has exact synonyms including MCOPS12 and microphthalmia with or without pulmonary hypoplasia, diaphragmatic hernia, and/or cardiac defects.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111801,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by clinical anophthalmia or microphthalmia, with various extraocular symptoms that has_material_basis_in heterozygous mutation in the SOX2 gene on chromosome 3q26.33."" ;
    :has_exact_synonym ""AEG syndrome"",
        ""MCOPS3"",
        ""SOX2 anophthalmia syndrome"",
        ""anophthalmia clinical with associated anomalies"",
        ""anophthalmia esophageal genital syndrome"",
        ""anophthalmia microphthalmia esophageal atresia"",
        ""anophthalmia/microphthalmia-esophageal atresia syndrome"",
        ""microphthalmia and esophageal atresia syndrome"",
        ""syndromic microphthalmia type 3"" .

","Syndromic microphthalmia 3 is a type of autosomal dominant disease, which is also categorized under syndromic microphthalmia and is associated with autosomal dominant inheritance. This condition is defined by a syndromic microphthalmia characterized by clinical anophthalmia or microphthalmia, accompanied by various extraocular symptoms, arising from a heterozygous mutation in the SOX2 gene located on chromosome 3q26.33. It is known by several exact synonyms, including AEG syndrome, MCOPS3, SOX2 anophthalmia syndrome, anophthalmia clinical with associated anomalies, anophthalmia esophageal genital syndrome, anophthalmia microphthalmia esophageal atresia, anophthalmia/microphthalmia-esophageal atresia syndrome, microphthalmia and esophageal atresia syndrome, and syndromic microphthalmia type 3.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0111802,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        :autosomal_genetic_disease,
        :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by microphthalmia with coloboma or clinical anophthalmia, with or without rhizomelic skeletal dysplasia that has_material_basis_in heterozygous or homozygous mutation in the MAB21L2 gene on chromosome 4q31.3."" ;
    :has_exact_synonym ""MCOPS14"",
        ""MCSKS"",
        ""colobomatous microphthalmia-rhizomelic dysplasia syndrome"",
        ""microphthalmia and/or coloboma with or without rhizomelic skeletal dysplasia"",
        ""microphthalmia/coloboma and skeletal dysplasia syndrome"" .

","Syndromic microphthalmia 14 is a type of autosomal genetic disease, specifically a form of syndromic microphthalmia, and it is characterized as a condition that inherently has a material basis in some form of autosomal inheritance. It is defined as a type of syndromic microphthalmia characterized by features such as microphthalmia with coloboma or clinical anophthalmia, with or without rhizomelic skeletal dysplasia. This condition is caused by either heterozygous or homozygous mutations in the MAB21L2 gene located on chromosome 4q31.3. Syndromic microphthalmia 14 is also known by several exact synonyms, including MCOPS14, MCSKS, colobomatous microphthalmia-rhizomelic dysplasia syndrome, microphthalmia and/or coloboma with or without rhizomelic skeletal dysplasia, and microphthalmia/coloboma and skeletal dysplasia syndrome.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111803,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        :autosomal_genetic_disease,
        :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by microcephaly, microphthalmia, ectrodactyly of the lower limbs, prognathism and intellectual disability that has_material_basis_in mutation in a region of chromosome 6q21."" ;
    :has_exact_synonym ""MCOPS8"",
        ""MMEP syndrome"",
        ""Viljoen-Smart syndrome"",
        ""microcephaly-microphthalmia-ectrodactyly of lower limbs-prognathism syndrome"",
        ""syndromic microphthalmia type 8"" .

","Syndromic microphthalmia 8 is a type of autosomal genetic disease, which is also a form of syndromic microphthalmia. It is characterized by a condition that has at least a material basis in some form of autosomal inheritance. Specifically, syndromic microphthalmia 8 is defined as a syndromic microphthalmia characterized by microcephaly, microphthalmia, ectrodactyly of the lower limbs, prognathism, and intellectual disability, with its material basis in a mutation in a region of chromosome 6q21. Additionally, it is known by several exact synonyms: MCOPS8, MMEP syndrome, Viljoen-Smart syndrome, microcephaly-microphthalmia-ectrodactyly of lower limbs-prognathism syndrome, and syndromic microphthalmia type 8.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111804,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_11 rdfs:subClassOf :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by microphthalmia, cleft lip and palate, and agenesis of the corpus callosum that has_material_basis_in homozygous or compound heterozygous mutation in VAX1 on chromosome 10q25.3."" ;
    :has_exact_synonym ""MCOPS11"" .

","Syndromic microphthalmia 11 is a type of syndromic microphthalmia, also known exactly as MCOPS11. It is characterized by microphthalmia, cleft lip and palate, and agenesis of the corpus callosum. This condition has a material basis in homozygous or compound heterozygous mutation in VAX1 on chromosome 10q25.3.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111805,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by clinical anophthalmia or microphthalmia, retinal dystrophy, and/or myopia, associated in some cases with cerebral anomalies that has_material_basis_in heterozygous mutation in the BMP4 gene on chromosome 14q22.2."" ;
    :has_exact_synonym ""Bakrania-Ragge syndrome"",
        ""MCOPS6"",
        ""anophthalmia clinical with micrognathia malformed ears digital anomalies and abnormal external genitalia"",
        ""microphthalmia and pituitary anomalies"",
        ""microphthalmia with brain and digit anomalies"",
        ""syndromic microphthalmia type 6"" .

","Syndromic microphthalmia 6 is a type of autosomal dominant disease and is also a subtype of syndromic microphthalmia. It is characterized as a condition that arises at least partially from autosomal dominant inheritance. Specifically, syndromic microphthalmia 6 is defined as a form of syndromic microphthalmia that includes clinical anophthalmia or microphthalmia, retinal dystrophy, and/or myopia, which in some cases is associated with cerebral anomalies. This condition has its material basis in a heterozygous mutation in the BMP4 gene located on chromosome 14q22.2. Syndromic microphthalmia 6 is also known by several exact synonyms, including Bakrania-Ragge syndrome, MCOPS6, anophthalmia clinical with micrognathia malformed ears digital anomalies and abnormal external genitalia, microphthalmia and pituitary anomalies, microphthalmia with brain and digit anomalies, and syndromic microphthalmia type 6.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111806,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by unilateral or bilateral microphthalmia or clinical anophthalmia and variable additional features that has_material_basis_in heterozygous mutation in the OTX2 gene on chromosome 14q22.3."" ;
    :has_exact_synonym ""MCOPS5"",
        ""syndromic microphthalmia type 5"",
        ""syndromic microphthalmia/anophthalmia due to OTX2 mutation"" .

","Syndromic microphthalmia 5, also known precisely as MCOPS5, syndromic microphthalmia type 5, and syndromic microphthalmia/anophthalmia due to OTX2 mutation, is categorized under autosomal dominant diseases and syndromic microphthalmia. It specifically manifests as a type of condition that necessarily involves material basis in some form of autosomal dominant inheritance. Syndromic microphthalmia 5 is defined by a unique form of syndromic microphthalmia characterized by unilateral or bilateral microphthalmia or clinical anophthalmia along with variable additional features, which is the result of a heterozygous mutation in the OTX2 gene located on chromosome 14q22.3.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111807,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by bilateral clinical anophthalmia, pulmonary hypoplasia or aplasia, cardiac malformations, and diaphragmatic defects that has_material_basis_in homozygous or compound heterozygous mutation in the STRA6 gene on chromosome 15q24.1."" ;
    :has_exact_synonym ""Matthew-Wood syndrome"",
        ""anophthalmia-pulmonary hypoplasia syndrome"",
        ""anophthalmia/microphthalmia and pulmonary hypoplasia"",
        ""clinical anophthalmia mild facial dysmorphism lung heart and diaphragm malformations"",
        ""pulmonary agenesis microphthalmi and diaphragmatic defect"",
        ""spear syndrome"" .

","Syndromic microphthalmia 9 is a type of autosomal recessive disease and also a type of syndromic microphthalmia, characterized by a condition that has a material basis in some autosomal recessive inheritance. It is specifically defined as a syndromic microphthalmia characterized by bilateral clinical anophthalmia, pulmonary hypoplasia or aplasia, cardiac malformations, and diaphragmatic defects, resulting from homozygous or compound heterozygous mutations in the STRA6 gene on chromosome 15q24.1. Syndromic microphthalmia 9 is known by several exact synonyms including Matthew-Wood syndrome, anophthalmia-pulmonary hypoplasia syndrome, anophthalmia/microphthalmia and pulmonary hypoplasia, clinical anophthalmia mild facial dysmorphism lung heart and diaphragm malformations, pulmonary agenesis microphthalmia and diaphragmatic defect, and spear syndrome.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111808,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:linear_skin_defects_with_multiple_congenital_anomalies_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :mls_syndrome,
        :physical_disorder,
        :x_linked_dominant_disease ;
    :has_definition ""A syndromic microphthalmia characterized by unilateral or bilateral microphthalmia and linear skin defects on the face and neck in females and in utero lethality in males that has_material_basis_in heterozygous or hemizygous mutation in the HCCS gene on chromosome Xp22.2."" ;
    :has_exact_synonym ""MCOPS7"",
        ""MIDAS syndrome"",
        ""Microphthalmia with linear skin defect syndrome"",
        ""microphthalmia-dermal aplasia-sclerocornea syndrome"",
        ""syndromic microphthalmia 7"",
        ""syndromic microphthalmia type 7"" .

","Linear Skin Defects with Multiple Congenital Anomalies 1 is identified as a type of X-linked dominant disease, a physical disorder, an MLS syndrome, and a condition that fundamentally has a material basis in some X-linked dominant inheritance. Additionally, it is categorized based on having its disease basis in some abnormality of prenatal development or birth. Its definition highlights it as a syndromic microphthalmia characterized by unilateral or bilateral microphthalmia and linear skin defects on the face and neck in females, and in utero lethality in males, which is due to heterozygous or hemizygous mutation in the HCCS gene on chromosome Xp22.2. This disease is precisely synonymous with MCOPS7, MIDAS syndrome, Microphthalmia with Linear Skin Defect Syndrome, microphthalmia-dermal aplasia-sclerocornea syndrome, Syndromic Microphthalmia 7, and Syndromic Microphthalmia Type 7.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111809,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :syndromic_microphthalmia,
        :x_linked_dominant_disease ;
    :has_definition ""A syndromic microphthalmia characterized by dental radiculomegaly, congenital cataract, microphthalmia, facial dismorphism and congenital heart disease that has_material_basis_in heterozygous mutation in the BCOR gene on chromosome Xp11.4."" ;
    :has_exact_synonym ""ANOP2"",
        ""MAA2"",
        ""MCOPS2"",
        ""OFCD syndrome"",
        ""cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome"",
        ""microphthalmia cataracts radiculomegaly and septal heart defects"",
        ""oculofaciocardiodental syndrome"",
        ""syndromic microphthalmia type 2"" .

","Syndromic microphthalmia 2 is a type of syndromic microphthalmia, which is classified as an X-linked dominant disease. It is also recognized as a condition that must have a material basis in some form of X-linked dominant inheritance. Syndromic microphthalmia 2 is specifically characterized by dental radiculomegaly, congenital cataract, microphthalmia, facial dysmorphism, and congenital heart disease, with its material basis attributed to a heterozygous mutation in the BCOR gene located on chromosome Xp11.4. Additionally, syndromic microphthalmia 2 is known by several exact synonyms, including ANOP2, MAA2, MCOPS2, OFCD syndrome, cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome, microphthalmia cataracts radiculomegaly and septal heart defects, oculofaciocardiodental syndrome, and syndromic microphthalmia type 2.",12,True
doid,http://purl.obolibrary.org/obo/DOID_0111811,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :syndromic_microphthalmia,
        :x_linked_monogenic_disease ;
    :has_definition ""A syndromic microphthalmia characterized by colobomatous microphthalmia, microcephaly, short stature, and psychomotor retardation that has_material_basis_in mutation in the HMGB3 gene on chromosome Xq28."" ;
    :has_exact_synonym ""MCOPS13"",
        ""Maine microphthalmos"",
        ""X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome"",
        ""colobomatous microphthalmia with microcephaly, short stature, and psychomotor retardation"" .

","Syndromic microphthalmia 13 is a type of X-linked monogenic disease and a specific form of syndromic microphthalmia. It involves a condition that has its material basis in some form of X-linked inheritance. This condition is characterized as a syndromic microphthalmia featuring colobomatous microphthalmia, microcephaly, short stature, and psychomotor retardation, which results from a mutation in the HMGB3 gene on chromosome Xq28. Additionally, syndromic microphthalmia 13 is known by several exact synonyms, including MCOPS13, Maine microphthalmos, X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome, and colobomatous microphthalmia with microcephaly, short stature, and psychomotor retardation.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111812,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndromic_microphthalmia_10 rdfs:subClassOf :syndromic_microphthalmia ;
    :has_definition ""A syndromic microphthalmia characterized by congenital microphthalmia and blindness, microcephaly, progressive spasticity, seizures, progressive atrophy of the brain and profound intellectual disability."" ;
    :has_exact_synonym ""MCOPS10"",
        ""MOBA"",
        ""microphthalmia-brain atrophy syndrome"" .

","Syndromic microphthalmia 10 is a type of syndromic microphthalmia defined as a syndromic microphthalmia characterized by congenital microphthalmia and blindness, microcephaly, progressive spasticity, seizures, progressive atrophy of the brain, and profound intellectual disability. It has exact synonyms MCOPS10, MOBA, and microphthalmia-brain atrophy syndrome.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111813,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndactyly_type_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndactyly,
        :x_linked_recessive_disease ;
    :has_definition ""A syndactyly characterized by isolated fusion of the fourth and fifth metacarpals that has_material_basis_in hemizygous or homozygous mutation in the FGF16 gene on chromosome Xq21.1."" ;
    :has_exact_synonym ""fusion of metacarpals 4 and 5"",
        ""metacarpal 4-5 fusion"" .

","Syndactyly Type 8 is classified as a type of X-linked recessive disease, which falls under the broader category of syndactyly. It is specifically associated with conditions that have a material basis in X-linked recessive inheritance. This form of syndactyly is defined by the isolated fusion of the fourth and fifth metacarpals, a condition that results from either hemizygous or homozygous mutation in the FGF16 gene located on chromosome Xq21.1. Additionally, Syndactyly Type 8 is precisely identified by the exact synonyms ""fusion of metacarpals 4 and 5"" and ""metacarpal 4-5 fusion.""",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111814,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:methylmalonic_acidemia_and_homocysteinemia_cblx_type rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :methylmalonic_acidemia,
        :x_linked_recessive_disease ;
    :has_definition ""A methylmalonic acidemia characterized by onset in infancy of severely delayed psychomotor development, failure to thrive, intellectual disability, and intractable epilepsy that has_material_basis_in hemizygous or homozygous mutation in the HCFC1 gene on chromosome Xq28."" ;
    :has_exact_synonym ""combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX"",
        ""mental retardation, X-linked 3"",
        ""methylmalonic aciduria with homocystinuria, type cblX"" .

","Methylmalonic acidemia and homocysteinemia cblx type is a type of X-linked recessive disease, which is also a form of methylmalonic acidemia and is characterized by being a condition that inherently has a material basis in some X-linked recessive inheritance. This condition is defined as a methylmalonic acidemia that presents itself in infancy with severely delayed psychomotor development, failure to thrive, intellectual disability, and intractable epilepsy, stemming from hemizygous or homozygous mutation in the HCFC1 gene on chromosome Xq28. It is precisely known by several exact synonyms which include combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX; mental retardation, X-linked 3; and methylmalonic aciduria with homocystinuria, type cblX.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111815,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:low_molecular_weight_proteinuria_with_hypercalciuric_nephrocalcinosis rdfs:subClassOf :dent_disease ;
    :has_definition ""A Dent disease characterized by elevted levels of low molecular weight proteins in the urine, hypercalciuria, and nephrocalcinosis that has_material_basis_in hemizygous or homozygous mutation in the CLCN5 gene on chromosome Xp11.22."" .

","Dent disease, which is a type of low molecular weight proteinuria with hypercalciuric nephrocalcinosis, is defined by elevated levels of low molecular weight proteins in the urine, hypercalciuria, and nephrocalcinosis. This condition has a material basis in hemizygous or homozygous mutations in the CLCN5 gene located on chromosome Xp11.22.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111816,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndactyly_type_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :chromosome ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :duplication ] ;
                            rdf:rest :nil ] ] ],
        :autosomal_dominant_disease,
        :chromosomal_duplication_syndrome,
        :syndactyly ;
    :has_definition ""A syndactyly characterized by complete or partial webbing between the third and fourth fingers and/or the second and third toes that has_material_basis_in heterozygous duplication of a region of chromosome 2q34-q36."" ;
    :has_exact_synonym ""SDTY1"",
        ""chromosome 2q35 duplication syndrome"",
        ""syndactyly, type 1, with or without craniosynostosis"" .

","Syndactyly type 1 is characterized as a type of autosomal dominant disease, chromosomal duplication syndrome, and syndactyly. It is described by an intersection of conditions that have a material basis in some chromosome and duplication, specifically highlighting its basis in autosomal dominant inheritance. The definition of Syndactyly type 1 is a syndactyly characterized by complete or partial webbing between the third and fourth fingers and/or the second and third toes, which is caused by a heterozygous duplication of a region on chromosome 2q34-q36. Additionally, Syndactyly type 1 is also known by its exact synonyms: SDTY1, chromosome 2q35 duplication syndrome, and syndactyly, type 1, with or without craniosynostosis.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111817,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndactyly_type_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndactyly ;
    :has_definition ""A syndactyly characterized by complete and bilateral syndactyly between the 4th and 5th fingers that has_material_basis_in heterozygous mutation in the GJA1 gene on chromosome 6q22.31."" ;
    :has_exact_synonym ""SDTY3"",
        ""ringand little finger syndactyly"",
        ""syndactyly of fingers 4 and 5"",
        ""syndactyly, type III"" .

","Syndactyly type 3 is a type of autosomal dominant disease, which also falls under the broader category of syndactyly. It is defined as a syndactyly characterized by complete and bilateral syndactyly between the 4th and 5th fingers, with its material basis in a heterozygous mutation in the GJA1 gene on chromosome 6q22.31. This condition is an example of something that has a material basis in autosomal dominant inheritance. Syndactyly type 3 is also known by its exact synonyms: SDTY3, ring and little finger syndactyly, syndactyly of fingers 4 and 5, and syndactyly, type III.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111818,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndactyly_type_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndactyly ;
    :has_definition ""A syndactyly characterized by complete bilateral syndactyly involving all digits 1 to 5 that has_material_basis_in heterozygous mutation of a SHH regulatory element in intron 5 of the LMBR1 gene on chromosome 7q36.3."" ;
    :has_exact_synonym ""Haas type syndactyly"",
        ""SDTY4"",
        ""polysyndactyly, Haas type"" .

","Syndactyly type 4 is a form of autosomal dominant disease and a specific type of syndactyly, characterized by complete bilateral syndactyly involving all digits from 1 to 5. This condition arises from a heterozygous mutation in a Sonic Hedgehog (SHH) regulatory element located in intron 5 of the LMBR1 gene on chromosome 7q36.3. Additionally, Syndactyly type 4 is also known by its exact synonyms: Haas type syndactyly, SDTY4, and polysyndactyly, Haas type. It is described as stemming from autosomal dominant inheritance at a material basis.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111819,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndactyly_type_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndactyly ;
    :has_definition ""A syndactyly characterized by postaxial syndactyly of the hands and feet associated with metacarpal and metatarsal fusion typically affecting the 4th and 5th or the 3rd and 4th digits that has_material_basis_in heterozygous mutation in the HOXD13 gene on chromosome 2q31.1."" ;
    :has_exact_synonym ""SDTY5"",
        ""syndactyly with associated metacarpal and metatarsal fusion"" .

","Syndactyly Type 5 is a type of autosomal dominant disease and syndactyly, specifically characterized by a condition that inherently has a material basis in autosomal dominant inheritance. It is defined as a syndactyly characterized by postaxial syndactyly of the hands and feet associated with metacarpal and metatarsal fusion, typically affecting the 4th and 5th or the 3rd and 4th digits, and has its material basis in a heterozygous mutation in the HOXD13 gene on chromosome 2q31.1. Furthermore, Syndactyly Type 5 is also known by the exact synonyms SDTY5 and syndactyly with associated metacarpal and metatarsal fusion.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111820,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:zygodactyly_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_location ;
            owl:someValuesFrom :foot ],
        :syndactyly ;
    :has_definition ""A syndactyly characterized by webbing between the second and third toes in the absence of hand involvement."" .

",Zygodactyly 1 is a type of syndactyly and is also a type of condition that affects the foot. It is defined as a syndactyly characterized by webbing between the second and third toes without involving the hands.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0111821,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ichthyosis_follicularis_alopecia_photophobia_syndrome_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :has_phenotype ;
            owl:someValuesFrom :epidermal_thickening ],
        :syndrome,
        :x_linked_recessive_disease ;
    :has_definition ""A syndrome characterized by ichthyosis follicularis, atrichia, and photophobia that has_material_basis_in hemizygous or homozygous mutation in the MBTPS2 gene on chromosome Xp22.12."" ;
    :has_exact_synonym ""IFAP syndrome 1"",
        ""IFAP syndrome 1 with or without BRESHECK syndrome"",
        ""ichthyosis follicularis-atrichia-photophobia syndrome 1"" .

","Ichthyosis Follicularis Alopecia Photophobia Syndrome 1 (IFAP Syndrome 1) is a type of syndrome that falls under the category of X-linked recessive diseases. It manifests as a condition that not only has a material basis in X-linked recessive inheritance but also is characterized by specific phenotypes such as epidermal thickening. This syndrome is defined by a combination of ichthyosis follicularis, atrichia (absence of hair), and photophobia, which originates from either hemizygous or homozygous mutations in the MBTPS2 gene located on chromosome Xp22.12. Furthermore, IFAP Syndrome 1 is also known by its exact synonyms: IFAP Syndrome 1 with or without BRESHECK syndrome, and ichthyosis follicularis-atrichia-photophobia syndrome 1, encapsulating the diverse presentations of this genetic condition.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111822,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:child_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :syndrome,
        :x_linked_dominant_disease ;
    :has_definition ""A syndrome characterized by congenital hemidysplasia, ichythyosiform erythrodema, and limb defects that has_material_basis_in heterozygous mutation in the NSDHL gene on chromosome Xq28."" ;
    :has_exact_synonym ""CHILD nevus"",
        ""congenital hemidysplasia with ichthyosiform nevus and limbs defects"" .

","Child syndrome is a type of syndrome and a specific form of X-linked dominant disease. It is characterized by a condition that at least has a material basis in some X-linked dominant inheritance. The definition of Child syndrome is a syndrome characterized by congenital hemidysplasia, ichthyosiform erythroderma, and limb defects, which has a material basis in a heterozygous mutation in the NSDHL gene on chromosome Xq28. Furthermore, Child syndrome has exact synonyms, including CHILD nevus and congenital hemidysplasia with ichthyosiform nevus and limb defects.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111823,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_hemophilia_a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        :autosomal_genetic_disease,
        :blood_coagulation_disease ;
    :has_definition ""A blood coagulation disease characterized by autosomal inheritence of a Factor VIII deficiency."" ;
    :has_exact_synonym ""autosomal Factor VIII deficiency"" .

","Autosomal hemophilia A is a type of blood coagulation disease and also a type of autosomal genetic disease, which essentially has a material basis in autosomal inheritance. It is characterized by the autosomal inheritance of a Factor VIII deficiency, which is precisely defined as a blood coagulation disease. Moreover, it is exactly synonymous with autosomal Factor VIII deficiency.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111824,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:aarskog_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by facial, limbs and genital anomalies, and a disproportionate acromelic short stature."" ;
    :has_exact_synonym ""Aarskog-Scott syndrome"",
        ""faciodigitogenital syndrome"",
        ""faciogenital dysplasia"" .

","Aarskog syndrome is a type of syndrome characterized by facial, limbs, and genital anomalies, along with a disproportionate acromelic short stature. It is also known by its exact synonyms: Aarskog-Scott syndrome, faciodigitogenital syndrome, and faciogenital dysplasia.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111825,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_aarskog_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :aarskog_syndrome,
        :autosomal_dominant_disease ;
    :has_definition ""An Aarskog syndrome characterized by autosomal dominant inheritance."" .

","Autosomal dominant Aarskog syndrome is a type of Aarskog syndrome and a type of autosomal dominant disease. It is characterized by autosomal dominant inheritance, representing a type of condition that at least has a material basis in some autosomal dominant inheritance.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111826,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:abruzzo_erickson_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :syndrome,
        :x_linked_monogenic_disease ;
    :has_definition ""A syndrome characterized by cleft palate, coloboma, hypospadias, deafness, short stature, and radial synostosis that has_material_basis_in hemizygous mutation in the TBX22 gene on chromosome Xq21.1."" ;
    :has_exact_synonym ""CHARGE-like syndrome, X-linked"",
        ""cleft palate-coloboma-deafness syndrome"" .

","Abruzzo Erickson syndrome is a type of syndrome and an X-linked monogenic disease, which means it at least has a material basis in some X-linked inheritance. It is characterized by cleft palate, coloboma, hypospadias, deafness, short stature, and radial synostosis, resulting from a hemizygous mutation in the TBX22 gene on chromosome Xq21.1. Additionally, Abruzzo Erickson syndrome is also known by its exact synonyms: CHARGE-like syndrome, X-linked and cleft palate-coloboma-deafness syndrome.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111827,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spinal_muscular_atrophy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :spinal_muscular_atrophy,
        :x_linked_recessive_disease ;
    :has_definition ""A spinal muscular atrophy characterized by neonatal onset of severe hypotonia, areflexia, and multiple congenital contractures associated with loss of anterior horn cells and infantile death that has_material_basis_in hemizygous mutation in the UBA1 gene on chromosome Xp11.3."" ;
    :has_exact_synonym ""SMAX2"",
        ""X-linked distal arthrogryposis multiplex congenita"",
        ""X-linked spinal muscular atrophy type 2"",
        ""infantile-onset X-linked spinal muscular atrophy"",
        ""spinal muscular atrophy with arthrogryposis"" .

","X-linked spinal muscular atrophy 2 is a type of spinal muscular atrophy and falls under the category of X-linked recessive diseases. It is characterized by a condition that essentially has a material basis in X-linked recessive inheritance. Specifically, X-linked spinal muscular atrophy 2 is defined as a spinal muscular atrophy that is marked by neonatal onset of severe hypotonia, areflexia, and multiple congenital contractures associated with the loss of anterior horn cells and typically results in infantile death. The condition has its material basis in a hemizygous mutation in the UBA1 gene located on chromosome Xp11.3. Additionally, X-linked spinal muscular atrophy 2 is known by several exact synonyms including SMAX2, X-linked distal arthrogryposis multiplex congenita, X-linked spinal muscular atrophy type 2, infantile-onset X-linked spinal muscular atrophy, and spinal muscular atrophy with arthrogryposis.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111828,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_cerebellar_ataxia rdfs:subClassOf :x_linked_hereditary_ataxia ;
    :has_definition ""A hereditary ataxia characterized by X-linked inheritance."" .

","X-linked cerebellar ataxia is a type of X-linked hereditary ataxia, which is defined as a hereditary ataxia characterized by X-linked inheritance.",2,True
doid,http://purl.obolibrary.org/obo/DOID_0111829,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spinocerebellar_ataxia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :x_linked_cerebellar_ataxia,
        :x_linked_recessive_disease ;
    :has_definition ""An X-linked cerebellar ataxia characterized by hypotonia at birth, delayed motor development, gait ataxia, difficulty standing, dysarthria, and slow eye movements that has_material_basis_in hemizygous mutation in the ATP2B3 gene on chromosome Xq28."" ;
    :has_exact_synonym ""SCAX1"",
        ""X-linked progressive cerebellar ataxia"" .

","X-linked spinocerebellar ataxia 1 (SCAX1), also known as X-linked progressive cerebellar ataxia, is a type of X-linked recessive disease and a type of X-linked cerebellar ataxia. It is characterized by a condition that at least has a material basis in some form of X-linked recessive inheritance. Specifically, it is defined as an X-linked cerebellar ataxia characterized by symptoms such as hypotonia at birth, delayed motor development, gait ataxia, difficulty standing, dysarthria, and slow eye movements, all of which have a material basis in a hemizygous mutation in the ATP2B3 gene on chromosome Xq28.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111830,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spinocerebellar_ataxia_2 rdfs:subClassOf :x_linked_cerebellar_ataxia ;
    :has_definition ""An X-linked cerebellar ataxia characterized by infantile onset of ataxia, severe atrophy of the cerebellum, diffuse small cysts, pale inferior olives, and gliosis with X-linked inheritance."" ;
    :has_exact_synonym ""SCAX2"",
        ""cerebellar ataxia with extrapyramidal involvement early-onset"" .

","X-linked spinocerebellar ataxia 2 is a type of X-linked cerebellar ataxia, which is characterized by an infantile onset of ataxia, severe atrophy of the cerebellum, diffuse small cysts, pale inferior olives, and gliosis, following an X-linked inheritance pattern. It is also precisely known as SCAX2 and cerebellar ataxia with extrapyramidal involvement early-onset.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111831,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spinocerebellar_ataxia_3 rdfs:subClassOf :x_linked_cerebellar_ataxia ;
    :has_definition ""An X-linked cerebellar ataxia characterized by onset in infancy of hypotonia, ataxia, sensorineural deafness, developmental delay, esotropia, and optic atrophy with X-linked inheritance."" ;
    :has_exact_synonym ""SCAX3"",
        ""X-linked ataxia-deafness syndrome"",
        ""X-linked spinocerebellar ataxia type 3"" .

","X-linked spinocerebellar ataxia 3 is a type of X-linked cerebellar ataxia, characterized by onset in infancy of hypotonia, ataxia, sensorineural deafness, developmental delay, esotropia, and optic atrophy with X-linked inheritance. It has exact synonyms: SCAX3, X-linked ataxia-deafness syndrome, and X-linked spinocerebellar ataxia type 3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111832,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spinocerebellar_ataxia_4 rdfs:subClassOf :x_linked_cerebellar_ataxia ;
    :has_definition ""An X-linked cerebellar ataxia characterized by ataxia, pyramidal tract signs and adult-onset dementia with X-linked inheritance."" ;
    :has_exact_synonym ""SCAX4"",
        ""X-linked ataxia-dementia syndrome"",
        ""X-linked spinocerebellar ataxia type 4"" .

","X-linked spinocerebellar ataxia 4 is a type of X-linked cerebellar ataxia, characterized by ataxia, pyramidal tract signs, and adult-onset dementia with X-linked inheritance. Furthermore, it is exactly synonymous with SCAX4, X-linked ataxia-dementia syndrome, and X-linked spinocerebellar ataxia type 4.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111833,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_spinocerebellar_ataxia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :x_linked_cerebellar_ataxia,
        :x_linked_recessive_disease ;
    :has_definition ""An X-linked cerebellar ataxia characterized by neonatal hypotonia, delayed motor development, nonprogressive ataxia, nystagmus, and dysarthria that has_material_basis_in hemizygous mutation in region of chromosome Xq25-q27.1."" ;
    :has_exact_synonym ""SCAX5"",
        ""Spinocerebellar Ataxia, X-Linked 5"",
        ""X-linked non progressive cerebellar ataxia"" .

","X-linked spinocerebellar ataxia 5 is a type of X-linked recessive disease and also falls under the category of X-linked cerebellar ataxia. It is associated with conditions that have a material basis in some form of X-linked recessive inheritance. The condition is characterized by neonatal hypotonia, delayed motor development, nonprogressive ataxia, nystagmus, and dysarthria, with its material basis in a hemizygous mutation in the region of chromosome Xq25-q27.1. This condition is known by several exact synonyms, including SCAX5, Spinocerebellar Ataxia, X-Linked 5, and X-linked nonprogressive cerebellar ataxia.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111834,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_reticulate_pigmentary_disorder rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :pigmentation_disease,
        :x_linked_monogenic_disease ;
    :has_definition ""A pigmentation disease characterized by early onset of recurrent respiratory infections, failure to thrive resulting from inflammatory gastroenteritis or colitis, and reticular pigmentation abnormalities of the skin in hemizygous males and only pigmentary abnormalities along the lines of Blaschko in heterozygous females that has_material_basis_in mutation in the POLA1 gene on chromosome Xp22.1-p21.3."" ;
    :has_exact_synonym ""PDR"",
        ""Partington disease"",
        ""X-linked reticulate pigmentary disorder with systemic manifestations"" .

","X-linked reticulate pigmentary disorder is a type of pigmentation disease, which also falls under the category of X-linked monogenic diseases and is a condition that essentially has a material basis in some form of X-linked inheritance. It is characterized by a specific set of symptoms including early onset of recurrent respiratory infections, failure to thrive due to inflammatory gastroenteritis or colitis, and distinctive reticular pigmentation abnormalities of the skin observed in hemizygous males, alongside only pigmentary abnormalities following the lines of Blaschko in heterozygous females. These clinical manifestations are the result of a mutation in the POLA1 gene located on chromosome Xp22.1-p21.3. Additionally, X-linked reticulate pigmentary disorder is known by several exact synonyms including PDR, Partington disease, and X-linked reticulate pigmentary disorder with systemic manifestations.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111835,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :congenital_hypothyroidism,
        :x_linked_recessive_disease ;
    :has_definition ""A congenital hypothyroidism characterized by a small thyroid gland with low free T4 levels and inappropriately normal levels of thyroid-stimulating hormone that has_material_basis_in hemizygous mutation in the IRS4 gene on chromosome Xq22.3."" ;
    :has_exact_synonym ""CHNG9"" .

","Congenital nongoitrous hypothyroidism 9 (CHNG9) is a type of congenital hypothyroidism and is categorized as an x-linked recessive disease. It is a condition that has a material basis in x-linked recessive inheritance and is associated with abnormalities of prenatal development or birth. The definition of congenital nongoitrous hypothyroidism 9 includes being a congenital hypothyroidism characterized by a small thyroid gland with low free T4 levels and inappropriately normal levels of thyroid-stimulating hormone, which has its material basis in a hemizygous mutation in the IRS4 gene on chromosome Xq22.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111836,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism characterized by normal-to-low T4 and normal-to-high thyrotropin levels, with reduced or absent pituitary responsiveness to thyrotropin-releasing hormone that has_material_basis_in homozygous or compound heterozygous mutation in the TRHR gene on chromosome 8q23.1."" ;
    :has_exact_synonym ""CHNG7"",
        ""TRH resistance syndrome"",
        ""central hypothyroidism due to TRH receptor deficiency"",
        ""resistance to thyrotropin-releasing hormone syndrome"" .

","Congenital nongoitrous hypothyroidism 7, also exactly known as CHNG7, TRH resistance syndrome, central hypothyroidism due to TRH receptor deficiency, and resistance to thyrotropin-releasing hormone syndrome, is a type of congenital hypothyroidism and an autosomal recessive disease. This condition is characterized by a material basis in autosomal recessive inheritance and is rooted in some abnormality of prenatal development or birth. It is specifically defined as a congenital hypothyroidism characterized by normal-to-low T4 and normal-to-high thyrotropin levels, with reduced or absent pituitary responsiveness to thyrotropin-releasing hormone, which has its material basis in homozygous or compound heterozygous mutation in the TRHR gene on chromosome 8q23.1.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111837,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_nongoitrous_hypothyroidism_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_dominant_disease,
        :congenital_hypothyroidism ;
    :has_definition ""A congenital hypothyroidism characterized by relatively mild central hypothyroidism that has_material_basis_in heterozygous or hemizygous mutation in the TBL1X gene on chromosome Xp22.3-p22.2."" ;
    :has_exact_synonym ""CHNG8"" .

","Congenital nongoitrous hypothyroidism 8, also precisely known as CHNG8, is a subtype of congenital hypothyroidism and an autosomal dominant disease. It is defined by a form of congenital hypothyroidism that is relatively mild in its central manifestation and results from either heterozygous or hemizygous mutations in the TBL1X gene located on chromosome Xp22.3-p22.2. This condition is linked to autosomal dominant inheritance and is characterized by abnormalities in prenatal development or birth.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111838,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:basilicata_akhtar_syndrome rdfs:subClassOf :syndromic_x_linked_intellectual_disability ;
    :has_definition ""A syndromic X-linked intellectual disability characterized by global developmental delay apparent from infancy, feeding difficulties, hypotonia, and poor or absent speech that has_material_basis_in hemizygous or heterozygous mutation in the MSL3 gene on chromosome Xp22.2."" ;
    :has_exact_synonym ""MRXS36"",
        ""X-linked syndromic mental retardation 36"",
        ""X-linked syndromic mental retardation Basilicata-Akhtar type"" .

","Basilicata Akhtar syndrome is recognized as a type of syndromic X-linked intellectual disability, which is precisely defined as a condition characterized by global developmental delay apparent from infancy, feeding difficulties, hypotonia, and poor or absent speech. This condition's material basis is found in either hemizygous or heterozygous mutations in the MSL3 gene on chromosome Xp22.2. Moreover, Basilicata Akhtar syndrome is exactly synonymous with MRXS36, X-linked syndromic mental retardation 36, and X-linked syndromic mental retardation Basilicata-Akhtar type.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111839,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_disorder_of_glycosylation_icc rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :congenital_disorder_of_glycosylation_type_i,
        :x_linked_recessive_disease ;
    :has_definition ""A congenital disorder of glycosylation type I characterized by developmental delay, impaired intellectual development, and mild facial dysmorphism associated with abnormal serum transferrin isoelectic focusing consistent with a type 1 pattern that has_material_basis_in hemizygous mutation in the MAGT1 gene on chromosome Xq21.1."" ;
    :has_exact_synonym ""congenital disorder of glycosylation type Icc"" .

","Congenital Disorder of Glycosylation ICC (CDG-Icc) is classified as a type of Congenital Disorder of Glycosylation Type I, and it also falls under the category of X-linked recessive diseases. This condition is characterized by its genetic foundation in X-linked recessive inheritance and is also recognized for its association with abnormalities in prenatal development or birth. CDG-Icc is specifically defined as a Congenital Disorder of Glycosylation Type I that is characterized by developmental delay, impaired intellectual development, and mild facial dysmorphism. This disorder is associated with abnormal serum transferrin isoelectric focusing consistent with a type 1 pattern, which is caused by a hemizygous mutation in the MAGT1 gene located on chromosome Xq21.1. Furthermore, Congenital Disorder of Glycosylation ICC is exactly synonymous with Congenital Disorder of Glycosylation Type Icc.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111840,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:van_esch_o_driscoll_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndromic_x_linked_intellectual_disability,
        :x_linked_recessive_disease ;
    :has_definition ""A syndromic X-linked intellectual disability characterized by variable degrees of intellectual disability, moderate to severe short stature, microcephaly, hypogonadism, and variable congenital malformations that has_material_basis_in hemizygous mutation in the POLA1 gene on chromosome Xp22.1-p21.3."" ;
    :has_exact_synonym ""MRXSVEOD"",
        ""VEODS"",
        ""X-linked intellectual disability, Van Esch type"",
        ""X-linked syndromic mental retardation Van Esch-O'Driscoll type"" .

","Van Esch-O'Driscoll syndrome is a type of syndromic X-linked intellectual disability, which is also recognized as a type of X-linked recessive disease. It is characterized by variable degrees of intellectual disability, moderate to severe short stature, microcephaly, hypogonadism, and variable congenital malformations due to a hemizygous mutation in the POLA1 gene on chromosome Xp22.1-p21.3. This condition is synonymous with MRXSVEOD, VEODS, X-linked intellectual disability, Van Esch type, and X-linked syndromic mental retardation Van Esch-O'Driscoll type.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111841,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:shukla_vernon_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndrome,
        :x_linked_recessive_disease ;
    :has_definition ""A syndrome characterized by global developmental delay, variably impaired intellectual development, variable dysmorphic features, and behavioral abnormalities, including autism spectrum disorder and ADHD that has_material_basis_in hemizygous mutation in the BCORL1 gene on chromosome Xq26.1."" ;
    :has_exact_synonym ""SHUVER"" .

","Shukla Vernon Syndrome, also exactly known as SHUVER, is a type of syndrome that falls under the category of X-linked recessive diseases. It is described as a syndrome with a material basis in X-linked recessive inheritance. This syndrome is characterized by global developmental delay, variably impaired intellectual development, variable dysmorphic features, and behavioral abnormalities, which include autism spectrum disorder and ADHD. These characteristics are due to a hemizygous mutation in the BCORL1 gene located on chromosome Xq26.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111842,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:keipert_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndrome,
        :x_linked_recessive_disease ;
    :has_definition ""A syndrome characterized by craniofacial and digital abnormalities, mild to severe congenital sensorineural hearing loss, and variable learning difficulties that has_material_basis_in hemizygous mutation in the GPC4 gene on chromosome Xq26.2."" ;
    :has_exact_synonym ""KPTS"",
        ""nasodigitoacoustic syndrome"" .

","Keipert syndrome, which has exact synonyms KPTS and nasodigitoacoustic syndrome, is a type of syndrome and specifically a type of X-linked recessive disease. It is characterized by a syndrome that at least has a material basis in some X-linked recessive inheritance. The definition of Keipert syndrome is a syndrome characterized by craniofacial and digital abnormalities, mild to severe congenital sensorineural hearing loss, and variable learning difficulties that has a material basis in a hemizygous mutation in the GPC4 gene on chromosome Xq26.2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111843,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:paganini_miozzo_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndromic_x_linked_intellectual_disability,
        :x_linked_recessive_disease ;
    :has_definition ""A syndromic X-linked intellectual disability characterized by global developmental delay, impaired intellectual development, high myopia, and mild dysmorphic facial features that has_material_basis_in hemizygous mutation in the HS6ST2 gene on chromosome Xq26.2."" ;
    :has_exact_synonym ""MRXSPM"" .

","Paganini Miozzo Syndrome is a type of syndromic X-linked intellectual disability, X-linked recessive disease, and it is characterized by a condition that fundamentally has a material basis in X-linked recessive inheritance. It is defined specifically as a syndromic X-linked intellectual disability featuring global developmental delay, impaired intellectual development, high myopia, and mild dysmorphic facial features, with its material basis in hemizygous mutation in the HS6ST2 gene located on chromosome Xq26.2. Furthermore, Paganini Miozzo Syndrome is exactly synonymous with MRXSPM.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111844,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_intellectual_developmental_disorder_108 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndromic_x_linked_intellectual_disability,
        :x_linked_recessive_disease ;
    :has_definition ""A syndromic X-linked intellectual disability characterized by global developmental delay, delayed walking, and poor speech acquisition that has_material_basis_in hemizygous mutation in the SLC9A7 gene on chromosome Xp11.3."" ;
    :has_exact_synonym ""MRX108"" .

","X-linked intellectual developmental disorder 108 is classified as a syndromic X-linked intellectual disability, an X-linked recessive disease, and a condition with a material basis in X-linked recessive inheritance. It is defined as a syndromic X-linked intellectual disability characterized by global developmental delay, delayed walking, and poor speech acquisition, arising from a hemizygous mutation in the SLC9A7 gene on chromosome Xp11.3. Additionally, this disorder is exactly synonymous with MRX108.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111845,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mullegama_klein_martinez_syndrome rdfs:subClassOf :syndromic_x_linked_intellectual_disability ;
    :has_definition ""A syndromic X-linked intellectual disability characterized by global developmental delay with impaired intellectual development and poor speech and commonly associated with ear abnormalities, hearing loss, and dysmorphic facial features that has_material_basis_in heterozygous or hemizygous mutation in the STAG2 gene on chromosome Xq25."" ;
    :has_exact_synonym ""MKMS"",
        ""NEDXCF"",
        ""X-linked neurodevelopmental disorder with craniofacial abnormalities"" .

","Mullegama Klein Martinez Syndrome (MKMS), also known by its exact synonyms NEDXCF and X-linked neurodevelopmental disorder with craniofacial abnormalities, is a type of syndromic X-linked intellectual disability. It is characterized by global developmental delay with impaired intellectual development and poor speech, and is commonly associated with ear abnormalities, hearing loss, and dysmorphic facial features. The syndrome has its material basis in heterozygous or hemizygous mutation in the STAG2 gene on chromosome Xq25.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111846,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_congenital_hemolytic_anemia rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :congenital_hemolytic_anemia,
        :x_linked_recessive_disease ;
    :has_definition ""A congenital hemolytic anemia characterized by mild congenital hemolytic anemia without morphologic red cell abnormalities that has_material_basis_in hemizygous mutation in the ATP11C gene on chromosome Xq27.1."" .

","X-linked congenital hemolytic anemia is a type of X-linked recessive disease and a type of congenital hemolytic anemia. It is characterized by at least having a material basis in some X-linked recessive inheritance and is a type of disease that has its basis in some abnormality of prenatal development or birth. It is defined as a congenital hemolytic anemia characterized by mild congenital hemolytic anemia without morphologic red cell abnormalities, having a material basis in a hemizygous mutation in the ATP11C gene on chromosome Xq27.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111847,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:osteogenesis_imperfecta_type_19 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :osteogenesis_imperfecta,
        :x_linked_recessive_disease ;
    :has_definition ""An osteogenesis imperfecta characterized by prenatal fractures and generalized osteopenia, with severe short stature in adulthood, variable scoliosis and pectal deformity, and marked anterior angulation of the tibia that has_material_basis_in hemizygous mutation in MBTPS2 on chromosome Xp22.12."" ;
    :has_exact_synonym ""OI19"",
        ""osteogenesis imperfecta type XIX"" .

","Osteogenesis imperfecta type 19 is a type of X-linked recessive disease and a subtype of osteogenesis imperfecta, which is characterized by having a material basis in some X-linked recessive inheritance. It is defined by prenatal fractures and generalized osteopenia, resulting in severe short stature in adulthood, variable scoliosis and pectus deformity, and notable anterior angulation of the tibia. This condition has its material basis in a hemizygous mutation in the MBTPS2 gene located on chromosome Xp22.12. Additionally, osteogenesis imperfecta type 19 is precisely referred to as OI19 and osteogenesis imperfecta type XIX.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111848,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:osteogenesis_imperfecta_type_18 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :osteogenesis_imperfecta ;
    :has_definition ""An osteogenesis imperfecta characterized by congenital bowing of the long bones, wormian bones, blue sclerae, vertebral collapse, and multiple fractures in the first years of life that has_material_basis_in homozygous or compound heterozygous mutation in TENT5A on chromosome 6q14.1."" ;
    :has_exact_synonym ""OI18"",
        ""osteogenesis imperfecta, type XVIII"" .

","Osteogenesis imperfecta type 18 (OI18), also known precisely as osteogenesis imperfecta, type XVIII, is categorized within the broader classification of autosomal recessive diseases and is specifically a variant of osteogenesis imperfecta. This particular type of osteogenesis imperfecta is characterized by congenital bowing of the long bones, wormian bones, blue sclerae, vertebral collapse, and multiple fractures occurring in the first years of life. The material basis for this condition is identified as being either homozygous or compound heterozygous mutations in the TENT5A gene located on chromosome 6q14.1. Furthermore, osteogenesis imperfecta type 18 exemplifies a condition that fundamentally arises from some form of autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111849,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:osteogenesis_imperfecta_type_20 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :osteogenesis_imperfecta ;
    :has_definition ""An osteogenesis imperfecta characterized by osteopenia, skeletal deformity, and both healed and new fractures on radiography that has_material_basis_in homozygous or compound heterozygous mutation in MESD on chromosome 15q25.1."" ;
    :has_exact_synonym ""OI20"",
        ""osteogenesis imperfecta type XX"" .

","Osteogenesis imperfecta type 20 (OI20), also known exactly as osteogenesis imperfecta type XX, is a specific form of osteogenesis imperfecta and an autosomal recessive disease. It is characterized by osteopenia, skeletal deformity, and the presence of both healed and new fractures visible on radiography. The condition specifically arises from homozygous or compound heterozygous mutations in the MESD gene located on chromosome 15q25.1. This type of osteogenesis imperfecta inherently has a material basis in autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111850,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_36 rdfs:subClassOf :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by absence of outer dynein arms, defects in inner dynein arms, chronic airway disease and recurrent sinopulmonary infections, male infertility, and laterality defects in about half of patients that has_material_basis_in hemizygous mutation in the PIH1D3 gene on chromosome Xq22.3."" ;
    :has_exact_synonym ""CILD36"",
        ""X-linked primary ciliary dyskinesia 36"" .

","Primary ciliary dyskinesia 36 is a type of primary ciliary dyskinesia characterized by the absence of outer dynein arms, defects in inner dynein arms, chronic airway disease, recurrent sinopulmonary infections, male infertility, and laterality defects in about half of the patients. This condition is attributed to a hemizygous mutation in the PIH1D3 gene located on chromosome Xq22.3. It is also known by its exact synonyms, CILD36 and X-linked primary ciliary dyskinesia 36.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111851,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_44 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by recurrent sinopulmonary infections, defective mucociliary clearance, short respiratory epithelial cell motile cilia with decreased motility, and absence of situs inversus that has_material_basis_in homozygous or compound heterozygous mutation in the NEK10 gene on chromosome 3p24.1."" ;
    :has_exact_synonym ""CILD44"",
        ""primary ciliary dyskinesia 44 without situs inversus"" .

","Primary ciliary dyskinesia 44 (CILD44) is a type of autosomal recessive disease and a specific form of primary ciliary dyskinesia. It is defined as a primary ciliary dyskinesia characterized by recurrent sinopulmonary infections, defective mucociliary clearance, short respiratory epithelial cell motile cilia with decreased motility, and the absence of situs inversus. This condition has a material basis in homozygous or compound heterozygous mutation in the NEK10 gene on chromosome 3p24.1. Additionally, primary ciliary dyskinesia 44 is exactly synonymous with primary ciliary dyskinesia 44 without situs inversus, indicating that it is a type of condition that at least has a material basis in some form of autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111852,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_38 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by significant loss of both the inner and outer dynein arms, chronic airway disease, recurrent sinopulmonary infections, and laterality defects in about half of patients that has_material_basis_in homozygous or compound heterozygous mutation in the CFAP300 gene on chromosome 11q22.1."" ;
    :has_exact_synonym ""CILD38"",
        ""primary ciliary dyskinesia 38 with or without situs inversus"" .

","Primary Ciliary Dyskinesia 38 (PCD38) is a specific form of Primary Ciliary Dyskinesia and an autosomal recessive disease. It shares the characteristic of having a material basis in autosomal recessive inheritance. PCD38 is defined as a Primary Ciliary Dyskinesia characterized by significant loss of both the inner and outer dynein arms, chronic airway disease, recurrent sinopulmonary infections, and laterality defects in about half of the patients. This condition is caused by homozygous or compound heterozygous mutation in the CFAP300 gene located on chromosome 11q22.1. It is also precisely referred to as CILD38 and Primary Ciliary Dyskinesia 38 with or without situs inversus.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111853,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_40 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by a subtle defect in the bend of the distal portion of the cilia, reduced ciliary clearance in-vitro, relatively mild respiratory phenotype and laterality defects in all reported patients that has_material_basis_in homozygous or compound heterozygous mutation in the DNAH9 gene on chromosome 17p12."" ;
    :has_exact_synonym ""CILD40"",
        ""primary ciliary dyskinesia 40 with or without situs inversus"" .

","Primary Ciliary Dyskinesia 40 (PCD40) is an autosomal recessive disease classified under primary ciliary dyskinesia and is characterized by a specific type of material basis in autosomal recessive inheritance. It is defined as a primary ciliary dyskinesia characterized by a subtle defect in the bend of the distal portion of the cilia, reduced ciliary clearance in-vitro, a relatively mild respiratory phenotype, and laterality defects in all reported patients. This condition has its material basis in homozygous or compound heterozygous mutation in the DNAH9 gene on chromosome 17p12. PCD40 is also exactly synonymous with CILD40 and primary ciliary dyskinesia 40 with or without situs inversus.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111854,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_39 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by ciliary kinetic defects in some patients, chronic sinopulmonary infections beginning soon after birth and laterality defects in about half of patients that has_material_basis_in homozygous or compound heterozygous mutation in the LRRC56 gene on chromosome 11p15.5."" ;
    :has_exact_synonym ""CILD39"",
        ""primary ciliary dyskinesia 39 with or without situs inversus"" .

","Primary ciliary dyskinesia 39 (CILD39), also known exactly as primary ciliary dyskinesia 39 with or without situs inversus, is a type of autosomal recessive disease and a specific kind of primary ciliary dyskinesia. This condition is characterized by its autosomal recessive inheritance nature and has a material basis in homozygous or compound heterozygous mutation in the LRRC56 gene on chromosome 11p15.5. It is defined by features including ciliary kinetic defects in some patients, chronic sinopulmonary infections beginning soon after birth, and laterality defects in about half of the patients.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111855,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_42 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by severe reduction or absence of multiple motile cilia in respiratory epithelia, onset of respiratory insufficiency soon after birth, recurrent upper and lower respiratory infections, and absence of laterality defects that has_material_basis_in homozygous or compound heterozygous mutation in the MCIDAS gene on chromosome 5q11.2."" ;
    :has_exact_synonym ""CILD42"",
        ""primary ciliary dyskinesia 42 without situs inversus"" .

","Primary ciliary dyskinesia 42 (CILD42), also known exactly as primary ciliary dyskinesia 42 without situs inversus, is a type of autosomal recessive disease, which falls under the broader category of primary ciliary dyskinesia. This specific condition is characterized by a severe reduction or absence of multiple motile cilia in respiratory epithelia, leading to respiratory insufficiency soon after birth, recurrent upper and lower respiratory infections, and the absence of laterality defects. This condition has its material basis in homozygous or compound heterozygous mutations in the MCIDAS gene located on chromosome 5q11.2. It is also noted as a type of disorder that inherently has a material basis in some form of autosomal recessive inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111856,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_43 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by reduced generation of multiple motile cilia, onset of respiratory insufficiency soon after birth, recurrent upper and lower respiratory infections,variable infertility, and laterality defects in about half of patients that has_material_basis_in heterozygous mutation in FOXJ1 on chromosome 17q25.1."" ;
    :has_exact_synonym ""CILD43"",
        ""primary ciliary dyskinesia 43 with or without situs inversus"" .

","Primary Ciliary Dyskinesia 43 (PCD43), also known exactly as CILD43 and Primary Ciliary Dyskinesia 43 with or without situs inversus, is a type of autosomal dominant disease, specifically a form of Primary Ciliary Dyskinesia. It is characterized by a condition that fundamentally arises from autosomal dominant inheritance and is defined by a reduced generation of multiple motile cilia, respiratory insufficiency that begins soon after birth, recurrent upper and lower respiratory infections, variable infertility, and laterality defects in approximately half of the patients. This condition has its material basis in a heterozygous mutation in the FOXJ1 gene located on chromosome 17q25.1.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111857,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_45 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by absence of inner dynein arms with some axonemal disorganization in airway epithelial cells, absence of both inner and outer dynein arms in sperm from infertile male patients, recurrent sinopulmonary infections, defective mucociliary clearance, and absence of laterality defects that has_material_basis_in homozygous or compound heterozygous mutation in the TTC12 gene on chromosome 11q23.2."" ;
    :has_exact_synonym ""CILD45"",
        ""primary ciliary dyskinesia 45 without situs inversus"" .

","Primary Ciliary Dyskinesia 45 (PCD45) is a specific type of Primary Ciliary Dyskinesia and an autosomal recessive disease, which inherently means it has a material basis in autosomal recessive inheritance. PCD45 is defined by the absence of inner dynein arms with some axonemal disorganization in airway epithelial cells, the absence of both inner and outer dynein arms in sperm from infertile male patients, recurrent sinopulmonary infections, defective mucociliary clearance, and the absence of laterality defects. This condition is due to homozygous or compound heterozygous mutation in the TTC12 gene on chromosome 11q23.2. Moreover, PCD45 is precisely synonymous with CILD45 and also referred to as Primary Ciliary Dyskinesia 45 without situs inversus.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111858,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:primary_ciliary_dyskinesia_41 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_ciliary_dyskinesia ;
    :has_definition ""A primary ciliary dyskinesia characterized by hyperkinetic ciliary beat patterns, defects in ciliary orientation, chronic sinusitis, otitis media, and bronchiectasis that has_material_basis_in homozygous or compound heterozygous mutation in the GAS2L2 gene on chromosome 17q12."" ;
    :has_exact_synonym ""CILD41"" .

","Primary Ciliary Dyskinesia 41 (PCD41), also known exactly as CILD41, is a specific form of Primary Ciliary Dyskinesia and falls under the broader category of autosomal recessive diseases. It is defined as a type of disorder characterized by hyperkinetic ciliary beat patterns, defects in ciliary orientation, chronic sinusitis, otitis media, and bronchiectasis. This condition has its material basis in homozygous or compound heterozygous mutations in the GAS2L2 gene located on chromosome 17q12, illustrating an autosomal recessive inheritance pattern.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111859,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:midface_hypoplasia_hearing_impairment_elliptocytosis_and_nephrocalcinosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :syndrome,
        :x_linked_recessive_disease ;
    :has_definition ""A syndrome characterized by midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis that has_material_basis_in hemizygous mutation in the AMMECR1 gene on chromosome Xq23."" ;
    :has_exact_synonym ""MFHIEN"" .

","Midface hypoplasia hearing impairment elliptocytosis and nephrocalcinosis is a syndrome and a type of X-linked recessive disease that is characterized by midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis. It has a material basis in a hemizygous mutation in the AMMECR1 gene on chromosome Xq23. This condition is also precisely known as MFHIEN.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111860,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:amme_complex rdfs:subClassOf [ owl:intersectionOf [ rdf:first [ a owl:Restriction ;
                            owl:onProperty :has_material_basis_in ;
                            owl:someValuesFrom :deletion ] ;
                    rdf:rest [ rdf:first [ a owl:Restriction ;
                                    owl:onProperty :has_material_basis_in ;
                                    owl:someValuesFrom :chromosome ] ;
                            rdf:rest :nil ] ] ],
        :chromosomal_deletion_syndrome,
        :syndrome ;
    :has_definition ""A syndrome characterized by Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis that has_material_basis_in hemizygous deletion of multiple genes including COL4A5, FACL4 and AMMECR1 on chromosome Xq22.3."" ;
    :has_exact_synonym ""AMME syndrome"",
        ""ATS-MR"",
        ""Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome"",
        ""chromosome Xq22.3 telomeric deletion syndrome"" .

","The Amme complex is a type of chromosomal deletion syndrome, which is a subtype of syndrome. It specifically intersects with conditions that at least have a material basis in some deletion and some chromosome. The Amme complex is defined as a syndrome characterized by Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis, having its material basis in the hemizygous deletion of multiple genes including COL4A5, FACL4, and AMMECR1 on chromosome Xq22.3. Moreover, the Amme complex is precisely synonymous with AMME syndrome, ATS-MR, Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome, and chromosome Xq22.3 telomeric deletion syndrome.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111861,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:meester_loeys_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :syndrome,
        :x_linked_monogenic_disease ;
    :has_definition ""A syndrome characterized by early-onset aortic aneurysm and dissection in hemizygous males and variable presentation from unaffected to fatal aortic dissection in heterozygous females, as well as facial dysmorphism, connective tissue anomalies, and features of Loeys-Dietz syndrome that has_material_basis_in mutation in BGN on chromosome Xq28."" ;
    :has_exact_synonym ""MRLS"" .

","Meester Loeys Syndrome (MRLS) is a type of syndrome that falls under the category of X-linked monogenic diseases and is something that inherently has a material basis in some form of X-linked inheritance. It is defined as a syndrome characterized by an early-onset of aortic aneurysm and dissection in hemizygous males, with a variable presentation in heterozygous females ranging from unaffected to fatal aortic dissection. Additionally, individuals with this syndrome may exhibit facial dysmorphism, connective tissue anomalies, and features of Loeys-Dietz Syndrome, all of which have a material basis in a mutation in the BGN gene located on chromosome Xq28.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111862,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:congenital_bilateral_absence_of_vas_deferens rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :male_infertility,
        :physical_disorder,
        :x_linked_monogenic_disease ;
    :has_definition ""A male infertility that is characterized by bilateral absence of the vas deferens resulting in obstroctive azoospermia and male infertility."" ;
    :has_exact_match ""OMIM:PS277180"" ;
    :has_exact_synonym ""CAVD"",
        ""CBAVD"",
        ""congenital bilateral agenesis of vas deferens"",
        ""congenital bilateral aplasia of vas deferens"" .

","Congenital Bilateral Absence of Vas Deferens (CBAVD) is a type of male infertility, physical disorder, and X-linked monogenic disease. It is characterized by the bilateral absence of the vas deferens, leading to obstructive azoospermia and male infertility. This condition has a material basis at least in part in X-linked inheritance and is rooted in some abnormality of prenatal development or birth. CBAVD is also known by its exact synonyms: CAVD, congenital bilateral agenesis of vas deferens, and congenital bilateral aplasia of vas deferens. Additionally, it has an exact match in the OMIM database with the identifier PS277180.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111863,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_congenital_bilateral_absence_of_vas_deferens rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :congenital_bilateral_absence_of_vas_deferens ;
    :has_definition ""A congenital bilateral absence of vas deferens that has_material_basis_in mutation in the ADGRG2 gene on chromosome Xp22.13."" ;
    :has_exact_synonym ""CBAVDX"" .

","X-linked congenital bilateral absence of vas deferens is a type of congenital bilateral absence of vas deferens and also falls under the category of diseases that have their basis in abnormalities of prenatal development or birth. It is defined as a congenital bilateral absence of vas deferens that has its material basis in a mutation in the ADGRG2 gene on chromosome Xp22.13. Additionally, it is exactly synonymous with CBAVDX.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111864,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_congenital_bilateral_absence_of_vas_deferens rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        :autosomal_recessive_disease,
        :congenital_bilateral_absence_of_vas_deferens ;
    :has_definition ""A congenital bilateral absence of vas deferens that has_material_basis_in homozygous or compound heterozygous mutation in the CFTR gene on chromosome 7q31.2."" .

",Autosomal recessive congenital bilateral absence of vas deferens is a form of autosomal recessive disease and a specific type of congenital bilateral absence of vas deferens. It is characterized by having a material basis in autosomal recessive inheritance and is associated with abnormalities of prenatal development or birth. The condition is defined as a congenital bilateral absence of vas deferens that results from homozygous or compound heterozygous mutations in the CFTR gene located on chromosome 7q31.2.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111865,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mend_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :lipid_metabolism_disorder,
        :x_linked_recessive_disease ;
    :has_definition ""A lipid metabolism disorder characterized by a defect in sterol biosynthesis that results in variable features including intellectual disability, short stature, scoliosis, digital abnormalities, cataracts, and dermatologic abnormalities that has_material_basis_in hemizygous mutation in EBP on chromosome Xp11.23."" ;
    :has_exact_synonym ""male EBP disorder with neurological defects"" .

","Mend syndrome is a type of X-linked recessive disease and a lipid metabolism disorder characterized by a defect in sterol biosynthesis, resulting in variable features such as intellectual disability, short stature, scoliosis, digital abnormalities, cataracts, and dermatologic abnormalities. This disorder has its material basis in a hemizygous mutation in the EBP gene located on chromosome Xp11.23. Furthermore, Mend syndrome is also referred to by its exact synonym, ""male EBP disorder with neurological defects."" Additionally, it is a condition that at least has a material basis in some X-linked recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111866,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:trichothiodystrophy rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by sparse, brittle, sulfur-deficient hair that is easily broken and in more severe cases delayed development, significant intellectual disability, and recurrent infections."" ;
    :has_exact_synonym ""TTD"" .

","Trichothiodystrophy is a type of syndrome that is characterized by sparse, brittle, sulfur-deficient hair that is easily broken and, in more severe cases, delayed development, significant intellectual disability, and recurrent infections. Moreover, trichothiodystrophy has an exact synonym, TTD.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111867,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nonphotosensitive_trichothiodystrophy rdfs:subClassOf :trichothiodystrophy ;
    :has_definition ""A trichothiodystrophy characterized by absence of extreme sensitivity to UV radiation."" .

",Nonphotosensitive trichothiodystrophy is a type of trichothiodystrophy characterized by the absence of extreme sensitivity to UV radiation.,2,True
doid,http://purl.obolibrary.org/obo/DOID_0111868,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nonphotosensitive_trichothiodystrophy_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :nonphotosensitive_trichothiodystrophy,
        :x_linked_dominant_disease ;
    :has_definition ""A nonphotosensitive trichothiodystrophy characterized by sparse and brittle hair, facial dysmorphism, global developmental delays, growth deficiency, hypogonadism, and structural brain abnormalities that has_material_basis_in hemizygous mutation in the RNF113A gene on chromosome Xq24."" ;
    :has_exact_synonym ""TTD5"" .

","Nonphotosensitive trichothiodystrophy 5 (TTD5) is a type of X-linked dominant disease and a specific form of nonphotosensitive trichothiodystrophy. It is defined as a nonphotosensitive trichothiodystrophy characterized by sparse and brittle hair, facial dysmorphism, global developmental delays, growth deficiency, hypogonadism, and structural brain abnormalities. The condition's material basis is a hemizygous mutation in the RNF113A gene located on chromosome Xq24. Furthermore, it falls under the category of conditions that have at least a material basis in some X-linked dominant inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111869,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:photosensitive_trichothiodystrophy_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :photosensitive_trichothiodystrophy ;
    :has_definition ""A photosensitive trichothiodystrophy that has_material_basis_in homozygous or compound heterozygous mutation in the ERCC3 gene on chromosome 2q14.3."" ;
    :has_exact_synonym ""TTD2"" .

","Photosensitive trichothiodystrophy 2, which has the exact synonym TTD2, is a type of autosomal recessive disease and a type of photosensitive trichothiodystrophy. It is characterized by a condition that fundamentally involves autosomal recessive inheritance. Specifically, photosensitive trichothiodystrophy 2 is defined as a photosensitive trichothiodystrophy that arises from homozygous or compound heterozygous mutations in the ERCC3 gene located on chromosome 2q14.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111870,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nonphotosensitive_trichothiodystrophy_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :nonphotosensitive_trichothiodystrophy ;
    :has_definition ""A nonphotosensitive trichothiodystrophy characterized by cysteine- and threonine-deficient hair that displays a diagnostic alternating light and dark 'tiger-tail' banding pattern under polarization microscopy, as well as ichthyosis that has_material_basis_in homozygous or compound heterozygous mutation in the TARS1 gene on chromosome 5p13.3."" ;
    :has_exact_synonym ""TTD7"" .

","Nonphotosensitive trichothiodystrophy 7, also precisely known as TTD7, is categorized under autosomal recessive diseases and is a specific form of nonphotosensitive trichothiodystrophy. It is defined by its unique characteristics, including cysteine- and threonine-deficient hair, which exhibits a distinctive alternating light and dark 'tiger-tail' banding pattern when observed under polarization microscopy, and ichthyosis. The condition stems from either homozygous or compound heterozygous mutation in the TARS1 gene located on chromosome 5p13.3. This implies that nonphotosensitive trichothiodystrophy 7 fundamentally has its material basis in some form of autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111871,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:photosensitive_trichothiodystrophy_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :photosensitive_trichothiodystrophy ;
    :has_definition ""A photosensitive trichothiodystrophy that has_material_basis_in homozygous or compound heterozygous mutation in the GTF2H5 gene on chromosome 6q25.3."" ;
    :has_exact_synonym ""TTD3"",
        ""trichothiodystrophy complementation group A"" .

","Photosensitive trichothiodystrophy 3, which is also exactly synonymous with TTD3 and trichothiodystrophy complementation group A, is identified as a type of autosomal recessive disease, photosensitive trichothiodystrophy, and something that inherently has a material basis in autosomal recessive inheritance. It is defined as a photosensitive trichothiodystrophy characterized by a material basis in homozygous or compound heterozygous mutation in the GTF2H5 gene located on chromosome 6q25.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111872,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:nonphotosensitive_trichothiodystrophy_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :nonphotosensitive_trichothiodystrophy ;
    :has_definition ""A nonphotosensitive trichothiodystrophy that has_material_basis_in homozygous or compound heterozygous mutation in the GTF2E2 gene on chromosome 8p12."" ;
    :has_exact_synonym ""TTD6"" .

",Nonphotosensitive trichothiodystrophy 6 (TTD6) is a specific type of nonphotosensitive trichothiodystrophy and autosomal recessive disease. It is characterized by conditions that essentially have a material basis in autosomal recessive inheritance. This particular condition is defined by nonphotosensitive trichothiodystrophy that arises from homozygous or compound heterozygous mutations in the GTF2E2 gene located on chromosome 8p12.,5,True
doid,http://purl.obolibrary.org/obo/DOID_0111873,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:photosensitive_trichothiodystrophy_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :photosensitive_trichothiodystrophy ;
    :has_definition ""A photosensitive trichothiodystrophy that has_material_basis_in homozygous or compound heterozygous mutation in the ERCC2 gene on chromosome 19q13.32."" ;
    :has_exact_synonym ""TTD1"" .

","Photosensitive trichothiodystrophy 1, which has the exact synonym TTD1, is a type of autosomal recessive disease and a specific form of photosensitive trichothiodystrophy. It is characterized by a material basis in autosomal recessive inheritance. Moreover, photosensitive trichothiodystrophy 1 is defined as a photosensitive trichothiodystrophy that has its material basis in homozygous or compound heterozygous mutation in the ERCC2 gene located on chromosome 19q13.32.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111874,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:sabinas_brittle_hair_syndrome rdfs:subClassOf :nonphotosensitive_trichothiodystrophy ;
    :has_definition ""A nonphotosensitive trichothiodystrophy characterized by congenital hypotrichosis, mild to moderate onychodysplasia, varying intellectual disability, and sterility."" ;
    :has_exact_synonym ""brittle hair-mental deficiency syndrome"",
        ""trichothiodystrophy type B"" .

","Sabinas brittle hair syndrome is a type of nonphotosensitive trichothiodystrophy characterized by congenital hypotrichosis, mild to moderate onychodysplasia, varying intellectual disability, and sterility. It is also exactly synonymous with brittle hair-mental deficiency syndrome and trichothiodystrophy type B.",4,True
doid,http://purl.obolibrary.org/obo/DOID_0111875,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:mls_syndrome rdfs:subClassOf :syndrome ;
    :has_definition ""A syndrome characterized by linear skin defects and various other congenital anomalies. The classical diagnosis consisted of unilateral or bilateral microphthalmia and/or anophthalmia and linear skin defects but patients with a molecular diagnosis of MLS syndrome may not display eye abnormalities."" ;
    :has_exact_synonym ""linear skin defects with multiple congenital anomalies"" .

","MLS syndrome is a type of syndrome characterized by linear skin defects and various other congenital anomalies. The classical diagnosis of MLS syndrome consisted of unilateral or bilateral microphthalmia and/or anophthalmia and linear skin defects, but patients with a molecular diagnosis of MLS syndrome may not display eye abnormalities. It is also known by its exact synonym, linear skin defects with multiple congenital anomalies.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111876,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:linear_skin_defects_with_multiple_congenital_anomalies_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :mls_syndrome,
        :physical_disorder,
        :x_linked_dominant_disease ;
    :has_definition ""A linear skin defects with multiple congenital anomalies characterized by linear skin defects, cardiomyopathy, and various other congenital anomalies that has_material_basis_in heterozygous mutation in the NDUFB11 gene on chromosome Xp11.3."" ;
    :has_exact_synonym ""LSDMCA3"",
        ""linear skin defects with cardiomyopathy and other congenital anomalies"" .

","Linear Skin Defects with Multiple Congenital Anomalies 3 (LSDMCA3), also known as Linear Skin Defects with Cardiomyopathy and Other Congenital Anomalies, is a type of physical disorder and a form of MLS syndrome that falls under the category of X-linked dominant diseases. This condition is characterized by linear skin defects, cardiomyopathy, and various other congenital anomalies, with its material basis in a heterozygous mutation in the NDUFB11 gene on chromosome Xp11.3. It is considered a disease with its basis in some abnormality of prenatal development or birth, and it at least has a material basis in some X-linked dominant inheritance.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111877,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:linear_skin_defects_with_multiple_congenital_anomalies_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_dominant_inheritance ],
        :mls_syndrome,
        :physical_disorder,
        :x_linked_dominant_disease ;
    :has_definition ""A linear skin defects with multiple congenital anomalies characterized by linear skin defects, microcephaly, facial dysmorphism, and other congenital anomalies that has_material_basis_in heterozygous mutation in the COX7B gene on chromosome Xq21.1."" ;
    :has_exact_synonym ""APLCC"",
        ""LSDMCA2"",
        ""aplasia cutis congenita, reticulolinear, with microcephaly, facial dysmorphism, and other congenital anomalies"" .

","Linear Skin Defects with Multiple Congenital Anomalies 2 (LSDMCA2) is a type of physical disorder, also known as an X-linked dominant disease, and falls under the category of MLS syndrome. It is characterized by having a material basis in X-linked dominant inheritance and its disease basis lies in some abnormality of prenatal development or birth. Specifically, LSDMCA2 is defined by linear skin defects, microcephaly, facial dysmorphism, and other congenital anomalies due to a heterozygous mutation in the COX7B gene on chromosome Xq21.1. Additionally, LSDMCA2 is synonymous with APLCC, LSDMCA2, and Aplasia Cutis Congenita, reticulolinear, with microcephaly, facial dysmorphism, and other congenital anomalies.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111878,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_7 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL11 gene on chromosome 1p36.11."" ;
    :has_exact_synonym ""DBA7"",
        ""RPL11-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 7 (DBA7), also known as RPL11-related Diamond-Blackfan Anemia, is a type of Diamond Blackfan Anemia and an autosomal dominant disease. It is characterized by a specific type that has its material basis in autosomal dominant inheritance. DBA7 is defined by a Diamond-Blackfan Anemia that arises from a heterozygous mutation in the RPL11 gene located on chromosome 1p36.11.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111879,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_6 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL5 gene on chromosome 1p22.1."" ;
    :has_exact_synonym ""DBA6"",
        ""RPL5-related Diamond-Blackfan anemia"" .

",Diamond Blackfan Anemia 6 is a type of Diamond Blackfan Anemia and an autosomal dominant disease that at least has a material basis in some autosomal dominant inheritance. It is defined as a Diamond-Blackfan anemia that has its material basis in a heterozygous mutation in the RPL5 gene on chromosome 1p22.1. Diamond Blackfan Anemia 6 is exactly synonymized with DBA6 and RPL5-related Diamond-Blackfan anemia.,6,True
doid,http://purl.obolibrary.org/obo/DOID_0111880,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_17 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS27 gene on chromosome 1q21.3."" ;
    :has_exact_synonym ""DBA17"",
        ""RPS27-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 17, which is an autosomal dominant disease and a type of Diamond Blackfan anemia, has a material basis in autosomal dominant inheritance. This specific anemia, DBA17, also known as RPS27-related Diamond-Blackfan anemia, is defined by a heterozygous mutation in the RPS27 gene located on chromosome 1q21.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111881,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_8 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS7 gene on chromosome 2p25.3."" ;
    :has_exact_synonym ""DBA8"",
        ""RPS7-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 8 (DBA8), also known as RPS7-related Diamond-Blackfan Anemia, is a type of Diamond Blackfan Anemia and an autosomal dominant disease. It specifically relates to something that fundamentally arises from autosomal dominant inheritance. DBA8 is defined by a Diamond-Blackfan Anemia that has its material basis in a heterozygous mutation in the RPS7 gene located on chromosome 2p25.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111882,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_12 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL15 gene on chromosome 3p24.2."" ;
    :has_exact_synonym ""DBA12"",
        ""RPL15-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 12 is a type of autosomal dominant disease and a specific form of Diamond Blackfan Anemia, which inherently has a material basis in autosomal dominant inheritance. It is defined as a Diamond-Blackfan anemia that has a material basis in a heterozygous mutation in the RPL15 gene on chromosome 3p24.2. Additionally, Diamond Blackfan Anemia 12 is exactly synonymous with DBA12 and RPL15-related Diamond-Blackfan anemia.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111883,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_5 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL35A gene on chromosome 3q29."" ;
    :has_exact_synonym ""DBA5"",
        ""RPL35A-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 5 is a type of autosomal dominant disease and a specific form of Diamond Blackfan Anemia, characterized as a condition that inherently has a material basis in autosomal dominant inheritance. It is defined by a Diamond-Blackfan anemia that originates from a heterozygous mutation in the RPL35A gene located on chromosome 3q29. Furthermore, Diamond Blackfan Anemia 5 is exactly synonymous with DBA5 and RPL35A-related Diamond-Blackfan anemia.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111884,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_9 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS10 gene on chromosome 6p21.31."" ;
    :has_exact_synonym ""DBA9"",
        ""RPS10-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 9 (DBA9), also known as RPS10-related Diamond-Blackfan anemia, is a type of autosomal dominant disease and a specific form of Diamond Blackfan Anemia. This condition fundamentally arises from a heterozygous mutation in the RPS10 gene located on chromosome 6p21.31. Additionally, it is characterized as a type of disorder that inherently possesses a material basis in some form of autosomal dominant inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111885,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_2 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in mutation in a region of chromosome 8p23.3-p22."" ;
    :has_exact_synonym ""DBA2"" .

","Diamond Blackfan Anemia 2 (DBA2) is a type of Diamond Blackfan Anemia and an autosomal dominant disease, which means it is a type of condition that at least has a material basis in some form of autosomal dominant inheritance. Specifically, DBA2 is defined as a Diamond-Blackfan anemia that has its material basis in a mutation in a region of chromosome 8p23.3-p22. Additionally, it has an exact synonym, DBA2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111886,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_19 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL35 gene on chromosome 9q33.3."" ;
    :has_exact_synonym ""DBA19"",
        ""RPL35-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 19 is a type of autosomal dominant disease and a specific form of Diamond Blackfan Anemia, which inherently has a material basis in some autosomal dominant inheritance. It is defined as a Diamond-Blackfan anemia that is caused by a heterozygous mutation in the RPL35 gene on chromosome 9q33.3. This condition is exactly synonymous with DBA19 and RPL35-related Diamond-Blackfan anemia.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111887,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_3 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS24 gene on chromosome 10q22.3."" ;
    :has_exact_synonym ""DBA3"",
        ""RPS24-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 3 (DBA3), also known as RPS24-related Diamond-Blackfan anemia, is a type of autosomal dominant disease and a specific form of Diamond Blackfan anemia. It is characterized by having a material basis in autosomal dominant inheritance. DBA3 is defined by a heterozygous mutation in the RPS24 gene located on chromosome 10q22.3.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111888,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_10 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS26 gene on chromosome 12q13.2."" ;
    :has_exact_synonym ""DBA10"",
        ""RPS26-related Diamond-Blackfan anemia"" .

","Diamond Blackfan anemia 10 is a type of Diamond Blackfan anemia and an autosomal dominant disease. It is characterized by a specific kind that has a material basis in autosomal dominant inheritance. This particular form of Diamond-Blackfan anemia, also known as DBA10 or RPS26-related Diamond-Blackfan anemia, is defined by a heterozygous mutation in the RPS26 gene located on chromosome 12q13.2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111889,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_13 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS29 gene on chromosome 14q21.3."" ;
    :has_exact_synonym ""DBA13"",
        ""RPS29-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 13 is a type of autosomal dominant disease, which is a subtype of Diamond Blackfan Anemia and is characterized by having a material basis in autosomal dominant inheritance. It is defined as a Diamond-Blackfan anemia that has a material basis in a heterozygous mutation in the RPS29 gene on chromosome 14q21.3. Additionally, Diamond Blackfan Anemia 13 has exact synonyms, including DBA13 and RPS29-related Diamond-Blackfan anemia.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111890,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_4 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS17 gene on chromosome 15q25.2."" ;
    :has_exact_synonym ""DBA4"",
        ""RPS17-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 4 (DBA4), also known as RPS17-related Diamond-Blackfan anemia, is a type of Diamond Blackfan anemia and an autosomal dominant disease. It is characterized by a heterozygous mutation in the RPS17 gene located on chromosome 15q25.2. This condition is a specific instance of a broader category of diseases that have a material basis in some form of autosomal dominant inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111891,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_20 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS15A gene on chromosome 16p12.3."" ;
    :has_exact_synonym ""DBA20"",
        ""RPS15A-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 20 (DBA20) is a type of Diamond Blackfan Anemia and an autosomal dominant disease that at least has a material basis in some autosomal dominant inheritance. It is specifically defined as a Diamond-Blackfan anemia that has a material basis in heterozygous mutation in the RPS15A gene on chromosome 16p12.3. Additionally, DBA20 has exact synonyms, including ""DBA20"" and ""RPS15A-related Diamond-Blackfan anemia.""",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111892,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_11 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL26 gene on chromosome 17p13.1."" ;
    :has_exact_synonym ""DBA11"",
        ""RPL26-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 11 (DBA11) is a type of Diamond Blackfan Anemia and an autosomal dominant disease, which specifically has a material basis in autosomal dominant inheritance. It is defined as a Diamond-Blackfan anemia that has its material basis in a heterozygous mutation in the RPL26 gene on chromosome 17p13.1. DBA11 is also exactly synonymous with RPL26-related Diamond-Blackfan anemia.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111893,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL27 gene on chromosome 17q21.31."" ;
    :has_exact_synonym ""DBA16"",
        ""RPL27-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 16 is a type of Diamond Blackfan Anemia and an autosomal dominant disease that, at least in part, has its material basis in some form of autosomal dominant inheritance. It is defined as a Diamond-Blackfan anemia that has its material basis in a heterozygous mutation in the RPL27 gene on chromosome 17q21.31. Furthermore, Diamond Blackfan Anemia 16 is exactly synonymous with DBA16 and RPL27-related Diamond-Blackfan anemia.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111894,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_15_with_mandibulofacial_dysostosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia characterized by Diamond-Blackfan anemia and mandibulofacial dysostosis (micrognathia, downslanting palpebral fissures, submucosal cleft palate or bifid uvula, and malar hypoplasia) that has_material_basis_in heterozygous mutation in the RPS28 gene on chromosome 19p13.2."" ;
    :has_exact_synonym ""DBA15"" .

","Diamond Blackfan Anemia 15 with Mandibulofacial Dysostosis, also known exactly as DBA15, is a type of Diamond Blackfan Anemia and a specific autosomal dominant disease. This condition is characterized by features of Diamond-Blackfan anemia combined with mandibulofacial dysostosis, which includes micrognathia, downslanting palpebral fissures, a submucosal cleft palate or bifid uvula, and malar hypoplasia. The underlying cause of DBA15 is a heterozygous mutation in the RPS28 gene located on chromosome 19p13.2. Moreover, it is considered a type of condition that fundamentally has a material basis in some form of autosomal dominant inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111895,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_1 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPS19 gene on chromosome 19q13.2."" ;
    :has_exact_synonym ""DBA1"",
        ""RPS19-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 1 (DBA1), also known as RPS19-related Diamond-Blackfan Anemia, is a specific type of Diamond Blackfan Anemia and a form of autosomal dominant disease. It is defined by having a material basis in at least some form of autosomal dominant inheritance, specifically through a heterozygous mutation in the RPS19 gene located on chromosome 19q13.2.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111896,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_18 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :diamond_blackfan_anemia ;
    :has_definition ""A Diamond-Blackfan anemia that has_material_basis_in heterozygous mutation in the RPL18 gene on chromosome 19q13.33."" ;
    :has_exact_synonym ""DBA18"",
        ""RPL18-related Diamond-Blackfan anemia"" .

","Diamond Blackfan Anemia 18 (DBA18), also known precisely as RPL18-related Diamond-Blackfan anemia, is a type of autosomal dominant disease and a specific form of Diamond Blackfan anemia. It is characterized by a condition that fundamentally arises from autosomal dominant inheritance. DBA18 is defined by a Diamond-Blackfan anemia that is due to a heterozygous mutation in the RPL18 gene located on chromosome 19q13.33.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111897,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:diamond_blackfan_anemia_14_with_mandibulofacial_dysostosis rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :diamond_blackfan_anemia,
        :x_linked_recessive_disease ;
    :has_definition ""A Diamond-Blackfan anemia characterized by Diamond-Blackfan anemia, bilateral microtia, and cleft palate that has_material_basis_in hemizygous mutation in the TSR2 gene on chromosome Xp11.22."" ;
    :has_exact_synonym ""DBA14"" .

","Diamond Blackfan Anemia 14 with Mandibulofacial Dysostosis, also known precisely as DBA14, is a specific type of Diamond Blackfan Anemia. It is characterized by the features of Diamond-Blackfan anemia, including bilateral microtia and cleft palate, which result from a hemizygous mutation in the TSR2 gene located on chromosome Xp11.22. This condition falls under the category of X-linked recessive diseases, indicating that its material basis involves some form of X-linked recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111898,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:ck_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :lipid_metabolism_disorder,
        :x_linked_recessive_disease ;
    :has_definition ""A lipid metabolism disorder characterized by increased methylsterol levels in cells and cerebrospinal fluid, mild to severe cognitive impairment, seizures, microcephaly, cerebral cortical malformations, dysmorphic facial features, and thin body habitus that has_material_basis_in hemizygous mutation in the NSDHL gene on chromosome Xq28."" ;
    :has_exact_synonym ""X-linked intellectual disability-microcephaly-cortical malformation-thin habitus syndrome"" .

","CK syndrome is a type of X-linked recessive disease and a lipid metabolism disorder, which implies that it has a material basis in some X-linked recessive inheritance. It is defined as a lipid metabolism disorder characterized by increased methylsterol levels in cells and cerebrospinal fluid, along with mild to severe cognitive impairment, seizures, microcephaly, cerebral cortical malformations, dysmorphic facial features, and thin body habitus. This disorder has its material basis in a hemizygous mutation in the NSDHL gene on chromosome Xq28. Additionally, CK syndrome has the exact synonym ""X-linked intellectual disability-microcephaly-cortical malformation-thin habitus syndrome.""",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111899,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:x_linked_thrombophilia_due_to_factor_ix_defect rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_inheritance ],
        :thrombophilia,
        :x_linked_monogenic_disease ;
    :has_definition ""A thrombophilia characterized by normal levels of F9 antigen, but very high levels of F9 activity that has_material_basis_in hemizygous gain of function mutation in F9 on chromosome Xq27.1."" ;
    :has_exact_synonym ""THPH8"" .

","X-linked thrombophilia due to factor IX defect is a type of thrombophilia and a specific form of X-linked monogenic disease, which falls under the broader category of conditions that have a material basis in some form of X-linked inheritance. This thrombophilia is defined by normal levels of F9 antigen but very high levels of F9 activity, attributed to a hemizygous gain of function mutation in the F9 gene located on chromosome Xq27.1. Furthermore, X-linked thrombophilia due to factor IX defect is exactly synonymous with THPH8.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111900,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_thrombophilia_due_to_protein_s_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :protein_s_deficiency ;
    :has_definition ""A protein S deficiency characterized by reduced serum protein S levels and recurrent venous thrombosis that has_material_basis_in heterozygous mutation in the PROS1 gene on chromosome 3q11.1."" ;
    :has_exact_synonym ""THPH5"" .

","Autosomal dominant thrombophilia due to protein S deficiency is a type of autosomal dominant disease, a type of protein S deficiency, and a type of condition that at least has a material basis in some autosomal dominant inheritance. It is defined as a protein S deficiency characterized by reduced serum protein S levels and recurrent venous thrombosis that has its material basis in a heterozygous mutation in the PROS1 gene on chromosome 3q11.1. Additionally, it has the exact synonym THPH5.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111901,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:heparin_cofactor_ii_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :thrombophilia ;
    :has_definition ""A thrombophilia characterized by increased risk of thromboembolism that has_material_basis_in heterozygous mutation in the HCF2 gene on chromosome 22q11.21."" ;
    :has_exact_synonym ""HCF 2 deficiency"",
        ""HCF II deficiency"",
        ""THPH10"",
        ""thrombophilia due to heparin cofactor II deficiency"" .

","Heparin cofactor II deficiency is a type of autosomal dominant disease, thrombophilia, and something that at least has a material basis in some autosomal dominant inheritance. It is characterized by an increased risk of thromboembolism, resulting from a heterozygous mutation in the HCF2 gene on chromosome 22q11.21. This condition is also precisely known by several synonyms including HCF 2 deficiency, HCF II deficiency, THPH10, and thrombophilia due to heparin cofactor II deficiency.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111902,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thrombophilia_due_to_activated_protein_c_resistance rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :thrombophilia ;
    :has_definition ""A thrombophilia characterized by resistance of F5 to cleavage and inactivation and increased tendency for thrombosis that has_material_basis_in heterozygous mutation in F5 on chromosome 1q24.2."" ;
    :has_exact_synonym ""APC resistance"",
        ""PCCF deficiency"",
        ""PROC cofactor deficiency"",
        ""THPH2"",
        ""activated protein C resistance"",
        ""thrombophilia V"",
        ""thrombophilia due to deficiency of activated protein C cofactor"" .

","Thrombophilia due to activated protein c resistance is a type of thrombophilia and an autosomal dominant disease that at least has a material basis in some form of autosomal dominant inheritance. This condition is characterized by resistance of F5 to cleavage and inactivation, leading to an increased tendency for thrombosis, which is caused by a heterozygous mutation in F5 on chromosome 1q24.2. It is also known by several exact synonyms, including APC resistance, PCCF deficiency, PROC cofactor deficiency, THPH2, activated protein C resistance, thrombophilia V, and thrombophilia due to deficiency of activated protein C cofactor.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111903,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thrombophilia_due_to_hrg_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :thrombophilia ;
    :has_definition ""A thrombophilia characterized by decreased histidine-rich glycoprotein (HRG) plasma levels and a tendency to develop thrombosis that has_material_basis_in heterozygous mutation in HRG on chromosome 3q27.3."" ;
    :has_exact_synonym ""THPH11"",
        ""hereditary thrombophilia due to congenital HRG deficiency"",
        ""hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency"" .

","Thrombophilia due to HRG deficiency is a type of autosomal dominant disease and a specific form of thrombophilia. It is characterized by a condition that fundamentally has a material basis in some autosomal dominant inheritance. This particular thrombophilia is defined by decreased histidine-rich glycoprotein (HRG) plasma levels and a predisposition to develop thrombosis, which originates from a heterozygous mutation in HRG on chromosome 3q27.3. Additionally, thrombophilia due to HRG deficiency is also known by its exact synonyms: THPH11, hereditary thrombophilia due to congenital HRG deficiency, and hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111904,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_thrombophilia_due_to_protein_c_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :protein_c_deficiency ;
    :has_definition ""A protein C deficiency characterized by typically early onset of venous thrombosis although in some cases it may have a milder, later onset that has_material_basis_in homozygous or compound heterozygous mutation in the PROC gene on chromosome 2q14.3."" ;
    :has_exact_synonym ""THPH4"",
        ""autosomal recessive PROC deficiency"",
        ""autosomal recessive protein C deficiency"" .

","Autosomal recessive thrombophilia due to protein C deficiency is classified as a type of autosomal recessive disease and a type of protein C deficiency. It is also identified as a condition that fundamentally arises from autosomal recessive inheritance. The condition is specifically defined as a protein C deficiency characterized by typically early onset of venous thrombosis, although in some cases, it may have a milder, later onset. This is due to a homozygous or compound heterozygous mutation in the PROC gene located on chromosome 2q14.3. Furthermore, autosomal recessive thrombophilia due to protein C deficiency is precisely synonymous with THPH4, autosomal recessive PROC deficiency, and autosomal recessive protein C deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111905,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_recessive_thrombophilia_due_to_protein_s_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :protein_s_deficiency ;
    :has_definition ""A protein S deficiency characterized by thrombosis and secondary hemorrhage usually beginning in early infancy that has_material_basis_in homozygous or compound heterozygous mutation in the PROS1 gene on chromosome 3q11.1."" ;
    :has_exact_synonym ""THPH6"",
        ""autosomal recessive thrombophilia due to congenital protein S deficiency"",
        ""severe hereditary thrombophilia due to congenital protein S deficiency"" .

","Autosomal recessive thrombophilia due to protein S deficiency is a condition that falls under the category of autosomal recessive diseases, protein S deficiencies, and conditions that inherently have a material basis in autosomal recessive inheritance. This specific protein S deficiency is characterized by thrombosis and secondary hemorrhage, typically beginning in early infancy, and is caused by homozygous or compound heterozygous mutations in the PROS1 gene located on chromosome 3q11.1. Additionally, this condition is also known by its exact synonyms: THPH6, autosomal recessive thrombophilia due to congenital protein S deficiency, and severe hereditary thrombophilia due to congenital protein S deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111906,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thrombophilia_due_to_decreased_release_of_plat rdfs:subClassOf :thrombophilia ;
    :has_definition ""A thrombophilia characterized by impaired capacity for release of fibrinolytic activity from the blood vessel walls."" ;
    :has_exact_synonym ""THPH9"" .

",Thrombophilia due to decreased release of plat is a type of thrombophilia characterized by an impaired capacity for the release of fibrinolytic activity from the blood vessel walls. It is also known by the exact synonym THPH9.,3,True
doid,http://purl.obolibrary.org/obo/DOID_0111907,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thrombophilia_due_to_thrombin_defect rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :thrombophilia ;
    :has_definition ""A thrombophilia characterized by recurrent thrombophilia that has_material_basis_in heterozygous mutation in F2 on chromosome 11p11.2."" ;
    :has_exact_synonym ""THPH1"",
        ""prothrombin-related thrombophilia"",
        ""thrombophilia due to factor 2 defect"" .

","Thrombophilia due to thrombin defect is a specific type of thrombophilia and an autosomal dominant disease, which is defined as a condition characterized by recurrent thrombophilia that arises from a heterozygous mutation in the F2 gene located on chromosome 11p11.2. This condition is also linked to autosomal dominant inheritance at its material basis. It is known by several exact synonyms, including THPH1, prothrombin-related thrombophilia, and thrombophilia due to factor 2 defect.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111908,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:thrombophilia_due_to_thrombomodulin_defect rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_inheritance ],
        :autosomal_genetic_disease,
        :thrombophilia ;
    :has_definition ""A thrombophilia characterized by increased risk of developing arterial but not venous thrombosis that has_material_basis_in mutation in the THBD gene on chromosome 20p11.21."" ;
    :has_exact_synonym ""THBD-related bleeding disorder"",
        ""THBD-related coagulopathy"",
        ""THPH12"",
        ""thrombomodulin-related bleeding disorder"",
        ""thrombomodulin-related coagulopathy"" .

","Thrombophilia due to thrombomodulin defect is an autosomal genetic disease and a specific type of thrombophilia, which is characterized by an increased risk of developing arterial but not venous thrombosis. This condition has a material basis in a mutation in the THBD gene located on chromosome 20p11.21. It is also known by several exact synonyms including THBD-related bleeding disorder, THBD-related coagulopathy, THPH12, thrombomodulin-related bleeding disorder, and thrombomodulin-related coagulopathy.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111909,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:autosomal_dominant_thrombophilia_due_to_protein_c_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :protein_c_deficiency ;
    :has_definition ""A thrombophilia characterized by reduced serum levels or impaired activity of PROC and in some patients recurrent venous thrombosis that has_material_basis_in heterozygous mutation in the PROC gene on chromosome 2q14.3."" ;
    :has_exact_synonym ""THPH3"",
        ""autosomal dominant PROC deficiency"",
        ""autosomal dominant protein C deficiency"" .

","Autosomal dominant thrombophilia due to protein C deficiency is a type of protein C deficiency and represents a form of thrombophilia that at least has a material basis in some autosomal dominant inheritance. This condition is characterized by reduced serum levels or impaired activity of PROC, and in some patients, it leads to recurrent venous thrombosis. The cause of this condition is traced back to a heterozygous mutation in the PROC gene located on chromosome 2q14.3. It is also known by its exact synonyms THPH3, autosomal dominant PROC deficiency, and autosomal dominant protein C deficiency.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111910,"@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure rdfs:subClassOf :male_infertility ;
    :has_definition ""A male infertility characterized by disruption of the process of sperm development from diploid cells into mature haploid spermatozoa."" ;
    :has_exact_synonym ""SPGF"" .

","Spermatogenic failure is a type of male infertility, which is characterized by the disruption of the process of sperm development from diploid cells into mature haploid spermatozoa. It is also known by its exact synonym, SPGF.",3,True
doid,http://purl.obolibrary.org/obo/DOID_0111911,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_34 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, resulting in immotile spermatozoa and infertility that has_material_basis_in homozygous or compound heterozygous mutation in the FSIP2 gene on chromosome 2q32.1."" ;
    :has_exact_synonym ""SPGF34"" .

","Spermatogenic failure 34, which has the exact synonym SPGF34, is a type of spermatogenic failure and an autosomal recessive disease. It is defined as a spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, resulting in immotile spermatozoa and infertility, which has its material basis in homozygous or compound heterozygous mutation in the FSIP2 gene on chromosome 2q32.1. This condition is also described as a type of disorder that at least has a material basis in some form of autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111912,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_41 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by oligozoospermia and multiple morphologic abnormalities of the flagella that has_material_basis_in homozygous or compound heterozygous mutation in the CFAP70 gene on chromosome 10q22.2."" ;
    :has_exact_synonym ""SPGF41"" .

","Spermatogenic failure 41 (SPGF41) is a type of spermatogenic failure, an autosomal recessive disease, and is characterized by oligozoospermia and multiple morphologic abnormalities of the flagella. This condition has a material basis in homozygous or compound heterozygous mutation in the CFAP70 gene on chromosome 10q22.2. It is also defined as a type of condition that at least has a material basis in some autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111913,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_30 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by nonobstructive azoospermia or cryptozoospermia that has_material_basis_in homozygous or compound heterozygous mutation in the TDRD9 gene on chromosome 14q32.33."" ;
    :has_exact_synonym ""SPGF30"" .

","Spermatogenic failure 30, which has the exact synonym SPGF30, is identified as a type of autosomal recessive disease and a specific kind of spermatogenic failure. It is also recognized as something that fundamentally arises from autosomal recessive inheritance. It is characterized by a spermatogenic failure, specifically nonobstructive azoospermia or cryptozoospermia, which has its material basis in homozygous or compound heterozygous mutations in the TDRD9 gene located on chromosome 14q32.33.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111914,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_35 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella resulting in severely impaired sperm motility and infertility that has_material_basis_in homozygous or compound heterozygous mutation in the QRICH2 gene on chromosome 17q25.1."" ;
    :has_exact_synonym ""SPGF35"" .

","Spermatogenic failure 35, also known exactly as SPGF35, is a type of spermatogenic failure and an autosomal recessive disease. It is characterized by a condition that fundamentally has a material basis in some form of autosomal recessive inheritance. Specifically, spermatogenic failure 35 is defined as a spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, resulting in severely impaired sperm motility and infertility. This condition is caused by homozygous or compound heterozygous mutation in the QRICH2 gene located on chromosome 17q25.1.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111915,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_33 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella resulting in immotile spermatozoa and infertility that has_material_basis_in homozygous or compound heterozygous mutation in the WDR66 gene on chromosome 12q24.31."" ;
    :has_exact_synonym ""SPGF33"" .

","Spermatogenic failure 33, which has the exact synonym SPGF33, is a type of autosomal recessive disease and a specific form of spermatogenic failure. It is defined by a spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, resulting in immotile spermatozoa and infertility. This condition has its material basis in homozygous or compound heterozygous mutation in the WDR66 gene located on chromosome 12q24.31. Additionally, spermatogenic failure 33 is described as something that inherently has a material basis in some form of autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111916,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_28 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by nonobstructive azoospermia and a Sertoli cell-only phenotype in testes that has_material_basis_in homozygous or compound heterozygous mutation in the FANCM gene on chromosome 14q21.2."" ;
    :has_exact_synonym ""SPGF28"" .

","Spermatogenic failure 28 is a type of spermatogenic failure, which is an autosomal recessive disease with a material basis in some autosomal recessive inheritance. It is characterized by nonobstructive azoospermia and a Sertoli cell-only phenotype in testes due to homozygous or compound heterozygous mutation in the FANCM gene on chromosome 14q21.2. Additionally, spermatogenic failure 28 is exactly synonymous with SPGF28.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111917,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_43 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella resulting in absence of forward motility in spermatozoa and infertility that has_material_basis_in homozygous or compound heterozygous mutation in the SPEF2 gene on chromosome 5p13.2."" ;
    :has_exact_synonym ""SPGF43"" .

","Spermatogenic failure 43 is a type of autosomal recessive disease and spermatogenic failure, which at least has a material basis in some form of autosomal recessive inheritance. It is characterized by multiple morphologic abnormalities of the flagella, resulting in the absence of forward motility in spermatozoa and infertility. This condition has its material basis in homozygous or compound heterozygous mutation in the SPEF2 gene located on chromosome 5p13.2. Furthermore, spermatogenic failure 43 is exactly synonymous with SPGF43.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111918,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_40 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella resulting in severely reduced to absent sperm motility and abnormalities of the sperm head that has_material_basis_in homozygous or compound heterozygous mutation in the CFAP65 gene on chromosome 2q35."" ;
    :has_exact_synonym ""SPGF40"" .

","Spermatogenic failure 40, which has the exact synonym SPGF40, is a type of autosomal recessive disease and spermatogenic failure. It is also described as something that at least has a material basis in autosomal recessive inheritance. This condition is specifically defined as a spermatogenic failure characterized by multiple morphologic abnormalities of the flagella resulting in severely reduced to absent sperm motility and abnormalities of the sperm head. The condition's material basis is in homozygous or compound heterozygous mutation in the CFAP65 gene on chromosome 2q35.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111919,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_38 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella resulting in infertility and asthenoteratozoospermia that has_material_basis_in homozygous or compound heterozygous mutation in the ARMC2 gene on chromosome 6q21."" ;
    :has_exact_synonym ""SPGF38"" .

","Spermatogenic failure 38 is a type of autosomal recessive disease and spermatogenic failure that at least has its material basis in some form of autosomal recessive inheritance. It is specifically characterized by multiple morphologic abnormalities of the flagella, which result in infertility and asthenoteratozoospermia; this condition has its material basis in homozygous or compound heterozygous mutation in the ARMC2 gene on chromosome 6q21. Furthermore, spermatogenic failure 38 is exactly synonymous with SPGF38.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111920,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_25 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by maturation arrest at the primary spermatocyte stage resulting in severe oligozoospermia or azoospermia, small testes, and infertility that has_material_basis_in homozygous or compound heterozygous mutation in the TEX15 gene on chromosome 8p12."" ;
    :has_exact_synonym ""SPGF25"" .

","Spermatogenic failure 25 (SPGF25) is a type of autosomal recessive disease and spermatogenic failure that has its material basis in autosomal recessive inheritance. It is defined as a spermatogenic failure characterized by maturation arrest at the primary spermatocyte stage, resulting in severe oligozoospermia or azoospermia, small testes, and infertility. This condition has its material basis in homozygous or compound heterozygous mutation in the TEX15 gene on chromosome 8p12.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111921,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_36 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by spermatozoa showing anomalies of the head, acrosome, and nucleus of the sperm resulting in reduced fertility that has_material_basis_in heterozygous mutation in the PPP2R3C gene on chromosome 14q13.2."" ;
    :has_exact_synonym ""SPGF36"" .

","Spermatogenic failure 36 is a type of spermatogenic failure and an autosomal dominant disease, which is a condition that at least has a material basis in some form of autosomal dominant inheritance. It is defined as a spermatogenic failure characterized by spermatozoa showing anomalies of the head, acrosome, and nucleus of the sperm, leading to reduced fertility, and this condition has a material basis in a heterozygous mutation in the PPP2R3C gene located on chromosome 14q13.2. Spermatogenic failure 36 is also exactly synonymous with SPGF36.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111922,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_31 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :male_infertility_due_to_acephalic_spermatozoa ;
    :has_definition ""A male failure due to acephalic spermatozoa that is characterized by oligozoospermia with a high proportion of acephalic sperm that has_material_basis_in homozygous or compound heterozygous mutation in the PMFBP1 gene on chromosome 16q22.2."" ;
    :has_exact_synonym ""SPGF31"" .

","Spermatogenic failure 31, also known exactly as SPGF31, is classified as a type of autosomal recessive disease that specifically leads to male infertility due to acephalic spermatozoa. This condition inherently has a material basis in autosomal recessive inheritance and is characterized by oligozoospermia with a high proportion of acephalic spermatozoa. The underlying cause is found to be homozygous or compound heterozygous mutations in the PMFBP1 gene located on chromosome 16q22.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111923,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_42 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella resulting in severly impaired sperm progressive motility and infertility that has_material_basis_in homozygous or compound heterozygous mutation in the TTC29 gene on chromosome 4q31.22."" ;
    :has_exact_synonym ""SPGF42"" .

","Spermatogenic failure 42, which is also exactly synonymous with SPGF42, is categorized as a type of spermatogenic failure, autosomal recessive disease, and specifically as something that fundamentally arises from autosomal recessive inheritance. It is defined as a spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, leading to severely impaired sperm progressive motility and infertility. This condition has its material basis in either homozygous or compound heterozygous mutations in the TTC29 gene located on chromosome 4q31.22.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111924,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_26 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :male_infertility_due_to_acephalic_spermatozoa ;
    :has_definition ""A spermatogenic failure due to acephalic spermatozoa that is characterized by acephalic spermatozoa due to breakage at the midpiece of the sperm that has_material_basis_in homozygous or compound heterozygous mutation in the TSGA10 gene on chromosome 2q11.2."" ;
    :has_exact_synonym ""SPGF26"" .

","Spermatogenic failure 26, also known exactly as SPGF26, is a type of autosomal recessive disease and a form of male infertility due to acephalic spermatozoa. This condition is characterized by acephalic spermatozoa resulting from breakage at the midpiece of the sperm, which has its material basis in homozygous or compound heterozygous mutation in the TSGA10 gene on chromosome 2q11.2. It is associated with autosomal recessive inheritance, indicating that it arises from a specific type of genetic inheritance pattern.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111925,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_32 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by nonobstructive azoospermia, absence of spermatogenic cells and a Sertoli cell-only phenotype in testes that has_material_basis_in heterozygous mutation in the SOHLH1 gene on chromosome 9q34.3."" ;
    :has_exact_synonym ""SPGF32"" .

","Spermatogenic failure 32, which has the exact synonym SPGF32, is a type of autosomal dominant disease and a specific kind of spermatogenic failure. This condition is characterized by a particular kind of autosomal dominant inheritance. It is defined as a spermatogenic failure that is featured by nonobstructive azoospermia, the absence of spermatogenic cells, and a Sertoli cell-only phenotype in the testes. This condition's material basis is in a heterozygous mutation in the SOHLH1 gene located on chromosome 9q34.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111926,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_39 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic anomalies of the sperm flagellum, lack of the outer dynein arms in the flagella, and asthenozoospermia that has_material_basis_in homozygous or compound heterozygous mutation in the DNAH17 gene on chromosome 17q25.3."" ;
    :has_exact_synonym ""SPGF39"" .

","Spermatogenic failure 39, which is exactly synonymous with SPGF39, is recognized as a type of autosomal recessive disease and spermatogenic failure. It is characterized by a condition that inherently has a material basis in some form of autosomal recessive inheritance. Specifically, this spermatogenic failure is defined by multiple morphologic anomalies of the sperm flagellum, the absence of outer dynein arms in the flagella, and asthenozoospermia. This condition results from homozygous or compound heterozygous mutations in the DNAH17 gene located on chromosome 17q25.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111927,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_37 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, asthenoteratozoospermia, and infertility that has_material_basis_in homozygous or compound heterozygous mutation in the TTC21A gene on chromosome 3p22.2."" ;
    :has_exact_synonym ""SPGF37"" .

","Spermatogenic failure 37 is a type of spermatogenic failure and can also be classified as an autosomal recessive disease. It is described by a specific condition that at least has a material basis in some form of autosomal recessive inheritance. The definition of spermatogenic failure 37 encompasses a spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, asthenoteratozoospermia, and infertility, which has its material basis in homozygous or compound heterozygous mutation in the TTC21A gene located on chromosome 3p22.2. Additionally, spermatogenic failure 37 is exactly synonymous with SPGF37.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111928,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_27 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the sperm flagella, loss of the central pair of microtubules, loss of the inner dynein arms, and peripheral doublet disorganization of the flagella that has_material_basis_in homozygous or compound heterozygous mutation in AK7 on chromosome 14q32.2."" ;
    :has_exact_synonym ""SPGF27"" .

","Spermatogenic failure 27, also known precisely as SPGF27, is a type of spermatogenic failure classified as an autosomal recessive disease. It is characterized by a condition that inherently has a material basis in some form of autosomal recessive inheritance. The detailed definition of spermatogenic failure 27 includes it being a spermatogenic failure typified by multiple morphologic abnormalities of the sperm flagella, such as the loss of the central pair of microtubules, absence of the inner dynein arms, and disorganization of the peripheral doublet of the flagella. This condition is fundamentally caused by homozygous or compound heterozygous mutation in the AK7 gene located on chromosome 14q32.2.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111929,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_24 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, malformed sperm heads, and very low sperm counts that has_material_basis_in homozygous or compound heterozygous mutation in the CFAP69 gene on chromosome 7q21.13."" ;
    :has_exact_synonym ""SPGF24"" .

","Spermatogenic failure 24, which has the exact synonym SPGF24, is categorized as a type of spermatogenic failure and an autosomal recessive disease. It is defined by a specific spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, malformed sperm heads, and very low sperm counts, rooted in homozygous or compound heterozygous mutations in the CFAP69 gene on chromosome 7q21.13. This condition exemplifies a case where the disease has a material basis in some form of autosomal recessive inheritance.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111930,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:spermatogenic_failure_29 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :spermatogenic_failure ;
    :has_definition ""A spermatogenic failure characterized by nonobstructive azoospermia or oligozoospermia, immotile sperm, and sperm acrosome and head-neck junction abnormalities that has_material_basis_in homozygous or compound geterozygous mutation in the SPINK2 gene on chromosome 4q12."" ;
    :has_exact_synonym ""SPGF29"" .

","Spermatogenic failure 29 is a type of spermatogenic failure and an autosomal recessive disease. It is defined as a spermatogenic failure characterized by nonobstructive azoospermia or oligozoospermia, immotile sperm, and sperm acrosome and head-neck junction abnormalities. This condition is caused by homozygous or compound heterozygous mutation in the SPINK2 gene on chromosome 4q12. Additionally, spermatogenic failure 29 is referred to by its exact synonym, SPGF29.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111931,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:syndactyly_telecanthus_anogenital_and_renal_malformations_syndrome rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :syndrome ;
    :has_definition ""A syndrome characterized by toe syndactyly, telecanthus and anogenital and renal malformations that has_material_basis_in heterozygous mutation in the FAM58A gene on chromosome Xq28."" ;
    :has_exact_synonym ""STAR syndrome"",
        ""syndactyly with renal and anogenital malformations"",
        ""toe syndactyly, telecanthus, and anogenital and renal malformations"" .

","Syndactyly telecanthus anogenital and renal malformations syndrome, also known precisely as STAR syndrome and alternatively referred to as syndactyly with renal and anogenital malformations or toe syndactyly, telecanthus, and anogenital and renal malformations, is a type of syndrome and autosomal dominant disease. It is characterized by a syndrome that encompasses toe syndactyly, telecanthus, and anogenital and renal malformations, which has its material basis in a heterozygous mutation in the FAM58A gene on chromosome Xq28. This condition is also described as something that at least has its material basis in some form of autosomal dominant inheritance.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111932,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:severe_congenital_encephalopathy_due_to_mecp2_mutation rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :disease_has_basis_in ;
            owl:someValuesFrom :abnormality_of_prenatal_development_or_birth ],
        [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :brain_disease,
        :physical_disorder,
        :x_linked_recessive_disease ;
    :has_definition ""A brain disease characterized by severe neonatal encephalopathy, developmental delay, and microcephaly that has_material_basis_in hemizygous mutation in the MECP2 gene on chromosome Xq28."" ;
    :has_exact_synonym ""neonatal severe encephalopathy due to MECP2 mutations"",
        ""severe neonatal-onset encephalopathy with microcephaly"" .

","Severe congenital encephalopathy due to MECP2 mutation is a type of X-linked recessive disease, a physical disorder, and a brain disease. It is characterized by a material basis in X-linked recessive inheritance and is rooted in some abnormality of prenatal development or birth. This condition is defined as a brain disease characterized by severe neonatal encephalopathy, developmental delay, and microcephaly, having its material basis in a hemizygous mutation in the MECP2 gene on chromosome Xq28. Additionally, it is also known by its exact synonyms, neonatal severe encephalopathy due to MECP2 mutations, and severe neonatal-onset encephalopathy with microcephaly.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111933,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:phosphoglycerate_kinase_1_deficiency rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :x_linked_recessive_inheritance ],
        :glucose_metabolism_disease,
        :x_linked_recessive_disease ;
    :has_definition ""A glucose metabolism disease characterized by impaired ability to break down glucose resulting in the variable presentation of hemolytic anemia, myopathy, and neurologic anomalies that has_material_basis_in hemizygous or homozygous mutation in the PGK1 gene on chromosome Xq21.1."" ;
    :has_exact_synonym ""GSD due to phosphoglycerate kinase 1 deficiency"",
        ""PGK1 deficiency"",
        ""glycogen storage disease due to phosphoglycerate kinase 1 deficiency"",
        ""glycogenosis due to phosphoglycerate kinase 1 deficiency"" .

","Phosphoglycerate kinase 1 deficiency is a type of disease that falls under several categories: it is an X-linked recessive disease, a type of glucose metabolism disease, and something that inherently has a material basis in X-linked recessive inheritance. The definition of this condition is a glucose metabolism disease characterized by an impaired ability to break down glucose. This results in a variable presentation that includes hemolytic anemia, myopathy, and neurologic anomalies. These symptoms are due to either hemizygous or homozygous mutations in the PGK1 gene located on chromosome Xq21.1. Phosphoglycerate kinase 1 deficiency is also known by several exact synonyms, including GSD due to phosphoglycerate kinase 1 deficiency, PGK1 deficiency, glycogen storage disease due to phosphoglycerate kinase 1 deficiency, and glycogenosis due to phosphoglycerate kinase 1 deficiency.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111934,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_38 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by development of severe clinical disease upon infection with weakly virulent mycobacteria and intracranial calcification that has_material_basis_in homozygous or compound heterozygous mutation in the ISG15 gene on chromosome 1p36.33."" ;
    :has_exact_synonym ""IMD38"",
        ""Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency"",
        ""autosomal recessive ISG15 deficiency"",
        ""immunodeficiency 38 with basal ganglia calcification"",
        ""immunodeficiency 38, mycobacteriosis, autosomal recessive"" .

","Immunodeficiency 38 is categorized as a type of autosomal recessive disease, a primary immunodeficiency disease, and is defined by a condition that arises from autosomal recessive inheritance. It is characterized by severe clinical disease following infection with weakly virulent mycobacteria and intracranial calcification. This condition results from homozygous or compound heterozygous mutations in the ISG15 gene located on chromosome 1p36.33. Immunodeficiency 38 is also known by several exact synonyms, including IMD38, Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency, autosomal recessive ISG15 deficiency, immunodeficiency 38 with basal ganglia calcification, and immunodeficiency 38, mycobacteriosis, autosomal recessive.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111935,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_16 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_t_cell_and_b_cell_immunodeficiency ;
    :has_definition ""A combined T cell and B cell immunodeficiency characterized by classic Kaposi sarcoma of childhood, poor T-cell recall immune responses, and decrease in the proportion of circulating memory B cells that has_material_basis_in homozygous or compound heterozygous mutation in the TNFRSF4 gene on chromosome 1p36.33."" ;
    :has_exact_synonym ""IMD16"",
        ""OX40 deficiency"",
        ""combined immunodeficiency due to OX40 deficiency"",
        ""combined immunodeficiency with childhood-onset Kaposi sarcoma"",
        ""combined immunodeficiency with impaired immunity to HHV-8"",
        ""combined immunodeficiency with impaired immunity to human herpes virus 8"" .

","Immunodeficiency 16 is a type of disease classified as autosomal recessive and falls under the category of combined T cell and B cell immunodeficiencies. Additionally, it is characterized by being a condition that, at a minimum, has a material basis in autosomal recessive inheritance. This specific immunodeficiency is defined as a combined T cell and B cell immunodeficiency distinguished by childhood classic Kaposi sarcoma, weakened T-cell recall immune responses, and a reduced proportion of circulating memory B cells. The condition is caused by homozygous or compound heterozygous mutations in the TNFRSF4 gene located on chromosome 1p36.33. Immunodeficiency 16 is known by several exact synonyms, including IMD16, OX40 deficiency, combined immunodeficiency due to OX40 deficiency, combined immunodeficiency with childhood-onset Kaposi sarcoma, combined immunodeficiency with impaired immunity to HHV-8, and combined immunodeficiency with impaired immunity to human herpes virus 8.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111936,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_14 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :combined_t_cell_and_b_cell_immunodeficiency ;
    :has_definition ""A combined T cell and B cell immunodeficiency characterized by B- and T-cell abnormalities and onset of recurrent sinopulmonary and other infections in early childhood that has_material_basis_in heterozygous activating mutation in the PIK3CD gene on chromosome 1p36.22."" ;
    :has_exact_synonym ""APDS"",
        ""IMD14"",
        ""PASLI disease"",
        ""activated PI3K-delta syndrome"",
        ""senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation"" .

","Immunodeficiency 14 is a type of autosomal dominant disease and is also a type of combined T cell and B cell immunodeficiency. It is characterized by a condition that at least has a material basis in some form of autosomal dominant inheritance. Specifically, Immunodeficiency 14 is described as a combined T cell and B cell immunodeficiency characterized by B- and T-cell abnormalities and the onset of recurrent sinopulmonary and other infections in early childhood. This condition has a material basis in a heterozygous activating mutation in the PIK3CD gene on chromosome 1p36.22. Additionally, Immunodeficiency 14 is known by several exact synonyms including APDS, IMD14, PASLI disease, activated PI3K-delta syndrome, and senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111937,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_22 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :severe_combined_immunodeficiency ;
    :has_definition ""A severe combined immunodeficiency characterized by severe combined immunodeficiency, selective CD4 lymphopenia, and lack of CD28 expression on CD8+ T cells that has_material_basis_in homozygous or compound heterozygous mutation in the LCK gene on chromosome 1p35.2."" ;
    :has_exact_synonym ""IMD22"",
        ""SCID due to LCK deficiency"",
        ""SCID due to lymphocyte-specific protein tyrosine kinase deficiency"",
        ""severe combined immunodeficiency due to LCK deficiency"",
        ""severe combined immunodeficiency due to lymphocyte-specific protein tyrosine kinase deficiency"" .

","Immunodeficiency 22 is a type of autosomal recessive disease and also a type of severe combined immunodeficiency. It is characterized by a condition that at least has a material basis in some autosomal recessive inheritance. Specifically, Immunodeficiency 22 is defined as a severe combined immunodeficiency characterized by severe combined immunodeficiency, selective CD4 lymphopenia, and lack of CD28 expression on CD8+ T cells, which is caused by homozygous or compound heterozygous mutation in the LCK gene on chromosome 1p35.2. Furthermore, Immunodeficiency 22 is known by several exact synonyms including IMD22, SCID due to LCK deficiency, SCID due to lymphocyte-specific protein tyrosine kinase deficiency, severe combined immunodeficiency due to LCK deficiency, and severe combined immunodeficiency due to lymphocyte-specific protein tyrosine kinase deficiency.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111938,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_24 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :severe_combined_immunodeficiency ;
    :has_definition ""A severe combined immunodeficiency characterized by impaired proliferation of activated T and B cells in response to antigen receptor-mediated activation that has_material_basis_in homozygous or compound heterozygous mutation in the CTPS1 gene on chromosome 1p34.2."" ;
    :has_exact_synonym ""IMD24"",
        ""SCID due to CTPS1 deficiency"",
        ""severe combined immunodeficiency due to CTPS1 deficiency"" .

","Immunodeficiency 24 is a type of autosomal recessive disease and also a type of severe combined immunodeficiency, which at least has a material basis in some autosomal recessive inheritance. It is defined as a severe combined immunodeficiency characterized by impaired proliferation of activated T and B cells in response to antigen receptor-mediated activation, which has material basis in homozygous or compound heterozygous mutation in the CTPS1 gene on chromosome 1p34.2. Immunodeficiency 24 has the exact synonyms IMD24, SCID due to CTPS1 deficiency, and severe combined immunodeficiency due to CTPS1 deficiency.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111939,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_37 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_t_cell_and_b_cell_immunodeficiency ;
    :has_definition ""A combined T cell and B cell immunodeficiency characterized by hypogammaglobulinemia with profoundly reduced memory B cells and memory T cells and increased numbers of circulating naive lymphocytes that has_material_basis_in homozygous or compound heterozygous mutation in the BCL10 gene on chromosome 1p22.3."" ;
    :has_exact_synonym ""IMD37"" .

","Immunodeficiency 37, also known exactly as IMD37, is a type of autosomal recessive disease that is also classified as a combined T cell and B cell immunodeficiency. This condition is characterized by a specific kind, where its material basis is in some form of autosomal recessive inheritance. Furthermore, it is defined as a combined T cell and B cell immunodeficiency marked by hypogammaglobulinemia with significantly reduced memory B cells and memory T cells, alongside an increase in the numbers of circulating naive lymphocytes. This is due to either homozygous or compound heterozygous mutations in the BCL10 gene located on chromosome 1p22.3.",5,True
doid,http://purl.obolibrary.org/obo/DOID_0111940,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_42 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by onset in infancy of increased susceptibility to mycobacterial and candidal infections that has_material_basis_in homozygous or compound heterozygous mutation in the RORC gene on chromosome 1q21.3."" ;
    :has_exact_synonym ""IMD42"",
        ""autosomal recessive MSMD due to complete RORgamma receptor defiency"",
        ""autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency"",
        ""autosomal recessive primary immunodeficiency due to RORC mutation"" .

","Immunodeficiency 42 is classified as a type of autosomal recessive disease, primary immunodeficiency disease, and is characterized by a material basis in autosomal recessive inheritance. This condition is defined as a primary immunodeficiency disease that manifests in infancy with an increased susceptibility to mycobacterial and candidal infections, caused by homozygous or compound heterozygous mutation in the RORC gene located on chromosome 1q21.3. It is precisely known by several exact synonyms: IMD42, autosomal recessive MSMD due to complete RORgamma receptor deficiency, autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, and autosomal recessive primary immunodeficiency due to RORC mutation.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111941,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_20 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by a defect in spontaneous NK cell cytotoxicity that has_material_basis_in homozygous or compound heterozygous mutation in the FCGR3A gene on chromosome 1q23.3."" ;
    :has_exact_synonym ""CD16 deficiency"",
        ""IMD20"",
        ""autosomal recessive primary immunodeficiency with defective spontaneous NK cell cytotoxicity"",
        ""autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity"" .

","Immunodeficiency 20 is a type of primary immunodeficiency disease, specifically an autosomal recessive disease, which inherently has a material basis in autosomal recessive inheritance. It is characterized by a defect in spontaneous NK cell cytotoxicity, which is due to homozygous or compound heterozygous mutation in the FCGR3A gene on chromosome 1q23.3. This condition is known by several exact synonyms, including CD16 deficiency, IMD20, autosomal recessive primary immunodeficiency with defective spontaneous NK cell cytotoxicity, and autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111942,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_25 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :t_cell_deficiency ;
    :has_definition ""A T cell deficiency characterized by decreased T cell counts, normal B cell counts, and eosinophilia that has_material_basis_in homozygous or compound heterozygous mutation in the CD247 gene on chromosome 1q24.2."" ;
    :has_exact_synonym ""IMD25"",
        ""immunodeficiency due to defect in CD3-zeta"" .

","Immunodeficiency 25 is a type of autosomal recessive disease and a type of T cell deficiency, which is also categorized as something that at least has a material basis in some autosomal recessive inheritance. It is characterized by a T cell deficiency marked by decreased T cell counts, normal B cell counts, and eosinophilia, which stems from homozygous or compound heterozygous mutation in the CD247 gene on chromosome 1q24.2. Furthermore, Immunodeficiency 25 is precisely known as IMD25 and immunodeficiency due to defect in CD3-zeta.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111943,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_48 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :t_cell_deficiency ;
    :has_definition ""A T cell deficiency characterized by a selective T cell defect where circulating T cells exclusively express CD4, CD3, and T-cell receptor-alpha/beta and not CD8 on their surfaces that has_material_basis_in homozygous or compound heterozygous mutation in the ZAP70 gene on chromosome 2q11.2."" ;
    :has_exact_synonym ""IMD48"",
        ""combined immunodeficiency due to ZAP70 deficiency"",
        ""zeta-associated-protein 70 deficiency"" .

","Immunodeficiency 48, which is also exactly known as IMD48, combined immunodeficiency due to ZAP70 deficiency, and zeta-associated-protein 70 deficiency, is a type of autosomal recessive disease, a type of T cell deficiency, and a type of condition that at least has a material basis in some form of autosomal recessive inheritance. It is characterized by a selective T cell defect where circulating T cells exclusively express CD4, CD3, and T-cell receptor-alpha/beta, and not CD8, on their surfaces. This condition has its material basis in homozygous or compound heterozygous mutations in the ZAP70 gene on chromosome 2q11.2.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111944,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_31b rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by impaired cellular responses to interferons A, B, and G resulting increased susceptibility to mycobacteria, Salmonella, and viruses that has_material_basis_in homozygous or compound heterozygous mutation in the STAT1 gene on chromosome 2q32.2."" ;
    :has_exact_synonym ""IMD31B"",
        ""autosomal recessive STAT1 deficiency"",
        ""autosomal recessive immunodeficiency 31B, mycobacterial and viral infections"",
        ""predisposition to severe viral infection due to STAT1 deficiency"",
        ""susceptibility to viral and mycobacterial infections due to STAT1 deficiency"" .

","Immunodeficiency 31b is a type of autosomal recessive disease, primary immunodeficiency disease, and something that at least has a material basis in some autosomal recessive inheritance. It is characterized by impaired cellular responses to interferons A, B, and G, resulting in increased susceptibility to mycobacteria, Salmonella, and viruses. This is due to a homozygous or compound heterozygous mutation in the STAT1 gene on chromosome 2q32.2. Immunodeficiency 31b is also known by its exact synonyms IMD31B, autosomal recessive STAT1 deficiency, autosomal recessive immunodeficiency 31B, mycobacterial and viral infections, predisposition to severe viral infection due to STAT1 deficiency, and susceptibility to viral and mycobacterial infections due to STAT1 deficiency.",9,True
doid,http://purl.obolibrary.org/obo/DOID_0111945,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_31a rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by impaired response to IFNG but not to INFA or IFNB resulting in increased susceptibility to mycobacterial infection that has_material_basis_in heterozygous mutation in the STAT1 gene on chromosome 2q32.2."" ;
    :has_exact_synonym ""IMD31A"",
        ""MSMD due to partial STAT1 deficiency"",
        ""MSMD due to partial signal transducer and activator of transcription 1 deficiency"",
        ""Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency"",
        ""Mendelian susceptibility to mycobacterial diseases due to partial signal transducer and activator of transcription 1 deficiency"",
        ""autosomal dominant immunodeficiency 31A, mycobacteriosis"" .

","Immunodeficiency 31a is a type of primary immunodeficiency disease, which also falls under the category of autosomal dominant diseases. It is specifically characterized as a disease that inherently has a material basis in autosomal dominant inheritance. The definition of immunodeficiency 31a delineates it as a primary immunodeficiency disease characterized by an impaired response to IFNG, but not to INFA or IFNB, leading to an increased susceptibility to mycobacterial infection. This condition is attributed to a heterozygous mutation in the STAT1 gene located on chromosome 2q32.2. Furthermore, immunodeficiency 31a is known by various exact synonyms including IMD31A, MSMD due to partial STAT1 deficiency, MSMD due to partial signal transducer and activator of transcription 1 deficiency, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Mendelian susceptibility to mycobacterial diseases due to partial signal transducer and activator of transcription 1 deficiency, and autosomal dominant immunodeficiency 31A, mycobacteriosis.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111946,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_31c rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by onset in infancy or childhood of chronic mucocutaneous candidiasis and increased IFNG activation that has_material_basis_in heterozygous gain of function mutation in the STAT1 gene on chromosome 2q32.2."" ;
    :has_exact_synonym ""CANDF7"",
        ""IMD31C"",
        ""autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome"",
        ""autosomal dominant chronic mucocutaneous familial candidiasis"",
        ""autosomal dominant immunodeficiency 31C"",
        ""familial candidiasis 7"" .

","Immunodeficiency 31c is a type of autosomal dominant disease and a primary immunodeficiency disease, characterized by its material basis in some autosomal dominant inheritance. It is defined as a primary immunodeficiency disease that manifests in infancy or childhood with chronic mucocutaneous candidiasis and increased IFNG activation, stemming from a heterozygous gain of function mutation in the STAT1 gene on chromosome 2q32.2. Immunodeficiency 31c is also known by several exact synonyms, including CANDF7, IMD31C, autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome, autosomal dominant chronic mucocutaneous familial candidiasis, autosomal dominant immunodeficiency 31C, and familial candidiasis 7.",10,True
doid,http://purl.obolibrary.org/obo/DOID_0111947,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_21 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by profoundly decreased or absent monocytes, B lymphocytes, natural killer (NK) lymphocytes, and circulating and tissue dendritic cells with normal or nearly normal T cell numbers that has_material_basis_in heterozygous mutation in the GATA2 gene on chromosome 3q21.3."" ;
    :has_exact_synonym ""DCML"",
        ""GATA2 deficiency"",
        ""IMD21"",
        ""MonoMAC"",
        ""combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections"",
        ""dendritic cell, monocyte, B and NK lymphoid deficiency"",
        ""monocyte-B-natural killer-dendritic cell deficiency syndrome"",
        ""monocytopenia and mycobacterial infection syndrome"",
        ""monocytopenia with susceptibility to infections"" .

","Immunodeficiency 21 is classified as a primary immunodeficiency disease, which is a type of autosomal dominant disease. It specifically arises from a heterozygous mutation in the GATA2 gene on chromosome 3q21.3 and is characterized by a profound decrease or absence of monocytes, B lymphocytes, natural killer (NK) lymphocytes, and circulating and tissue dendritic cells, while having normal or nearly normal T cell numbers. Furthermore, immunodeficiency 21 is known by several exact synonyms, including DCML, GATA2 deficiency, IMD21, MonoMAC, combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections, dendritic cell, monocyte, B and NK lymphoid deficiency, monocyte-B-natural killer-dendritic cell deficiency syndrome, monocytopenia and mycobacterial infection syndrome, and monocytopenia with susceptibility to infections.",13,True
doid,http://purl.obolibrary.org/obo/DOID_0111948,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_46 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_t_cell_and_b_cell_immunodeficiency ;
    :has_definition ""A combined T cell and B cell immunodeficiency characterized by hypo- or agammaglobulinemia, normal lymphocyte counts, intermittent neutropenia, intermittent thrombocytopenia, decreased numbers of memory B cells, impaired immunoglobulin class-switching, and decreased proliferative responses of T cells that has_material_basis_in homozygous or compound heterozygous mutation in the TFRC gene on chromosome 3q29."" ;
    :has_exact_synonym ""CID due to TFRC deficiency"",
        ""IMD46"",
        ""TFRC-related combined immunodeficiency"",
        ""combined immunodeficiency due to TFRC deficiency"" .

","Immunodeficiency 46, also known exactly as CID due to TFRC deficiency, IMD46, TFRC-related combined immunodeficiency, and combined immunodeficiency due to TFRC deficiency, is characterized as an autosomal recessive disease and a type of combined T cell and B cell immunodeficiency. It is described by a condition that essentially arises from autosomal recessive inheritance. Specifically, immunodeficiency 46 is defined as a combined T cell and B cell immunodeficiency marked by hypo- or agammaglobulinemia, normal lymphocyte counts, intermittent neutropenia and thrombocytopenia, reduced numbers of memory B cells, impaired ability for immunoglobulin class-switching, and diminished proliferative responses of T cells, all attributing to homozygous or compound heterozygous mutations in the TFRC gene on chromosome 3q29.",8,True
doid,http://purl.obolibrary.org/obo/DOID_0111949,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_36 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_dominant_inheritance ],
        :autosomal_dominant_disease,
        :combined_t_cell_and_b_cell_immunodeficiency ;
    :has_definition ""A combined T cell and B cell immunodeficiency characterized by recurrent respiratory tract infections, lymphoproliferation, and antibody deficiency that has_material_basis_in heterozygous mutation in the PIK3R1 gene on chromosome 5q13.1."" ;
    :has_exact_synonym ""IMD36"",
        ""activated phosphoinositide 3-kinase delta syndrome 2"" .

","Immunodeficiency 36 (IMD36), also known as activated phosphoinositide 3-kinase delta syndrome 2, is a type of autosomal dominant disease characterized by a combined T cell and B cell immunodeficiency. This condition involves recurrent respiratory tract infections, lymphoproliferation, and antibody deficiency, which originates from a heterozygous mutation in the PIK3R1 gene located on chromosome 5q13.1. Additionally, immunodeficiency 36 is categorized as a disease that fundamentally has a material basis in some form of autosomal dominant inheritance.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111950,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_29 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by undetectable IL12B secretion by leukocytes and increased susceptibility to intracellular bacterial infections that has_material_basis_in homozygous or compound heterozygous mutation in the IL12B gene on chromosome 5q33.3."" ;
    :has_exact_synonym ""IL12B deficiency"",
        ""IMD29"",
        ""MSMD due to complete IL12B deficiency"",
        ""MSMD due to complete interleukin 12B deficiency"",
        ""Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency"",
        ""Mendelian susceptibility to mycobacterial diseases due to complete interleukin 12B deficiency"",
        ""immunodeficiency 29, mycobacteriosis"" .

","Immunodeficiency 29 is recognized as a type of autosomal recessive disease, a primary immunodeficiency disease, and is characterized by having at least a material basis in autosomal recessive inheritance. It is defined as a primary immunodeficiency disease characterized by undetectable IL12B secretion by leukocytes and increased susceptibility to intracellular bacterial infections, which is due to homozygous or compound heterozygous mutation in the IL12B gene on chromosome 5q33.3. Immunodeficiency 29 is known by several exact synonyms, including IL12B deficiency, IMD29, MSMD due to complete IL12B deficiency, MSMD due to complete interleukin 12B deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency, Mendelian susceptibility to mycobacterial diseases due to complete interleukin 12B deficiency, and immunodeficiency 29, mycobacteriosis.",11,True
doid,http://purl.obolibrary.org/obo/DOID_0111951,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_40 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_t_cell_and_b_cell_immunodeficiency ;
    :has_definition ""A combined T cell and B cell immunodeficiency characterized by reduced T-cell number and function, with variable defects in B-cell and NK-cell function resulting in onset in early childhood of invasive bacterial and viral infections that has_material_basis_in homozygous or compound heterozygous mutation in the DOCK2 gene on chromosome 5q35.1."" ;
    :has_exact_synonym ""DOCK2 deficiency"",
        ""IMD40"" .

","Immunodeficiency 40 is an autosomal recessive disease characterized by a combined T cell and B cell immunodeficiency, which indicates a material basis in some autosomal recessive inheritance. This condition is defined by a reduced number of T cells and diminished function, alongside variable defects in B-cell and NK-cell function. These impairments lead to the early onset of invasive bacterial and viral infections. The disease is caused by homozygous or compound heterozygous mutations in the DOCK2 gene located on chromosome 5q35.1. Immunodeficiency 40 is also known by its exact synonyms, DOCK2 deficiency and IMD40.",6,True
doid,http://purl.obolibrary.org/obo/DOID_0111952,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_57 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :primary_immunodeficiency_disease ;
    :has_definition ""A primary immunodeficiency disease characterized by recurrent infections starting in the first year of life, lymphopenia, altered production of various cytokines, inflammatory polyarthritis, and chronic active inflammation of the digestive tract that has_material_basis_in homozygous or compound heterozygous mutation in the RIPK1 gene on chromosome 6p25.2."" ;
    :has_exact_synonym ""IMD57"",
        ""immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome"",
        ""immunodeficiency 57 with autoinflammation"" .

","Immunodeficiency 57 is a type of primary immunodeficiency disease, which is also classified as an autosomal recessive disease. It is further described as a condition that has a material basis in autosomal recessive inheritance. This disease is characterized by recurrent infections starting in the first year of life, lymphopenia, altered production of various cytokines, inflammatory polyarthritis, and chronic active inflammation of the digestive tract. These symptoms are due to homozygous or compound heterozygous mutation in the RIPK1 gene on chromosome 6p25.2. Immunodeficiency 57 is also known by its exact synonyms: IMD57, immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome, and immunodeficiency 57 with autoinflammation.",7,True
doid,http://purl.obolibrary.org/obo/DOID_0111953,"@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .

:immunodeficiency_23 rdfs:subClassOf [ a owl:Restriction ;
            owl:onProperty :has_material_basis_in ;
            owl:someValuesFrom :autosomal_recessive_inheritance ],
        :autosomal_recessive_disease,
        :combined_t_cell_and_b_cell_immunodeficiency ;
    :has_definition ""A combined T cell and B cells immunodeficiency characterized by marked atopy and autoimmunity caused by increased T(H)2 and T(H)17 cytokine production by CD4(+) T cells, T-cell lymphopenia, reduced memory B-cell numbers, recurrent respiratory and skin infections beginning in early childhood, increased serum IgE, and variable developmental delay or intellectual impairment that has_material_basis_in homozygous or compound heterozygous mutation in the PGM3 gene on chromosome 6q14.1."" ;
    :has_exact_synonym ""CID due to PGM3 deficiency"",
        ""IMD23"",
        ""PGM3-CDG"",
        ""PGM3-related congenital disorder of glycosylation"",
        ""combined immunodeficiency due to PGM3 deficiency"" .

","Immunodeficiency 23 is a type of autosomal recessive disease, specifically a combined T cell and B cell immunodeficiency. This condition is characterized by marked atopy and autoimmunity, which results from increased T(H)2 and T(H)17 cytokine production by CD4(+) T cells. Patients experience T-cell lymphopenia, reduced memory B-cell numbers, recurrent respiratory and skin infections beginning in early childhood, increased serum IgE, and variable developmental delay or intellectual impairment. The material basis of this disease is found in homozygous or compound heterozygous mutation in the PGM3 gene on chromosome 6q14.1. Immunodeficiency 23 is also known by several exact synonyms, including CID due to PGM3 deficiency, IMD23, PGM3-CDG, and PGM3-related congenital disorder of glycosylation, all of which refer to combined immunodeficiency due to PGM3 deficiency.",9,True
